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Abstract 
 
This thesis presents site-selective Suzuki-Miyaura reactions of 2,3,5-tribromo-
thiophene and 2,3,5-tribromo-N-methylpyrrole, which are controlled by steric and electronic 
parameters. The reactions proceed with very good site-selectivity in favour of position 5 
which is more reactive than position 2, due to steric reasons. The second attack occurs at 
position 2 which is more electron deficient than position 3. The Suzuki reactions of 2,4,5-
tribromothiophene provide a convenient and site-selective approach to 2,4-diaryl-3-bromo- 
thiophenes, 2,3,5-triarylthiophenes and 2,3,4-triarylthiophenes. 
 
In this work, palladium-catalyzed Heck reactions of brominated thiophenes, N-
methylimidazole, N-methylpyrrole and N-methylindole are also presented. The products were 
transformed by subsequent 6π-electrocyclization and dehydrogenation to functionalized 
benzothiophenes, dibenzothiophenes, benzimidazoles, indoles and carbazoles, respectively. 
The reactions were influenced by the temperature, the time of reaction, the choice of base, of 
catalyst and the solvent. 
 
Im Rahmen der vorliegenden Arbeit wurden regioselektive Suzuki-Miyaura-
Reaktionen von 2,3,5-Tribromthiophenen und 2,3,5-Tribrom-N-methylpyrrolen untersucht. 
Dabei stellen sterische und elektronische Parameter entscheidende Einflussfaktoren dar. Die 
Reaktionen verlaufen mit sehr guter Regioselektivität, wobei Position 5 bevorzugt angegriffen 
wird, da diese aufgrund sterischer Gründe reaktiver als Position 2 ist. Der zweite Angriff 
findet an Position 2 statt, da diese elektronenärmer als Position 3 ist. Die Suzuki-Reaktionen 
von 2,3,5-Tribromthiophenen stellt eine sehr effiziente regioselektive Methode zur Synthese 
von 2,4-Diaryl-3-bromthiophenen, 2,3,5-Triarylthiophenen und 2,3,4-Triarylthiophenen dar. 
 
Außerdem wurden in der vorliegenden Arbeit palladiumkatalysierte Heck-Reaktionen 
von bromierten Thiophenen, N-Methylimidazolen, N-Methylpyrrolen und N-Methylindolen 
untersucht. Durch eine nachfolgende 6π-Elektrocyclisierung und anschließende Dehydrierung 
der synthetisierten Produkte konnten funktionalisierte Benzothiophene, Dibenzothiophene, 
Benzimidazole, Indole und Carbazole gewonnen werden. Die Reaktionen werden durch die 
Wahl von Reaktionszeit, Reaktionstemperatur, Base, Katalysator und Lösungsmittel 
beeinflusst.  
1 
 
GENERAL INTRODUCTION 
 
Most drugs prescribed today for the treatment of diseases are organic compounds, 
while some are derived from natural sources. However, drugs from natural origins are small 
in quantity whereas synthetically produced ones are much more. Due to the occurence of 
natural products, often in very small quantities, it is difficult to investigate whether the 
compounds can be extracted and isolated from natural sources. Organic chemists can provide 
a solution to the problem by devising practicable laboratory syntheses. Sometimes, the 
chemical synthesis cost less than extraction of a product. The organic synthesis plays an 
important role in the preparation of biologically active compounds and natural products. 
Many methods have been developed for the synthesis of molecules that may have a 
pharmaceutical or therapeutic relevance. Among these methods, processes catalyzed by 
transition metals have received special attention.
1
 Catalyzed coupling reactions by palladium 
are an effective tool for the formation of C-C bonds in organic chemistry.
2
 The aromatic 
carbon-carbon coupling has recently emerged as an extremely important method for the 
preparation of complex organic molecules, such as pharmaceuticals
3
. Among the many 
coupling reactions commonly used, we cite the reactions such as Heck,
4
 Suzuki,
5
 
Sonogashira
6
 and Stille
7
. As most important representatives of this class of reactions, Heck 
and Suzuki couplings have been noted. 
 
The Heck reaction, originally discovered independently by Mizoroki in 1971
4,8 
and 
Heck in 1972,
4
 is the chemical reaction between a halogenated derivative or triflate with an 
alkene in the presence of a base and a palladium catalyst to form substituted alkenes. It has 
been applied to a wide range of natural product syntheses and to the synthesis of biologically 
active molecules.
3,9
 On the industrial front (scale), it has led to the production of naproxen 
commonly used as analgesic and anti-inflammatory agent
10
 and of octyl methoxycinnamate 
used to reduce the appearance of scars.
11
  
 
As for the Suzuki reaction, first published in 1979 by Akira Suzuki and Norio 
Miyaura, is the organic reaction of aryl- or vinyl-boronic acids with aryl or vinyl halides 
catalyzed by palladium (0).
5 
This type of coupling has been used as a key step in the synthesis 
of a wide variety of natural and unnatural molecules (dendrimers, porphyrins and unusual 
amino acids and peptides).
3 
2 
 
In the first part of the present work, the site-selectivity of tribromothiophene and 
tribromo-N-methylpyrrole in the Suzuki cross-coupling reaction has been studied. The Heck 
reaction has been used in the second part, to synthesize key intermediates for the preparation 
of functionalized benzothiophenes, benzimidazoles, indoles, carbazoles and dibenzo-
thiophenes via 6π-electrocyclization and aromatization, catalyzed by palladium on charcoal, 
starting with dibromothiophene, tribromo-N-methylimidazole, tribromo-N-methylpyrrole, 
tetrabromo-N-methylpyrrole, tetrabromo-N-methylindole and tetrabromothiophene, 
respectively.  
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PART I   Site-selective Palladium(0)-catalyzed coupling reactions    
                of tribromo-substituted thiophenes and pyrroles  
 
Introduction and background of Suzuki reaction 
 
 
In 1979, Akira Suzuki reported the Palladium-catalyzed cross-coupling reaction of 
organoboronic acids with vinyl and aryl halides in the presence of base, a process known 
today as Suzuki reaction.
5 
The reaction has later been extended to also include couplings with 
alkyl groups. It works also with pseudohalides like triflates according to the following 
reactivity order:  R2- I > R2-OTf > R2-Br >> R2-Cl.  
 
 
 
Scheme 1. Suzuki reaction 
 
The Suzuki cross-coupling is one of the most efficient methods for the preparation of 
bi- or polyaryl compounds.
12
 This reaction has been applied in wide areas (including 
herbicides
 
and natural product syntheses).
3,13 
The advantages include the use of boronic acids, 
which are easy to obtain, mostly non-toxic, air and moisture stable. In the same vein, the 
inorganic by-product is non-toxic and easily removed from the reaction. 
 
The reaction is catalyzed by a palladium(0) complex formed from Pd(OAc)2, PdCl2, 
Ph(PPh3)2Cl2, and Pd(dba)2 as catalyst precursors. The phosphines are commonly used as 
ligands. The ligand has the role to stabilize the palladium catalyst. Traditionally, 
triarylphosphine/Pd complexes are employed as catalysts for the Suzuki reaction.
14 
Buchwald 
and co-workers have developed electron-rich, bulky biphenylphosphine ligands, such as S-
Phos, X-Phos, Dave-Phos, which give often a good yield. However, it has been shown that in 
some cases the reaction can be achieved by using palladium catalysts without a phosphine 
ligand.
15
 The most commonly used bases in the Suzuki reaction are Na2CO3, K2CO3, NaOH, 
KOH, K3PO4, and Cs2O3. It has been found that the base is involved in the coordination 
4 
 
sphere of the palladium and the formation of the R
1
-PdL2-OR from R
1
-PdL2-X is known to 
accelerate the transmetallation step.
16 
The mechanism of the Suzuki cross-coupling reaction is given in the following 
scheme:  
 
 
Scheme 2. Mechanism of the Suzuki palladium-catalyzed cross-coupling reactions 
 
The first step of the catalytic cycle involves the oxidative addition of Pd(0) to the halide to 
form the organopalladium compound, which reacts with the base to give an intermediate. The 
intermediate via transmetallation with the boronate complex forms an organopalladium 
complex. The palladium(0) catalyst is regenerated in the reductive elimination step to form 
the desired product. 
 
As one of the most commonly used methods of the formation of carbon-carbon bonds, 
the Suzuki reaction has been applied in the synthesis of many biologically active molecules,
17
 
useful materials
18
 and in pharmaceutical industry.
19
 For example, the Suzuki cross-coupling  
reaction of an isoquinolineboronic acid with a binaphthalene ditriflate gave the anti-HIV 
alkaloids michellamine A and B.
20 
It is good to notice that the Suzuki reaction can also be a regioselective reaction and it 
is thus interesting to study the site-selectivity for polyhalogenated compounds. 
5 
 
Site-selective Suzuki reactions 
 
Polyhalogenated heterocycles are of considerable current interest as substrates in site-
selective palladium(0)-catalyzed cross-coupling reactions.
21
 The site-selectivity often relies on 
the different rates of oxidative additions of palladium(0) species to carbon-halide bonds and 
on steric parameters. Electron-poor are usually more reactive than electron-rich carbon atoms. 
This methodology is very practical and helpful in the total synthesis of natural compounds 
and pharmaceuticals.
22
 
 
The reactivity order regarding the leaving group is I> OTf> Br>> Cl. This effect can 
be used to induce selectivity, but it is more difficult to synthesize starting materials with 
different halide groups than those with only one type of halogen atom. However, the problem 
of selectivity is more difficult to solve in this second case.  
 
Several examples of regioselective cross-coupling reactions have been reported. For 
example, in the research group of Prof. Peter Langer, the synthesis of symmetrical and 
unsymmetrical mono-, di-, tri- and tetraaryl-pyrimidines by site-selective Suzuki cross-
coupling reactions of 2,4,5,6-tetrachloropyrimidine was studied.
23
 An excellent selectivity has 
also been observed for Suzuki-Miyaura reactions of the bis(triflate) of 1,2-dihydroxy-
anthraquinone (alizarin).
24 
The site-selectivity for tetrabromofuran, tetrabromo-thiophene, 
tribromopyrazole, and pentachloropyridine has also been reported.
25
  
 
                   
 
 
Figure 1.  Site selective Suzuki cross-coupling reactions of the Langer group   
 
6 
 
It has been proved that the origin of selectivity in cross-coupling reactions is 
dominated by sterical and electronic effects. The presence of neighboring groups, such as 
ester, amino, imine, and hydroxyl, has a significant effect on the selectivity.  
 
As part of my work, I studied the Suzuki reaction of tri-brominated thiophenes and N-
methylpyrrole, which gave new functionalized derivatives of thiophene and pyrrole. The 
monoarylated compounds are used as starting materials in the second part of this work to 
perform the twofold Heck cross-coupling reaction of the corresponding substrates in good 
yields. 
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1 Site-selective Suzuki-Miyaura reactions of 2,3,5-tribromothiophene 
and 2,3,4-tribromothiophene 
 
1.1       Introduction 
 
   Thiophene derivatives are of special interest in organic chemistry. Aryl-substituted 
thiophenes are of significant relevance in medicinal chemistry.
26
 Functionalized thiophenes 
also occur in a number of natural products.
27 
Due to their electronic properties, such as 
luminescence, redox activity, nonlinear optical chromism and electron-transport, thiophenes 
are also important in the field of material sciences.
28
 This includes, for example, 
dibenzothiophenes,
29 
terthiophenes
30
 and thienyl-diynes.
31
  
 
   Site-selective Sonogashira and Kumada reactions of the 2-position of 2,3- and 2,4-
dibromothiophene have been studied.
32,33 
Metal-halide exchange reactions
34
 and Kumada 
cross-coupling reactions
33
 of 2,3,5-tribromothiophene have been reported. In addition, an 
isolated example of a Stille coupling
35
 and of a polymer synthesis have been reported.
36
 2,5-
Disubstituted thiophenes were prepared by regioselective Sonogashira coupling reactions of 
2,3,4,5-tetraiodothiophene
37
 and 2,3,4,5-tetrabromothiophene.
38
 In this chapter, I reported the 
first Suzuki-Miyaura reactions of 2,3,5-tribromothiophene and 2,3,4-tribromothiophene, 
which have not been reported to the date. The reaction of the latter with one, two and three 
equivalents of arylboronic acids afforded monoaryldibromothiophenes, diarylbromothio- 
phenes and triarylthiophenes with very good site-selectivity, respectively. 
 
1.2       Results and discussion 
 
1.2.1    Site-selective Suzuki-Miyaura reactions of 2,3,5-tribromothiophene 
 
   The Suzuki-Miyaura reaction of commercially available 2,3,5-tribromothiophene (1) 
with various arylboronic acids (1.1 equiv.) afforded the 5-aryl-2,3-dibromothiophenes 2a-h in 
40-53% yield (Scheme 3, Table 1).  
 
8 
 
 
 
Scheme 3. Synthesis of 2a-h, 3a-d and 4a-k. Conditions: i, 1 (1.0 equiv.), Ar-B(OH)2 (1.1 
equiv), Pd(PPh3)4 (5 mol-%), K2CO3 (2M), 1,4-dioxane / toluene = 1:1, 100 °C, 8 h (see Table 
1); ii, 1 (1.0 equiv.), ArB(OH)2 (2.2 equiv.), Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv.), 1,4-
dioxane / toluene = 1:1), 100 °C, 12 h (see Table 2); iii, 1 (1.0 equiv.), ArB(OH)2 (4.0 equiv.), 
Pd(PPh3)4 (10 mol-%), K2CO3 (2M), 1,4-dioxane, 90 °C, 8 h (see Table 3) 
 
Table 1. Synthesis of 5-aryl-2,3-dibromothiophenes 2a-h 
2 Ar % (2)
a
 
a 4-MeC6H4 47 
b 4-EtC6H4 53 
c 4-tBuC6H4 51 
d 3,5-Me2C6H3 40 
e 2,6-(MeO)C6H3 44 
f 2-(MeO)C6H4 46 
g 3-FC6H4 40 
h 4-ClC6H4 45 
a
 Yields of isolated products 
 
   The Suzuki-Miyaura reaction of 1 with 2.2 equiv. of arylboronic acids afforded the 
2,5-diaryl-3-bromothiophenes 3a-d in 45-67% yield (Scheme 3, Table 2). The reactions again 
proceeded with very good site-selectivity. The use of 4.0 equiv. of arylboronic acids resulted 
in the formation of 2,3,5-triarylthiophenes 4a-k in very good yields (Scheme 3, Table 3).  
9 
 
Table 2. Synthesis of 2,5-diaryl-3-bromothiophenes 3a-d 
3 Ar % (3)
a
 
a 4-MeC6H4 55 
b 4-EtC6H4 67 
c 3,5-Me2C6H3 49 
d 3-FC6H4 45 
a 
Yields of isolated products 
 
Table 3. Synthesis of 2,3,5-triarylthiophenes  4a-k 
4 Ar % (4)
a
 
a 4-MeC6H4 92 
b 4-tBuC6H4 87 
c 3,5-Me2C6H3 78 
d 3-FC6H4 76 
e 2-(MeO)C6H4 81 
f 2,5-(MeO)2C6H3 91 
g 4-vinylC6H4 88 
h 4-ClC6H4 72 
i 4-FC6H4 84 
j 2,4-(MeO)2C6H3 94 
k 3,4-(MeO)2C6H3 88 
a 
Yields of isolated products 
 
The Suzuki-Miyaura reaction of 2,5-diaryl-3-bromothiophenes 3a,b with 2.0 equiv. of 
arylboronic acids afforded the 2,3,5-triarylthiophenes 5a-c containing two different aryl 
groups (Scheme 4, Table 4).  
 
 
 
 
Scheme 4. Synthesis of 5a-c. Conditions: i, 3a,b (1.0 equiv), Ar
2
-B(OH)2 (2.0 equiv.), 
Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 12 h 
10 
 
Table 4. Synthesis of 2,3,5-triarylthiophenes  5a-c 
5 Ar
1
 Ar
2
 % (5)
a
 
a 4-MeC6H4 4-EtC6H4 92 
b 4-EtC6H4 4-MeC6H4 87 
c 4-EtC6H4 2-(EtO)C6H4 83 
a
 Yields of isolated products 
 
The Suzuki-Miyaura reaction of 5-aryl-2,3-dibromothiophenes 2a with 3.0 equiv. of 
arylboronic acids afforded the 2,3,5-triarylthiophenes 6 containing two different aryl groups 
(Scheme 5, Table 5).  
 
 
 
 
Scheme 5. Synthesis of 6. Conditions: i, 2a (1.0 equiv), Ar
2
-B(OH)2 (3.0 equiv.), Pd(PPh3)4 
(10 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 12 h 
 
Table 5. Synthesis of 2,3,5-triarylthiophenes  6 
 Ar
1
 Ar
2
 % (6)
a
 
6 4-MeC6H4 4-MeOC6H4 84 
a 
Yields of isolated products 
 
   The Suzuki reaction of 5-aryl-2,3-dibromothiophenes 2a,b,d,e with 1.1 equivalent of  
arylboronic acids allows a site-selective synthesis of  2,5-diaryl-3-bromothiophenes 7a-f 
containing two different aryl groups (scheme 6, Table 6).  The employment of 2.0 equiv. of 
arylboronic acids to react with 1.0 equivalent of 7a,c-f gave the 2,3,5-triarylthiophenes 8a,c-f 
containing three different  aryl groups in very good yields (Scheme 6, Table 7).  
 
11 
 
 
Scheme 6. Synthesis of 7a-f and 8a,c-f. Conditions: i, 2a,b,d,e (1.0 equiv), Ar
2
-B(OH)2 (1.1 
equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 12 h; 
ii, 7a,c-f (1.0 equiv), Ar
3
-B(OH)2 (2.0 equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv), 1,4-
dioxane / toluene = 1:1, 100 °C, 12 h 
 
Table 6. Synthesis of 2,5-diaryl-3-bromothiophenes 7a-f 
7 Ar
1
 Ar
2
 % (7) 
a
 
a 4-MeC6H4 2-(MeO)C6H4 58 
b 4-EtC6H4 2-(MeO)C6H4 61 
c 4-EtC6H4 2,6-(MeO)2C6H3 43 
d 3,5-Me2C6H3 2-(MeO)C6H4 56 
e 2,6-(MeO)2C6H3 4-MeC6H4 67 
f 2-(MeO)C6H4 4-MeC6H4 51 
a
 Yields of isolated products 
 
Table 7. Synthesis of 2,3,4-triarylthiophenes 8a,c-f 
8 Ar
1
 Ar
2
 Ar
3
 % (8)
a
 
a 4-MeC6H4 2-(MeO)C6H4 4-EtC6H4 77 
b 4-EtC6H4 2,6-(MeO)2C6H3 2-(EtO)C6H4 -
b
 
c 4-EtC6H4 2-(MeO)C6H4 4-tBuC6H4 81 
d 3,5-Me2C6H3 2-(MeO)C6H4 4-EtC6H4 72 
e 2,6-(MeO)2C6H3 4-MeC6H4 4-EtC6H4 75 
f 2-(MeO)C6H4 4-MeC6H4 2-(EtO)C6H4 64 
a
 Yields of isolated products, 
b
 experiment was not carried out 
 
  In all reactions, the best yields were obtained when Pd(PPh3)4 was used as the catalyst. 
The use of other catalysts (such as Pd(OAc)2 / X-Phos) proved to be less successful in terms 
of yield. All reactions were carried out at 90-100 °C. For the synthesis of 2a-h and 4a-k, 
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K2CO3 was used as the base. For the synthesis of 3a-d and 5a-c, K3PO4 was used as the base. 
1,4-Dioxane or a 1:1 mixture of 1,4-dioxane and toluene was used as the solvent. The yields 
of products derived from arylboronic acids containing electron-donating and electron-
withdrawing substituents are in a similar range. The yields of products 4a-k and 5a-c, where 
no issue of site-selectivity was present, were generally higher than those of 2a-h and 3a-d. 
Although products 2a-h and 3a-d were isolated in only moderate yields, the site-selectivities 
of all reactions were very good. In fact, inspection of selected crude spectra of 2 and 3 showed 
that significant amounts of other heterocyclic products were not formed. The moderate yields 
of the isolated products can be explained by practical problems during the chromatographic 
purification.  
 
   The structures of all products were established by spectroscopic methods. The 
structures of 2a, 3a and 4i were independently confirmed by X-ray crystal structure analyses 
(Figures 2, 3, 4, 5 and 6). 
 
 
Figure 2. HMBC and NOESY correlations of 2a 
 
The structure of 2a was established by 2D NMR using HMBC and NOESY 
correlations. In the HMBC spectrum, the phenyl protons resonating at δ 7.26 correlated with 
the quaternary carbon of the thiophene ring C-5 (δ 145.6). In the NOESY spectrum, an 
interaction between the phenyl proton δ 7.26 and the proton of the thiophene ring at δ 6.94 is 
observed.  
 
Figure 3. Crystal structure of 2a 
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   The crystal structure of 2a showed that the phenyl ring is twisted slightly out of the 
plane of the thiophene (with torsion angles of 179.3(3)° for C6-C5-C4-S1a). 
 
 
 
 
Figure 4. Crystal structure of 3a 
 
 
   The crystal structure of 3a showed that the phenyl ring are twisted slightly out of the 
plane of thiophene, with torsion angles of 34.5(2) and 23.4(2)° for C6-C5-C1-S and S-C4-
C12-C17, respectively. 
 
 
  
Figure 5. Crystal structure of 4i 
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   The crystal structure of 4i showed that the phenyl rings are twisted slightly out of the 
plane of thiophene, with torsion angles of 160.63(10), 55.11(14) and 32.8(2)° for S1a-C4-
C17-C18, S1a-C1-C5-C6 and C1-C2-C11-C12, respectively.  
 
The regioselectivites reported herein can be explained based on the different electronic 
and steric properties of the three different C-Br bonds of 1. Carbon atom C-5 is the most 
reactive position because of its electron-deficient character and because it is easily sterically 
accessible (Figure 6). From the electronic viewpoint, carbon C-2 is similar to C-5, but it is 
more sterically hindered because of the neighbourhood of the bromine atom attached to 
carbon C-3. The latter position is least reactive because of electronic reasons. 
 
 
Figure 6. Possible explanation for the site-selectivity of the reactions of 1 
 
 
1.2.2  Site-selective Suzuki-Miyaura reactions of 2,3,4-tribromothiophene 
 
   The Suzuki-Miyaura reaction of commercially available 2,3,4-tribromothiophene (9) 
with various arylboronic acids (1.1 equiv.) afforded the 2-aryl-3,4-dibromothiophenes 10a-g 
in 67-94% yield (Scheme 7, Table 8).  
 
   The Suzuki-Miyaura reaction of 9 with 2.1 equiv. of arylboronic acids afforded the 
2,4-diaryl-3-bromothiophenes 11a-e in 35-55% yield (Scheme 7, Table 9). The employment 
of 4.0 equiv. of arylboronic acids resulted in the formation of 2,3,4-triarylthiophenes 12a-e in 
very good yields (Scheme 7, Table 10).  
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Scheme 7. Synthesis of 10a-g, 11a-e and 12a-e. Conditions: i, 9 (1.0 equiv.), Ar-B(OH)2 (1.1 
equiv.), Pd(PPh3)4 (5 mol-%), K2CO3 (2M), 1,4-dioxane / toluene = 1:1, 100 °C , 5 h (see 
Table 8);  ii, 9 (1.0 equiv.), Ar-B(OH)2 (2.1 equiv.), Pd(PPh3)4 (6 mol-%), K3PO4 (4.0 equiv.), 
1,4-dioxane / toluene = 1:1, 1mL of H2O, 100 °C, 12 h, (see Table 9); iii, 9 (1.0 equiv.), Ar-
B(OH)2 (4.0 equiv.), Pd(PPh3)4 (6 mol-%), K2CO3 (2M),1,4-dioxane, 90 °C,12 h (see Table 
10) 
 
Table 8. Synthesis of 2-aryl-3,4-dibromothiophenes 10a-g 
10 Ar % (10) 
a
 
a 4-MeC6H4 89 
b 4-EtC6H4 87 
c 4-tBuC6H4 94 
d 2-(MeO)C6H4 85 
e 2,6-(MeO)2C6H3 67 
f 3,5-Me2C6H3 79 
g 3-ClC6H4 67 
a
 Yields of isolated products 
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Table 9. Synthesis of 3-bromo-2,4-diarylthiophenes 11a-e 
11 Ar % (11) 
a
 
a 4-MeC6H4 55 
b 4-EtC6H4 51 
c 3,5-Me2C6H3 46 
d 4-tBuC6H4 49 
e 3-ClC6H4 35 
a
 Yields of isolated products 
 
Table 10. Synthesis of 2,3,4-triarylthiophenes  12a-e 
12 Ar % (12) 
a
 
a 4-MeC6H4 93 
b 3,5-Me2C6H3 86 
c 4-tBuC6H4 94 
d 4-(MeO)C6H4 96 
e 4-ClC6H4 78 
a
 Yields of isolated products 
 
The Suzuki-Miyaura reaction of 2-aryl-3,4-dibromothiophenes 10a,b with 1.1 equiv. 
of arylboronic acids resulted in site-selective formation of the 2,4-diarylthiophenes 13a-c,e,f 
containing two different aryl groups (Scheme 8, Table 11). The reaction of 1.0 equiv. of 13a-e 
with 2.0 equiv. of boronic acids allows the synthesis of 2,3,4-triarylthiophenes 14a,b,d,e 
containing three different aryl groups (Scheme 8, Table 12). 
 
 
 
Scheme 8. Synthesis of 13a-f and 14a-e. Conditions: i, 10a,b (1.0 equiv.), Ar
2
-B(OH)2 (1.1 
equiv.), Pd(PPh3)4 (6 mol-%), K3PO4 (4.0 equiv.), 1,4-dioxane / toluene = 1:1, 1 mL of H2O, 
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100 °C, 12 h; ii, 13a,b,d,e (1.0 equiv), Ar
3
-B(OH)2 (2.0 equiv.), Pd(PPh3)4 (10 mol-%), 
K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 12 h 
 
Table 11. Synthesis of 3-bromo-2,4-diarylthiophenes  13a-c,e,f 
13 Ar
1
 Ar
2
 % (13) 
a
 
a 4-MeC6H4 2-(MeO)C6H4 87 
b 4-EtC6H4 2-(MeO)C6H4 81 
c 4-EtC6H4 2,6-(MeO)2C6H3 53 
d 4-MeC6H4 4-EtC6H4 -
b 
e 4-MeC6H4 4-tBuC6H4 57 
f 4-MeC6H4 2,6-(MeO)2C6H3 46 
a
 Yields of isolated products; 
b
 complex mixture 
 
Table 12. Synthesis of 2,3,4-triarylthiophenes 14a,b,d,e 
14 Ar
1
 Ar
2
 Ar
3
 % (14)
a
 
a 4-MeC6H4 2-(MeO)C6H4 2-(EtO)C6H4 92 
b 4-EtC6H4 2-(MeO)C6H4 2-(EtO)C6H4 87 
c 4-EtC6H4 2,6-(MeO)2C6H3 2-(EtO)C6H4 -
b
 
d 4-MeC6H4 4-EtC6H4 4-(MeO)C6H4 93 
e 4-MeC6H4 4-tBuC6H4 4-(MeO)C6H4 96 
a
 Yields of isolated products; 
b 
complex mixture 
 
The Suzuki-Miyaura reaction of 3-bromo-2,4-diarylthiophene 11b,d with 2.0 equiv. of 
arylboronic acids afforded the 2,3,4-triarylthiophenes 15a-c containing two different aryl 
groups (Scheme 9, Table 13).  
 
 
 
 
Scheme 9. Synthesis of 15a-c. Conditions: i, 11b,d (1.0 equiv), Ar
2
-B(OH)2 (2.0 equiv.), 
Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 12 h 
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Table 13. Synthesis of 2,3,4-triarylthiophenes  15a-c 
15 Ar
1
 Ar
2
 % (15)
a
 
a 4-EtC6H4 4-(MeO)C6H4 92 
b 4-tBuC6H4 4-(MeO)C6H4 87 
c 4-EtC6H4 2-(MeO)C6H4 80 
a 
Yields of isolated products  
 
 
The Suzuki-Miyaura reaction of 2-aryl-3,4-dibromothiophene 10a,c with 3.0 equiv. of 
arylboronic acids afforded the 2,3,4-triarylthiophenes 16a-c containing two different aryl 
groups (Scheme 10, Table 14). 
 
 
 
Scheme 10. Synthesis of 16a-c. Conditions: i, 10a,c (1.0 equiv), Ar
2
-B(OH)2 (3.0 equiv.), 
Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 12 h 
 
Table 14. Synthesis of 2,3,4-triarylthiophenes  16a-c 
16 Ar
1
 Ar
2
 % (16)
a
 
a 4-MeC6H4 4-EtC6H4 92 
b 4-MeC6H4 4-tBuC6H4 87 
c 4-tBuC6H4 4-EtC6H4 83 
a
 Yields of isolated products.  
 
 
   In all reactions, the best yields were obtained when Pd(PPh3)4 was used as the catalyst. 
The use of other catalysts (such as Pd(OAc)2 / X-Phos) proved to be less successful in terms 
of yield. All reactions were carried out at 90-100 °C. For the synthesis of 10a-g and 12a-e 
K2CO3 and for the synthesis of 11a-e and 13a-f, K3PO4 was used as the base. 1,4-Dioxane or 
a 1:1 mixture of 1,4-dioxane and toluene was used as the solvent.  
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   The structures of all products were established by spectroscopic methods (COSY, 
HMBC and NOESY).  
 
 
 
Figure 7. HMBC and NOESY correlations of 11d 
 
The structure of 11d was established by 2D NMR using HMBC and NOESY 
correlations. In the HMBC spectrum, the phenyl protons δ 7.38 and δ 7.54 showed strong 
correlations with the quaternary carbons of the thiophene ring (C-2 δ 139.2 and C-5 δ 143.2). 
It was also observed in the NOESY spectrum an interaction between the phenyl proton δ 7.38 
and the proton of the thiophene ring δ 7.18.  
 
The structures of 11a, and 12c were independently confirmed by X-ray crystal 
structure analyses (Figures 8 and 9). 
 
 
Figure 8. Crystal structure of 11a 
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   In the structure of 11a, the two phenyl rings are twisted slightly out of the plane of 
thiophene, with torsion angles of 136.6 (2)° for S-C1-C4-C5. 
 
 
 
 
Figure 9. Crystal structure of 12c 
 
 
 
   In the structure 12c, the phenyl rings are also twisted slightly out of the plane of 
thiophene, with torsion angles of 143.51 (11), 127.12 (13) and 131.2 (4)° for S1a-C1-C5-C10, 
C1-C2-C15-C20 and C4a-C3-C25-C26, respectively.  
 
   The yields of 2-aryl-3,4-dibromothiophenes 10a-g and of 2,3,4-triarylthiophenes 12a-
e were significantly higher than those of 2,4-diaryl-3-bromothiophenes 11a-e. The high yields 
of 12a-e can be explained by the fact that no issue of site-selectivity exists. The high yields 
show that the last step, the reaction of carbon atom C-3, must also proceed in good yields. The 
high yields of 10a-g suggest that the rate of the reaction of carbon C-2 is considerably higher 
than that of carbon C-4. This can be explained by electronic reasons (Figure 10). Inspection of 
selected crude spectra of 10 and 11 showed that no significant amounts of other heterocyclic 
products were formed. The moderate yields of products 11 can be explained by practical 
problems during the chromatographic purification. In fact, the transformation of thiophenes 
10 into 13 proceeded in very good yields (except for 13c,f which are derived from sterically 
hindered 2,6-dimethoxyphenylboronic acid). These results suggest that the rate of the reaction 
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of carbon C-4 is considerably higher than that of carbon C-3. This can be explained by steric 
effects.  
 
 
Figure 10. Possible explanation for the site-selectivity of the reactions of 9 
 
 
As discussed above, the regioselectivites reported herein can be explained based on 
the different electronic and steric properties of the three different C-Br bonds of 9. Carbon 
atom C-2 is the most reactive position because of its electron-deficient character and because 
it is easily sterically accessible (Figure 10). From the electronic viewpoint, carbon C-3 is 
similar to C-4, but C-3 is more sterically hindered than C-4 because of the neighbourhood of 
two bromine atoms.  
 
1.3     Conclusion 
 
   I have reported the first Suzuki-Miyaura reactions of 2,3,5-tribromothiophene and 
2,3,4-tribromothiophene. The reaction with one, two and three equivalents of arylboronic 
acids resulted in formation of 5-aryl-2,3-dibromothiophenes, 2,5-diaryl-3-bromothiophenes, 
and 2,3,5-triarylthiophenes with very good site-selectivity. 
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2  Site-selective Suzuki-Miyaura reactions of 2,3,5-tribromo-N-methyl 
pyrrole 
 
2.1 Introduction  
 
   The pyrrole system is of great importance in organic chemistry, due to its occurrence in 
many natural products and pharmacologically active molecules.
39
 For example, a pyrrole core 
structure is present in marine natural products, such as the lamellarines (Figure 11), 
storniamide A, ningalin A and halitulin, which show considerable potential for the treatment 
of various cancers and AIDS.
40
 Pyrroles also occur in the structure of atorvastatin (lipitor), an 
oral drug which lowers the level of cholesterol in the blood.
41
 They are also found in the 
natural product porphobilinogen, a trisubstituted pyrrole which is a biosynthetic precursor of 
many natural products such as haemoglobin.
42
 Structurally more simple pyrroles have been 
also isolated as natural products, e. g. pyrrolnitrin, isolated from Pseudomonas pyrrocinia, 
which possesses potent antifungal and antibiotic activities.
43 
 
 
 
 
Figure 11. Structure of Lamellarin O 
 
   Schröter and Bach studied Suzuki-Miyaura (S-M) reactions of 2,3,4-tribromopyrrole-5-
carboxylate and of 2,3-dibromo-5-nitropyrrole and observed site-selectivity in favour of 
position 2.
44
 Handy and co-workers reported site-selective one-pot double S-M reactions of 
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4,5-dibromopyrroles using ligand free conditions.
45
 Recently, Langer and coworkers have 
reported site-selective S-M reactions of various polyhalogenated heterocycles  including  
tetrabromo-N-methylpyrrole. Herein, I studied what are, to the best of my knowledge, the first 
site-selective Suzuki-Miyaura reactions of 2,3,5-tribromo-N-methylpyrrole. These reaction 
provide a convenient approach to novel 5-aryl-2,3-dibromo-N-methylpyrroles, 2,5-diaryl-3-
bromo-N-methylpyrroles and 2,3,5-triaryl-N-methylpyrroles. 
 
2.2   Results and discussion 
 
2,3,5-Tribromo-N-methylpyrrole 18 was prepared, following a known procedure,
46
 by 
reaction of  N-methylpryrrole  (17) with NBS  (3.1 equiv)  in THF (Scheme 11). 
 
 
Scheme 11.  Synthesis of 18. Conditions:  1 (1.0 equiv.), NBS (3.1 equiv), THF, -78  20 
°C, 12 h 
 
   The S-M reaction of 18 with 1.1 equiv. of various arylboronic acids afforded the 5-aryl-
2,3-dibromo-N-methylpyrroles 19a-g in 41-82% yields (Scheme 12, Table 15). The reactions 
proceeded with very good site-selectivity in favour of position 5. The relatively low yield of 
19a can be explained by the steric hindrance of 2,6-di(methoxy)phenylboronic acid. Good 
yields were obtained for nearly all products when Pd(PPh3)4 (5 mol-%) and K3PO4 (4.0 equiv) 
were employed as the catalyst and as the base, respectively, when 1.1 equiv. of the boronic 
acid was used and when the reaction was carried out at 100 °C (8 h). The temperature should 
not be too high and the reaction time not too long to avoid multiple coupling. The 
employment of a solvent mixture dioxane/toluene proved to be important, due to reasons of 
solubility of the boronic acids. Analysis of the crude product mixture (GC-MS, 
1
H NMR) 
shows that small amounts of products derived from double-coupling are present which could, 
however, be removed by chromatography. The structure of 19a was independently confirmed 
by X-ray crystal structure analysis (Figure 12). 
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Scheme 12. Synthesis of 19a-g and 20. Conditions: i, 18 (1.0 equiv.), Ar
1
B(OH)2 (1.1 equiv.), 
Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 8 h; ii, 19c (1.0 
equiv.), Ar
2
B(OH)2 (3 equiv.), Pd(PPh3)4 (5 mol-%), K3 PO4(4.0 equiv.), toluene, 110 °C, 36 h 
 
 
 
Table 15. Synthesis of 5-aryl-2,3-dibromo-N-methylpyrroles 19a-g 
19 Ar
1
 T [°C]           t [h] % (19)
a
 
a 2,6-(MeO)2C6H3 90 8 43 
b 4-EtC6H4 100 6 73 
c 4-tBuC6H4 90 8 64 
d 2-(MeO)C6H4 90 8 61 
e 3,5-Me2C6H3 110 6 58 
f 4-ClC6H4 100 8 41 
g 4-MeC6H4 100 8 82 
a
 Yields of isolated products 
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Figure 12. Ortep plot of 19a 
 
  The crystal structure of 19a showed that the phenyl ring is twisted slightly out of the 
plane of pyrrole, with torsion angles of 66.7 (4)° for  C10-C5-C4-N1.  
 
   The S-M reaction of 19c with 4-methoxyphenylboronic acid afforded the 2,3,5-triaryl-
N-methylpyrrole 20a in 74% yield (Scheme 12, Table 16). The best yield of this compound 
was obtained when an excess of the boronic acid was employed (3.0 equiv.) and when the 
reaction time was extended to 36 h and the temperature elevated to 110 °C. The yield of the 
one-pot synthesis of 20a from 18 (sequential addition of the boronic acids) was less than the 
yield of the stepwise process. Therefore, the one-pot synthesis was not further studied. 
 
Table 16. Synthesis of 2,3,5-triaryl-N-methylpyrrole 20                                             
 Ar
1
 Ar
2
 % (20)
a
 
20 4-tBuC6H4 4-(MeO)C6H4 74 
a
 Yields of isolated products 
 
 The S-M reaction of 18 with 2.3 equiv. of arylboronic acids gave the 2,5-diaryl-3-
bromo-N-methylpyrroles 21a-c in 37-58% yields (Scheme 13, Table 17). The reactions were 
carried out at 100 °C (12 h). The S-M reactions of 21b,c with 2.0 equiv. of arylboronic acids 
afforded the 2,3,5-triaryl-N-methylpyrroles 22a,b (Scheme 13, Table 18). Similar to the 
synthesis of 20a, the yield of the one-pot synthesis of 22a was lower compared to the 
stepwise synthesis. The structure of 22a was independently confirmed by X-ray crystal 
structure analysis (Figure 13). 
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Scheme 13. Synthesis of 21a-c and 22a,b. Conditions: i, 18 (1.0 equiv), Ar
1
B(OH)2 (2.3 
equiv.), Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 12 h; ii, 
21b,c (1.0 equiv), Ar
2
B(OH)2 (2.0 equiv.), Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv), toluene, 
110 °C, 36 h 
 
Table 17. Synthesis of 2,5-diaryl-3-bromo-N-methylpyrroles 21a-c 
21 Ar
1
 % (21)
a
 
a 3,5-Me2C6H3 42 
b 4-tBuC6H4 37 
c 4-(MeO)C6H4 58 
a
 Yields of isolated products 
 
Table 18. Synthesis of 2,3,5-triaryl-N-methylpyrroles 22a,b 
22 Ar
1
 Ar
2
 % (22)
a
 
a 4-(MeO)C6H4 4-ClC6H4 72 
b 4-tBuC6H4 2-(EtO)C6H3 83 
a
 Yields of isolated products 
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Figure 13. Crystal structure of 22a 
 
  In the structure of 22a, the phenyl ring at C2 is twisted from the plane of the pyrrole ring 
by 33.8(2)°. The phenyl rings at C1 and C4 are twisted slightly out of the plane of pyrrole, 
with torsion angles of 71.8 (19) and 142.4 (15)°, respectively.  
 
  The S-M reaction of 18 with 4.0 equiv. of arylboronic acids resulted in the formation of 
the 2,3,5-triarylpyrroles 23a-f in 62-92% yields (Scheme 14, Table 19). The reactions were 
carried using Pd(OAc)2/P(Cy)3 (Cy = cyclohexyl) which gave better yields than Pd(PPh3)4.  
 
 
 
 
Scheme 14. Synthesis of 23a-f. Conditions: i, 2 (1.0 equiv), Ar-B(OH)2 (4.0 equiv ), 
Pd(OAc)2 (5 mol-%) / P(Cy)3 (10 mol-%), K3PO4 (4.0 equiv), toluene, 110 °C, 36 h 
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Table 19. Synthesis of 2,3,5-triaryl-N-methylpyrroles 23a-f 
23 Ar % (23)
a
 
a 4-MeC6H4 68 
b 4-(MeO)C6H4 89 
c 3-(MeO)C6H4 76 
d 4-tBuC6H4 72 
e 2,3,4-(MeO)3C6H2 92 
f 3-FC6H4 62 
a
 Yields of isolated products; Cy = cyclohexyl 
 
  The one-pot reaction of  19c,e with two different arylboronic acids, which were 
sequentially added, gave the 2,3,5-triaryl-N-methylpyrrole 24a,b containing three different 
aryl groups in  moderate yields (Scheme 15, Table 20). 
 
 
Scheme 15. Synthesis of 24a,b. Conditions: i, 19c,e (1.0 equiv), Ar
2
B(OH)2 (1.1 equiv.), 
Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv), 1,4-dioxane / toluene = 1:1, 100 °C, 6h; ii, 
Ar
3
B(OH)2 (2.0 equiv.), K3PO4 (2.0 equiv),  110 °C, 24 h. 
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Table 20. Synthesis of 2,3,5-triaryl-N-methylpyrroles 24a,b                                               
24 Ar
1
 Ar
2
 Ar
3
 % (24) 
a 4-tBuC6H4 2-(MeO)C6H4 4-Et C6H4 43 
b 3,5-Me2C6H3 2,6-(MeO)2C6H3 4-Et C6H4 48 
a
 Yields of isolated products 
 
The structure of 21c was established by 2D NMR using HMBC and NOESY 
correlations (Figure 14). In the HMBC spectrum, the phenyl protons δ 7.25 and δ 7.26 
showed strong correlations with the quaternary carbons of the pyrrole ring C-2 and C-5. It is 
observed in the NOESY spectrum an interaction between phenyl proton δ 7.26 and the proton 
of the pyrrole ring δ 6.08.  
 
 
Figure 14. HMBC Correlations of 21c 
 
The site-selectivites can be explained by electronic and steric parameters.
21,47
 Position 
5 is most reactive because it is more electron deficient than position 3 and less sterically 
hinderd than position 2 (Figure 15). From the electronic viewpoint, positions 2 and 5 are 
similar. 
 
 
 
 
Figure 15. Possible explanation for the site-selectivity of the reactions of 18 
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2.3      Conclusion 
 
I have reported the first Suzuki-Miyaura reactions of 2,3,5-tribromo-N-methylpyrrole. 
The reaction provides a convenient and site-selective approach to various arylated pyrroles 
which are not readily available by other methods. 
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PART II   Palladium-catalyzed Mizoroki-Heck reaction of bromo 
                  substituted thiophenes, pyrroles, imidazoles and indoles 
 
 
Introduction and background of the Heck reaction 
 
The palladium-catalyzed Mizoroki-Heck reaction is known as the most efficient route 
for the alkenylation or arylation of olefins.
4
 It is one of the most powerful tools to make new 
C-C bonds, in the presence of an inorganic or organic base (triethylamine, sodium carbonate, 
potassium carbonate or sodium acetate) and palladium catalyst (Scheme 16).
4
 The olefin 
contains at least one proton and is often electron-deficient such as an acrylate ester or an 
acrylonitrile. The halide or triflate is an aryl, benzyl, or vinyl compound. The catalyst can be 
tetrakis(triphenylphosphine)palladium(0), palladium chloride or palladium(II) acetate. During 
the past decades, the most common ligands used are phosphine-based ones. But due to the air 
and /or moisture sensitive nature of most phosphine-based ligands, in recent years, phosphine-
free ligands have also been employed.
48
 The Mizoroki-Heck reaction has been intensively 
developed from a synthetic and mechanistic view point, as expressed by the impressive 
number of reviews and book chapters.
49
 
 
 
 
Scheme 16. Heck reaction 
 
Reaction mechanism 
 
In the preactivation step, the Pd(0) catalyst is formed by reduction of Pd(II) complexes 
and the following steps of the catalytic cycle were proposed: 
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Scheme 17. The catalytic cycle of the Heck reaction 
 
The oxidative addition is the first step of the catalytic cycle, in which the C-X bond 
rupture is synchronized with the formation of Pd-C and Pd-X bonds. The trans-R
1
PdXL2, 
resulting from the oxidative addition, first coordinates to the alkene after dissociation of one 
phosphine and then undergoes a syn insertion to the alkene leading to a σ-alkenyl or σ-aryl-
palladium(II) halide. The reaction of R
1
PdXL2 with an alkene, also referred to as carbo 
palladation, is at the origin of the regioselectivity of Mizoroki-Heck reactions.
50,51
 After an 
internal C-C bond rotation, the syn elimination happened to give the new substituted alkene 
(R
1
CH=CHR
2
) and a hydridopalladium (II) halide.  In the last step, the base is added to 
quench the hydrogen halide and to regenerate the active Pd(0) complex, which is ready to 
enter another catalytic cycle.  
 
It is good to notice that besides the usual parameters of all reactions (temperature, 
solvent and concentration), other parameters may be varied (Pd precursors, ligands, bases, 
additives, etc.) to optimize Mizoroki-Heck reactions.  
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Electrocyclic reactions 
 
 
In this work, the products obtained from the Heck reaction were cyclized via a 6π-
electrocyclization process. In fact, the electrocyclic reaction is a pericyclic reaction which 
proceeds by formation of one new sigma bond across the ends of a conjugated polyene or 
reverse. This reaction follows different rules: 
-   All electrocyclic reactions follow the Woodward-Hoffmann rules, 
-   Thermal electrocyclic reactions involving (4n + 2) π electrons are disrotatory, 
-   Thermal electrocyclic reactions involving (4n) π electrons are conrotatory, 
-  In conrotatory reactions the two groups rotate in the same way: both clockwise or 
both anticlockwise, 
-   In disrotatory reactions, one group rotates clockwise and one anticlockwise
52
. 
 
As an classical and simple example of electrocyclic reaction, hexatriene is cyclized 
thermally to yield to cyclohexa-1,3-diene (Scheme 18).
53
 
 
 
 
 
 
Scheme 18. Synthesis of cyclohexadiene by 6π-electrocyclization 
 
The Heck cross-coupling reaction can provide easy access to various unsymmetrical 
1,6-disubstituted 1,3,5-hexatrienes, which can be cyclized by 6π-electrocyclization to give the 
corresponding hexadienes. 
 
Heck cross-coupling reaction and subsequent 6π-electrocyclization 
 
 
De Meijere and co-workers in 1987 reported the first twofold (and fourfold) Heck 
reactions, in which the 1,2,9,10-tetrabromo[2.2] paracyclophane-1,9-diene reacts with alkenes 
to give tetraalkenylated products in moderate yields. The thermal electrocyclization and 
subsequent dehydrogenation of tetraalkenylated products provided bis-benzoannelated [2.2] 
paracyclophanediene derivatives.
54
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Scheme 19.  Conditions: i, Pd(OAc)2, Bu4NBr, K2CO3 or NaHCO3, DMF, 40-100 °C, 12 h to 
5 days; ii, Pd/C (+O2) or S8, Xylene, 150 °C  
 
Later in 1998, the same research group reported the twofold Heck-coupling reaction of 
1,2-dihalocycloalkenes and subsequent 6π-electrocyclization of the resulting 1,2-dialkenyl- 
cycloalkenes to give ring-annelated  cis-disubstituted cyclohexadienes (Scheme 20).
55
 
 
 
 
Scheme 20. Conditions:  i, Pd(OAc)2, PPh3, NEt3 DMF, 90-100 °C; ii, xylene or (n-Bu2O), 
150 °C; iii, Pd/C (+O2) or S, xylene, 150 °C; iv, Pd/C (+O2) or S, xylene, 150 °C 
 
The (E,Z,E)-1,3,5-hexatrienes were formed when 2.5 equiv of acrylate were added to 
dihalocycloalkenes. To perform the electrocyclization, the (E,Z,E)-1,3,5-hexatrienes were 
heated to 130-150 °C in deoxygenated xylene or dibutyl ether. The two substituents of the 
former 1- and 6-positions have a stereochemical cis relationship in the products due to the 
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disrotatory ring closure under thermal conditions. The aromatized product was isolated when 
the solvent for chromatography and silica gel were not purged with nitrogen. 
 
In my thesis I have studied „twofold Heck / 6π-electrocyclization‟ as a useful method 
for the direct and convenient synthesis of functionalized benzothiophenes, benzimidazoles, 
indoles, carbazoles and dibenzothiophenes starting with dibromothiophenes, tribromo-N-
methylimidazole, tribromo-N-methylpyrrole, tetrabromo-N-methylpyrrole, tetrabromo-N-
methylindole and tetrabromothiophene.  
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3   Synthesis of functionalized benzothiophenes by twofold Heck and 
subsequent 6-electrocyclization reactions of 2,3-dibromothiophene, 
4,5-dibromothiophene-2-carbaldehyde and 5-aryl-2,3-dibromo-
thiophene 
 
 
3.1     Introduction 
 
 
Benzothiophenes are incorporated in many pharmaceuticals, such as raloxifene, 
zileuton and sertaconazole. It occurs also in some natural products, such as the antiangiogenic 
bryoanthrathiophene, which has an anti-angiogenesis effect.
56
 Parent benzothiophene is 
present in coffee beans. Benzothiophenes are also used in crop-protection. For example, 
mobam (4-(N-methylcarbamoyl)benzo[b]-thiophene) represents a potent insecticide which 
inhibits, similar to its naphthalene analogue (1-(N-methylcarbamoyl) naphthalene), the 
enzyme acetylcholinesterase.
57
 Benzothiophenes are often bioisosteric with naphthalenes and 
indoles.  (Benzo[b]thien-3-yl)acetic acid accelerates, similar to its indole analogue, the growth 
of plants. 3-(2-aminoethyl)benzo[b]thiophene is known to stimulate the CNS. Its activity is 
even higher than that of the indole analogue tryptamine.
58
 Last but not the least, 
benzothiophenes are present in many dyestuffs. Prominent examples are thioindigo and its 
derivatives. Benzothiophenes are synthetically available by condensation of thiophenolates or 
2-formyl- or 2-acylthiophenolates with-haloketones and subsequent cyclization.59, 60  
 
                                                                              
                                                                                                                                                                                                                                                                                                    
Figure 16. Structure of bryoanthrathiophene and (benzo[b]thien-3-yl)acetic acid 
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Sonogashira,
61
 Kumada,
62
 Suzuki
63
 and Stille
64
 coupling reactions of 2,3-dibromothiophene 
have been reported to regioselectively occur at position C-2. In this chapter, I report the first 
Heck reactions of 2,3-dibromothiophene, 4,5-dibromothiophenes-2-carbaldehyde and 5-aryl-
2,3-dibromo thiophene to give 2,3-dialkenylthiophenes, 4,5-dialkenylthiophenes-2-carbalde- 
hydes and 2,3-dialkenyl-5-arylthiophenes, respectively. Domino ′6-electrocyclization/ 
dehydrogenation′ reactions55, 65 of the products afforded functionalized benzothiophenes.  
 
3.2      Results and discussion 
 
3.2.1 Synthesis of benzothiophenes starting from 2,3-dibromothiophene 
 
   The Heck reaction of 2,3-dibromothiophene (25) with alkenes 26 (2.5 equiv.) afforded 
the 2,3-di(alkenyl)benzothiophenes 27a-k in good yields (Scheme 21, Table 21). The best 
yields were obtained when the reactions were carried out using Pd(OAc)2 (5 mol-%) and the 
biaryl monophosphine ligands SPhos or XPhos (10 mol-%) which were recently developed by 
Buchwald and coworkers (Figure 17).
66
 The reactions were carried out in DMF at 120 °C for 
12 h. The employment of Pd(PPh3)4 was less successful in terms of yield. Heating of a xylene 
solution of 27a-e and 27g-k in the presence of Pd/C resulted in the formation of 
benzothiophenes 28a-e and 28g-k in quantitative yields. The formation of the products can be 
explained by thermal 6-electrocyclization to give intermediate A and subsequent dehydro- 
genation. During the optimization, it proved to be important to carry out the reaction at 200 
°C. No conversion was observed at lower temperatures.  
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Scheme 21. Synthesis of 27a-k and 28a-e,g-k Conditions: i, 26 (2.5 equiv.), Pd(OAc)2 (5 
mol-%), SPhos or XPhos (10 mol-%), NEt3, DMF, 120 °C, 48 h; ii, xylene, 200 °C, 24 h; iii, 
Pd/C (10 mol-%), xylene, 200 °C, 48 h 
 
 
  Table 21. Synthesis of 27a-k and 28a-e,g-k 
27,28 R % (27) 
a 
% (28) 
a 
a CO2Me 81 
b 
100
 
b CO2Et 90 
c
 100
 
c CO2iBu 86 
b 
100
 
d CO2nBu 93 
c
 100
 
e CO2nHex 92 
c
 100 
f CO2tBu 89 
b 
- 
d
 
g CO2[CH2CH(Et)(CH2)3CH3] 85
 c
 100 
h 4-tBuC6H4 94
 c 
100 
i 4-(MeO)C6H4 83
 c
 100 
j 4-MeC6H4 88
b
 94 
k 4-ClC6H4 82
c
 - 
d
 
a
 Yields of isolated products; 
b
 XPhos was used; 
c
 SPhos was used; 
d
 experiment was not 
carried out 
39 
 
 
  
 
Figure 17. Biaryl monophosphine ligands developed by Buchwald and coworkers
66
 
 
The structures of 27b and 27i were independently confirmed by X-ray crystal structure 
analysis (Figure 18). 
 
                      
                                          
                              27b                                                                                           27i 
 
Figure 18. Crystal structures of 27b and 27i 
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   In both the structures 27b and 27i, the two alkenyl groups are in the same plane and 
almost in the plane of thiophene. The torsion angles between the thiophene ring and the 
alkenyl groups is 0.8 (2)° and  2.3 (4)° in structure 27b and 27i, respectively.  
 
The Heck reaction of 25 with only one equivalent of alkenes 26 resulted in the 
formation of 2-alkenylthiophenes 29a-e (Scheme 22, Table 22). The formation of these 
products can be explained by regioselective coupling of carbon atom C-2 of 25 with the 
acrylate and subsequent Pd(0)-catalyzed reduction. 
 
 
 
 
Scheme 22. Synthesis of 29a-e. Conditions: i,: 26 (1.0 equiv.), Pd(OAc)2 (2.5-5 mol-%), 
SPhos or XPhos (5-10 mol-%), NEt3, DMF, 120 °C, 24 h 
 
Table 22. Synthesis of 29a-e  
29 R % (29) 
a 
a CO2Me 75 
b 
b CO2Et 78 
c
 
c CO2iBu 74 
b 
d CO2tBu 87 
b 
e CO2nHex 76
 c 
 
a
 Yields of isolated products; 
b
 XPhos was used; 
c
 SPhos was used 
 
3.2.2 Synthesis of benzothiophenes starting from 4,5-dibromothiophene-2-carbaldhyde 
 
The Heck reaction of commercially available 4,5-dibromothiophene-2-carbaldehyde 
(30)  with 2.5 equivalents of alkenes 26 did not give the expected products 33, but 5-alkenyl-
4-aryl-N-[(4-bromothiophen-2-yl)methylenes]. The formation of these products can be 
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explained by regioselective coupling of carbon atom C-5 of 30 with the alkenes 26 and 
subsequent Pd(0)-catalyzed reduction of one C-Br bond. The reduction can be due to the 
presence of the aldehyde, an electron withdrawing group, which makes the molecule more 
active. To solve the problem, I have protected the aldehyde by making a Schiff base by 
reacting 30 with 1.5 equivalents of 4-methoxyaniline in glacial acetic acid to obtain (E)-4-
Aryl-N-((4,5-dibromothiophen-2-yl)methylenes) 31  (Scheme 23).  
 
The Heck reaction of 31 with alkenes 26 (2.5 equiv.) afforded compounds 32a-d in 
55-76% yield (Scheme 23, Table 23).
 
 The best yields were obtained when Pd(OAc)2 (5 mol-
%) with tris(cyclohexyl) phosphane [P(Cy)3, 10 mol-%] was employed as the catalyst. The 
expected compounds 33a-d were obtained with good yields after hydrolysis of the imino 
group of compounds 32a-d to recover the aldehyde (deprotection) (Scheme 23, Table 24).  
 
 
 
Scheme 23. Synthesis of 31, 32a-d, 33a-d and 28a,c,d,e. Conditions: i, 26 (2.5 equiv.), 
Pd(OAc)2 (5 mol-%), SPhos, XPhos or P(Cy)3 (10 mol-%), NEt3 (8.0 equiv.), DMF, 90 °C, 
12h; ii, 30 (1.0 equiv.), 4-methoxyaniline (1.5 equiv.), glacial acetic acid, 20°C, 15min; iii, 26 
(2.5 equiv.), Pd(OAc)2 (5 mol-%), P(Cy)3 (10 mol-%), NEt3 (8.0 equiv.), DMF, 90 °C, 12h; 
42 
 
iv, 32a-d, dichloromethane, (H2SO4, 2.5M), 20°C, 20h ; v, 33a-d, xylene, 200 °C, 24 h; vi, 
Pd/C (10 mol-%), xylene, 200 °C, 48 h 
 
Table 23 Synthesis of 32a-d  
32 R % (32) 
a 
a CO2Me 62
 
b CO2iBu 76
 
c CO2nBu 55 
d CO2nHex 67
 
a
 Yields of isolated products 
 
Table 24 Synthesis of 33a-d  
33 32 R % (33) 
a 
a a CO2Me 98
 
b b CO2iBu 95
 
c c CO2nBu 92 
d d CO2nHex 96
 
a
 Yields of isolated products 
 
The compounds 28a,c,d,e were formed after electrocyclization and aromatization of 
33a-d. The formation of 28a,c,d,e can be explained by the thermal extrusion of CO. 
 
The structures of 31 were independently confirmed by X-ray crystal structure analysis 
(Figure 19).  The phenyl ring at C6 is twisted from the plane of the thiophene by -2.9 (9)°. 
The N-C5-C4 bond angle is 121.5 (3)°. 
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Figure 19. Crystal structures of 31 
 
 
3.2.3 Synthesis of benzothiophenes starting from 5-aryl-2,3-dibromothiophene 
   
   2,3,5-Tribromothiophene (1) was prepared by reaction of  thiophene (34) with 
bromine  (3.1 equiv.) in 81% yield (Scheme 24).
67
 The Suzuki-Miyaura reaction of 1 with aryl 
boronic acids (1.1 equiv.) afforded the 5-aryl-2,3-dibromothiophenes 2a-d (see chapter 1). 
 
 
 
Scheme 24. Synthesis of 2,3,5-tribromothiophene 1 
 
 
The Heck reaction of 2b,c,d,f with alkenes 26 afforded the 2-aryl-4,5-di(alkenyl) 
thiophenes 35a-d in 52-91% yield (Scheme 25, Table 25). The reactions were carried out 
under the same conditions as the synthesis of 27a-k. Products 35a-d were transformed to the 
benzothiophene 36a-d in 65-93% yield. 
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Scheme 25. Synthesis of 35a-d and 36a-d. Conditions: i, 1 (1.0 equiv.), ArB(OH)2 (1.1 
equiv.), Pd(PPh3)4 (5 mol-%), K2CO3 (2M), 1,4-dioxane / toluene = 1:1, 100 °C , 12 h; ii, 
2b,c,d,f (1 equiv), 26 (2.5 equiv.), Pd(OAc)2 (5 mol-%), P(Cy)3 (10 mol-%), NEt3 (8.0 equiv.), 
DMF, 100 °C, 24 h; iii, 36a-d, diphenylether, 200 °C, 24 h; iv, Pd/C (10 mol-%), 
diphenylether, 200 °C, 48 h 
 
Table 25. Synthesis of 35a-d and 36a-d  
2 35,36 Ar R % (35) 
a 
% (36) 
a 
b a 4-EtC6H4 CO2iBu 89 
 
93 
 
c b 4-tBuC6H4 CO2nBu 75  82 
d c 3,5-Me2C6H3 CO2iBu 78 
 
85 
 
f d 2-(MeO)C6H4 CO2iBu 76
 
88
 
a
 Yields of isolated products 
 
   The structures of all products were established by spectroscopic methods. The 
structure of 36b was independently confirmed by X-ray crystal structure analysis (Figure 20). 
The benzothiophene moiety is essentially planar. The phenyl ring at C1a is twisted slightly 
out of the plane of benzothiophene, with an torsion angle of -0.5 (5)°. The torsion angles 
between the benzothiophene and alkenyl groups are 19.7(8) and 66.1 (3)° for O5a-C21a-C7a-
C8 and O3a- C16a-C6a-C7a, respectively. 
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Figure 20. Crystal structure of 36b 
 
 
3.3  Conclusion 
 
   2,3-Dialkenylthiophenes, 4,5-dialkenylthiophene-2-carbaldehydes and 2,3-dialkenyl-
5-arylthiophenes were prepared by the first Heck reactions of 2,3-dibromothiophenes, 4,5-
dibromothiophene-2-carbaldehydes and 5-aryl-2,3-dibromothiophenes, respectively. Functio-
nalized benzothiophenes were prepared by Pd/C-catalyzed domino 6-electrocyclization/ 
dehydrogenation reactions of the 2,3-dialkenylthiophenes, 4,5-dialkenylthiophene-2-carb- 
aldehydes and 2,3-dialkenyl-5-arylthiophenes. The reaction of 2,3-dibromothiophene with 
one equivalent of alkenes resulted in the formation of 2-alkenylthiophenes. 
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4 Synthesis of 2,5,6-trisubstituted benzimidazoles by Heck and 
subsequent 6-electrocyclization / dehydrogenation reactions of 2,4,5-
tribromo-N-methylimidazole and  2-aryl- or 2-alkyl-4,5-dibromo-N-
methylimidazoles  
 
 
4.1     Introduction 
 
   Benzimidazoles are of great relevance in medicinal chemistry and crop protection.
68
 
The benzimidazole moiety occurs in a number of natural products. The most prominent one is 
vitamin B12.
 
Benzimidazoles show a wide range of pharmacological activities and have been 
used, for example, as antifungals,
69
 antibacterials,
69,70
 anthelminthics,
71
 5-HT receptor 
antagonists,
72
 and thrombin receptor antagonists.
73
 Benzimidazole drugs (anthelmintics 
albendazole, fenbendazole, oxfenbendazole, thiabendazole, mebendazole and inhibitors of 
proton pump omeprazole, lansoprazole, pantoprazole) represent substances used in both 
human and veterinary medicine. The benzimidazole benomyl is a widely used plant fungicide. 
 
 
 
               
 
                                                              
                                                   
Figure 21. Some important benzimidazole derivatives 
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   Suzuki-Miyaura, Negishi and Stille cross-coupling reactions of protected 2,4,5-
tribromo- and 2,4,5-triiodoimidazole have been reported.
74
 The first attack generally occurs at 
carbon atom C-2. Heck reactions of di- or tri-halogenated imidazoles have, to the best of our 
knowledge, not yet been reported. In this chapter, I developed a new synthesis of 2,5,6-
trisubstituted benzimidazoles
75
 by Heck reactions of 2,4,5-tribromo-N-methylimidazole and 
2-aryl- or 2-alkyl-4,5-dibromo-N-methylimidazoles and subsequent domino ′6-electro- 
cyclization / dehydrogenation′ reactions.  The products are not readily available by other 
methods. 
 
4.2      Results and discussion 
 
 Commercially available tribromoimidazole (37) was transformed into tribromo-N-
methyl-imidazole (38) by reaction with potassium carbonate and methyl iodide in DMF 
(Scheme 26). The Heck reaction of 38 with alkenes 26 (3.3 equiv.) afforded the tri(alkenyl)-
N-methyl-imidazoles 39a-h in 46-86% yield (Table 26). The Heck reaction of 38 with styrene 
26 gave product 39h. The best yields were obtained when Pd(OAc)2 (5 mol-%) in the 
presence of tris(cyclohexyl)phosphane (P(Cy)3, 10 mol-%) was employed as the catalyst. 
During the optimization, the temperature also proved to be an important parameter. A clean 
transformation was observed when the reaction was carried out at 100 °C. Significant 
amounts of 2-alkenyl-4,5-dibromoimidazoles (0-10%) and of 2,5-di(alkenyl)-4-bromo-
imidazoles (15-30%) were formed when the reactions were carried out at 90 °C.  
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Scheme 26. Synthesis of 39a-g, 40a-b,d-g and 41d-f. Conditions: i, 37 (1 equiv), CH3I (2 
equiv), K2CO3 (2 equiv), DMF, 20 °C, 14 h; ii, 38 (1.0 equiv), 26 (3.3 equiv.), Pd(OAc)2 (5 
mol-%), P(Cy)3 (10 mol-%), NEt3, DMF, 100 °C, 24 h; iii, diphenylether, 200 °C, 24 h; iv, 
Pd/C (10 mol-%), diphenylether, 200 °C, 48 h 
 
   Heating of 39a,b and 39d-g in diphenyl ether for 24 h at 200 °C resulted in 6-
electrocyclization. Subsequent addition of Pd/C and heating for further 48 h at 200 °C 
afforded products 40a,b and 40d-g. Products 40a,b,g were isolated in excellent yields. In case 
of 39c and 39h, the formation of a complex mixture was observed. In case of 40d-f, 
considerable amounts of the hydrogenated products 41d-f were formed. Their formation can 
be explained by formation of one equivalent of hydrogen during the Pd/C catalyzed 
dehydrogenation. The hydrogen thus formed reacts, again catalyzed by Pd/C, with the alkenyl 
group located at carbon atom C-2 to give products 41d-f. It is surprising that the formation of 
hydrogenated products 41a,b,g was not observed. This might be explained by the assumption 
that the electrocyclization, dehydrogenation and, thus, the formation of hydrogen, is slower 
for 39a,b,g than for 39d-f. Therefore, there is not sufficient time for the hydrogenation of 
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products 40a,b,g. On the other hand, the formation of products 41a,b,g was observed when 
the reaction time was extended. 
 
Table 26. Synthesis of 39a-h, 40a,b,d-g and 41d-f 
39,40,41 R % (39) 
a 
% (40) 
a 
% (41)
a 
a CO2nBu 86
 
90
 
0
 
b CO2iBu 84 92
 
0 
c CO2tBu 81
 
- 
c
 - 
c
 
d CO2nHex 74 60
 
32 
e CO2Et 73 48 40 
f CO2Me 76
 
40 34 
g CO2R 
b
 82 88 0 
h MeC6H5 46 - 
c
 - 
c
 
a
 Yields of isolated products; 
b
 R = CH2CH(Et)(CH2)3CH3; 
c
 formation of a complex mixture 
 
 
The Suzuki-Miyaura reaction of tribromoimidazole 38 with different arylboronic acids 
afforded the 2-aryl-4,5-dibromoimidazoles 42a-d
74
 in 78-96% yield (Scheme 27, Table 27). 
The best yields for this transformation were obtained using Pd(PPh3)4 (5 mol-%) as the 
catalyst and an aqueous solution of K2CO3 (2 M) as the base (solvent: 1,4-dioxane / toluene). 
  
The Heck reaction of 42a-d with alkenes 26 afforded the 2-aryl-4,5-di(alkenyl) 
imidazoles 43a-r in 52-91% yield (Scheme 27, Table 28). The reactions were carried out 
under the same conditions as the synthesis of 39a-g. Products 43a-r were transformed to 
benzimidazoles 44 a-i, k-m, o-r in 65-93% yield.
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Scheme 27. Synthesis of 42, 43a-r, 44 a-i, k-m, o-r and 45j,n. Conditions: i, 38 (1.0 equiv.), 
ArB(OH)2 (1.1 equiv.), Pd(PPh3)4 (5 mol-%), K2CO3 (2M), 1,4-dioxane / toluene = 1:1, 100 
°C , 12 h; ii, 42a-d (1.0 equiv), 26 (2.5 equiv.), Pd(OAc)2 (5 mol-%), P(Cy)3 (10 mol-%), 
NEt3 (8.0 equiv.), DMF, 100 °C, 24 h; iii, diphenylether, 200 °C, 24 h; iv, Pd/C (10 mol-%), 
diphenylether, 200 °C, 48 h 
 
Table 27. Synthesis of 42a-d
74
 
42 Ar % (42) 
a 
a 4-(MeO)C6H4
 
78
 
b 4-MeC6H4 88 
c 4-tBuC6H4 96 
d 3,5-Me2C6H3 90 
a
 Yields of isolated products 
 
 
 
 
51 
 
Table 28. Synthesis of 43a-r, 44 a-i, k-m, o-r and 45j,n 
42 43,44,45 Ar R % (43)
a 
% (44)
a 
% (45)
a 
a a 4-(MeO)C6H4
 
CO2nBu 91
 
81
 
-
b 
a b 4-(MeO)C6H4
 
CO2iBu 85 77
 
-
b 
a c 4-(MeO)C6H4
 
CO2nHex 78 84
 
-
b 
a d 4-(MeO)C6H4
 
4-MeC6H4 63 79 -
b
 
a e 4-(MeO)C6H4
 
4-tBuC6H4 52 71 -
b
 
b f 4-MeC6H4 4-(MeO)C6H4 -
c
 83 -
b
 
b g 4-MeC6H4 CO2nHex 75 87 -
b
 
b h 4-MeC6H4 CO2iBu 82 86 -
b
 
b i 4-MeC6H4 CO2nBu 87 81 -
b
 
b  j 4-MeC6H4 CO2tBu 90 -
b
 82 
c  k 4-tBuC6H4 4-(MeO)C6H4 64 65 -
b
 
c  l 4-tBuC6H4 CO2Et 81 93 -
b
 
c  m 4-tBuC6H4 4-MeC6H4 56 77 -
b
 
c  n 4-tBuC6H4 CO2tBu 87 -
b
 65 
c  o 4-tBuC6H4 CO2nBu 87 85 -
b
  
d  p 3,5-Me2C6H3 CO2nBu 74 90 -
b
 
d  q 3,5-Me2C6H3 4-tBuC6H4 65 72 -
b
 
d  r 3,5-Me2C6H3  CO2iBu 75 83 -
b
 
a
 Yields of isolated products, 
b
 compound was not formed, 
c
 compound was not isolated 
 
The formation of 45j,n, in which the  ester groups were reduced, can be explained by 
the thermal extrusion of tert-butyl formate from intermediate A. 
 
The monomethylation of tribromoimidazole 38 in the presence of nBuLi and R
1
-I 
afforded the 2-alkyl-4,5-dibromoimidazoles 46a,b in 78-89% yield (Scheme 28, Table 29). 
The reaction was done in DMF at room temperature with K2CO3 as a base.   
 
The Heck reaction of 46a,b with alkenes 26 afforded the 2-alkyl-4,5-
di(alkenyl)imidazoles 47a-d in 82-91% yield (Scheme 28 , Table 30). The reactions were 
carried out under the same conditions as the synthesis of 40a-h and 43a-n. Products 47a-d 
were transformed to the benzimidazoles 48a-d in 69-81% yield.
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Scheme 28. Synthesis of 46a,b, 47a-d and 48a-d. Conditions: i, 2 (1.0 equiv.), nBuLi (1.2 
equiv.), R
1
I (2.0 equiv), -78° to 20 °C, 16h; ii, 46a,b (1.0 equiv), 26 (2.5 equiv.), Pd(OAc)2 (5 
mol-%), P(Cy)3 (10 mol-%), NEt3 (8.0 equiv.), DMF, 100 °C, 24 h; iii, diphenylether, 200 °C, 
24 h; iv, Pd/C (10 mol-%), diphenylether, 200 °C, 48 h 
 
Table 29. Synthesis of 46a,b  
46 R
1
 % (46) 
a 
a C3H7
 
78
 
b C4H9 89 
 
a
 Yields of isolated products 
 
Table 30. Synthesis of 47a-d and 48a-d 
46 47, 48 R
1
 R
2
 % (47)
a 
% (48)
a 
a a C3H7
 
CO2nBu 91
 
81
 
b b C4H9
 
CO2iBu 85 69
 
a c C3H7
 
CO2iBu 89
 
85
 
b d C4H9
 
CO2nBu 82 74
 
a
 Yields of isolated products 
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   The structures of all products were established by spectroscopic methods. The 
structure of 44f was independently confirmed by X-ray crystal structure analysis (Figure 22). 
The crystal structure of 44f showed that the phenyl rings are twisted slightly out of the plane 
of benzimidazole, with torsion angles of 92.9(9), 49.3(3) and 41.9(3)° for N1-C1-C8a- C13a, 
C6-C5-C16-C17, C3-C4-C23-C28, respectively. The two phenyl rings at C4 and C5 are 
almost in the same plane. 
 
 
 
 
Figure 22. Crystal structure of 44f 
 
 
4.3    Conclusion 
 
   I have reported an efficient synthesis of 2,5,6-trisubstituted benzimidazoles by Heck 
reactions of 2,4,5-tribromo-N-methylimidazole, 2-aryl-4,5-dibromo-N-methyl-imidazoles and 
2-alkyl-4,5-dibromo-N-methyl-imidazoles and subsequent 6-electrocyclization/ dehydro-
genation reactions.   
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5 Synthesis of 2,5,6-trisubstituted N-Methylindoles based on site- 
selective Suzuki-Miyaura cross-coupling, twofold Heck and 6-electro 
cyclization / dehydrogenation reactions of 2,3,5-tribromo-N-methyl- 
pyrrole 
 
5.1 Introduction 
 
Indole derivatives are found in many natural, synthetic, agrochemical and pharma- 
ceutical compounds.
76 
For example, indole-3-carbinol, isolated from cruciferous vegetables, 
which works as antioxidant, shows chemopreventive and anticancer activities.
77
 Indole 
derivatives influence the neurotransmitter serotonin,
78
 act as potent anti-inflammatory 
agents,
79 
neuroprotective agents affecting oxidative stress,
80
 as hallucinogen agents,
81
 potent 
PPAR-c binding agents with potential application for the treatment of osteoporosis,
82
 and 
antimicrobial agents.
83 
 Indoles constitute a privileged scaffold capable of providing useful 
ligands for diverse receptors.
84
 Indoles can be prepared by various classical methods, e. g. the 
Fischer indole synthesis, the Plieninger indole synthesis, the Madelung cyclization of N-acyl-
o-toluidines, the Bischler indole synthesis, the Batcho-Leimgruber synthesis of indoles from 
o-nitrotoluenes and dimethylformamide acetals, and the reductive cyclization of o-nitrobenzyl 
ketones.
85
 Most of the known methods allow to vary the substituents located at positions 2 
and 3 of the indole moiety. Positions 5 and 6 are much more difficult to access. 
 
                                                    
 
 
 
Figure 23. Some indole derivatives isolated from natural products 
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Due to the importance of indoles in organic and medicinal chemistry, I studied a new 
approach to 2,5,6-trisubstituted indoles based on the combination of hitherto unknown site-
selective Suzuki-Miyaura reactions of 2,3,5-tribromo-N-methylpyrrole with twofold Heck and 
6π-electrocyclization reactions. The building block strategy reported herein provides a 
powerful method for the synthesis of indoles which are not readily available by other 
methods. 
 
5.2      Results and discussion 
 
The Heck reaction of 19b,c,e,g with alkenes 26 afforded the 5-aryl-2,3-di(alkenyl)-N-
methylpyrroles 49a-r  in 47-76% yield (Scheme 29, Table 31). The best yields were obtained 
when the reactions were carried out using Pd(OAc)2 (5 mol-%) as the catalyst in the presence 
of tricyclohexylphosphine (P(Cy)3, 10 mol-%) (Table 32). The yields significantly dropped 
when Pd(PPh3)4 was employed. 
 
 
 
 
 
Scheme 29. Synthesis of 49a-r and 50a-o. i, 19b,c,e,g (1 equiv.), 26 (2.5 equiv.), Pd(OAc)2 (5 
mol-%), P(Cy)3 (10 mol-%), NEt3, DMF, 100 °C, 24 h; ii, diphenylether, 200 °C, 24 h; iii, 
Pd/C (10 mol-%), diphenylether, 200 °C, 48h 
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Table 31. Synthesis of 49a-r and 50a-o 
19 49,50 Ar R % (49)
a 
%  (50)
a 
g a 4-MeC6H4
 
CO2iBu 72
 
91
 
g b 4-MeC6H4
 
CO2nHex 75 80
 
b c 4-EtC6H4 CO2nBu 63 76 
b d 4-EtC6H4
 
CO2iBu 69 72
 
b e 4-EtC6H4
 
CO2nHex 60 90 
b f 4-EtC6H4
 
CO2Et 47 69 
b g 4-EtC6H4 CO2R 
b
 61 94 
b h 4-EtC6H4 CO2Me 58 74 
c i 4-tBuC6H4 CO2Me 53 70 
c j 4-tBuC6H4 CO2iBu 76 77 
c k 4-tBuC6H4 CO2nBu 56 89 
c l 4-tBuC6H4 CO2nHex 71 81 
c m 4-tBuC6H4 CO2Et 48 75 
e n 3,5-Me2C6H3 CO2R 
b
 51 77 
e o 3,5-Me2C6H3 CO2nBu 66 88 
e p 3,5-Me2C6H3 Ph -
c
 -
c
 
b q 4-EtC6H4
 
CO2tBu 65 -
c 
g r 4-MeC6H4
 
CO2tBu 72 -
c
 
 Yields of isolated products; 
b
 R = CH2CH(Et)(CH2)3CH3; 
c
 Compound was not isolated 
 
The reactions were carried out at 100 °C in DMF. The yields dropped when the 
temperature was increased or decreased (Table 33). The employment of styrene 26 instead of 
acrylates proved to be unsuccessful, due to decomposition under the reaction conditions 
employed. 
 
 
Table 32. Influence of the catalyst  
Catalyst % (49d)
a
 % (49f)
a
 % (49k)
a
 
10 mol % Pd(PPh3)4 37 45 19 
5 mol % Pd(OAc)2   
10 mol % P(Cy)3 
 
69 
 
47 
 
56 
a
 Yields of isolated products 
57 
 
Table 33. Influence of the temperature 
T [°C ] % (49a)
a
 % (49m)
a
 % (49k)
a
 
90 59 30 50 
100 72 48 56 
120 63 41 42 
a
 Yields of isolated products 
 
 
          5-Aryl-2,3-di(alkenyl)-N-methylpyrroles 49a-o were transformed into the indoles 50a-o 
in 69-94% yield. The pyrroles were heated in diphenyl ether for 24 h at 200 °C. Subsequently, 
Pd/C was added and the mixture was heated for further 48 h at 200 °C. The indoles were 
formed by 6π-electrocyclization and subsequent dehydrogenation. The yields dropped when 
the reaction was carried out at 160 °C for 96 h instead of 200 °C for 72 h (Table 34). 
 
Table 34. Influence of the temperature on the 6π-electrocyclisation 
T [°C ] t [h] % (50a)
a
 % (50b)
a
 
160 96 63 71 
200 72 91 80 
a
 Yields of isolated products 
 
 
Heating of 49q,r in diphenyl ether for 12 hours at 200 °C resulted in 6π-electro-
cyclization. Subsequent addition of Pd/C and heating for further 12 hours at 200 °C afforded 
products 51a,b  after another internal cyclisation (Scheme 30, Table 35). 
 
 
 
Scheme 30. Synthesis of 51a,b: Conditions, Pd/C, diphenylether, 200 °C, 24 h 
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Table 35. Synthesis of 51a,b 
51 Ar % (51)
a
 
a 4-EtC6H4
 
63 
b 4-MeC6H4
 
72 
a
 Yields of isolated products 
 
 
5.3    Conclusion 
 
   I have reported an efficient synthesis of 2,5,6-trisubstituted indoles based on Suzuki 
and Heck reactions of 2,4,5-tribromo-N-methypyrrole and subsequent 6-electrocyclization / 
dehydrogenation reactions. This methodology provides a convenient access to various indoles 
which are not readily available by other methods.  
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6 Synthesis of carbazoles and 1,2-dihydrocarbazoles by domino 
twofold Heck / 6-electrocyclization reactions of tetrabromo-N-
methylindole and tetrabromo-N-methylpyrrole 
 
6.1       Introduction  
 
Carbazole was isolated first from the anthracene fraction of coal tar by Graebe and 
Glaser in 1872.
86
 Later, in 1987, Bhattacharyya and coworkers, reported isolation of carbazole 
from glycomis pentaphylla, a plant source.
87
 The carbazole nucleus is found in many 
unnatural and natural products. Clausenapine,
88
 3-methylcarbazol,
89
 mukonidine
90
 and 
koenoline
91
 are some carbazole derivatives found in the nature. The carbazole system occurs 
in several significant modern drugs, such as caprofen, which has been used for the treatment 
of arthritis in man and in animals, and carvedilol, which has been used for the treatment of 
hypertension.
92
 Carbazoles have attracted much attention due to their biological and 
pharmacological activities.
93
 Carbazoles and their related structures show antibiotic, anti-
viral, anti-inflammatory, and anti-malarial activities.
94
 5,11-Dimethyl-6H-pyrido[4,3-
b]carbazole (ellipticine), which is a natural plant product, has shown significant antitumor 
activity.
95
 Bis(O-demethylmurrayafoline-A)  shows cytotoxic activities against diverse human 
cancer cell lines
96
 and exhibits moderate antimalarial activity.
97
  
 
 
                                           
                       
 
Figure 24.  Carbazole derivatives isolated from natural products 
 
 
   The carbazol ring has been synthesized by different methods such as the method of 
Graebe and Ullmann, in which o-aminodiphenylamine is treated with nitrous acid giving 1-
phenyl-1H-benzo[d][1,2,3]triazole, which loses nitrogen on heating to give cabazole.
98
 By the  
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Fischer indole synthesis, tetrahydrocarbazole is obtained when cyclohexanone phenyl 
hydrazone is heated with dilute sulfuric acid.
99
 Many other methods for the synthesis of 
carbazoles have been reported.
100
 Recently Ackermann et al. have reported a proficient 
synthesis of carbazoles and other heterocycles by a new palladium-catalyzed domino N-H/C-
H activation reaction of anilines with 1,2-dihaloalkenes.101 
 
   It occurred to me that ′twofold Heck / 6-electrocyclization′ might provide a useful 
method for the direct and convenient synthesis of dihydrocarbazoles and carbazoles. Herein, I 
reported the synthesis of new carbazole derivatives from tetrabrominated N-methylindole and 
tetrabrominated N-methylpyrrole. 
 
 
 
6.2      Result and discussion 
 
 
6.2.1   Synthesis of carbazoles starting with N-methylindole 
 
 
The reaction of N-methylindole (52) with NBS (5.0 equiv.) in THF (-78 °C, 1 h, then 
reflux for 4 h) afforded 2,3,5,6-tetrabromo- N-methylindole (53) in 78% yield (Scheme 31).
102 
 
 
 
 
Scheme 31. Synthesis of 2,3,4,5-tetrabromo-N-methylpyrrole 
 
The Heck cross-coupling reaction of 2,3,5,6-tetrabromoindole 53 with 5.0 equiv. of  
alkenes 26 (120 °C, 48 h) afforded the 6,7-di(alkenyl)-1,2-dihydrocarbazoles 54a-g (Scheme 
32, Table 36). The best yields were obtained when the reactions were carried out using 
Pd(OAc)2 (5 mol-%) and the ligand SPhos (10 mol-%) (Table 38) which was developed by 
Buchwald and coworkers. 
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The Pd/C-catalyzed dehydrogenation of 54a,c,g afforded the carbazoles 55a,c,g in 
quantitative yield (Scheme 32). An electrocyclization involving the alkenyl groups attached to 
carbon atoms C-5 and C-6 was not observed. This can be explained by the aromaticity of the 
benzene ring which would be interrupetd by the electrocyclization. At lower temperature (90 
°C) tetra-alkenylated indoles 56b,c,e,g were also prepared successfully (Scheme 32, Table 
36). Interestingly, due to the reduction of C-2 and C-3, by-product 57 (7 %) was isolated 
along with 56b (Figure 25). 
 
  
Scheme 32. Synthesis of 54a-g, 55a,c,g and 56b,c,e,g. Conditions: i, Pd(OAc)2 (5 mol-%), 
SPhos (10 mol-%), NEt3, DMF, 120 °C, 48 h; ii, Pd/C (10 mol-%), xylene, reflux, 2 d, iii, 
Pd(OAc)2 (5 mol-%), SPhos (10 mol-%), NEt3, DMF, 90 °C, 36 h 
 
 
Figure 25.  Structure of side product 57 derived from 56b 
62 
 
Table 36. Synthesis of 54a-g, 55a,c,g and 56b,c,e,g 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Yields of isolated products; 
b
 experiment was not carried out 
 
6.2.2 Synthesis of carbazoles starting with N-methylpyrrole 
 
2,3,4,5-Tetrabromo-N-methylpyrrole (58) was prepared in 93% yield by reaction of  
N-methylpyrrole (17) with  NBS (5.0 equiv.) in THF (-78°C, 12 h ) (scheme 33).
46 
 
 
 
 
Scheme 33. Synthesis of 2,3,4,5-tetrabromo-N-methylpyrrole 
 
The Heck reaction of 58 with alkenes 26 (5.0 equiv) afforded the tetra-alkenylated 
pyrroles 59a-g in 52-75% yield (Scheme 34, Table 37). Good yields were obtained when the 
reactions were carried out using Pd(OAc)2 (5 mol-%) as the catalyst in the presence of 
tricyclohexylphosphine (P(Cy)3, 10 mol-%) or SPhos (10 mol-%) (Table 38). Tricyclo-
hexylphosphine P(Cy)3 was employed, due to its lower price as compared to SPhos. During 
the optimization, the temperature also proved to be an important parameter. A clean 
transformation was observed when the reaction was carried out at 90 °C.  
 
54,55,56 R % (54) 
a
 % (55) 
a
 % (56) 
a
 
a Me 68 100 - 
b
 
b Et 86 - 
b
 76 
c nBu 71 100 71 
d iBu 72 - 
b
 - 
b
 
e tBu 72 - 
b
 88 
f nHex 80 - 
b
 - 
b
 
g 2-Ethylhexyl 71 100 75 
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Scheme 34.  Synthesis of 59a-g and 60a,b,d-g. Reagents and conditions:  i, 58 (1.0 equiv.), 
26 (5.0 equiv.), Pd(OAc)2 (5 mol-%), P(Cy)3 (10 mol-%), Et3N, DMF, 90 °C, 12 h; ii, 
diphenyl ether, 200 °C, 24 h; iv, Pd/C (10 mol-%), diphenylether, 200 °C, 48 h 
 
Table 37. Synthesis of 59a-g and 60a,b,d-g 
 
 
 
 
 
 
 
 
 
 
a
 Yields of isolated products;
 b 
No compounds were isolated; 
c 
experiment was not carried out 
 
 
 
 
 
59,60 R % (59) 
a
 % (60) 
a
 
a nBu 65 75 
b iBu 55 89 
c tBu 71 - 
b
 
d nHex 73 80 
e Me 52 69 
f Et 69 63 
g 2-Ethylhexyl 75 82 
h Ph - 
b
 - 
c
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Table 38.  Optimization of the reaction conditions for the synthesis 56c, 59a and 59e. 
Catalyst % (56c)
a
 % (59a)
a
 % (59e)
a
 
5 mol % Pd(OAc)2  
10 mol % P(Cy)3 
 
61 
 
65 
 
52 
5 mol % Pd(OAc)2  
10 mol % SPhos 
 
75 
 
71 
 
55 
 a
 Yields of isolated products 
 
 
Tetra(alkenyl)-N-methyl pyrroles 59a-g were transformed into the carbazoles 60a,b,d-
g in 63-89% yield. The pyrroles were heated in diphenyl ether for 24 h at 200 °C. 
Subsequently, Pd/C was added and the mixture was heated for further 48 h at 200 °C. The 
Carbazoles were formed by 6π-electrocyclization and subsequent dehydrogenation. Very low 
yields (Table 4) were observed when the reactions were carried out at 140 °C for 96 h instead 
of 200 °C for 72 h. 
 
 
Table 39. Influence of the temperature on the 6π-electrocyclisation 
T [°C ] t [h] % (60a)
a
 % (60f)
a
 
140 96 21 12 
200 72 75 63 
a
 Yields of isolated products 
 
The employment of styrene instead of acrylates proved to be unsuccessful, due to 
decomposition under the reaction conditions employed. 
 
6.3      Conclusion  
 
I have reported the synthesis of tetra-alkenyl-N-methyl indoles and pyrroles by 
palladium(0)-catalyzed Heck cross-coupling reactions of tetrabromo-N-methylindole and –
pyrrole, respectively. The reactions were carried out between 90-100 °C using P(Cy)3 or the 
novel biaryl monophosphine ligand (SPhos) developed by Buchwald and coworkers. 1,2-
Dihydrocarbazoles were formed by a domino twofold Heck / 6-electrocyclization when the 
65 
 
reaction was carried out at 120 °C rather than 90 °C. Some of the 1,2-dihydrocarbazoles 
prepared were transformed, by Pd/C-catalyzed dehydrogenation, into the corresponding 
carbazoles in high yield. The tetra-alkenyl-N-methylpyrroles were transformed at 200 °C in 
diphenylether, by subsequent 6-electrocyclization and aromatization to the corresponding 
carbazoles in good yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
7 Synthesis and photophysical properties of dibenzothiophene by 
domino twofold (tetrafold) Heck / 6π-electrocyclization reactions of 
2,3,4,5 -tetrabromothiophene 
 
7.1  Introduction 
  
Dibenzothiophene occurs naturally in the phenanthrene fraction of coal tar and was 
first isolated by Kruber.
103
 Dibenzothiophene and its alkylated derivatives represent one of the 
most abundant types of sulfur-containing compounds in crude oil.
104
 It has been shown that 
the dibenzothiophene derivatives, including 4,6-dimethyldibenzothiophene, possesses  
estrogenic activity.
105
 Dibenzothiophenes, including derivatives of dibenzothiophene-3,7-
diamine-5,5-dioxides are  used as dyes and fluorescent whiteners.
106
 Umemoto and coworkers 
have shown that 5-(trifluoromethyl)dibenzothiophenium salts are potentially usefull as 
electrophilic trifluoromethylating agents. Recently, dibenzothiophene derivatives were 
identified as new prototype semiconductors for organic field-effect transistors.
107
 Many 
compounds including the dibenzothiophene system show antitumor,
108
 genotoxic,
109
 
antiprotozoal,
110
 antidiabetic
111
 and antimicrobial
112 
activities.  
 
Dibenzothiophene was first synthetized by Stenhouse in 1870, by heating diphenyl 
sulfide in the presence of iron nails.
113
 Later, a large number of methods for the synthesis of 
dibenzothiophenes have been reported.  For example, the most general method for the 
synthesis of dibenzothiophenes is the cyclization of alpha-arylsulfanyl-cycloketones to give 
tetrahydro- or dihydrodibenzothiophenes, which are subsequently aromatized to form the 
desired products. That method can be inconvenient as it cannot be used to prepare 
dibenzothiophene derivatives with strong electron-withdrawing groups.
114
 Recently, Nielsen 
and coworkers have reported a novel and efficient three-step protocol for synthesizing 
functionalized dibenzothiophenes from common starting materials and by using palladium-
catalyzed carbon-carbon and carbon-sulfur bond formations.
115
  
 
In this chapter, I developed  a one-step and  three-step  synthesis of novel funtio- 
nalized dibenzothiophenes by domino tetrafold Heck reactions and subsquent 6π-
electrocyclization reactions of 2,3,4,5-tetrabromothiophene . 
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7.2     Results and discussion 
 
7.2.1   Synthesis of dibenzothiophenes 
 
2,3,4,5-Tetrabromothiophene (61) was prepared in 81% yield by reaction of  thiophene  
(34) with  bromine (5.0 equiv.) in chloroform for 9 h (Scheme 35).
116
 
 
 
 
Scheme 35. Synthesis of 2,3,4,5-tetrabromothiophene. Conditions: i, 1) Br2 (7.0 equiv., slow 
addition), 0 °C, CHCl3, 2) reflux, 3 h; 3) NaOH, H2O (2 M), reflux, 6 h 
 
The Heck cross-coupling reaction of 2,3,4,5-tetrabromothiophene 61 with 5.0 equiv. 
of  alkenes 26 (90 °C, 12 h) afforded the tetra-alkenylated thiophenes 62a-j (Scheme 36, 
Table 40). The best yields were obtained when the reactions were carried out using Pd(OAc)2 
(3 mol-%), Na2CO3 and P(Cy)3 (5 mol-%). 
 
The Pd/C-catalyzed dehydrogenation of 62a-j afforded the dibenzothiophenes 63a-j in 
good yield (Scheme 36, Table 40).  
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Scheme 36. Synthesis of 62a-j and 63a-j. Reagents and conditions: i, 61 (1 equiv), 26 (5.0 
equiv.), Pd(OAc)2 (3 mol-%), P(Cy)3 (5 mol-%), Na2CO3, DMF, 90 °C, 12 h; ii, diphenyl 
ether, 200 °C, 24 h; iii, Pd/C (10 mol-%), diphenylether, 200 °C, 48 h 
 
Table 40. Synthesis of 62a-j and 63a-j 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Yields of isolated products; 
b
 compound was not isolated 
 
62,63 R % (62) 
a
 % (63) 
a
 
a Me 71 60 
b Et 54 51 
c nBu 51 59 
d iBu 68 62 
e 2-Ethylhexyl 52 70 
f nHex 63 73
 
g Ph 80 74 
h 4-tBuC6H4 72 63 
i 4-(MeO)C6H4 62 67 
j 4-MeC6H4 78 59 
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During the optimization, the temperature also proved to be an important parameter.  
When the Heck reactions of 2,3,4,5-tetrabromothiophenes  with 26 (5.0 equiv.) were carried 
out at 140 °C for 24 h, compounds 63a-g were formed in a one-step reaction with moderate 
yields (Scheme 37, Table 41).  
 
 
 
 
 
Scheme 37.  Synthesis of 63a-g. Reagents and conditions:  i, 61 (1 equiv), 26 (5.0 equiv), 
Pd(OAc)2 (3 mol-%), P(Cy)3 (5 mol-%), Na2CO3, DMF, 140 °C, 24 h 
 
Table 41. Synthesis of 63a-g 
 
 
 
 
 
 
 
 
a
 Yields of isolated products 
 
 
The base plays also a very important role in the reaction (Table 42). The use of 
triethylamine as a base  gave  many products including mono-, di- and tri-alkenylated 
products, but not the products derived from fourfold Heck reactions.  The reaction with 
Na2CO3 gave better yields than using K2CO3. No product or only trace amounts were 
observed when the reactions carried out in toluene and xylene. 
 
 
63 R Base solvent T [°C ] t [h] % (63) 
a
 
a Me Na2CO3 DMF 140 24 43 
b Et Na2CO3 DMF 140 24 38 
c nBu K2CO3 DMF 120 24 40 
d iBu Na2CO3 DMF 140 24 52 
e 2-Ethylhexyl Na2CO3 DMF 120 24 36 
f nHex Na2CO3 DMF
 140 24 40
 
g ph Na2CO3 DMF 140 36 48 
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Table 42.  Optimization of reaction conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
compounds were not isolated  
 
 
7.2.2   UV analysis 
 
  To study the electronic properties of the synthesized compounds 62g, 63g, 63d, 62d, 
absorption spectroscopy was carried out. Representative UV-spectra of the different product 
classes (62g, 63g, 63d, 62d) are shown in Figure 23 (in CH2Cl2). 
 
Figure 26. Normalized absorption spectra of compounds 62g, 63g, 63d and 62d 
 
Compounds of 62g, 63g and 63d have max-values in the range of 260nm-290nm, 
while max values of compounds 62d are shifted about 80 nm to higher wavelengths. The 
transition with lowest energies S1←S0 belongs to the tetrastyryl derivatives (exemplarily 
R Base solvent T [°C ] t [h] % (62)  % (63)  
iBu Na2CO3 DMF 140 24 -
a 
52 
nBu K2CO3 DMF 120 24 -
a 
40 
iBu Et3N DMF 120 12 -
a
 -
a
 
nBu Et3N DMF 90 24 -
a
 -
a
 
nBu Na2CO3 toluene 110 24 -
a
 traces 
2-Ethylhexyl Na2CO3 xylene 150 12 -
a
 traces 
iBu K3PO4 DMF 140 24 -
a
 traces 
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shown for 62g). The alkenyl-derivatives absorb at lower energies than their corresponding 
dibenzothiophenes. This could be explained by hampered conjugation, due to steric hindrance 
by the phenyl- (62g) or ester-functions (63d), respectively. However, compound 62d is 
shifted about 80nm to lower energies compared to 63g, while 63d is only shifted about 30 nm 
compared to 62g.  
 
Substituents located at the tetraphenyldibenzothiophenes (63g, 63i and 63j) have a low 
impact on the absorption spectra (compare figure 26). Substituents at the phenyl group in the 
4-positions lead to a slight shift of the max to lower energies in accordance with their donor 
ability (Figure 27). 
 
Figure 17. Normalized absorption spectra of compounds 63i, 63j and 63g 
 
Table 43.  General overview measurements of 63a, 63d, 63f, 63g, 63i, 63j 62c, 62d, 62e, 62g 
and 62j                           
Compound max [nm] Sh1 [nm] 
63a 258 338 
63d 264 342 
63f 265 346 
63g 270 313 
63i 278 323 
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63j 274 316 
62c 290 354 
62d 287 343 
62e 289 343 
62g 340 401 
62j 342 416 
 
 
 
7.2.3 Fluorescence analysis 
 
To study the electronic properties of the synthesized compounds, fluorescence 
spectroscopy was carried out. The fluorescence spectra were recorded on a Hitachi F-4010 
fluorescence spectrometer in dichloromethane (c ≈ 10-3 - 10-4 mol/l; excitation wavelength: 
250 nm).  
Figure 28 shows the fluorescence spectra of three tetrastyrylthiophenes (62g, 62h and 
62i). 
 
Figure 28. Fluorescence spectra of 62g, 62h and 62i 
 
The compounds have max-values in the range of 465-490 nm (Table 44). The 
substitution of the phenyl group in 4-position leads to a shift of max to lower energies, 
probably because the substituents are electron donating.  
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Table 44. Structure and max-values of compounds 62g, 62h and 62i 
Compound R λmax, emission 
62g H 465 
62h t-Butyl 480 
62i OMe 490 
 
Figure 29 shows the fluorescence spectra of three tetrasubstituted dibenzothiophenes (63d, 
63a and 63i).  
 
Figure 29. Fluorescence spectra of 63d, 63a and 63i 
 
The compounds have max-values in the range of 365 nm-395 nm (Table 45). There 
seems to be a strong influence of the ester-group (i-Pr or Me, see Table 45) on the max-value. 
 
Table 45. Structure and max-values of compounds 63d, 63a and 63i 
Compound R λmax, emission 
63d COO(i-Pr) 395 
63a COOMe 365 
63i 4-Methoxyphenyl 370 
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In Figure 30, the representative compounds 63i and 62i are compared to investigate 
the influence of cyclization on the fluorescence properties. 
 
Figure 30. Comparison of 63i and 62i. 
 
The cyclization causes a strong fluorescence shift of 120 nm towards higher energies. 
Table 46 shows a general overview about the values of the fluorescence measurement.  
  
Table 46. General overview measurements of 63a, 63d, 63i, 62g, 62h, 62i and 62j    
 
 
 
 
        
 
 
 
 
 
 
 
Compound λe, max /nm  
63a 365 
63d 395 
63i 370 
62g 465 
62h 480 
62i 490 
62j 480 
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7.3     Conclusion 
 
I have reported the synthesis of tetra-alkenylthiophenes by palladium(0)-catalyzed 
fourfold Heck cross-coupling reactions of tetrabromothiophene. The reactions were carried 
out at 100 °C using P(Cy)3  and Na2CO3. Tetra-alkenylthiophenes were transformed, by Pd/C-
catalyzed dehydrogenation, into the corresponding dibenzothiophenes in good yield. The 
dibenzothiophenes were also obtained in one step by domino „fourfold Heck-6π-
electrocyclization' reactions of tetrabromothiophene when the reactions were carried out at 
140 °C for 24 h. The UV and fluorescence analysis showed that the compounds absorb UV 
light and are fluorescent. 
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Appendix 
 
8 Experimental section 
 
8.1 Material and methods 
 
8.1.1 General remarks 
 
Reactions were carried out under inert atmosphere (Argon 4.6) in order to simultaneously 
exclude oxygen and water when appropriate. Schlenck techniques were applied. Solvents for 
reactions were dried and destilled by standard methods or purchased from Merck, Aldrich, 
Acros Organics, ABCR and others whenever exclusion of water was desired. Solvents for 
liquid chromatography and extraction were always destilled prior to use and partly reused 
after fractionating destillation (n-heptane, ethyl acetate). 
 
8.1.2 Methods for compound characterization and analysis 
 
NMR spectroscopy 
 
Bruker AC 250, Bruker ARX 300, Bruker ARX 500, Bruker Avance 600. For NMR 
characterization the one-dimensional 1H NMR, proton-decoupled 13C NMR, and DEPT 135 
spectra were collected. If necessary, other techniques (APT, NOESY, COSY, HMBC) were 
applied as well. All NMR spectra presented in this work were collected in CDCl3 solution. 
All chemical shifts are given in ppm.  
References (1H NMR): TMS (δ = 0.00) or residual CHCl3 (δ = 7.26) were taken as internal 
standard. When these reference peaks were superimposed by signals belonging to the 
compound under investigation a small amount of CH2Cl2 (δ = 5.30) was added and taken as 
reference instead. 
References (13C NMR): TMS (δ = 0.0) or residual CHCl3 (δ = 77.0) were taken as internal 
standard. 
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Multiplicities are given as follows: s = singlet, d = doublet, t = triplet, q = quartet, sep = 
septet, m = multiplet, br = broad signal. More complex coupling patterns are represented by 
combinations of the respective symbols. For example, td indicates a triplet of doublets with 
the larger coupling constant associated with the first symbol (here: triplet). 
 
Infrared spectroscopy (IR) 
 
Nicolet 205 FT-IR, Nicolet Protége 460 FT-IR. Peaks are given the following assignments: w 
= weak, m = medium, s = strong, br = broad. 
 
Mass spektrometry (MS) 
 
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI), Finnigan MAT 95 (CI, 200 eV). 
 
High resolution mass spectrometry (HRMS) 
 
Varian MAT 311, Intecta AMD 402. 
 
Elemental analysis 
 
LECO CHNS-932, Thermoquest Flash EA 1112. 
 
Melting points 
 
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected. 
 
Rotation angles 
 
LP (IBZ Meßtechnik, NaD = 589 nm). 
 
 
78 
 
X-ray structures 
 
Bruker X8Apex diffractometer with CCD camera (Mo Kα radiation and graphite 
monochromator, = 0.71073 Å). The space group is determined by the XPREP program and 
the structures were solved via the SHELX-97 program package. Refinements were carried out 
according to the minimum square error method. 
 
8.1.3 Chromatographic methods  
 
Thin layer chromatography (TLC) 
 
Merck Kieselgel 60 F254 on aluminium foil from Macherey-Nagel. Detection was carried out 
under UV light at 254 nm and 365 nm. As colourizing reagent the following mixtures were 
used: 1-2/100 p-Anisaldehyde or vanillin, 10/100 glacial acetic acid, 5/100 sulphuric acid, 83- 
84/100 methanol. 
 
Column chromatography 
 
Column chromatography was performed with Merck Silica Gel 60 or Macherey-Nagel Silica 
Gel 60 (0.063-0.200 mm, 70-230 mesh). The finer Merck Silica Gel 60 (0.040-0.063 mm, 230 
-400 mesh) was chosen when appropriate. 
 
8.1.4 Procedures and spectroscopic data 
 
General procedure for the synthesis of 2,3-Dibromo-5-arylthiophenes  (2):  
 
To a mixture of 1 (0.159 g, 0.5 mmol), arylboronic acid (0.55 mmol), Pd(PPh3)4 (29 mg, 5 
mol-%) were added a mixture of 1,4-dioxane and toluene (1:1, 5 mL) and an aq solution of 
K2CO3 (2 mL, 2 M) under argon atmosphere. The reaction mixture was stirred at 100 °C for 8 
h and was subsequently allowed to cool to 20 °C. The solution was poured into H2O and 
CH2Cl2 (25 mL each) and the organic and the aqueous layer were separated. The latter was 
extracted with CH2Cl2 (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The 
residue was purified by flash column chromatography (flash silica gel, n-heptane). 
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2,3-Dibromo-5-p-tolylthiophene (2a): 
Starting with 1 (0.159 g, 0.5 mmol) and 4-tolylboronic acid 
(0.75 g, 0.55 mmol), 2a was isolated (0.078 g, 47%) as a 
colorless solid, mp. = 83-85 °C. 
1
H NMR (300 MHz, CDCl3): 
δ = 2.26 (s, 3H, CH3), 6.94 (s, 1H, ArH), 7.08 (d, 2H, 
J = 8.0 Hz, ArH), 7.26 (d, 2H, J = 8.2 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 21.3 (CH3), 
109.4, 114.5 (CBr), 125.0, 125.3, 128.7, 129.4, 129.8 (CH), 130.0, 138.6, 145.6 (C). IR (KBr, 
cm
−1
): v = 3091, 3019, 2918, 2852 (w), 1498 (m), 1433, 1118, 997, 821 (w), 801 (m), 550 
(w). GC-MS (EI, 70 eV): m/z (%) = 334(53) [M
+
 (
8¹
Br, 
8¹
Br)], 332(100) [M
+ 
(
8¹
Br, Br)], 
331(16), 330(49) [M
+ 
(Br, Br)], 172(35), 171(30), 86(11). HRMS (EI, 70 eV): calcd for 
C11H8Br2S [M
+
 (Br,
 8¹
Br)]: 331.86875; found: 331.86882.  
 
2,3-Dibromo-5-(4-ethylphenyl)thiophene (2b): 
Starting with 1 (0.159 g, 0.5 mmol)) and 4-ethylphenylboronic 
acid (0.083 g, 0.55 mmol), 2b was isolated (0.092 g, 53%) as a 
colorless oil. 
1
H NMR (300 MHz, CDCl3): δ = 1.18 (t, 3H, J = 
7.6 Hz, CH3), 2.59 (q, 2H, J = 7.6 Hz, CH2), 6.98 (s, 1H, 
CHthiophene), 7.14 (d, 2H, J = 8.4 Hz, ArH), 7.33 (d, 2H, J = 8.3 Hz, ArH). 
13
C NMR (62 MHz, 
CDCl3): δ = 15.4 (CH3), 28.6 (CH2),  109.5, 114.5 (CBr), 125.1 (CH), 125.5 (2CH), 128.6 
(2CH), 130.2, 145.0, 145.6 (C). IR (KBr, cm
−1
): v = 3019, 2964, 2871 (w), 1495, 1430 (m), 
1412, 1317, 1301, 1276, 1121, 955, 833, 810 (s), 769 (m), 685, 580, 553 (w). GC-MS (EI, 
70 eV): m/z (%) = 348(43) [M
+
 (
8¹
Br, 
8¹
Br)], 346(82) [M
+
 (
8¹
Br, Br)], 344(41) [M
+
 (Br, Br)], 
333(54), 331(100) [M
+
], 329(50), 171(24), 85(11). HRMS (EI, 70 eV): calcd for C12H10Br2S 
[M
+
 (Br,
 8¹
Br)]: 345.88440; found: 345.88445.  
 
2,3-Dibromo-5-(4-tert-butylphenyl)thiophene (2c): 
Starting with 1 (0.159 g, 0.5 mmol)) and 4-tert- butylphenyl 
boronic acid (0.098 g, 0.55 mmol), 2c was isolated (0.096 g, 
51%) as whitish semi solid. 
1
H NMR (250 MHz, CDCl3): 
δ = 1.26 (s, 9H, 3CH3), 6.98 (s, 1H, CHthiophene), 7.34 (br, 4H, 
ArH). 
13
C NMR (62 MHz, CDCl3): δ = 31.2 (3CH3), 34.7 (C), 
109.5, 114.4 (CBr), 125.1 (CH), 125.2 (2CH), 126.1 (2CH), 129.9, 145.5, 151.9 (C). IR (KBr, 
cm
−1
): v = 2958 (m), 2901, 2864, 1561, 1533 (w), 1497, 1460, 1432, 1408, 1362, 1306, 1267, 
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1200, 1109, 1016, 994, 834 (m), 810 (s), 731, 677 (m), 636, 610, 581 (w), 564 (s). GC-MS 
(EI, 70 eV): m/z (%) = 376(24) [M
+
 (
8¹
Br, 
8¹
Br)], 374(40) [M
+ 
(
8¹
Br, Br)], 372(21) [M
+ 
(Br, 
Br)], 361(54), 359(100) [M
+
], 357(51), 331(16), 165(12). HRMS (EI, 70 eV): calcd for 
C14H14Br2S [M
+
 (Br,
 8¹
Br)]: 373.91570; found: 373.91523.  
 
2,3-Dibromo-5-(3,5-dimethylphenyl)thiophene (2d): 
Starting with 1 (0.159 g, 0.5 mmol) and 3,5-dimethylphenyl 
boronic acid (0.083 g, 0.55 mmol), 2d was isolated (0.069 g, 
40%) as whitish semi solid.
 1
H NMR (300 MHz, CDCl3): 
δ = 2.25 (s, 6H, 2CH3), 6.88 (br, 1H, ArH), 6.98 (br, 1H, 
CHthiophene), 7.01 (br, 2H, ArH). 
13
C NMR (75 MHz, CDCl3): 
δ = 21.3 (2CH3), 109.7, 114.4 (CBr), 123.3 (2CH), 125.3, 130.3 (CH), 132.6 (C), 138.8 (2C), 
145.7 (C). IR (KBr, cm
−1
): v = 3109 (w), 2919 (m),  2845 (w), 1602, 1464, 1305 (m), 1264, 
1124, 1037 (w), 883, 844, 821 (s), 732 (m), 698 (s), 687 (m), 641, 568, 543 (w). GC-MS (EI, 
70 eV): m/z (%) = 348(52) [M
+
 (
8¹
Br, 
8¹
Br)], 346(100) [M
+ 
(Br, 
8¹
Br)], 344(49) [M
+ 
(Br, Br)], 
171(14). HRMS (EI, 70 eV): calcd for C12H10Br2S [M
+
 (Br,
 8¹
Br)]: 346.88440; found: 
346.88431.  
 
 2,3-Dibromo-5-(2,6-dimethoxyphenyl)thiophene (2e): 
Starting with 1 (0.159 g, 0.5 mmol) and 2,6-dimethoxyphenylboronic 
acid (0.100 g, 0.55 mmol), 2e was isolated (0.083 g, 44%) as a 
colorless oil. 
1
H NMR (300 MHz, CDCl3): δ =  3.80 (s, 6H, 2OCH3), 
6.56 (d, 2H, J = 8.4 Hz, ArH), 7.14-7.19 (m, 1H, ArH), 7.35 (s, 1H, 
CHthiophene). 
13
C NMR (75 MHz, CDCl3): δ = 55.9 (2OCH3), 104.4 (2CH), 110.8 (C), 111.1, 
112.7 (CBr), 129.3, 130.9 (CH),  136.0 (C), 157.5 (2C). IR (KBr, cm
−1
): v = 2999, 2931, 2833 
(w), 1584 (m), 1469 (s), 1435, 1425 (w), 1312, 1292 (w), 1248 (s), 1206, 1192, 1151 (w), 
1109 (s), 1037, 998, 947, 822, 813, 772 (m), 715 (s), 693, 684, 574, 539 (m). GC-MS (EI, 
70 eV): m/z (%) = 380(52) [M
+
 (
8¹
Br, 
8¹
Br)], 378(100) [M
+
 (
8¹
Br, Br)], 376(50) [M
+
 (Br, Br)], 
284(36), 282(37), 203(42), 149(11). HRMS (EI, 70 eV): calcd for C12H10Br2O2S [M
+
 (Br,
 
8¹
Br)]: 377.87423; found: 377.87420. 
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2,3-Dibromo-5-(2-methoxyphenyl)thiophene (2f): 
Starting with 1 (0.159 g, 0.5 mmol) and 2-methoxyphenylboronic 
acid (0.083 g, 0.55 mmol), 2f was isolated (0.08 g, 46%) as a 
colorless oil. 
1
H NMR (300 MHz, CDCl3): δ = 3.85 (s, 3H, OCH3), 
6.88-6.94 (m, 2H, ArH), 7.17-7.24 (m, 2H, ArH and CHthiophene), 7.47 
(dd, 1H, J = 1.6, 7.8 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 55.6 
(OCH3), 111.3 (CBr), 111.7 (CH), 113.5 (CBr), 121.0 (CH), 121.5 (C), 126.7, 127.1, 129.3 
(CH), 140.5, 155.5 (C). IR (KBr, cm
−1
): v = 3071, 2933, 2834, 1596, 1579 (w), 1519, 1483, 
1455, 1433, 1323, 1293, 1270 (m), 1247 (s), 1178, 1159 (m), 1114 (s), 1052 (m), 1021 (s), 
996, 818, 787 (m), 742 (s), 693, 582 (m). GC-MS (EI, 70 eV): m/z (%) = 350(51) [M
+
 (
8¹
Br, 
8¹
Br)], 348(100) [M
+
 (
8¹
Br, Br)], 346(39) [M
+
 (Br, Br)], 254(54), 252(53), 173(36), 145(25). 
HRMS (EI, 70 eV): calcd for C11H8 Br2NOS [M
+
 (Br,
 8¹
Br)]: 347.86367; found: 347.86378.  
 
2,3-Dibromo-5-(3-fluorophenyl)thiophene (2g): 
Starting with 1 (0.159 g, 0.5 mmol) and 3-fluorophenyl boronic 
acid (0.077 g, 0.55 mmol), 2g was isolated (0.067 g, 40%) as a 
white solid, mp. = 65-67 °C. 
1
H NMR (300 MHz, CDCl3): 
δ = 6.91-6.98 (m, 1H, ArH), 7.03 (s, 1H, CHthiophene), 7.07-7.12 
(m, 1H, ArH), 7.15-7.19 (m, 1H, ArH), 7.23-7.31 (m, 1H, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 110.9 (CBr), 112.4 (d, JF,C = 23.1 Hz, CH), 114.8 (CBr), 
115.4 (d, JF,C = 21.4 Hz, CH), 121.2 (d, JF,C = 3.0 Hz, CH), 126.3 (CH), 130.7 (d, 
JF,C = 8.7 Hz, CH), 134.6 (d, JF,C = 8.2 Hz, C), 143.8 (d, JF,C = 2.7 Hz, C), 163.1 (d, 
JF,C = 245.8 Hz, CF). 
19
F NMR (282 MHz, CDCl3): δ = -111.9 (ArF). IR (KBr, cm
−1
): v = 
2920, 2850, 1608, 1583, 1484, 1462, 1443, 1247, 1180, 1156, 1005, 985, 854, 821, 808 (m), 
776, 673 (s), 607, 570 (m). GC-MS (EI, 70 eV): m/z (%) = 338(52) [M
+
 (
8¹
Br)], 336(100) [M
+ 
(Br)], 176(58), 132(15), 88(15). HRMS (EI, 70 eV): calcd for C10H5Br2FS [M
+ 
(Br)]: 
335.84368; found: 335.84340.  
 
2,3-Dibromo-5-(4-chlorophenyl)thiophene (2h): 
Starting with 1 (0.159 g, 0.5 mmol) and 4-chlorophenylboronic 
acid (0.086 g, 0.55 mmol), 2h was isolated (0.079 g, 45%) as a 
white semi solid. 
1
H NMR (300 MHz, CDCl3): δ =  7.15 (s, 1H, 
CHthiophene), 7.27-7.31 (m, 1H, ArH), 7.33 (dd, 1H, J = 2.1, 
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6.6 Hz, ArH), 7.41 (dd, 1H, J = 2.1, 6.6 Hz, ArH), 7.54 (dd, 1H, J = 2.0, 6.6 Hz, ArH). 
13
C 
NMR (62 MHz, CDCl3): δ = 110.5, 114.8 (CBr), 125.9 (CH), 126.6 (2CH), 129.3 (2CH), 
131.2, 134.5, 144.0 (C). IR (KBr, cm
−1
): v = 3119, 2945, 2692 (w), 1479, 1454 (m), 1402, 
1374, 1349 (w), 1317 (m), 1266, 1212, 1180, 1134 (w), 1086, 1006, 945 (m), 829, 821, 767 
(s), 755, 735, 717, 700, 602, 574, 529 (m). GC-MS (EI, 70 eV): m/z (%) = 356(14) [M
+
 (
8¹
Br, 
8¹
Br,
37
Cl)], 354(69) [M
+
 (
8¹
Br, 
8¹
Br,
 
Cl); (Br, 
8¹
Br,
37
Cl)], 352(100) [M
+
 (Br, 
8¹
Br,
35
Cl); (Br, 
Br,
37
Cl)], 350(36) [M
+
 (Br, Br,
 
Cl)],  194(17), 192(51), 113(11). HRMS (EI, 70 eV): calcd for 
C10H5Br2ClS [M
+
 (Br, 
8¹
Br,
 
Cl)]: 351.81413; found: 351.81418; [M
+
 (Br, Br, 
37
Cl)]: 
351.81323; found: 351.81418. 
 
Synthesis of 2,5-diaryl-3-bromothiophes (3): 
 
 To a mixture of 1 (0.159 g, 0.5 mmol), aryl boronic acid (1.1 mmol), and Pd(PPh3)4  (29 mg, 
5 mol-%) was added a mixture of 1,4-dioxane and toluene (1:1; 5 mL) and K3PO4 (4.0 equiv, 
424 mg) under an argon atmosphere. The reaction mixture was stirred at 100 °C for 12 h and 
was subsequently allowed to cool to 20 °C. The solution was poured into H2O and EtOAc 
(25 mL each) and the organic and the aqueous layers were separated. The latter was extracted 
with EtOAc (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The residue 
was purified by flash column chromatography (flash silica gel, eluent: n-heptane/EtOAc).  
 
3-Bromo-2,5-di-p-tolylthiophene (3a): 
Starting with 1 (0.159 g, 0.5 mmol) and 4-methyl 
phenyl  boronic acid (0.149 g, 1.1 mmol), 3a was 
isolated (0.094 g, 55%) as yellowish solid, mp. = 101-
103 °C. 
1
H NMR (300 MHz, CDCl3): δ = 2.29 (s, 3H, 
CH3), 2.32 (s, 3H, CH3), 7.10-7.13 (m, 3H, ArH and CHthiophene), 7.16 (d, 2H, J = 8.0 Hz, 
ArH), 7.38 (d, 2H, J = 8.1 Hz, ArH), 7.50 (d, 2H, J = 8.1 Hz, ArH). 
13
C NMR (62 MHz, 
CDCl3): δ = 21.2, 21.3 (CH3), 107.5 (CBr), 125.4 (2CH), 126.7 (C), 126.8 (CH), 128.7 (2CH), 
129.3 (2CH), 129.7 (2CH), 130.0, 130.5, 138.1, 138.2, 143.0 (C). IR (KBr, cm
−1
): v = 3020, 
2916, 1494, 1453, 1326, 1307,1186, 1112, 1019, 971, 943, 830 (w), 806 (s), 712, 697, 638, 
624 (w), 609 (m), 566, 557 (w). GC-MS (EI, 70 eV): m/z (%) = 344(100) [M
+
 (
8¹
Br)], 342(98) 
[M
+ 
(Br)], 248(11). HRMS (EI, 70 eV): calcd for C18H15BrS [(
8¹
Br)]: 344.00519; found: 
344.00415.  
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 3-Bromo-2,5-bis(4-ethylphenyl)thiophene (3b): 
Starting with 1 (0.159 g, 0.5 mmol) and 4-ethyl 
phenylboronic acid (0.165 g, 1.1 mmol), 3b was 
isolated (0.124 g, 67%) as a colorless solid, mp. = 49-
50 °C. 
1
H NMR (300 MHz, CDCl3): δ = 1.17 (t, 3H, 
J = 7.6 Hz, CH3), 1.19 (t, 3H, J = 7.6 Hz, CH3), 2.59 
(q, 2H, J = 7.6 Hz, CH2), 2.61 (q, 2H, J = 7.6 Hz, CH2),  7.12-7.15 (m, 3H, ArH and 
CHthiophene), 7.18 (d, 2H, J = 8.3 Hz, ArH), 7.40 (dd, 2H, J = 1.8, 6.4 Hz, ArH), 7.53 (dd, 2H, 
J = 1.8, 6.4 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 15.4, 15.5 (CH3), 28.6, 28.7 (CH2), 
107.5 (CBr), 125.5 (2CH), 126.9 (CH), 128.0 (2CH), 128.5 (2CH), 128.8 (2CH), 130.3, 
130.7, 136.9, 143.0, 144.4, 144.5 (C). IR (KBr, cm
−1
): v = 3020, 2963, 2929 (w), 1495, 1453 
(m),1411, 1324, 1185, 1117, 1050, 1019, 973 (w), 840 (m), 814 (s), 771, 609, 531 (m). GC-
MS (EI, 70 eV): m/z (%) = 372(100) [M
+
 (
8¹
Br)], 370(99) [M
+ 
(Br)], 357(64), 355(64), 
342(18), 340(17), 130(10). HRMS (EI, 70 eV): calcd for C20H19BrS [M
+ 
(
8¹
Br)]: 372.03649; 
found: 372.03628.  
 
3-Bromo-2,5-bis(3,5-dimethylphenyl)thiophene (3c): 
Starting with 1 (0.159 g, 0.5 mmol) and 3,5-dimethyl 
phenyl boronic acid (0.165 g, 1.1 mmol), 3c was 
isolated (0.091 g, 49%) as a brown oil. 
1
H NMR 
(250 MHz, CDCl3): δ = 2.28 (s, 12H, 4CH3), 6.88 (br, 
2H,  ArH and CHthiophene), 7.10 (br,  5H, ArH). 
13
C NMR 
(62 MHz, CDCl3): δ = 21.4 (4CH3), 107.5 (CBr), 125.1 (5CH), 128.7 (2CH), 138.1 (6C), 
141.5 (2C). IR (KBr, cm
−1
): v = 3087, 2913, 2854 (w), 1596, 1454 (m), 1373 (w), 1321 (m), 
1286, 1155, 1034, 993, 885 (w), 836, 816 (s), 775, 679, 666, 593 (m), 543 (w). GC-MS (EI, 
70 eV): m/z (%) = 372(100) [M
+
 (
8¹
Br)], 370(92) [M
+ 
(Br)]. HRMS (EI, 70 eV): calcd for 
C20H19BrS [(
 8¹
Br)]: 372.03649; found: 372.03657.  
 
3-Bromo-2,5-bis(3-fluorophenyl)thiophene (3d): 
Starting with 1 (0.159 g, 0.5 mmol) and 3-fluorophenyl 
boronic acid (0.154 g, 1.1 mmol), 3d was isolated (0.079 g, 
45%) as a white solid, mp. = 54-56 °C. 
1
H NMR (300 MHz, 
CDCl3): δ = 6.90-7.04 (m, 2H, ArH), 7.18 (s, 1H, 
84 
 
CHthiophene), 7.24-7.40 (m, 6H, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 108.6 (CBr), 112.5 (d, 
JF,C = 23.0 Hz, CH), 115.2 (d, JF,C = 21.3 Hz, CH), 115.4 (d, JF,C = 21.2 Hz, CH), 115.7 (d, 
JF,C = 23.0 Hz, CH), 121.1 (d, JF,C = 3.0 Hz, CH), 124.5 (d, JF,C = 3.1 Hz, CH), 128.2 (CH), 
130.2 (d, JF,C = 8.6 Hz, CH), 130.7 (d, JF,C = 8.6 Hz, CH), 134.5 (d, JF,C = 8.5 Hz, C), 135.0 
(d, JF,C = 8.1 Hz, C), 136.4 (d, JF,C = 2.5 Hz, C), 142.2 (d, JF,C = 2.8 Hz, C), 162.6 (d, 
JF,C = 246.9 Hz, CF), 163.1 (d, JF,C = 246.9 Hz, CF). 
19
F NMR (282 MHz, CDCl3): δ = -112.2, 
-112.1 (ArF). IR (KBr, cm
−1
): v = 1608 (m), 1581 (s), 1483, 1470, 1436, 1262, 1247, 1174 
(m), 1156 (s), 1141, 1075, 1015, 993, 872, 839, 825, 817 (m), 781, 770 (s), 703, 684 (m), 674 
(s), 625, 606 (m). GC-MS (EI, 70 eV): m/z (%) = 352(100) [M
+
 (
8¹
Br)], 350(97) [M
+ 
(Br)], 
270(25), 238(14), 227(15), 139(18). HRMS (EI, 70 eV): calcd for C16H9BrF2S [M
+ 
(
8¹
Br)]: 
351.95504; found: 351.95582.  
 
Synthesis of 2,3,5-triarylthiophenes (4): 
 
To a mixture of 1 (0.080 g, 0.25 mmol), arylboronic acid (1.0 mmol), Pd(PPh3)4 (57 mg, 10 
mol-%) were added a mixture of 1,4-dioxane and toluene (1:1, 5 mL) and an aq solution of 
K2CO3 (2 mL, 2 M) under argon atmosphere. The reaction mixture was stirred at 90 °C for 8 
h and was subsequently allowed to cool to 20 °C. The solution was poured into H2O and 
CH2Cl2 (25 mL each) and the organic and the aqueous layer were separated. The latter was 
extracted with CH2Cl2 (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The 
residue was purified by flash column chromatography (flash silica gel, n-heptane). 
 
2,3,5-Tri-p-tolylthiophene (4a): 
Starting with 1 (0.080 g, 0.25 mmol) and 4-methyl 
phenylboronic acid (0.136 g, 1.0 mmol), 4a was 
isolated (0.081 g, 92%) as colorless solid, mp. =  
125-126 °C. 
1
H NMR (300 MHz, CDCl3): δ = 2.38 
(s, 3H, CH3), 2.39 (s, 3H, CH3), 2.41 (s, 3H, CH3), 
7.10-7.17 (m, 4H, ArH), 7.22-7.29 (m, 6H, ArH), 
7.34 (s, 1H, CHthiophene), 7.44 (dd, 2H, J = 1.7, 6.4 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 
21.2 (3CH3), 125.5 (2CH), 126.1 (CH), 128.9 (2CH), 129.0 (2CH), 129.1 (2CH), 129.2 
(2CH), 129.6 (2CH), 131.5, 131.4, 133.9, 136.5, 137.1, 137.2, 137.4, 138.5, 142.2 (C). IR 
(KBr, cm
−1
): v = 3023, 2915, 2855, 1512, 1497, 1443, 1309, 1183,  1118, 1035, 1017, 972, 
85 
 
943, 848 (w), 819 (m), 806 (s), 781 (m), 715, 673, 576, 565 (w), 539 (m). GC-MS (EI, 
70 eV): m/z (%) = 354(100) [M
+
]. HRMS (EI, 70 eV): calcd for C25H22S [M
+
]: 354.14367; 
found: 354.14372.  
 
2,3,5-Tris(4-tert-butylphenyl)thiophene (4b): 
Starting with 1 (0.08 g, 0.25 mmol) and 4-tert-
butylphenylboronic acid (0.178 g, 1.0 mmol), 4b 
was isolated (0.104 g, 87%) as a white solid, 
mp. = 166-168 °C. 
1
H NMR (300 MHz, CDCl3): 
δ = 1.24 (s, 9H, 3CH3), 1.26 (s, 9H, 3CH3), 1.27 (s, 
9H, 3CH3), 7.20 (br, 4H, ArH), 7.21-7.23 (m, 5H, 
ArH and CHthiophene), 7.32 (d, 2H, J = 8.5 Hz, ArH), 
7.44 (d, 2H, J = 8.3 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 31.3 (6CH3), 31.4 (3CH3), 
34.5, 34.6, 34.7 (C), 125.2 (2CH), 125.3 (4CH), 125.8 (2CH), 126.4 (CH), 128.5 (2CH), 
128.6 (2CH), 131.5 (2C), 133.9, 137.3, 138.4, 141.9, 149.7, 150.2, 150.6 (C). IR (KBr, cm
−1
): 
v = 2957, 2949 (m), 2900, 2863, 1512, 1496, 1460, 1392 (w), 1360, 1267 (m), 1245, 1201, 
1109, 1017, 977, 869 (w), 821 (s), 735, 719, 682, 670 (w), 568, 555, 540, 531 (m). GC-MS 
(EI, 70 eV): m/z (%) = 480(100) [M
+
], 466(12), 465(48). HRMS (EI, 70 eV): calcd for 
C34H40S [M
+
]: 480.28452; found: 480.28478.  
 
2,3,5-Tris(3,5-dimethylphenyl)thiophene (4c): 
Starting with 1 (0.08 g, 0.25 mmol) and 3,5-dimethyl 
phenylboronic acid (0.150 g, 1.0 mmol), 4c was isolated 
(0.077 g, 78%) as a white solid, mp. = 137-139 °C. 
1
H 
NMR (300 MHz, CDCl3): δ = 2.15 (s, 6H, 2CH3), 2.18 
(s, 6H, 2CH3), 2.28 (s, 6H, 2CH3), 6.79 (br, 1H, ArH), 
6.82 (br, 1H, ArH), 6.85 (br, 1H, ArH), 6.89 (br, 4H, 
ArH), 6.19 (br, 2H, ArH), 7.23 (s, 1H, CHthiophene). 
13
C 
NMR (62 MHz, CDCl3): δ = 21.1 (2CH3), 21.2 (2CH3), 21.3 (2CH3), 123.5 (2CH), 126.4 
(CH), 126.7 (2CH), 126.8 (2CH), 128.5, 128.9, 129.2 (CH), 134.1, 134.2, 136.6 (C), 137.6 
(2C), 137.7 (3C), 138.4 (2C), 138.8, 142.2 (C). IR (KBr, cm
−1
): v = 2918 (m), 2859 (w), 1599 
(m), 1458, 1369, 1261, 1088 (w), 846 (s), 799, 755, 705, 687 (m), 666 (w). GC-MS (EI, 
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70 eV): m/z (%) = 396(100) [M
+
]. HRMS (EI, 70 eV): calcd for C28H28S [M
+
]: 396.19062; 
found: 396.19064.  
 
2,3,5-Tris(3-fluorophenyl)thiophene (4d): 
Starting with 1 (0.080 g, 0.25 mmol) and 3-fluorophenyl boronic 
acid (0.140 g, 1.0 mmol), 4d was isolated (0.069 g, 76%) as a 
colorless oil. 
1
H NMR (300 MHz, CDCl3): δ = 6.85-7.01 (m, 7H, 
ArH), 7.11-7.32 (m, 6H, ArH and CHthiophene). 
13
C NMR 
(75 MHz, CDCl3): δ = 112.5 (d, JF,C = 22.9 Hz, CH), 114.3 (d, 
JF,C = 21.0 Hz, CH), 114.7 (d, JF,C = 21.1 Hz, CH), 114.8 (d, 
JF,C = 21.1 Hz, CH), 115.4 (d, JF,C = 21.8 Hz, CH), 115.5 (d, JF,C = 22.4 Hz, CH), 121.3 (d, 
JF,C = 2.9 Hz, CH), 124.8 (d, JF,C = 2.8 Hz, CH), 124.9 (d, JF,C = 2.8 Hz, CH), 126.9 (CH), 
130.1 (d, JF,C = 8.4 Hz, CH), 130.2 (d, JF,C = 8.5 Hz, CH), 130.6 (d, JF,C = 8.6 Hz, CH), 135.6 
(d, JF,C = 8.3 Hz, C), 135.8 (d, JF,C = 8.3 Hz, C), 137.6 (d, JF,C = 2.4 Hz, C), 138.1 (d, 
JF,C = 7.9 Hz, C), 138.4 (d, JF,C = 2.2 Hz, C), 142.0 (d, JF,C = 2.7 Hz, C), 162.7 (d, 
JF,C = 246.9 Hz, CF), 162.8 (d, JF,C = 246.3 Hz, CF), 163.6 (d, JF,C = 246.3 Hz, CF). IR (KBr, 
cm
−1
): v = 3069, 2925, 2853 (w), 1607, 1580 (s), 1474, 1439 (m), 1370 (w), 1266, 1257, 
1185, 1170 (m), 1154 (s), 1076, 941, 873, 844, 831 (m), 776 (s), 693, 679 (m), 613 (w). GC-
MS (EI, 70 eV): m/z (%) = 366(100) [M
+
]. HRMS (EI, 70 eV): calcd for C22H13F3S [M
+
]: 
366.06846; found: 366.06837.  
 
2,3,5-Tris(2-methoxyphenyl)thiophene (4e): 
Starting with 1 (0.080 g, 0.25 mmol) and 2-methoxyphenyl 
boronic acid (0.152 g, 1.0 mmol), 4e was isolated (0.081 g, 
81%) as a white solid, mp. =  121-123 °C. 
1
H NMR (300 MHz, 
CDCl3): δ = 3.40 (s, 3H, OCH3), 3.48 (s, 3H, OCH3), 3.80 (s, 
3H, OCH3), 6.69-6.76 (m, 4H, ArH), 6.85-6.91 (m, 2H, ArH), 
7.02 (dd, 1H, J = 1.5, 7.5 Hz, ArH). 7.01-7.17 (m, 4H, ArH), 
7.50 (s, 1H, CHthiophene), 7.59 (dd, 1H, J = 1.7, 7.6 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 
55.2, 55.3, 55.6 (OCH3), 111.0, 111.2, 111.7, 120.3, 120.4, 120.9 (CH), 123.7, 124.4, 127.2 
(C), 128.0, 128.1, 128.3, 128.7, 128.9, 131.0, 131.7 (CH), 135.7, 135.9, 137.5, 155.8, 156.5, 
156.6 (C). IR (KBr, cm
−1
): v = 2998, 2930, 2833 (w), 1609 (m), 1571, 1532 (w), 1520, 1509, 
1494, 1454, 1436, 1286 (m), 1244, 1173 (s), 1104 (m), 1029 (s), 952, 902, 876 (w), 824, 812 
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(s), 794, 785, 768, 750, 551 (m). GC-MS (EI, 70 eV): m/z (%) = 402(100) [M
+
]. HRMS (EI, 
70 eV): calcd for C25H22O3S [M
+
]: 402.12842; found: 402.12834.  
 
 2,3,5-Tris(2,5-dimethoxyphenyl)thiophene (4f): 
Starting with 1 (0.080 g, 0.25 mmol) and 2,5-
dimethoxyphenylboronic acid (0.182 g, 1.0 mmol), 4f 
was isolated (0.111 g, 91%) as a white solid, mp. =  
138-140 °C. 
1
H NMR (300 MHz, CDCl3): δ = 3.45 (s, 
3H, OCH3), 3.49 (s, 3H, OCH3), 3.53 (s, 3H, OCH3), 
3.54 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 3.81 (s, 3H, 
OCH3), 6.65-6.75 (m, 7H, ArH), 6.84 (d, 1H, J = 8.9 Hz, ArH), 7.18 (s, 1H, CHthiophene), 7.52 
(s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 55.6, 55.7, 55.8, 56.0, 56.1, 56.6 (OCH3), 
112.5, 112.7, 113.1, 113.2, 113.5, 113.7, 114.3, 116.3, 116.6 (CH), 118.6, 120.7, 124.4, 
124.9, 127.7 (C), 128.7 (CH), 135.8, 137.4, 150.2, 150.9, 153.2, 153.3, 153.7 (C). IR (KBr, 
cm
−1
): v = 2996, 2932, 2834 (w), 1606, 1573, 1494, 1452, 1413, 1304 (m), 1279, 1204, 1154 
(s), 1124, 1091 (m), 1025 (s), 973, 908, 836, 825 (m), 811  (s), 792, 628, 566 (m). GC-MS 
(EI, 70 eV): m/z (%) = 492(100) [M
+
], 446(11), 71(11), 57(17), 44(14). HRMS (EI, 70 eV): 
calcd for C28H28O6S [M
+
]: 492.16011; found: 492.16048.  
 
2,3,5-Tris(4-vinylphenyl)thiophene (4g): 
Starting with 1 (0.080 g, 0.25 mmol) and 4-vinyl 
phenylboronic acid (0.148 g, 1.0 mmol), 4g was 
isolated (0.086 g, 88%) as colorless solid, mp. =  
156-158 °C. 
1
H NMR (300 MHz, CDCl3): δ = 5.15-
5.21 (m, 3H, CH), 5.62-5.72 (m, 3H, CH), 6.55-6.69 
(m, 3H, CH), 7.19-7.22 (m, 6H, ArH), 7.26-7.29 (m, 
3H, ArH and CHthiophene), 7.34 (d, 2H, J = 8.3 Hz, 
ArH), 7.51 (dd, 2H, J = 1.7, 6.7 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 113.9, 114.0, 
114.1 (CH2), 125.6 (2CH), 126.3 (2CH), 126.4 (2CH), 126.5 (CH), 126.8 (2CH), 129.1 
(2CH), 129.1 (2CH), 133.4, 133.6, 136.0 (C), 136.2, 136.3 (CH), 136.4 (C), 136.5 (CH), 
136.7, 137.0, 137.8, 138.8, 142.3 (C). IR (KBr, cm
−1
): v = 1625, 1600, 1511, 1495, 1402, 
1202, 1116 (w), 987, 899 (m), 824 (s), 703, 678, 563, 534 (m). GC-MS (EI, 70 eV): m/z 
88 
 
(%) = 390(100) [M
+
], 173(13), 166(10). HRMS (EI, 70 eV): calcd for C28H22S [M
+
]: 
390.14367; found: 390.14391.  
 
2,3,5-Tris(4-chlorophenyl)thiophene (4h): 
Starting with 1 (0.08 g, 1.0 mmol) and 4-chloro 
phenylboronic acid (0.156 g, 1.0 mmol), 4h was 
isolated (0.074 g, 72%) as a brown oil. 
1
H NMR 
(300 MHz, CDCl3): δ = 7.12-7.15 (m, 4H, ArH), 7.17-
7.22 (m, 5H, ArH and CHthiophene), 7.28 (dd, 2H, 
J = 2.0, 6.7 Hz, ArH), 7.46 (dd, 2H, J = 2.1, 6.7 Hz, 
ArH). 
13
C NMR (62 MHz, CDCl3): δ = 126.5 (CH), 126.8 (2CH), 128.8 (2CH), 128.9 (2CH), 
129.2 (2CH), 130.2 (2CH), 130.3 (2CH), 132.2, 132.2, 133.3, 133.7, 133.8, 134.5, 137.2, 
138.2, 141.9 (C). IR (KBr, cm
−1
): v = 2921, 1905, 1546 (w), 1492, 1481 (m),  1454, 1395, 
1303, 1247, 1210, 1114 (w), 1092, 1084, 1012 (m), 976, 952, 865, 852 (w), 833 (m), 816 (s), 
738 (m),  715, 671, 628, 585, 565 (w). GC-MS (EI, 70 eV): m/z (%) = 420(6) [M
+
 (
37
Cl, 
37
Cl, 
37
Cl)], 418(38) [M
+
 (Cl, 
37
Cl, 
37
Cl)], 416(96) [M
+
 (Cl, Cl, 
37
Cl)], 414(100) [M
+
 (Cl, Cl, Cl)], 
378(10), 346(11), 344(25), 308(13), 173(14), 172(29), 155(12), 154(19), 132(17). HRMS (EI, 
70 eV): calcd for C22H13Cl3S  [M
+
 (Cl, Cl, 
37
Cl)]: 415.97686 found: 415.97688.  
 
2,3,5-Tris(4-fluorophenyl)thiophene (4i): 
Starting with 1 (0.080 g, 0.25 mmol) and 4-fluorophenyl 
boronic acid (0.140 g, 1.0 mmol), 4i was isolated 
(0.077 g, 84%) as a colorless solid, mp. = 109-111 °C. 
1
H 
NMR (300 MHz, CDCl3): δ = 6.84-6.92 (m, 4H, ArH), 
6.95-7.01 (m, 2H, ArH), 7.12-7.17 (m, 5H, ArH and 
CHthiophene), 7.45-7.50 (m, 2H, ArH) . 
13
C NMR (62 MHz, 
CDCl3): δ = 115.5 (d, JF,C = 21.3 Hz, CH), 115.6 (d, 
JF,C = 21.3 Hz, CH), 116.0 (d, JF,C = 21.3 Hz, CH), 126.1 (CH), 127.3 (d, JF,C = 8.0 Hz, 3CH), 
129.9 (d, JF,C = 3.5 Hz, C), 130.1 (d, JF,C = 3.5 Hz, C), 130.5 (d, JF,C = 8.0 Hz, 3CH), 130.8 (d, 
JF,C = 8.0 Hz, 3CH), 132.2 (d, JF,C = 3.4 Hz, C), 136.7, 138.0, 141.6 (C), 162.0 (d, 
JF,C = 246.9 Hz, CF), 162.3 (d, JF,C = 248.0 Hz, CF), 162.5 (d, JF,C = 247.7 Hz, CF).
 19
F NMR 
(282 MHz, CDCl3): δ = -113.8, -113.9, -114.7 (ArF). IR (KBr, cm
−1
): v = 2925, 2853 (w), 
1610, 1580 (s), 1475, 1439 (m), 1370 (w), 1265, 1257, 1189, 1172 (m), 1150 (s), 1076, 941, 
89 
 
873, 844, 831 (m), 777 (s), 693, 679 (m), 613 (w). GC-MS (EI, 70 eV): m/z (%) = 366(100) 
[M
+
]. HRMS (EI, 70 eV): calcd for C22H13F3S [M
+
]: 366.06846; found: 366.06840.  
 
 2,3,5-Tris(2,4-dimethoxyphenyl)thiophene (4j): 
Starting with 1 (0.080 g, 0.25 mmol) and 2,4-
dimethoxyphenylboronic acid (0.182 g, 1.0 mmol), 
4j was isolated (0.115 g, 94%) as a violet oil, 
mp. =  125-126 °C. 
1
H NMR (300 MHz, CDCl3): 
δ = 3.48 (s, 3H, OCH3), 3.54 (s, 3H, OCH3), 3.71 
(s, 6H, 2OCH3), 3.75 (s, 3H, OCH3), 3.81 (s, 3H, 
OCH3), 6.27-6.38 (m, 4H, ArH), 6.43-6.47 (m, 2H, 
ArH), 6.93 (d, 1H, J = 8.3 Hz, ArH), 7.04 (d, 1H, J = 8.0 Hz, ArH), 7.34 (s, 1H, CHthiophene), 
7.43 (d, 1H, J = 9.0 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 55.2 (2OCH3), 55.3 (2OCH3), 
55.4, 55.5 (OCH3), 98.8 (2CH), 104.1 (2CH), 104.3, 105.0 (CH), 117.0, 117.3 (C), 120.1 
(2C), 127.8, 129.1, 131.4, 132.2 (CH), 135.1 (2C), 156.8 (C), 157.6 (2C), 159.7 (3C). IR 
(KBr, cm
−1
): v = 2996, 2932, 2834 (w), 1606, 1573, 1494, 1452, 1413, 1304 (m), 1279, 1204, 
1154 (s), 1124, 1091 (m), 1025 (s), 973, 908, 836, 825 (m), 811  (s), 792, 628, 566 (m). GC-
MS (EI, 70 eV): m/z (%) = 492(100) [M
+
], 477(11), 246(13), 151(17). HRMS (EI, 70 eV): 
calcd for C28H28O6S [M
+
]: 492.16011; found: 492.16065.  
 
 2,3,5-Tris(3,4-dimethoxyphenyl)thiophene (4k): 
Starting with 1 (0.080 g, 0.25 mmol) and 3,4-
dimethoxyphenylboronic acid (0.182 g, 1.0 mmol) 
, 4k was isolated (0.108 g, 88%) as a pink semi 
solid. 
1
H NMR (300 MHz, CDCl3): δ = 3.45 (s, 
3H, OCH3), 3.49 (s, 3H, OCH3), 3.53 (s, 3H, 
OCH3), 3.54 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 
3.81 (s, 3H, OCH3), 6.65-6.66 (m, 1H, ArH), 
6.67-6.72 (m, 4H, ArH), 6.73-6.75 (m, 2H, ArH), 6.84 (d, 1H, J = 8.9 Hz, ArH), 7.18 (s, 1H, 
CHthiophene), 7.52 (s, 1H, ArH). 
13
C NMR (75 MHz, CDCl3): δ = 55.7, 55.8, 55.9, 55.9, 56.0, 
56.0 (OCH3), 109.1, 1121.1, 111.2, 111.6, 112.4, 112.5, 118.3, 121.4, 121.5, 125.5 (CH), 
127.1, 127.3, 129.6, 136.5, 138.1, 141.8, 148.1, 148.5, 148.6, 148.7, 148.9, 148.3 (C). IR 
(KBr, cm
−1
): v = 2993, 2929, 2834 (w), 1610, 1576, 1494, 1452, 1412, 1307 (m), 1281, 1204, 
90 
 
1154 (s), 1122, 1090 (m), 1027 (s), 978, 908, 835, 825 (m), 812  (s), 792, 629, 564 (m). MS 
(EI, 70 eV): m/z (%) = 492(100) [M
+
], 477(16), 181(10), 169(10), 131(12), 119(11), 71(10), 
69(48), 57(16), 55(13), 44(30), 41(12). HRMS (EI, 70 eV): calcd for C28H28O6S [M
+
]: 
492.16011; found: 492.16075.  
 
Synthesis of unsymmetrical 2,3,5-triarylbromothiophes (5): 
 
3-(4-Ethylphenyl)-2,5-di-p-tolylthiophene (5a): 
Starting with 3a (0.086 g, 0.25 mmol) and 4-
ethylphenylboronic acid (0.075 g, 0.5 mmol), 5a was 
isolated (0.084 g, 92%) as yellowish semi solid. 
1
H 
NMR (2500 MHz, CDCl3): δ = 1.16 (t, 3H, 
J = 7.6 Hz, CH3), 2.24 (s, 3H, CH3), 2.28 (s, 3H, 
CH3), 2.56 (q, 2H, J = 7.6 Hz, CH2), 2.59 (q, 2H, 
J = 7.6 Hz, CH2), 6.96-7.08 (m, 4H, ArH), 7.11-7.18 (m, 6H, ArH), 7.21 (s, 1H, CHthiophene), 
7.44 (d, 2H, J = 8.1 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 15.4 (CH3), 21.2 (2CH3), 28.6 
(CH2), 125.5 (2CH), 126.1 (CH), 127.9 (2CH), 128.9 (2CH), 129.0 (2CH), 129.2 (2CH), 
129.6 (2CH), 131.5, 131.6, 134.1, 137.1, 137.3, 137.4, 138.5, 142.2, 142.9 (C). IR (KBr, 
cm
−1
): v = 2963, 2916, 2852, 1512, 1497, 1455, 1184, 1120, 1016, 971 (w), 832, 819 (m), 809 
(s), 769, 730, 717, 675, 634, 585, 540 (w). GC-MS (EI, 70 eV): m/z (%) = 368(100) [M
+
], 
353(15). HRMS (EI, 70 eV): calcd for C26H24S [M
+
]: 368.15932; found: 368.15939.  
 
2,5-Bis(4-ethylphenyl)-3-p-tolylthiophene (5b) 
Starting with 3b (0.093 g, 0.25 mmol) and 4-methyl 
phenylboronic acid (0.068 g, 0.5 mmol), 5b was 
isolated (0.083 g, 87%) as a brown semi solid. 
1
H 
NMR (300 MHz, CDCl3): δ = 1.16 (t, 3H, J = 7.7 Hz, 
CH3), 1.19 (t, 3H, J = 7.7 Hz, CH3), 2.28 (s, 3H, CH3), 
2.56 (q, 2H, J = 7.6 Hz, CH2), 2.59 (q, 2H, J = 7.6 Hz, 
CH2), 7.01-7.05 (m, 4H, ArH), 7.13-7.19 (m, 6H, ArH), 7.21 (s, 1H, CHthiophene), 7.48 (d, 2H, 
J = 8.1 Hz, ArH). 
13
C NMR (75 MHz, CDCl3): δ = 15.3, 15.5, 21.2 (CH3), 28.5, 28.6 (CH2), 
125.6 (2CH), 126.1 (CH), 127.9 (2CH), 128.4 (2CH), 128.9 (2CH), 129.0 (2CH), 129.1 
(2CH), 131.8 (2C), 133.9, 136.5, 137.3, 138.5, 142.2, 143.4, 143.8 (C). IR (KBr, cm
−1
): v = 
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3022, 2961, 2920, 2852, 1513, 1497, 1453, 1182, 1117, 1019, 979 (w), 825 (m), 811 (s), 783 
(m), 719, 675, 635, 569 (w), 534 (m). GC-MS (EI, 70 eV): m/z (%) = 382(100) [M
+
], 
367(32). HRMS (EI, 70 eV): calcd for C27H26S [M
+
]: 382.17497; found: 382.17515.  
 
3-(2-Ethoxyphenyl)-2,5-bis(4-ethylphenyl)thiophene (5c): 
Starting with 3b (0.093 g, 0.25 mmol) and 2-ethoxy 
phenylboronic acid (0.083 g, 0.5 mmol), 5c was 
isolated (0.085 g, 83%) as a brown oil. 
1
H NMR 
(300 MHz, CDCl3): δ = 0.98 (t, 3H, J = 7.0 Hz, CH3), 
1.16 (t, 3H, J = 7.6 Hz, CH3), 1.18 (t, 3H, J = 7.6 Hz, 
CH3), 2.50 (q, 2H, J = 7.6 Hz, CH2), 2.58 (q, 2H, 
J = 7.6 Hz, CH2), 3.73 (q, 2H, J = 7.0 Hz, OCH2), 6.77-6.85 (m, 2H, ArH), 6.96 (d, 2H, 
J = 8.3 Hz, ArH), 7.11-7.17 (m, 6H, ArH), 7.23 (s, 1H, CHthiophene), 7.47 (d, 2H, J = 1.8, 
6.5 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 14.4 (CH3), 15.5 (2CH3), 28.5, 28.6 (CH2), 
63.7 (OCH2), 112.4, 120.5 (CH), 125.5 (2CH), 126.4 (C), 127.3 (CH), 127.7 (2CH), 127.9 
(2CH), 128.3 (2CH), 128.5, 131.7 (CH), 132.0, 132.7, 134.8, 138.8, 141.2, 143.1, 143.5, 
156.2 (C). IR (KBr, cm
−1
): v = 3020, 2961, 2927, 2870, 1597, 1579, 1548 (w), 1505, 1489, 
1474, 1450, 1439 (m), 1412, 1389, 1372, 1281 (w), 1241, 1119, 1044 (m), 1020, 978, 924 
(m), 825, 747 (s), 704, 676, 648, 634, 601, 575 (w). GC-MS (EI, 70 eV): m/z (%) = 412(100) 
[M
+
], 293(16). HRMS (EI, 70 eV): calcd for C28H28OS [M
+
]: 412.18554; found: 412.18582.  
 
Synthesis of unsymmetrical 2,3,5-triarylbromothiophes (6): 
 
2,3-Bis(4-methoxyphenyl)-5-p-tolylthiophene (6): 
Starting with 2a (0.083 g, 0.25 mmol) and 4-
methoxyphenylboronic acid (0.114 g, 0.75 mmol), 
6 was isolated (0.081 g, 84%) as a brown oil. 
1
H 
NMR (300 MHz, CDCl3): δ = 2.29 (s, 3H, CH3), 
3.72 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 6.73 (dd, 
2H, J = 2.1, 6.8 Hz, ArH), 6.76 (dd, 2H, J = 2.1, 
6.8 Hz, ArH), 7.10-7.13 (m, 2H, ArH), 7.15-7.18 (m, 4H, ArH), 7.20 (s, 1H, CHthiophene), 7.44 
(d, 2H, J = 1.9, 6.5 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 21.2 (CH3), 55.2 (2OCH3), 
113.8 (2CH), 113.9 (2CH), 125.4 (2CH), 125.9 (CH), 126.9, 129.3 (C), 129.6 (2CH), 130.1 
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(2CH), 130.3 (2CH), 131.5, 136.6, 137.3, 137.8, 141.8, 158.5, 158.9 (C). IR (KBr, cm
−1
): v = 
2996, 2952, 2928, 2832 (w), 1605 (m), 1570, 1550 (w), 1511 (m), 1496 (s), 1454, 1438, 1288 
(m), 1240, 1173 (s), 1109, 1095 (w), 1030 (s), 974, 865 (w), 824, 808, 793 (s), 730, 677, 627 
(w), 584, 561, 545, 528 (m). GC-MS (EI, 70 eV): m/z (%) = 386(100) [M
+
], 371(22). HRMS 
(EI, 70 eV): calcd for C25H22O2S [M
+
]: 386.13350; found: 386.13293.  
 
Synthesis of unsymmetrical 2,5-diaryl-3-bromothiophes (7): 
 
3-Bromo-2-(2-methoxyphenyl)-5-p-tolylthiophene (7a): 
Starting with 2a (0.166 g, 0.5 mmol) and 2-methoxy 
phenylboronic acid (0.083 g, 0.55 mmol), 7a was isolated 
(0.104 g, 58%) as a brown oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 2.28 (s, 3H, CH3), 3.76 (s, 3H, OCH3), 6.88-
6.96 (m, 2H, ArH), 7.09 (d, 2H, J = 7.9 Hz, ArH), 7.12 (s, 
1H, CHthiophene), 7.26-7.31 (m, 1H, ArH), 7.36-7.39 (m, 3H, ArH). 
13
C NMR (62 MHz, 
CDCl3): δ = 20.2 (CH3), 54.6 (OCH3), 109.3 (CBr), 110.3, 119.3 (CH), 120.6 (C), 124.4 
(2CH), 124.6 (CH), 128.6 (2CH), 129.1 (CH), 129.6 (C), 131.2 (CH), 132.2, 136.9, 143.0, 
156.0 (C). IR (KBr, cm
−1
): v = 3057, 2998, 2833, 1597, 1577, 1540, 1513 (w), 1486, 1462, 
1431 (m), 1325, 1277 (w), 1250 (s), 1178, 1161 (w), 1113, 1049, 1023, 972, 825 (m),  805 (s), 
787 (m), 747 (s), 698, 664, 623, 565, 541 (w). GC-MS (EI, 70 eV): m/z (%) = 360(83) [M
+
 
(
8¹
Br)], 358(83) [M
+ 
(Br)],  264(100) [M
+
], 263(21). HRMS (EI, 70 eV): calcd for 
C18H15BrOS, [M
+
 (Br)]: 358.00215; found: 358.00228.  
 
3-Bromo-5-(4-ethylphenyl)-2-(2-methoxyphenyl)thiophene (7b): 
Starting with 2b (0.173 g, 0.5 mmol) and 2-methoxyphenyl 
boronic acid (0.083 g, 0.55 mmol), 7b was isolated (0.114 g, 
61%) as a brown oil. 
1
H NMR (300 MHz, CDCl3): δ = 1.17 
(t, 3H, J = 7.5 Hz, CH3), 2.58 (q, 2H, J = 7.6 Hz, CH2), 3.77 
(s, 3H, OCH3), 6.88-6.97 (m, 2H, ArH), 7.11-7.15 (m, 3H, 
ArH and CHthiophene), 7.27-7.32 (m, 1H, ArH), 7.37-7.42 (m, 3H, ArH). 
13
C NMR (62 MHz, 
CDCl3): δ = 15.5 (CH3),  28.6 (CH2), 55.7 (OCH3), 110.3 (CBr), 111.3, 120.4 (CH), 121.6 
(C), 125.6 (2CH), 125.7 (CH), 128.5 (2CH), 130.2 (CH), 130.9 (C), 132.2 (CH), 133.3, 144.1, 
144.3, 157.1 (C). IR (KBr, cm
−1
): v = 3058, 2960, 2928, 2833, 1597, 1577, 1539, 1513 (w), 
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1487, 1461, 1431 (m), 1414, 1325, 1296 (w), 1277 (m), 1251 (s), 1179, 1161, 1116, 1049, 
1024, 973 (m), 816 (s), 790 (m), 748 (s), 698, 663, 623, 590, 574 (w). GC-MS (EI, 70 eV): 
m/z (%) = 374(100) [M
+
 (
8¹
Br)], 372(99) [M
+ 
(Br)],  359(21), 357(20), 278(42), 264(16), 
263(61), 234(10). HRMS (EI, 70 eV): calcd for C19H17BrOS, [M
+
 (
8¹
Br)]: 374.01575; found: 
374.01498.  
 
3-Bromo-2-(2,6-dimethoxyphenyl)-5-(4-ethylphenyl)thiophene (7c): 
Starting with 2b (0.173 g, 0.5 mmol) and 2,6-dimethoxy 
phenylboronic acid (0.100 g, 0.55 mmol), 7c was isolated 
(0.087 g, 43%) as a brown oil. 
1
H NMR (300 MHz, CDCl3): 
δ = 1.17 (t, 3H, J = 7.7 Hz, CH3), 2.57 (q, 2H, J = 7.7 Hz, 
CH2), 3.72 (s, 6H, 2OCH3), 6.55 (d, 1H, J = 8.4 Hz, ArH), 
7.11 (d, 2H, J = 8.4 Hz, ArH), 7.41(s, 1H, CHthiophene), 7.24 (m, 1H, ArH), 7.39-7.42 (m, 2H, 
ArH), 7.54 (d, 1H, J = 8.2 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 15.4 (CH3), 28.6 (CH2), 
56.1 (2OCH3), 104.1 (2CH), 106.2 (CBr), 112.2 (C), 125.5 (2CH), 127.9 (CH), 128.4 (2CH), 
130.7 (CH), 131.2, 132.8, 144.1, 144.6 (C), 158.9 (2C). IR (KBr, cm
−1
): v = 2958, 2930, 2835 
(w), 1582 (m), 1469 (s), 1429 (m), 1411, 1320, 1297, 1284 (w), 1249 (s), 1199 (w), 1104 (s), 
1033, 972, 945 (w), 836, 827, 810, 775, 741, 722, 693, 636, 539 (m). GC-MS (EI, 70 eV): 
m/z (%) = 404(100) [M
+
 (
8¹
Br)], 402(90) [M
+ 
(Br)], 389(18), 387(20), 308(32), 293(37), 
278(21). HRMS (EI, 70 eV): calcd for C20H19BrO2S, [M
+
 (
8¹
Br)]: 404.02632; found: 
404.02590.  
 
3-Bromo-5-(3,5-dimethylphenyl)-2-(2-methoxyphenyl)thiophene (7d): 
Starting with 2d (0.173 g, 0.5 mmol) and 2-methoxy 
phenylboronic acid (0.083 g, 0.55 mmol), 7d was isolated 
(0.104 g, 56%) as a brown oil. 
1
H NMR (300 MHz, CDCl3): 
δ = 2.25 (s, 6H, 2CH3), 3.77 (s, 3H, OCH3), 6.86 (br, 1H, 
ArH), 6.89-6.96 (m, 2H, ArH), 7.11 (br, 2H, ArH), 7.24 (s, 
1H, CHthiophene), 7.26-7.32 (m, 1H, ArH), 7.35-7.40 (m, 1H, ArH). 
13
C NMR (75 MHz, 
CDCl3): δ = 20.3 (2CH3), 54.6 (OCH3), 109.2 (CBr), 110.3, 119.3 (CH), 121.0 (C), 122.4 
(2CH), 125.0, 128.7, 129.1, 131.2 (CH), 132.2, 137.0 (C), 137.5 (2C), 143.1, 156.0 (C). IR 
(KBr, cm
−1
): v = 3058, 2960, 2928, 2833, 1597, 1577, 1539, 1513 (w), 1487, 1461, 1431 (m), 
1414, 1325, 1296 (w), 1277 (m), 1251 (s), 1179, 1161, 1116, 1049, 1024, 973 (m), 816 (s), 
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790 (m), 748 (s), 698, 663, 623, 590, 574 (w). GC-MS (EI, 70 eV): m/z (%) = 374(85) [M
+
 
(
8¹
Br)], 372(89) [M
+ 
(Br)], 279(22), 278(100). HRMS (EI, 70 eV): calcd for C19H17BrOS, [M
+
 
(
8¹
Br)]: 374.01575; found: 374.01414.  
 
3-Bromo-5-(2,6-dimethoxyphenyl)-2-p-tolylthiophene (7e): 
Starting with 2e (0.189 g, 0.5 mmol) and 4-methylphenyl 
boronic acid (0.074 g, 0.55 mmol), 7e was isolated 
(0.130 g, 67%) as a brown oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 2.31 (s, 3H, CH3), 3.79 (s, 6H, 2OCH3), 6.54 
(d, 2H, J = 8.4 Hz, ArH), 7.13-7.19 (m, 3H, ArH), 7.41(s, 
1H, CHthiophene), 7.52 (dd, 2H, J = 1.8, 6.4 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 21.3 
(CH3), 55.9 (2OCH3), 104.4 (2CH), 106.1 (CBr), 111.2 (C), 128.9 (2CH), 129.0 (CH), 129.1 
(2CH), 130.4 (C), 132.8 (CH), 133.3, 137.7, 137.8 (C), 157.8 (2C). IR (KBr, cm
−1
): v = 3002, 
2929, 2834 (w), 1592 (m), 1538, 1512 (w), 1470 (s), 1428 (m), 1318, 1305, 1286 (w), 1250 
(s), 1203, 1172 (w), 1106 (s), 1030, 971, 823, 808, 776, 720, 687, 633, 610, 565, 526 (m). 
GC-MS (EI, 70 eV): m/z (%) = 390(100) [M
+
 (
8¹
Br)], 388(97) [M
+ 
(Br)], 295(12), 294(54), 
279(41). HRMS (EI, 70 eV): calcd for C19H17BrO2S, [M
+
 (
8¹
Br)]: 390.01067; found: 
390.01055.  
 
3-Bromo-5-(2-methoxyphenyl)-2-p-tolylthiophene (7f): 
Starting with 2f (0.174 g, 0.5 mmol) and 4-methyl 
phenylboronic acid (0.075 g, 0.55 mmol), 7f was isolated 
(0.091 g, 51%) as a brown oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 2.29 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 6.87-
6.93 (m, 2H, ArH), 7.13 (d, 2H, J = 7.7 Hz, ArH), 7.18-7.21 (m, 1H, ArH), 7.36(s, 1H, 
CHthiophene), 7.49-7.52 (m, 3H, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 20.3 (CH3), 54.5 
(OCH3), 105.9 (CBr), 110.6, 120.0 (CH), 121.0 (C), 126.7 (CH), 127.7 (2CH), 127.9 (CH), 
128.2 (2CH), 128.3 (CH), 129.2, 136.8, 137.0, 137.3, 154.7 (C). IR (KBr, cm
−1
): v = 3020, 
2918, 2834, 1595, 1578, 1535, 1510 (w), 1484, 1461, 1433 (m), 1329, 1296 (w), 1249 (s), 
1179, 1114, 1052 (m), 1021 (s) 973 (m), 808, 747 (s), 715, 702, 642, 613, 571, 541 (w). GC-
MS (EI, 70 eV): m/z (%) = 360(100) [M
+
 (
8¹
Br)], 358(97) [M
+ 
(Br)],  265(18), 264(99), 
263(16). HRMS (EI, 70 eV): calcd for C18H15BrOS, [M
+
 (Br)]: 358.00215; found: 358.00174.  
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Synthesis of unsymmetrical 2,3,5-triarylbromothiophes (8): 
 
3-(4-Ethylphenyl)-2-(2-methoxyphenyl)-5-p-tolylthiophene (8a): 
Starting with 7a (0.090 g, 0.25 mmol) and 4-ethylphenyl 
boronic acid (0.075 g, 0.5 mmol), 8a was isolated (0.074 g, 
77%) as a brown oil. 
1
H NMR (300 MHz, CDCl3): 
δ = 1.13 (t, 3H, J = 7.6 Hz, CH3), 2.29 (s, 3H, CH3), 2.53 
(q, 2H, J = 7.6 Hz, CH2), 3.45 (s, 3H, OCH3), 6.77-6.80 
(m, 2H, ArH), 6.99 (d, 2H, J = 8.2 Hz, ArH), 7.11 (d, 3H, 
J = 8.0 Hz, ArH), 7.16-7.22 (m, 3H, ArH),  7.29 (s, 1H, 
CHthiophene), 7.46 (d, 2H, J =  8.1 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 14.5 (CH3), 20.2 
(CH3), 27.5 (CH2), 54.2 (OCH3), 110.4, 119.5 (CH), 122.4 (C), 123.8 (CH), 124.6 (2CH), 
126.5 (2CH), 127.0 (2CH), 128.1 (CH), 128.5 (2CH), 130.6 (C), 131.3 (CH), 131.7, 133.8, 
136.2, 139.4, 141.5, 142.0, 155.9 (C). IR (KBr, cm
−1
): v = 3019, 2960, 2927, 2832, 1596, 
1577, 1549 (w), 1504, 1489, 1461, 1431 (m), 1368, 1275 (w), 1249 (s), 1179, 1118, 1048, 
1023, 828 (m), 809 (s), 790 (m), 748 (s), 680, 584, 530 (w). GC-MS (EI, 70 eV): m/z 
(%) = 384(100) [M
+
], 340(11). HRMS (EI, 70 eV): calcd for C26H24OS [M
+
]: 384.15424; 
found: 384.15385.  
 
3-(4-tert-Butylphenyl)-5-(4-ethylphenyl)-2-(2-methoxyphenyl)thiophene (8c): 
Starting with 7c (0.093 g, 0.25 mmol) and 4-tert-butyl 
phenylboronic acid (0.089 g, 0.5 mmol), 8c was isolated 
(0.086 g, 81%) as a brown oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 1.18 (t, 3H, J = 7.7 Hz, CH3), 1.21 (s, 9H, 
3CH3), 2.58 (q, 2H, J = 7.5 Hz, CH2), 3.39 (s, 3H, OCH3), 
6.76 (d, 1H, J = 8.2 Hz, ArH), 6.79-6.84 (m, 1H, ArH), 
7.11-7.14 (m, 4H, ArH), 7.16-7.19 (m, 3H, ArH), 7.21-
7.23 (m, 1H, ArH), 7.30 (s, 1H, CHthiophene), 7.47 (d, 2H, J = 1.8, 6.5 Hz, ArH). 
13
C NMR 
(62 MHz, CDCl3): δ = 14.4 (CH3), 28.6 (CH2), 30.3 (3CH3), 33.4 (C), 54.1 (OCH3), 111.4, 
119.5 (CH), 122.5 (C), 123.8 (CH), 123.9 (2CH), 124.7 (2CH), 126.6 (2CH), 127.3 (2CH), 
128.1 (CH), 130.9 (C), 131.3 (CH), 131.8, 133.6, 139.2, 142.0, 142.5, 148.4, 155.8 (C). IR 
(KBr, cm
−1
): v = 2959, 2930, 2901, 2832, 1503 (w), 1489, 1461 (m), 1431, 1361, 1275 (w), 
1251 (m), 1202, 1179, 1160, 1116, 1088, 1049 (m), 1024 (s), 976, 907 (w), 821, 749, 730 (s), 
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696, 647, 593 (w), 566 (m). GC-MS (EI, 70 eV): m/z (%) = 426(100) [M
+
], 412(13), 411(39). 
HRMS (EI, 70 eV): calcd for C29H30OS [M
+
]: 426.20119; found: 426.20134.  
 
5-(3,5-Dimethylphenyl)-3-(4-ethylphenyl)-2-(2-methoxyphenyl)thiophene (8d): 
Starting with 7d (0.093 g, 0.25 mmol) and 4-ethylphenyl 
boronic acid (0.075 g, 0.5 mmol), 8d was isolated (0.072 g, 
72%) as a brown oil. 
1
H NMR (300 MHz, CDCl3): δ = 1.13 
(t, 3H, J = 7.7 Hz, CH3), 2.27 (s, 6H, 2CH3), 2.53 (q, 2H, 
J = 7.6 Hz, CH2), 3.45 (s, 3H, OCH3), 6.77-6.81 (m, 2H, 
ArH), 6.84 (br, 1H, ArH), 6.90 (d, 1H, J = 7.9 Hz, ArH), 
6.98 (d, 2H, J = 8.1 Hz, ArH), 7.11 (dd, 2H, J = 1.8, 6.3 Hz, 
ArH), 7.17-7.21 (m, 3H, ArH),  7.30 (s, 1H, CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 15.5 
(CH3), 21.3 (2CH3), 28.5 (CH2), 55.3 (OCH3), 111.4, 120.5 (CH), 122.5 (C), 123.6 (2CH), 
125.1 (CH), 127.5 (2CH), 128.0 (2CH), 129.2 (2CH), 132.3 (CH), 134.3, 134.9 (C), 138.3 
(2C), 140.4, 142.5, 143.2, 156.9 (2C). IR (KBr, cm
−1
): v = 3020, 2959, 2925, 2833, 1596, 
1577, 1549 (w), 1505, 1479, 1463, 1431 (m), 1370, 1275 (w), 1250 (s), 1179, 1120, 1048, 
1023, 828 (m), 809 (s), 792 (m), 748 (s), 680, 584 (w). GC-MS (EI, 70 eV): m/z 
(%) = 398(100) [M
+
]. HRMS (EI, 70 eV): calcd for C27H26OS [M
+
]: 398.16989; found: 
398.16929.  
 
5-(2,6-Dimethoxyphenyl)-3-(4-ethylphenyl)-2-p-tolylthiophene (8e): 
Starting with 7e (0.097 g, 0.25 mmol) and 4-ethylphenyl 
boronic acid (0.075 g, 0.5 mmol), 8e was isolated (0.077 g, 
75%) as a brown oil. 
1
H NMR (300 MHz, CDCl3): 
δ = 1.17 (t, 3H, J = 7.7 Hz, CH3), 2.24 (s, 3H, CH3), 2.56 
(q, 2H, J = 7.5 Hz, CH2), 3.78 (s, 6H, 2OCH3), 6.58 (d, 
2H, J = 8.4 Hz, ArH), 6.98 (d, J = 8.2 Hz, 2H, ArH), 7.03 
(d, 2H, J = 8.0 Hz, ArH), 7.15-7.21 (m, 5H, ArH),  7.45 (s, 
1H, CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 14.3 (CH3), 20.2 (CH3), 27.5 (CH2), 54.9 
(2OCH3), 103.3 (2CH), 111.3, 120.8 (C), 126.6 (2CH), 127.5 (CH), 128.0 (2CH), 128.1 
(2CH), 128.2 (2CH), 130.8 (C), 131.5 (CH), 133.6, 135.5, 135.7, 137.0, 141.3 (C), 156.6 
(2C). IR (KBr, cm
−1
): v = 2960, 2929, 2834 (w), 1581 (m), 1512 (w), 1469 (s), 1430 (m), 
1248 (s), 1214, 1201, 1183, 1170 (w), 1105 (s), 1031, 1020 (m), 974, 946 (w), 906, 830 (m), 
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812 (s), 778 (m), 724 (s), 647, 597, 567, 541 (w). GC-MS (EI, 70 eV): m/z (%) = 414(100) 
[M
+
]. HRMS (EI, 70 eV): calcd for C27H26O2S [M
+
]: 414.16480; found: 414.16368.  
 
3-(2-Ethoxyphenyl)-5-(2-methoxyphenyl)-2-p-tolylthiophene (8f): 
Starting with 7f (0.090 g, 0.25 mmol) and 2-ethoxyphenyl 
boronic acid (0.083 g, 0.5 mmol), 8f was isolated (0.064 g, 
64%) as a brown oil. 
 1
H NMR (300 MHz, CDCl3): 
δ = 1.01 (t, 3H, J = 7.0 Hz, CH3), 2.21 (s, 3H, CH3), 3.75 
(q, 2H, J = 6.9 Hz, OCH2), 3.85 (s, 3H, OCH3), 6.78-6.94 
(m, 2H, ArH), 6.89 (d, 2H, J = 7.9 Hz, ArH), 6.93 (d, 2H, 
J = 7.9 Hz, ArH), 7.11-7.19 (m, 5H, ArH),  7.46 (s, 1H, CHthiophene), 7.59 (d, 1H, J = 1.6, 
8.2 Hz, ArH). 
13
C NMR (75 MHz, CDCl3): δ = 13.5 (CH3), 20.1 (CH3), 54.5 (OCH3), 62.7 
(CH2), 110.6, 111.4, 119.4, 119.9 (CH), 122.4, 125.6 (C), 127.0 (3CH), 127.1, 127.3 (CH), 
127.8 (2CH), 129.0, 130.8 (CH), 131.6, 132.7, 135.3, 135.5, 138.7, 154.7, 155.2 (C). IR (KBr, 
cm
−1
): v = 2961, 1595, 1485, 1412 (w), 1258 (s), 1086 (m), 1017, 795 (s), 745, 705 (w). GC-
MS (EI, 70 eV): m/z (%) = 400(100) [M
+
], 295(20). HRMS (EI, 70 eV): calcd for C26H24O2S 
[M
+
]: 400.14915; found: 400.14881.  
 
General Procedure for the Synthesis of 2-Aryl-3,4-dibromothiophenes (10): 
  
To a mixture of 9 (0.159 g, 0.5 mmol), arylboronic acid (0.55 mmol), Pd(PPh3)4 (29 mg, 5 
mol-%) were added a mixture of 1,4-dioxane and toluene (1:1, 5 mL) and an aq solution of 
K2CO3 (2 mL, 2 M) under argon atmosphere. The reaction mixture was stirred at 100 °C for 5 
h and was subsequently allowed to cool to 20 °C. The solution was poured into H2O and 
CH2Cl2 (25 mL each), and the organic and the aqueous layer were separated. The latter was 
extracted with CH2Cl2 (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The 
residue was purified by flash column chromatography (flash silica gel, heptanes). 
 
3,4-Dibromo-2-p-tolylthiophene (10a): 
Starting with 9 (0.159 g, 0.5 mmol) and 4-methylphenylboronic 
acid (0.074 g, 0.55 mmol), 10a was isolated (0.147 g, 89%) as a 
white solid, mp. = 78-80 °C.
 1
H NMR (300 MHz, CDCl3): 
δ = 2.32 (s, 3H, CH3), 7.17 (d, 2H, J = 7.9 Hz, ArH), 7.27 (s, 1H, 
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CHthiophene), 7.42 (dd, 2H, J = 1.7, 6.4 Hz, ArH). 
13
C NMR (75 MHz, CDCl3): δ = 21.3 (CH3), 
111.0, 114.6 (CBr), 122.0 (CH), 128.9 (2CH), 129.4 (2CH), 130.1, 139.0, 139.7 (C). IR (KBr, 
cm
−1
): v = 3011, 2914, 1486 , 1409, 1378, 1313 (w), 1303 (m), 1180, 1106, 1019, 874 (m), 
729 (s), 707, 646 (w), 530 (m). GC-MS (EI, 70 eV): m/z (%) = 334(53) [M
+
 (
8¹
Br, 
8¹
Br)], 
332(100) [M
+ 
(
8¹
Br, Br)], 330(51) [M
+ 
(Br, Br)], 172(48), 171(31). HRMS (EI, 70 eV): calcd 
for C11H8Br2S (M
+
, [Br,
 8¹
Br]): 331.86875; found: 331.86649.  
 
2-(4-Ethylphenyl)thiophene (10b): 
Starting with 9 (0.159 g, 0.5 mmol) and 4-ethylphenylboronic acid 
(0.083 g, 0.55 mmol), 10b was isolated (0.150 g, 87%) as whitish 
oil. 
1
H NMR (300 MHz, CDCl3): δ =1.32 (t, J = 7.6 Hz, 3H,
 
CH3), 
2.75 (q, 2H, J = 7.6 Hz, CH2), 7.32 ( d, 2H, J = 8.4 Hz, ArH), 7.38 
(s, 1H, CHthiophene), 7.58 (d, 2H, J = 8.3 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 15.4 
(CH3), 28.7 (CH2), 111.0, 114.7 (CBr), 122.0 (CH), 128.2 (2CH), 128.9 (2CH), 130.3, 139.7, 
145.7 (C). IR (KBr, cm
−1
): v = 3107 (w), 3020 (w), 2961 (m), 2927 (m), 2630 (w), 2306 (w), 
1903 (w), 1524 (w), 1484 (m), 1308 (w), 1126 (w), 963 (w), 877 (s), 828 (s), 785 (m), 722 (s), 
645 (w), 585 (m), 539 (m). GC-MS (EI, 70 eV): m/z (%) = 348(44) [M
+
 (
81
Br, 
81
Br)], 346(83) 
[M
+
 (
81
Br, Br)], 344(41) [M
+ 
(Br, Br)], 333(54), 331( 100), 329(50), 186(11), 171(38), 13(11). 
HRMS (EI, 70 eV): calcd for C12H10Br2S [M
+
 (Br,
 81
Br)]: 345.88440; found: 345.8845. 
 
3,4-Dibromo-2-(4-tert-butylphenyl)thiophene (10c): 
Starting with 9 (0.159 g, 0.5 mmol)) and 4-tert- butylphenyl 
boronic acid (0.098 g, 0.55 mmol), 10c was isolated (0.176 g, 
94%) as a white solid, mp. = 93-94 °C. 
1
H NMR (300 MHz, 
CDCl3): δ = 1.28 (s, 9H, 3CH3), 7.27 (s, 1H, CHthiophene), 7.38 
(dd, J = 2.1, 2H, 6.6 Hz, ArH), 7.48 (dd, 2H, J = 2.2, 6.5 Hz, 
ArH). 
13
C NMR (62 MHz, CDCl3): δ = 31.2 (3CH3), 34.8 (C), 110.9, 114.7 (CBr), 122.0 
(CH), 125.6 (2CH), 128.6 (2CH), 130.0, 139.6, 152.0 (C). IR (KBr, cm
−1
): v = 3019, 2953, 
2860, 1485 ,  1456, 1406, 1390, 1303, 1267, 1107, 1020 (w), 879 (m), 828 (s), 765, 736 (m), 
727 (s), 690 (m), 562 (s). GC-MS (EI, 70 eV): m/z (%) = 376(21) [M
+
 (
8¹
Br, 
8¹
Br)], 374(40) 
[M
+ 
(
8¹
Br, Br)], 372(20) [M
+ 
(Br, Br)], 361(53), 359(100) [M
+
], 357(50), 331(15). HRMS (EI, 
70 eV): calcd for C14H14Br2S [M
+
 (Br,
 8¹
Br)]: 373.91570; found: 373.91523.  
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3,4-Dibromo-2-(2-methoxyphenyl)thiophene (10d): 
Starting with 9 (0.159 g, 0.5 mmol) and 2-methoxyphenylboronic acid 
(0.084 g, 0.55 mmol), 10d was isolated (0.148 g, 85%) as whitish oil. 
1
H NMR (300 MHz, CDCl3): δ = 3.76 (s, 3H, OCH3), 6.89-6.97 (m, 
2H, ArH), 7.27 (dd, 1H, J = 1.7, 7.6 Hz, ArH), 7.30-7.36 (m, 2H, ArH 
and CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 55.6 (OCH3), 111.3 
(CH), 111.5, 111.6 (CBr), 121.4 (CH), 121.6 (C), 122.8, 130.7, 132.1 (CH), 135.9, 157.0 (C). 
IR (KBr, cm
−1
): v = 3104, 2934, 2833, 1596, 1578, 1518 (w), 1480, 1460, 1433, 1312, 1291, 
1276 (m), 1247 (s), 1178, 1161, 1115, 1048 (m), 1022 (s), 970, 935 (w), 878 (s), 844, 795 
(m), 748, 716 (s), 630, 571 (m). GC-MS (EI, 70 eV): m/z (%) = 350(52) [M
+
 (
8¹
Br, 
8¹
Br)], 
348(100) [M
+
 (
8¹
Br, Br)], 346(50) [M
+
 (Br, Br)], 254(66), 252(66), 188(52), 187(36), 173(16), 
145(30). HRMS (EI, 70 eV): calcd for C11H8Br2OS [M
+
 (Br,
 8¹
Br)]: 347.86367; found: 
347.86314.  
 
3,4-Dibromo-2-(2,6-dimethoxyphenyl)thiophene (10e): 
Starting with 9 (0.159 g, 0.5 mmol) and 2,6-dimethoxyphenylboronic 
acid (0.100 g, 0.55 mmol), 10e was isolated (0.127 g, 67%) as a white 
solid, mp. = 106-108 °C. 
1
H NMR (250 MHz, CDCl3): δ =  3.70 (s, 6H, 
2OCH3), 6.55 (d, 2H, J = 8.4 Hz, ArH), 7.29 (t, 1H, J = 8.3 Hz, ArH), 
7.36 (s, 1H, CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 55.0 
(2OCH3), 102.9 (2CH), 109.0 (C), 112.0, 114.0 (CBr), 122.3 (C), 122.3, 130.9 (CH), 157.7 
(2C). IR (KBr, cm
−1
): v = 3102, 3003, 2963, 2836 (w), 1579 (m), 1469 (s), 1430 (m), 1303, 
1284 (w), 1250 (s), 1210, 1172, 1150 (w), 1101 (s), 1027, 875, 786, 765, 722, 704, 694, 604, 
595, 539 (m). GC-MS (EI, 70 eV): m/z (%) = 380(54) [M
+
 (
8¹
Br, 
8¹
Br)], 378(100) [M
+
 (
8¹
Br, 
Br)], 376(49) [M
+
 (Br, Br)], 284(42), 282(40), 269(22), 267(24), 218(43), 204(10). HRMS 
(EI, 70 eV): calcd for C12H10Br2O2S [M
+
 (Br,
 8¹
Br)]: 377.87423; found: 377.87406. 
 
3,4-Dibromo-2-(3,5-dimethylphenyl)thiophene (10f): 
Starting with 9 (0.159 g, 0.5 mmol) and 3,5-dimethylphenylboronic 
acid (0.083 g, 0.55 mmol), 10f was isolated (0.136 g, 79%) as a 
colorless oil.
 1
H NMR (300 MHz, CDCl3): δ = 2.28 (s, 3H, CH3), 
2.29 (s, 3H, CH3), 6.96 (br, 1H, ArH), 7.12 (br, 2H, ArH), 7.26 (s, 
1H, CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 21.3 (2CH3), 
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111.0, 114.6 (CBr), 122.0 (CH), 126.7 (2CH), 130.6 (CH), 132.7 (C), 138.3 (2C), 139.9 (C). 
IR (KBr, cm
−1
): v = 3107 (w), 2917 (m),  2854 (w), 1600, 1462, 1307 (m), 1264, 1126, 1037 
(w), 883, 846, 821 (s), 731 (m), 699 (s), 683 (m), 642, 567, 543 (w). GC-MS (EI, 70 eV): m/z 
(%) = 348(52) [M
+
 (
8¹
Br, 
8¹
Br)], 346(100) [M
+ 
(
8¹
Br, Br)], 344(51) [M
+ 
(Br, Br)], 331(11), 
186(30), 185(14), 171(20). HRMS (EI, 70 eV): calcd for C12H10Br2S [M
+
 (Br,
 8¹
Br)]: 
346.88440; found: 346.88334.  
 
3,4-Dibromo-2-(3-chlorophenyl)thiophene (10g): 
Starting with 9 (0.159 g, 0.5 mmol) and 3-chlorophenylboronic acid 
(0.086 g, 0.55 mmol), 10g was isolated (0.117 g, 67%) as as a white  
solid, mp. = 67-69 °C. 
1
H NMR (300 MHz, CDCl3): δ = 7.29-7.31 
(m, 2H, ArH), 7.32 (s, 1H, CHthiophene), 7.39-7.43 (m, 1H, ArH), 
7.52-7.53 (m, 1H, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 112.1, 115.0 (CBr), 122.8 (CH), 
127.2, 128.8, 128.9, 129.9 (CH), 134.8, 137.8, 141.6 (C). IR (KBr, cm
−1
): v = 3103, 2922, 
2851 (w), 1593, 1562, 1463 (m), 1425, 1385 (w), 1307 (m), 1260, 1164, 1095 (w), 1078, 995 
(m), 877, 766, 737, 682 (s), 636 (m). GC-MS (EI, 70 eV): m/z (%) = 356(16) [M
+
 (
8¹
Br, 
8¹
Br,
37
Cl)], 354(72) [M
+
 (
8¹
Br, 
8¹
Br,
 
Cl); (Br, 
8¹
Br,
37
Cl)], 352(100) [M
+
 (Br, 
8¹
Br,
35
Cl); (Br, 
Br,
37
Cl)], 350(43) [M
+
 (Br, Br,
 
Cl)],  194(16), 192(41), 113(12). HRMS (EI, 70 eV): calcd for 
C10H5Br2ClS [M
+
 (Br, 
8¹
Br,
 
Cl)]: 351.81413; found: 351.81376; [M
+
 (Br, Br, 
37
Cl)]: 
351.81323; found: 351.81476. 
 
Synthesis of 2,4-diaryl-3-bromothiophenes (11): 
 
To a mixture of 9 (0.159 g, 0.5 mmol), aryl boronic acid (1.1 mmol), and Pd(PPh3)4 (35mg, 
6 mol-%) was added a mixture of 1,4-dioxane and toluene (1:1; 5 mL), K3PO4 (4.0 equiv, 
424 mg) and 1mL of H2O, under an argon atmosphere. The reaction mixture was stirred at 
100 °C for 12 h and was subsequently allowed to cool to 20 °C. The solution was poured into 
H2O and EtOAc (25 mL each) and the organic and the aqueous layers were separated. The 
latter was extracted with EtOAc (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in 
vacuo. The residue was purified by flash column chromatography (flash silica gel, eluent: 
heptanes/EtOAc).  
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3-Bromo-2,4-di-p-tolylthiophene (11a): 
Starting with 9 (0.159 g, 0.5 mmol) and 4-methylphenyl  
boronic acid (0.149 g, 1.1 mmol), 11a was isolated 
(0.095 g, 55%) as yellowish solid, mp. = 122-124 °C. 
1
H 
NMR (300 MHz, CDCl3): δ = 2.32 (br, 6H, 2CH3), 7.14-
7.18 (m, 5H, ArH and CHthiophene), 7.32 (dd, 2H, J = 1.7, 
6.3 Hz, ArH), 7.47 (dd, 2H, J = 1.7, 6.5 Hz, ArH). 
13
C 
NMR (62 MHz, CDCl3): δ = 21.3, 21.4 (CH3), 108.9 (CBr), 121.6 (CH), 128.9 (2CH), 129.1 
(2CH), 129.2 (2CH), 129.3 (2CH), 130.5, 130.7, 133.3, 137.6, 138.3, 143.3 (C). IR (KBr, 
cm
−1
): v = 2960 (m), 2864, 1521, 1493, 1456, 1361, 1200, 1109, 1021, 963, 892 (w), 832 (m),  
815, 797, 742 (s), 722, 707 (m), 684, 675, 640, 602 (w), 582, 566, 541, 528 (m). GC-MS (EI, 
70 eV): m/z (%) = 344(100) [M
+
 (
8¹
Br)], 342(97) [M
+ 
(Br)], 248(26), 247(15). HRMS (EI, 
70 eV): calcd for C18H15BrS [(
8¹
Br)]: 344.00519; found: 344.00529.  
 
3-Bromo-2,4-bis(4-ethylphenyl)thiophene (11b): 
Starting with 9 (0.159 g, 0.5 mmol) and 4-ethylphenylboronic 
acid (0.165 g, 1.1 mmol), 11b was isolated (0.095 g, 51%) as 
a whitish oil. 
1
H NMR (300 MHz, CDCl3): δ = 1.20 (t, 3H, 
J = 7.6 Hz, CH3), 1.21 (t, 3H, J = 7.6 Hz, CH3), 2.59-2.267 
(m, 4H, 2CH2), 7.18-7.22 (m, 5H, ArH and CHthiophene), 7.37 
(dd, 2H, J = 1.9, 6.3 Hz, ArH), 7.51 (dd, 2H, J = 1.8, 6.4 Hz, 
ArH). 
13
C NMR (62 MHz, CDCl3): δ = 15.3, 15.4 (CH3), 28.6, 28.7 (CH2), 108.8 (CBr), 121.6 
(CH), 127.6 (2CH), 128.0 (2CH), 129.2 (2CH), 129.4 (2CH), 130.9, 133.5, 139.3, 143.3, 
143.8, 144.6 (C). IR (KBr, cm
−1
): v = 3100, 3021 (w),  2961, 2927 (m), 1536, 1513 (w), 1491, 
1453 (m), 1410, 1334, 1184, 1115, 1049, 1020, 964 (w), 894 (m), 828 (s), 792, 751, 726 (m), 
678, 641, 539 (w). GC-MS (EI, 70 eV): m/z (%) = 372(100) [M
+
 (
8¹
Br)], 370(97) [M
+ 
(Br)], 
357(64), 355(64), 247(19), 171(12), 170(11). HRMS (EI, 70 eV): calcd for C20H19BrS [M
+ 
(
8¹
Br)]: 372.03649; found: 372.03594.  
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3-Bromo-2,4-bis(3,5-dimethylphenyl)thiophene (11c): 
Starting with 9 (0.159 g, 0.5 mmol) and 3,5-dimethyl 
phenyl boronic acid (0.165 g, 1.1 mmol), 11c was 
isolated (0.086 g, 46%) as a yellowish solid, mp. = 80-
82 °C. 
1
H NMR (300 MHz, CDCl3): δ = 2.29 (s, 12H, 
4CH3), 6.94 (br, 2H,  ArH), 7.04 (br, 2H,  ArH),   7.13 (s, 
1H, CHthiophene), 7.18 (br,  2H, ArH). 
13
C NMR (75 MHz, 
CDCl3): δ = 21.3 (2CH3), 21.4 (2CH3), 108.8 (CBr), 
121.8 (CH), 127.2 (2CH), 127.3 (2CH), 129.5, 130.1 (CH), 133.5, 136.1 (C), 137.7 (2C), 
138.1 (2C), 139.5, 143.5 (C). IR (KBr, cm
−1
): v = 3092, 2913, 2853 (w), 1598 (m), 1454, 
1374, 1336, 1036, 941, 903 (w), 847, 827 (s), 757 (m), 699 (s), 677, 667 (m), 542, 536 (w). 
GC-MS (EI, 70 eV): m/z (%) = 372(100) [M
+
 (
8¹
Br)], 371(23), 370(96) [M
+ 
(Br)], 276(16), 
275(12). HRMS (EI, 70 eV): calcd for C20H19BrS [M
+
 (
8¹
Br)]: 372.03649; found: 372.03590.  
 
3-Bromo-2,4-bis(4-tert-butylphenyl)thiophene (11d): 
Starting with 9 (0.159 g, 0.5 mmol) and 4-tert-
butylphenylboronic acid (0.195 g, 1.1 mmol), 11d was 
isolated (0.105 g, 49%) as a white  solid, mp. = 144-146 
°C. 
1
H NMR (300 MHz, CDCl3): δ = 1.27 (s, 9H, 9CH3), 
1.28 (s, 9H, 9CH3), 7.15 (s, 1H, CHthiophene), 7.36-7.39 (m, 
6H, ArH), 7.37 (dd, 2H, J = 2.0, 6.5 Hz, ArH). 
13
C NMR 
(62 MHz, CDCl3): δ = 31.3 (3CH3), 31.4 (3CH3), 34.6, 
34.7 (C), 108.8 (CBr), 121.8 (CH), 125.1 (2CH), 125.5 (2CH), 128.9 (2CH), 129.1 (2CH), 
130.7, 133.2, 139.2, 143.2, 150.7, 151.4 (C). IR (KBr, cm
−1
): v = 2958 (m), 2900, 2863, 1537, 
1489, 1460, 1392 (w), 1361 (m), 1267, 1201, 1115, 1017 (w), 896 (m), 832 (s), 778, 756, 732 
(m), 684 (w), 575, 562 (m). GC-MS (EI, 70 eV): m/z (%) = 428(65) [M
+
 (
8¹
Br)], 426(64) [M
+ 
(Br)], 413(100), 411(98), 171(12), 170(11), 57(25). HRMS (EI, 70 eV): calcd for C24H27BrS 
[M
+ 
(
8¹
Br)]: 428.09909; found: 428.09834.  
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 3-Bromo-2,4-bis(3-chlorophenyl)thiophene (11e): 
Starting with 9 (0.159 g, 0.5 mmol) and 3-chlorophenylboronic 
acid (0.171 g, 1.1 mmol), 11e was isolated (0.128 g, 67%) as a 
white solid, mp. = 162-164 °c. 
1
H NMR (300 MHz, CDCl3): δ =  
7.26-7.46 (m, 8H, ArH and CHthiophene), 7.57 (s, 1H, ArH). 
13
C 
NMR (75 MHz, CDCl3): δ = 109.3 (CBr), 123.3 (CH), 127.5, 
127.6, 128.1, 128.6, 129.4, 129.4, 129.5, 129.8 (CH), 134.1, 
134.5, 135.0, 137.4, 138.0, 142.1 (C). IR (KBr, cm
−1
): v = 3062, 1928, 1681 (w), 1595, 1565, 
1462, 1435, 1415, 1332, 1296 (m), 1226, 1163 (w), 1092, 1077, 996, 915, 876, 802 (m), 772, 
740, 690, 683 (s), 646 (m), 626, 591, 534 (w). GC-MS (EI, 70 eV): m/z (%) = 388(08) [M
+
 
(
8¹
Br, 
37
Cl, 
37
Cl)], 386(50) [M
+ 
(Br, 
37
Cl, 
37
Cl)] or [M
+ 
(
8¹
Br, Cl, 
37
Cl)],  384(100) [M
+ 
(Br, Cl, 
37
Cl)] or [M
+ 
(
8¹
Br, Cl, Cl)], 
 
382(59) [M
+ 
(Br, Cl, Cl)], 270(12), 268(31), 232(10). HRMS (EI, 
70 eV): calcd for C16H9BrCl2S [M
+ 
(Br, Cl, 
37
Cl)]: 383.89504; found: 383.89549; [M
+ 
(
8¹
Br, 
Cl, Cl)]: 383.89594; found: 383.89549.  
 
Synthesis of 2,3,4-triarylthiophenes (12): 
 
To a mixture of 9 (0.080 g, 0.25 mmol), arylboronic acid (1.0 mmol), Pd(PPh3)4 (35 mg, 6 
mol-%) were added a mixture of 1,4-dioxane and toluene (1:1, 5 mL) and an aq solution of 
K2CO3 (2 mL, 2 M) under argon atmosphere. The reaction mixture was stirred at 90 °C for 12 
h and was subsequently allowed to cool to 20 °C. The solution was poured into H2O and 
CH2Cl2 (25 mL each) and the organic and the aqueous layer were separated. The latter was 
extracted with CH2Cl2 (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The 
residue was purified by flash column chromatography (flash silica gel, n-heptane). 
 
2,3,4-Tri-p-tolylthiophene (12a): 
Starting with 9 (0.08 g, 0.25 mmol) and 4-methylphenyl 
boronic acid (0.136 g, 1.0 mmol), 12a was isolated 
(0.082 g, 93%) as a white solid, mp. = 122-124 °C. 
1
H 
NMR (250 MHz, CDCl3): δ = 2.22 (s, 9H, 3CH3), 6.81 
(dd, 2H, J = 2.1, 6.4 Hz, ArH), 6.87-6.96 (m, 8H, ArH), 
7.02 (dd, 2H, J = 1.9, 6.3 Hz, ArH), 7.15 (s, 1H, 
CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 20.0, 20.1, 20.2 (CH3), 120.2 (CH), 127.6 
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(2CH), 127.7 (2CH), 127.8 (2CH), 127.9 (2CH), 128.1 (2CH), 129.7 (2CH), 130.9, 132.2, 
133.2, 135.1, 135.2, 135.8, 135.9, 139.3, 142.7 (C). IR (KBr, cm
−1
): v = 3019, 2962, 2919, 
2964, 1512, 1494, 1361, 1264, 1111, 1020 (w), 904 (m), 818 (s), 803, 753, 746, 726 (m), 647, 
617, 572 (w), 545 (m). GC-MS (EI, 70 eV): m/z (%) = 354(100) [M
+
], 339(12), 324(11). 
HRMS (EI, 70 eV): calcd for C25H22S [M
+
]: 354.14367; found: 354.14355.  
 
2,3,4-Tris(3,5-dimethylphenyl)thiophene (12b): 
Starting with 9 (0.08 g, 0.25 mmol) and 3,5-dimethyl 
phenylboronic acid (0.150 g, 1.0 mmol), 12b was isolated 
(0.085 g, 86%) as a white solid, mp. = 113-115 °C. 
1
H 
NMR (300 MHz, CDCl3): δ = 2.06 (s, 6H, 2CH3), 2.11 (s, 
12H, 4CH3),  6.56 (br, 2H, ArH), 6.66 (br, 2H, ArH), 
6.72-6.74 (m, 3H, ArH), 6.77 (s, 2H, ArH), 7.15 (s, 1H, 
CHthiophene). 
13
C NMR (75 MHz, CDCl3): δ = 20.1 (2CH3), 
20.2 (4CH3), 120.0 (CH), 125.8 (2CH), 126.0 (2CH), 127.0, 127.1 (CH), 127.6 (2CH), 127.7 
(CH), 133.5, 135.1, 135.8 (C), 135.9 (2C), 136.0 (2C), 136.4 (2C), 136.5, 139.3, 142.9 (C). IR 
(KBr, cm
−1
): v = 3004 (w), 2916 (m), 2856 (w), 1598 (m), 1455, 1375, 1260, 1080, 1036, 909 
(w), 845 (s), 799, 754, 705, 698 (m), 667, 540 (w). GC-MS (EI, 70 eV): m/z (%) = 396(100) 
[M
+
]. HRMS (EI, 70 eV): calcd for C28H28S [M
+
]: 396.19062; found: 396.19030.  
 
2,3,4-Tris(4-tert-butylphenyl)thiophene (12c): 
Starting with 9 (0.08 g, 0.25 mmol) and 4-tert-butyl 
phenylboronic acid (0.178 g, 1.0 mmol), 12c was 
isolated (0.112 g, 94%) as a white solid, mp. = 168-
170 °C. 
1
H NMR (300 MHz, CDCl3): δ = 1.20 (s, 9H, 
3CH3), 1.21 (s, 9H, 3CH3), 1.22 (s, 9H, 3CH3), 6.87 
(dd, 2H, J = 2.0, 6.5 Hz, ArH), 6.94 (dd, 2H, J = 2.0, 
6.6 Hz, ArH), 7.06 (dd, 2H, J = 2.1, 6.5 Hz, ArH), 7.10 
(dd, 4H, J = 2.0, 6.5 Hz, ArH), 7.13 (dd, 2H, J = 2.1, 6.5 Hz, ArH), 7.16 (s, 1H, CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 31.2 (3CH3), 31.3 (3CH3), 31.4 (3CH3), 34.3, 34.4, 34.5 (C), 
121.1 (CH), 124.7 (2CH), 124.8 (2CH), 125.1 (2CH), 128.5 (2CH), 128.7 (2CH), 130.4 
(2CH), 131.8, 133.3, 134.2, 137.1, 140.2, 143.8, 149.3, 149.5, 149.9 (C). IR (KBr, cm
−1
): v = 
2959 (m), 2900, 2864, 1520, 1493, 1460 (w), 1360, 1266 (m), 1199, 1110, 1021, 904 (w), 831 
105 
 
(s), 795, 757, 721, 684, 602, 580, 563, 542 (m). GC-MS (EI, 70 eV): m/z (%) = 480(100) 
[M
+
], 466(26), 465(73), 57(14). HRMS (EI, 70 eV): calcd for C34H40S [M
+
]: 480.28452; 
found: 480.28570.  
 
2,3,4-Tris(4-methoxyphenyl)thiophene (12d): 
Starting with 9 (0.08 g, 0.25 mmol) and 4-methoxy 
phenyl boronic acid (0.152 g, 1.0 mmol), 12d was 
isolated (0.096 g, 96%) as a white solid, mp. = 137-
139 °C. 
1
H NMR (300 MHz, CDCl3): δ = 3.69 (s, 3H, 
OCH3), 3.70 (s, 6H, 2OCH3), 6.63-6.70 (m, 6H, ArH), 
6.84 (dd, 2H, J = 2.1, 6.6 Hz, ArH), 6.95 (dd, 2H, 
J = 2.1, 6.7 Hz, ArH), 7.06 (dd, 2H, J = 2.1, 6.7 Hz, ArH), 7.09 (s, 1H, CHthiophene). 
13
C NMR 
(62 MHz, CDCl3): δ = 55.0, 55.1, 55.2 (OCH3), 113.4 (2CH), 113.6 (2CH), 113.7 (2CH), 
120.4 (CH), 127.3, 128.6, 129.8 (C), 130.1 (2CH), 130.5 (2CH), 132.0 (2CH), 136.3, 139.9, 
143.3, 158.3, 158.4, 158.7 (C). IR (KBr, cm
−1
): v = 2998, 2930, 2833 (w), 1609 (m), 1571, 
1532 (w), 1520, 1509, 1494, 1454, 1436, 1286 (m), 1244, 1173 (s), 1104 (m), 1029 (s), 952, 
902, 876 (w), 824, 812 (s), 794, 785, 768, 750, 551 (m). GC-MS (EI, 70 eV): m/z 
(%) = 402(100) [M
+
]. HRMS (EI, 70 eV): calcd for C25H22O3S [M
+
]: 402.12897; found: 
402.12812.  
 
2,3,4-Tris(4-chlorophenyl)thiophene (12e): 
Starting with 9 (0.08 g, 0.25 mmol) and 4-chlorophenyl 
boronic acid (0.156 g, 1.0 mmol), 12e was isolated (0.081 g, 
78%) as a white solid, mp. = 238-240 °C. 
1
H NMR 
(300 MHz, CDCl3): δ = 6.82 (dd, 2H, J = 1.9, 6.5 Hz, ArH), 
6.92 (dd, 2H, J = 1.9, 6.5 Hz, ArH), 7.02 (dd, 2H, J = 2.0, 
6.6 Hz, ArH), 7.07-7.16 (m, 6H, ArH), 7.22 (s, 1H, 
CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 122.7 (CH), 128.4 (2CH), 128.7 (4CH), 130.2 
(2CH), 130.5 (2CH), 132.0 (2CH), 132.5, 133.1, 133.2, 133.6, 133.9, 134.9, 136.2, 139.9, 
142.4 (C). IR (KBr, cm
−1
): v = 1595, 1567, 1529, 1503 (w), 1490, 1478 (m), 1395, 1278, 1176 
(w), 1089, 1013, 905 (m), 824 (s), 790, 755, 736, 711 (m), 676, 636, 580, 569 (w). GC-MS 
(EI, 70 eV): m/z (%) = 420(6) [M
+
 (
37
Cl, 
37
Cl, 
37
Cl)], 418(39) [M
+
 (Cl, 
37
Cl, 
37
Cl)], 416(100) 
[M
+
 (Cl, Cl, 
37
Cl)], 414(99) [M
+
 (Cl, Cl, Cl)], 346(14), 344(31), 309(10), 154(31), 153(14). 
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HRMS (EI, 70 eV): calcd for C22H13Cl3S [M
+
 (Cl, Cl, 
37
Cl)]: 415.97686 found: 415.97670. 
Anal. calcd for C22H13Cl3S: C, 63.55; H, 3.15; S, 7.71. Found: C, 63.39; H, 3.25; S, 6.10. 
 
Synthesis of unsymmetrical 2,4-diaryl-3-bromothiophes (13): 
 
3-Bromo-4-(2-methoxyphenyl)-2-p-tolylthiophene (13a): 
Starting with 10a (0.165 g, 0.5 mmol) and 2-methoxy 
phenyl boronic acid (0.083 g, 0.55 mmol), 13a was 
isolated (0.155 g, 87%) as whitish solid, mp. = 80-82 °C. 
1
H NMR (300 MHz, CDCl3): δ = 2.32 (s, 3H, CH3), 3.75 
(s, 3H, OCH3), 6.90-6.97 (m, 2H, ArH), 7.15-7.20 (m, 4H, 
ArH and CHthiophene), 7.25-7.28 (m, 1H, ArH), 7.30-7.33 
(m, 1H, ArH), 7.51 (dd, 1H, J = 1.7, 6.3 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 21.3 
(CH3), 55.6 (OCH3), 110.4 (CBr), 111.0, 120.3, 122.5 (CH), 125.3 (C), 129.1 (2CH), 129.2 
(2CH), 129.6 (CH), 130.8 (C), 131.7 (CH), 138.1, 138.2, 140.2, 157.2 (C). IR (KBr, cm
−1
): v 
= 3022, 2926, 2825, 1598, 1578, 1536, 1507 (w), 1478, 1457, 1427 (m), 1341, 1295, 1272 
(w), 1239 (s), 1172, 1161, 1122, 1090, 1046 (m), 1025 (s), 890, 816, 787 (m), 763, 753, 727 
(s), 694, 675, 631, 567, 539 (m). GC-MS (EI, 70 eV): m/z (%) = 360(100) [M
+
 (
8¹
Br)], 
358(92) [M
+ 
(Br)], 279(21), 264(43), 246(17), 234(15), 221(12), 205(13), 202(14), 189(11), 
117(12). HRMS (EI, 70 eV): calcd for C18H15BrOS, [M
+
 (Br)]: 358.00215; found: 358.00153.  
 
3-Bromo-2-(4-ethylphenyl)-4-(2-methoxyphenyl)thiophene (13b): 
Starting with 10b (0.173 g, 0.5 mmol) and 2-methoxyphenyl 
boronic acid (0.083 g, 0.55 mmol), 13b was isolated 
(0.151 g, 81%) as a brownish oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 1.19 (t, 3H, J = 7.6 Hz, CH3), 2.60 (q, 2H, 
J = 7.6 Hz, CH2), 3.72 (s, 3H, OCH3), 6.88-6.95 (m, 2H, 
ArH), 7.16-7.21 (m, 4H, ArH and CHthiophene), 7.25-7.32 (m, 
1H, ArH), 7.53 (d, 2H, J = 8.2 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 14.3 (CH3), 27.6 
(CH2), 54.5 (OCH3), 109.3 (CBr), 110.0, 119.2, 121.5 (CH), 124.2 (C), 126.9 (2CH), 128.3 
(2CH), 128.5 (CH), 129.9 (C), 130.7 (CH), 137.2, 139.2, 143.3, 156.2 (C). IR (KBr, cm
−1
): v 
= 3098, 2960, 2929, 2832, 1600, 1579, 1537, 1513 (w), 1483, 1459, 1432 (m), 1373, 1335, 
1291 (w), 1273 (m), 1243 (s), 1178, 1160, 1121, 1091, 1047, 1024, 893, 832, 798 (m), 749 
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(s), 632, 571 (m). GC-MS (EI, 70 eV): m/z (%) = 374(100) [M
+
 (
8¹
Br)], 373(23), 372(97) [M
+ 
(Br)], 359(15), 357(15), 293(18), 278(17), 264(23), 263(51), 247(16), 234(11), 231(11), 
202(14), 189(11). HRMS (EI, 70 eV): calcd for C19H17BrOS, [M
+
 (
8¹
Br)]: 374.01575; found: 
374.01516.  
 
3-Bromo-4-(2,6-dimethoxyphenyl)-2-(4-ethylphenyl)thiophene (13c): 
Starting with 10b (0.173 g, 0.5 mmol) and 2,6-dimethoxy 
phenyl boronic acid (0.100 g, 0.55 mmol), 13c was isolated 
(0.106 g, 53%) as brownish oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 1.19 (t, 3H, J = 7.6 Hz, CH3), 2.60 (q, 2H, 
J = 7.6 Hz, CH2), 3.68 (s, 6H, 2OCH3), 6.56 (d, 2H, 
J = 8.4 Hz, ArH), 7.18 (d, 2H, J = 8.3 Hz, ArH), 7.11 (s, 
1H, CHthiophene), 7.21-7.27 (m, 2H, ArH), 7.56 (dd, 1H, J = 1.8, 6.4 Hz, ArH). 
13
C NMR 
(62 MHz, CDCl3): δ = 14.3 (CH3), 27.6 (CH2), 54.9 (2OCH3), 103.0 (2CH), 110.2 (CBr), 
112.8 (C), 122.0 (CH), 126.8 (2CH), 128.2 (2CH), 128.8 (CH), 130.1, 134.8, 136.5, 143.1 
(C), 157.5 (2C). IR (KBr, cm
−1
): v = 3000, 2960, 2931, 2834 (w), 1585 (m), 1469 (s), 1430 
(m), 1329, 1285 (w), 1247 (s), 1207, 1171, 1150 (w), 1105 (s), 1108, 1033, 892, 831, 778, 
752, 722, 695, 540 (m). GC-MS (EI, 70 eV): m/z (%) = 404(100) [M
+
 (
8¹
Br)], 402(94) [M
+ 
(Br)], 323(22), 308(21), 293(30), 278(19), 201(11), 147(10). HRMS (EI, 70 eV): calcd for 
C20H19BrO2S, [M
+
 (
8¹
Br)]: 404.02632; found: 404.02691.  
 
3-Bromo-4-(4-tert-butylphenyl)-2-p-tolylthiophene (13e): 
Starting with 10a (0.166 g, 0.5 mmol) and 4-tert-butyl 
phenyl boronic acid (0.098 g, 0.55 mmol), 13e was 
isolated (0.110 g , 57%) as a white solid, mp. = 81-
83 °C.
1
H NMR (300 MHz, CDCl3): δ = 1.28 (s, 9H, 
3CH3), 2.31 (s, 3H, CH3), 7.15-7.18 (m, 3H, ArH and 
CHthiophene), 7.37 (br, 4H, ArH), 7.47 (d, 2H, J = 8.0 Hz, 
ArH). 
13
C NMR (75 MHz, CDCl3): δ = 21.4 (CH3), 31.4 
(3CH3), 34.7 (C), 108.9 (CBr), 121.7 (CH), 125.1 (2CH), 128.9 (2CH), 129.3 (2CH), 129.4 
(2CH), 130.8, 133.2, 138.3, 139.3, 143.2, 150.7 (C). IR (KBr, cm
−1
): v = 2957 (m), 2902, 
2862, 1536 (w), 1492 (m), 1472, 1461, 1392, 1361, 1336, 1306, 1267, 1114, 1018 (w), 895, 
831 (m), 818 (s), 798, 759 (m), 735 (s), 714, 588, 570, 558 (m). GC-MS (EI, 70 eV): m/z 
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(%) = 386(64) [M
+
 (
8¹
Br)], 384(60) [M
+ 
(Br)],  371(100) [M
+
], 369(96), 290(14), 275(10),  
171(14). HRMS (EI, 70 eV): calcd for C21H21BrS [M
+
 (
8¹
Br)]: 386.05214; found: 386.05169.  
 
3-Bromo-4-(2,6-dimethoxyphenyl)-2-p-tolylthiophene (13f): 
Starting with 10a (0.166 g, 0.5 mmol) and 2,6-dimethoxy 
phenyl boronic acid (0.100 g, 0.55 mmol), 13f was isolated 
(0.089 g, 46%) as a brownish oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 2.30 (s, 3H, CH3), 3.68 (s, 3H, OCH3), 3.70 (s, 
3H, OCH3),  6.56 (d, 2H, J = 8.4 Hz, ArH), 7.11 (s, 1H, 
CHthiophene), 7.13-7.16 (m, 2H, ArH), 7.21-7.27 (m, 2H, 
ArH), 7.53 (dd, 1H, J = 1.7, 6.5 Hz, ArH). 
13
C NMR (62 MHz, CDCl3): δ = 20.3 (CH3), 54.9 
(2OCH3), 103.0 (2CH), 110.2 (CBr), 112.8 (C), 122.0 (CH), 128.0 (2CH), 128.1 (2CH), 128.7 
(CH), 128.8, 129.9, 134.8, 136.8 (C), 157.5 (2C). IR (KBr, cm
−1
): v = 3099, 2927, 2829 (w), 
1585, 1469, 1427 (m), 1334, 1299, 1282 (w), 1248 (s), 11198, 1182, 1171 (w), 1112 (s), 
1076, 1034, 1019 889, 823, 800, 775, 761, 714, 595, 541 (m). GC-MS (EI, 70 eV): m/z 
(%) = 390(100) [M
+
 (
8¹
Br)], 388(94) [M
+ 
(Br)], 309(22), 294(30), 279(11), 276(11), 263(14), 
221(10), 187(11), 147(13). HRMS (EI, 70 eV): calcd for C19H17BrO2S, [M
+
 (
8¹
Br)]: 
390.01067; found: 390.01087.  
 
Synthesis of unsymmetrical 2,3,4-triarylthiophenes (14): 
 
3-(2-Ethoxyphenyl)-4-(2-methoxyphenyl)-2-p-tolylthiophene (14a): 
Starting with 13a (0.090 g, 0.25 mmol) and 2-ethoxy 
phenyl boronic acid (0.083 g, 0.5 mmol), 14a was isolated 
(0.092 g, 92%) as a brown oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 0.85 (t, 3H, J = 7.0 Hz, CH3), 2.19 (s, 3H, 
CH3), 3.33 (s, 3H, OCH3), 3.44-3.51 (m, 2H, CH2O),  6.61 
(t, 2H, J = 7.6 Hz, ArH), 6.70-6.76 (m, 1H, ArH), 6.78-6.81 (m, 1H, ArH), 6.90 (d, 2H, J = 
8.0 Hz, ArH), 6.98-7.01 (m, 1H, ArH), 7.02 (m, 5H, ArH), 7.20 (s, 1H, CHthiophene). 
13
C NMR 
(75 MHz, CDCl3): δ = 14.4, 21.2 (CH3), 54.9 (OCH3), 63.1 (CH2O), 110.5, 111.4, 119.8, 
119.9, 122.0 (CH), 126.2, 126.7 (C), 128.0, 128.2 (CH), 128.4 (2CH), 128.8 (2CH), 131.3, 
132.2 (CH), 134.7 (C), 136.5 (2C), 139.9, 140.8, 156.4, 156.6 (C). IR (KBr, cm
−1
): v = 3051, 
2975, 2921, 2831, 1598, 1579, 1539 (w), 1500, 1483, 1446, 1433, 1260 (m), 1240 (s), 1178, 
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1159 (w), 1116, 1043, 1026 (m), 926, 900 (w), 808 (m), 746 (s), 658 (w), 633 (m), 573, 561 
(w). GC-MS (EI, 70 eV): m/z (%) = 400(100) [M
+
], 295(15). HRMS (EI, 70 eV): calcd for 
C26H24O2S [M
+
]: 400.14915; found: 400.14894. 
 
3-(2-Ethoxyphenyl)-2-(4-ethylphenyl)-4-(2-methoxyphenyl)thiophene (14b): 
Starting with 13b (0.093 g, 0.25 mmol) and 2-ethoxyphenyl 
boronic acid (0.083 g, 0.5 mmol), 14b was isolated 
(0.090 g, 87%) as a brown oil. 
1
H NMR (300 MHz, 
CDCl3): δ = 0.85 (t, 3H, J = 7.0 Hz, CH3), 1.09 (t, 3H, 
J = 7.6 Hz, CH3), 2.49 (q, 2H, J = 7.6 Hz, CH2), 3.31 (s, 
3H, OCH3), 3.43-3.52 (m, 2H, CH2O), 6.57 (m, 3H, ArH), 6.70-6.76 (m, 1H, ArH), 6.79 (dd, 
1H, J = 1.7, 7.7 Hz, ArH), 6.93 (d, 2H, J = 8.3 Hz, ArH), 6.99 (dd, 1H, J = 1.8, 7.5 Hz, ArH), 
7.04-7.09 (m, 4H, ArH), 7.19 (s, 1H, CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 13.2, 14.2 
(CH3), 27.5 (CH2), 53.8 (OCH3), 62.0 (CH2O), 109.4, 110.3, 118.7, 113.9, 120.9 (CH), 125.2, 
125.7 (C), 126.5 (2CH), 126.9, 127.2 (CH), 127.3 (2CH), 130.3, 131.1 (CH), 132.0, 133.5, 
138.8, 139.8, 141.8, 155.3, 155.5 (C). IR (KBr, cm
−1
): v = 2961, 2928, 2831, 1598, 1579 (w), 
1500, 1483, 1457, 1446, 1260 (m), 1240 (s), 1178, 1159 (w), 1117, 1046, 1026 (m), 926, 900 
(w), 834, 814 (m), 746 (s), 658, 623, 567, 532 (w). GC-MS (EI, 70 eV): m/z (%) = 414(100) 
[M
+
], 295(10). HRMS (EI, 70 eV): calcd for C27H26O2S [M
+
]: 414.16480; found: 414.16509. 
 
4-(4-Ethylphenyl)-3-(4-methoxyphenyl)-2-p-tolylthiophene (14d): 
Starting with 13d (0.089 g, 0.25 mmol) and 4-methoxy 
phenyl boronic acid (0.076 g, 0.5 mmol), 14d was isolated 
(0.089 g, 93%) as a white solid, mp. = 125-127 °C. 
1
H NMR 
(300 MHz, CDCl3): δ = 1.14 (t, 3H, J = 7.6 Hz, CH3), 2.22 
(s, 3H, CH3), 2.53 (q, 2H, J = 7.6 Hz, CH2), 3.69 (s, 3H, 
OCH3), 6.64 (d, 2H, J = 8.7 Hz, ArH), 6.84 (d, 2H, 
J = 8.6 Hz, ArH), 6.93-6.96 (m, 6H, ArH), 7.02 (d, 2H, J = 8.1 Hz, ArH), 7.14 (s, 1H, 
CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 15.3, 21.2 (CH3), 28.5 (CH2), 55.1 (OCH3), 
113.5 (2CH), 121.2 (CH), 127.4 (2CH), 128.5 (C), 128.8 (2CH), 128.9 (2CH), 129.2 (2CH), 
131.9 (2CH), 135.5, 136.8 (C), 136.8 (2C), 140.2, 142.5, 143.7, 158.3 (C). IR (KBr, cm
−1
): v 
= 2964, 2930, 2831 (w), 1607 (m), 1573, 1540 (w), 1512, 1495, 1460 (m), 1440, 1376, 1361 
(w), 1284 (m), 1241 (s), 1170, 1034, 1020, 904 (m), 826, 820, 804 (s), 778, 754, 728, 711, 
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647, 564, 548, 528 (m). GC-MS (EI, 70 eV): m/z (%) = 384(100) [M
+
]. HRMS (EI, 70 eV): 
calcd for C26H24OS [M
+
]: 384.15424; found: 384.15413. 
 
4-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)-2-p-tolylthiophene (14e): 
Starting with 13e (0.096 g, 0.25 mmol) and 4-methoxy 
phenylboronic acid (0.076 g, 0.5 mmol), 14e was isolated 
(0.099 g, 96%) as a brown oil.  
1
H NMR (250 MHz, 
CDCl3): δ = 1.21 (s, 9H, 3CH3), 2.21 (s, 3H, CH3), 3.68 
(s, 3H, OCH3), 6.63 (d, J = 8.8 Hz, 2H, ArH), 6.85 (d, 
2H, J = 8.8 Hz, ArH), 6.92-6.97 (m, 4H, ArH), 7.02 (d, 
2H, J = 8.1 Hz, ArH), 7.11-7.15 (m, 3H, ArH and CHthiophene). 
13
C NMR (62 MHz, CDCl3): 
δ = 20.1 (CH3), 30.3 (3CH3), 33.3 (C), 54.0 (OCH3), 112.5 (2CH), 120.2 (CH), 123.8 (2CH), 
127.5 (2CH), 127.6 (C), 127.9 (2CH), 128.1 (2CH), 130.9 (2CH), 133.1, 135.6 (C), 135.8 
(2C), 139.1, 142.6, 148.4, 157.3 (C). IR (KBr, cm
−1
): v = 2952, 2902, 2835 (w), 1608 (m), 
1573, 1537 (w), 1512, 1495, 1462 (m), 1439, 1360, 1282 (w), 1243 (s), 1173, 1031, 1020 (m), 
904 (w), 820, 803 (s), 756, 726, 567, 565, 553, 544 (m). GC-MS (EI, 70 eV): m/z 
(%) = 412(100) [M
+
], 398(17), 397(56). HRMS (EI, 70 eV): calcd for C28H28OS [M
+
]: 
412.18554; found: 412.18562.  
 
Synthesis of unsymmetrical 2,3,4-triarylthiophenes (15): 
 
2,4-Bis(4-ethylphenyl)-3-(4-methoxyphenyl)thiophene (15a): 
Starting with 11b (0.093 g, 0.25 mmol) and 4-methoxy 
phenylboronic acid (0.076 g, 0.5 mmol), 15a was isolated 
(0.091 g, 92%) as a whitish semi solid. 
1
H NMR 
(250 MHz , CDCl3): δ = 1.13 (t, 6H, J = 7.8 Hz, 2CH3), 
2.52 (q, 4H, J = 7.6 Hz, 2CH2), 3.68 (s, 3H, OCH3), 6.64 
(d, 2H, J = 8.7 Hz, ArH), 6.85 (d, 2H, J = 8.7 Hz, ArH), 
6.95-6.98 (m, 6H, ArH), 7.05 (d, 2H, J = 8.1 Hz, ArH), 7.14 (s, 1H, CHthiophene). 
13
C NMR 
(62 MHz, CDCl3): δ = 15.2, 15.3 (CH3), 28.5 (2CH2), 55.1 (OCH3), 113.5 (2CH), 121.2 (CH), 
127.4 (2CH), 127.8 (2CH), 128.6 (C), 128.9 (2CH), 129.2 (2CH), 131.9 (2CH), 132.1, 134.5, 
136.6, 140.2, 142.5, 143.1, 143.8, 158.3 (C). IR (KBr, cm
−1
): v = 2960, 2929, 2855 (w), 1607 
(m), 1573, 1538 (w), 1511, 1495, 1460, 1435 (m), 1407, 1375, 1330 (w), 1284 (m), 1241 (s), 
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1171, 1116, 1101, 1071, 1035, 1020 (m), 963, 904, 868 (w), 825, 805 (s), 784, 754, 736, 720, 
694, 617, 588, 567, 547 (m). GC-MS (EI, 70 eV): m/z (%) = 398(100) [M
+
], 383(14). HRMS 
(EI, 70 eV): calcd for C27H26OS [M
+
]: 398.16989; found: 398.16960.  
 
2,4-Bis(4-tert-butylphenyl)-3-(4-methoxyphenyl)thiophene (15b): 
Starting with 11d (0.106 g, 0.25 mmol) and 4-methoxy 
phenylboronic acid (0.076 g, 0.5 mmol), 15b was isolated 
(0.098 g, 87%) as yellowish semi solid. 
1
H NMR 
(300 MHz, CDCl3): δ = 1.21 (s, 18H, 6CH3), 3.70 (s, 3H, 
OCH3), 6.65 (d, 2H, J = 8.8 Hz, ArH), 6.87 (d, 2H, 
J = 8.8 Hz, ArH), 6.96 (d, 2H, J = 8.3 Hz, ArH), 7.06 (dd, 
2H, J = 1.8, 6.8 Hz, ArH) 7.12-7.17 (m, 5H, ArH and 
CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 31.2 (3CH3), 31.3 (3CH3), 34.4, 34.5 (C), 55.1 
(OCH3), 113.5 (2CH), 121.2 (CH), 124.8 (2CH), 125.2 (2CH), 127.7 (C), 128.5 (2CH), 128.8 
(2CH), 131.8 (C), 132.0 (2CH), 134.2, 137.0, 140.1, 143.7, 149.4, 149.9, 158.3 (C). IR (KBr, 
cm
−1
): v = 2957 (m), 2902, 2864, 2831, 1607, 1537 (w), 1513, 1461, 1361, 1267 (m), 1241 
(s), 1173, 1106, 1032, 1017 (m), 905, 875 (w), 831 (s), 802, 730, 722 (m), 688, 644, 600 (w), 
579, 566, 547 (m) . GC-MS (EI, 70 eV): m/z (%) = 454(100) [M
+
], 440(22), 439(62), 
212(12). HRMS (EI, 70 eV): calcd for C31H34OS [M
+
]: 454.23249; found: 454.23281.  
 
2,4-Bis(4-ethylphenyl)-3-(2-methoxyphenyl)thiophene (15c): 
Starting with 11b (0.093 g, 0.25 mmol) and 2-methoxy 
phenylboronic acid (0.076 g, 0.5 mmol), 15c was isolated 
(0.079 g, 80%) as yellowish semi solid. 
1
H NMR 
(300 MHz , CDCl3): δ = 1.10 (t, 3H, J = 7.6 Hz, CH3), 1.11 
(t, 3H, J = 7.6 Hz, CH3), 2.49 (q, 2H, J = 7.7 Hz, CH2), 
2.50 (q, 2H, J = 7.5 Hz, CH2), 3.18 (s, 3H, OCH3), 6.64-
6.74 (m, 2H, ArH), 6.87 (dd, 1H, J = 1.8, 7.4 Hz, ArH), 6.93-6.96 (m, 6H, ArH), 7.06 (dd, 
2H, J = 1.8, 6.3 Hz, ArH), 7.09-7.13 (m, 1H, ArH), 7.16 (s, 1H, CHthiophene). 
13
C NMR 
(62 MHz, CDCl3): δ = 14.3, 14.5 (CH3), 27.4 (2CH2), 54.0 (OCH3), 110.3, 119.5, 119.6 (CH), 
124.7 (C), 126.2 (2CH), 126.6 (2CH), 127.0 (2CH), 127.5 (CH), 127.6 (2CH), 131.4 (C), 
131.5 (CH), 132.5, 134.0, 139.9, 141.3, 142.0, 143.2, 156.5 (C). IR (KBr, cm
−1
): v = 3054, 
2963, 2929, 2835, 1598, 1579, 1537, 1503 (w), 1485, 1461, 1455, 1432 (m), 1411, 1283 (w), 
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1262, 1244, 1237 (m), 1178, 1158 (w), 1062, 1049 (m), 1022 (s), 974, (w), 904 (m), 832, 761, 
744 (s), 657, 569, 529 (m). GC-MS (EI, 70 eV): m/z (%) = 398(100) [M
+
], 383(17). HRMS 
(EI, 70 eV): calcd for C27H26OS [M
+
]: 398.16989; found: 398.16971.  
 
Synthesis of unsymmetrical 2,3,4-triarylthiophenes (16): 
 
3,4-Bis(4-ethylphenyl)-2-p-tolylthiophene (16a): 
Starting with 10a (0.083 g, 0.25 mmol) and 4-ethyl 
phenyl boronic acid (0.112 g, 0.75 mmol), 16a was 
isolated (0.088 g, 92%) as a brownish oil. 
1
H NMR 
(300 MHz, CDCl3): δ = 1.12 (t, 3H, J = 7.6 Hz, CH3), 
1.13 (t, 3H, J = 7.6 Hz, CH3), 2.21 (s, 3H, CH3), 2.52 (q, 
4H, J = 7.8 Hz, 2CH2), 6.84 (d, 2H, J = 8.2 Hz, ArH), 
6.90-6.94 (m, 8H, ArH), 7.02 (d, 2H, J = 8.2 Hz, ArH), 7.14 (s, 1H, CHthiophene). 
13
C NMR 
(62 MHz, CDCl3): δ = 15.2, 15.3 (CH3), 21.2 (CH3), 28.4, 28.5 (CH2), 121.2 (CH), 127.4 
(2CH), 127.5 (2CH), 128.9 (2CH), 129.0 (2CH), 129.2 (2CH), 130.7 (2CH), 131.9, 133.4, 
134.5, 136.8, 137.0, 140.3 (C), 142.5 (2C), 143.8 (C). IR (KBr, cm
−1
): v =  2966, 2928, 2852, 
1538, 1512, 1494, 1452, 1374, 1115, 1019, 961, 904 (w), 829, 817, 803 (s), 753, 733 (m), 
709, 645, 615 (w), 586, 570, 550, 528 (m). GC-MS (EI, 70 eV): m/z (%) = 382(100) [M
+
]. 
HRMS (EI, 70 eV): calcd for C27H26S [M
+
]: 382.17497; found: 382.17547.  
 
3,4-Bis(4-tert-butylphenyl)-2-p-tolylthiophene (16b): 
Starting with 10a (0.083 g, 0.25 mmol) and 4-tert-butyl 
phenyl boronic acid (0.133 g, 0.75 mmol), 16b was 
isolated (0.095 g, 87%) as whitish solid, mp. = 184-
186 °C. 
1
H NMR (300 MHz, CDCl3): δ = 1.20 (s, 18H, 
6CH3), 2.22 (s, 3H, CH3), 6.86 (dd, 2H, J = 2.0, 6.6 Hz, 
ArH), 6.91-6.96 (m, 4H, ArH), 7.02 (dd, 2H, J = 1.7, 
6.3 Hz, ArH), 7.08-7.13 (m, 4H, ArH) 7.24 (s, 1H, 
CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 21.2 (CH3), 31.3 (3CH3), 31.4 (3CH3), 34.4, 
34.5 (C), 121.1 (CH), 124.7 (2CH), 124.9 (2CH), 128.5 (2CH), 128.9 (2CH), 129.1 (2CH), 
130.4 (2CH), 131.9, 133.2, 134.1, 136.8, 137.1, 140.3, 143.8, 149.4, 149.5 (C). IR (KBr, 
cm
−1
): v =  2959, 2901, 2864 (m), 1520, 1492, 1434, 1392 (w), 1360, 1264, 1200, 1192, 1111, 
113 
 
1089, 1068, 1017 (m), 965, 944 (w), 906, 877 (m),832, 822, 803 (s), 777, 761 (m), 740, 694 
(s), 640, 607, 579, 568, 556, 540 (m). GC-MS (EI, 70 eV): m/z (%) = 438(100) [M
+
], 
424(24), 423(71), 204(11), 57(14). HRMS (EI, 70 eV): calcd for C31H34S [M
+
]: 438.23757; 
found: 438.23746.  
      
2-(4-tert-Butylphenyl)-3,4-bis(4-ethylphenyl)thiophene (16c): 
Starting with 10c (0.094 g, 0.25 mmol) and 4-ethyl 
phenyl boronic acid (0.112 g, 0.75 mmol), 16c was 
isolated (0.088 g, 83%) as whitish solid, mp. = 125-
127 °C. 
1
H NMR (300 MHz, CDCl3): δ = 1.13 (t, 3H, 
J = 7.6 Hz, CH3), 1.14 (t, 3H, J = 7.6 Hz, CH3), 1.21 (s, 
9H, 3CH3), 2.53 (q, 2H, J = 7.6 Hz, CH2), 2.54 (q, 2H, 
J = 7.6 Hz, CH2), 6.85 (dd, 2H, J = 2.0, 6.3 Hz, ArH), 
6.92-6.93 (m, 6H, ArH), 7.06 (dd, 2H, J = 2.1, 6.6 Hz, ArH), 7.12-7.17 (m, 3H, ArH and 
CHthiophene). 
13
C NMR (62 MHz, CDCl3): δ = 15.2, 15.3 (CH3), 28.4, 28.5 (CH2), 31.3 (3CH3), 
34.5 (C), 121.2 (CH), 125.1 (2CH), 127.3 (2CH), 127.5 (2CH), 128.8 (2CH), 128.9 (2CH), 
130.7 (2CH), 131.8, 133.5, 134.5, 137.0, 140.3 (C), 142.5 (2C), 143.8, 149.9 (C). IR (KBr, 
cm
−1
): v =  2962 (m), 2925, 2871, 1538, 1493, 1455, 1360, 1266, 1116, 1017, 936, 904 (m), 
829 (s), 802, 760, 750, 698, 571, 559 (m). GC-MS (EI, 70 eV): m/z (%) = 424(100) [M
+
], 
410(28), 409(87). HRMS (EI, 70 eV): calcd for C30H32S [M
+
]: 424.22192; found: 424.22141.  
      
General procedure for synthesis of 5-aryl-2,3-dibromo-N-methylpyrroles (19): 
 
To a mixture of 18 (0.159 g, 0.5 mmol), aryl boronic acid (0.55 mmol), and Pd(PPh3)4  (29 
mg, 5 mol-%) was added a mixture of 1,4-dioxane and toluene (1:1; 5 mL) and 
K3PO4 (4.0 equiv, 424 mg) under an argon atmosphere. The reaction mixture was stirred at 
100 °C for 8 h and was subsequently allowed to cool to 20 °C. The solution was poured into 
H2O and EtOAc (25 mL each) and the organic and the aqueous layers were separated. The 
latter was extracted with EtOAc (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in 
vacuo. The residue was purified by flash column chromatography (flash silica gel, eluent: n-
heptane).  
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2,3-Dibromo-5-(2,6-dimethoxyphenyl)-1-methyl-1H-pyrrole (19a): 
Starting with 18 (0.159 g, 0.5 mmol) and 2,6-dimethoxylphenyl 
boronic acid (0.100 g, 0.55 mmol), 19a was isolated (0.080 g, 43%) 
as a white solid, mp. = 128-130°C. 
1
H NMR (300 MHz, acetone-d6): 
δ = 3.18 (s, 3H, NCH3), 3.61 (s, 6H, 2OCH3), 5.97 (s, 1H, CHpyrrole), 
6.60 (d, 2H, J = 8.4 Hz, ArH), 7.25 (t, 1H, J = 8.4 Hz, ArH). 
13
C 
NMR (62 MHz, , acetone-d6): δ = 34.4 (NCH3), 56.1 (2OCH3), 97.4, 103.1 (CBr), 104.9 
(2CH), 110.0 (C), 112.8 (CH), 128.7 (C), 131.7 (CH), 160.2 (2C). IR (KBr, cm
−1
): v = 3003, 
2936, 2834 (w), 1598, 1588 (m), 1472 (s), 1454, 1439 (m), 1430 (s), 1377, 1314, 1298, 1288 
(m), 1250 (s), 1207, 1150 (m), 1102 (s), 1050, 1027, 1004, 945 (m), 782 (s), 761 (m), 734 (s), 
712, 687, 600, 568 (m). GC-MS (EI, 70 eV): m/z (%) = 377(49) [M
+
 (
8¹
Br, 
8¹
Br)], 375(100) 
[M
+
 (
8¹
Br, Br)], 373(51) [M
+
 (Br, Br)], 296(13), 294(20), 281(10), 279(11), 266(13), 264(15), 
215(17), 200(14), 148(23), 146(21). HRMS (EI, 70 eV): calcd for C13H13 Br2NO2 [M
+
 (Br,
 
8¹
Br)]: 374.92871; found: 374.92931.  
 
2,3-Dibromo-5-(4-ethylphenyl)-1-methyl-1H-pyrrole (19b): 
Starting with 18 (0.159 g, 0.5 mmol) and 4-ethylphenyl boronic 
acid (0.082 g, 0.55 mmol), 19b was isolated (0.125 g, 73%) as a 
colorless oil. 
1
H NMR (250 MHz, acetone-d6): δ = 1.23 (t, 3H, 
J = 7.5 Hz, CH3), 2.68 (q, 2H, J = 7.4 Hz, CH2), 3.61 (s, 3H, 
NCH3), 6.28 (s, 1H, CHpyrrole), 7.32 (br, 4H, ArH). 
13
C NMR (62 MHz, acetone-d6): δ = 15.9 
(CH3), 29.1 (CH2), 35.3 (NCH3), 98.5, 105.4 (CBr), 111.3 (CH), 129.0 (2CH), 129.7 (2CH), 
130.4, 137.5, 145.0 (C). IR (KBr, cm
−1
): v = 3018, 2961, 2869 (w), 1496, 1457 (s), 1437, 
1375 (m), 1318 (s), 1216, 1184, 1135 (w), 1089 (m), 1059, 1008 (w), 943 (m), 833, 774 (s),  
744, 667, 619 (w), 600, 560, 530 (m). GC-MS (EI, 70 eV): m/z (%) = 345(49) [M
+
 (
8¹
Br, 
8¹
Br)], 343(100) [M
+
 (
8¹
Br, Br)], 341(51) [M
+
 (Br, Br)], 330(32), 328(63), 326(34). HRMS 
(EI, 70 eV): calcd for C13H13Br2N [M
+
 (Br,
 
Br)]: 340.94093; found: 340.94196.  
 
2,3-Dibromo-5-(4-tert-butylphenyl)-1-methyl-1H-pyrrole (19c): 
Starting with 18 (0.159 g, 0.5 mmol) and 4-tert-butylphenyl 
boronic acid (0.098 g, 0.55 mmol), 19c was isolated (0.118 g, 
64%) as a colorless oil. 
1
H NMR (250 MHz, acetone-d6): 
δ = 1.34 (s, 9H, 3CH3), 3.61 (s, 3H, NCH3), 6.29 (s, 1H, 
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CHpyrrole), 7.34 (d, 2H, J = 8.6 Hz, ArH), 7.49 (d, 2H, J = 8.6 Hz, ArH). 
13
C NMR (62 MHz, 
acetone-d6): δ = 31.6 (3CH3), 35.2 (C), 35.4 (NCH3), 98.5, 105.5 (CBr), 111.3 (CH), 126.4 
(2CH), 129.4 (2CH), 130.2, 137.4, 151.7 (C). IR (KBr, cm
−1
): v = 2959 (m), 2903, 2866, 
1697, 1606, 1537 (w), 1499, 1456, 1362, 1318, 1265, 1109, 1086, 1017, 946 (m), 837, 779 
(s), 741, 595, 574, 555 (m). GC-MS (EI, 70 eV): m/z (%) = 373(36) [M
+
 (
8¹
Br, 
8¹
Br)], 371(73) 
[M
+ 
(
8¹
Br, Br)], 369(36) [M
+ 
(Br, Br)], 358(49), 356(100), 354(53). HRMS (EI, 70 eV): calcd 
for C15H17Br2N [M
+
 (Br,
 8¹
Br)]: 370.97018; found: 370.97046.  
 
 2,3-Dibromo-5-(2-methoxyphenyl)-1-methyl-1H-pyrrole (19d): 
Starting with 18 (0.159 g, 0.5 mmol) and 2-methoxyphenylboronic 
acid (0.083 g, 0.55 mmol), 19d was isolated (0.105 g, 61%) as a 
colourless oil. 
1
H NMR (300 MHz, acetone-d6): δ = 3.32 (s, 3H, 
NCH3), 3.72 (s, 3H, OCH3), 6.13 (s, 1H, CHpyrrole), 6.85-6.93 (m, 
2H, ArH), 7.11 (dd, 1H, J = 1.6, 7.5 Hz, ArH), 7.26-7.32 (m, 1H, ArH). 
13
C NMR (75 MHz, , 
acetone-d6): δ = 34.6 (NCH3), 55.5 (OCH3), 97.7, 104.4 (CBr), 110.9, 111.3, 120.8 (CH), 
121.2 (C), 130.2, 132.3 (CH), 132.7, 157.3 (C). IR (KBr, cm
−1
): v = 3120, 2943, 2833, 1601, 
1577, 1541 (w), 1486, 1459, 1452, 1430 (m), 1376 (w), 1317, 1292, 1275 (m), 1243 (s), 1178, 
1161, 1116, 1086, 1050, 1023, 1006, 946 (m), 748 (s), 669, 601, 577 (w). GC-MS (EI, 
70 eV): m/z (%) = 347(50) [M
+
 (
8¹
Br, 
8¹
Br)], 345(100) [M
+
 (
8¹
Br, Br)], 343(51) [M
+
 (Br, Br)], 
289(12), 266(16), 264(22), 251(24), 249(25), 184(36), 170(13), 148(16), 127(12), 115(16). 
HRMS (EI, 70 eV): calcd for C12H11Br2NO [M
+
 (Br,
 8¹
Br)]: 344.91814; found: 344.91909.  
 
2,3-Dibromo-5-(3,5-dimethylphenyl)-1-methyl-1H-pyrrole (19e): 
Starting with 18 (0.159 g, 0.5 mmol) and 3,5-dimethylphenyl 
boronic acid (0.082 g, 0.55 mmol), 19e was isolated (0.099 g, 
58%) as a colourless oil. 
1
H NMR (300 MHz, acetone-d6): δ = 
2.21 (s, 3H,
 
CH3), 2.22 (s, 3H,
 
CH3), 3.50 (s, 3H, NCH3), 6.16 
(s, 1H, CHpyrrole), 6.92 (s, 3H, ArH). 
13
C NMR (75 MHz, 
acetone-d6): δ = 21.3 (2CH3), 35.4 (NCH3), 98.4, 105.5 (CBr), 111.3 (CH), 127.4 (2CH), 
130.3 (CH), 132.9, 137.7 (C), 138.9 (2C). IR (KBr, cm
−1
): v = 3120, 2947, 2915, 2855 (w), 
1600, 1466, 1450, 1372, 1322, 1302, 1273 (m), 1205, 1181 (w), 1086, 1036, 950 (m), 899 
(w), 851, 840, 775, 695 (s), 663, 602 (m). GC-MS (EI, 70 eV): m/z (%) = 345(49) [M
+
 (
8¹
Br, 
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8¹
Br)], 34(100) [M
+
 (
8¹
Br, Br)], 341(52) [M
+
 (Br, Br)], 183(10), 168(13). HRMS (EI, 70 eV): 
m/z [M
+
 (Br, 
8¹
Br)] calcd for C13H13Br2N: 342.93888; found: 342.939847. 
 
2,3-Dibromo-5-(4-chlorophenyl)-1-methyl-1H-pyrrole (19f): 
 Starting with 18 (0.159 g, 0.5 mmol) and 4-chlorophenyl 
boronic acid (0.086 g, 0.55 mmol), 19f was isolated (0.072 g, 
41%) as a colourless oil. 
1
H NMR (300 MHz, , acetone-d6): δ =  
3.50 (s, 3H, NCH3), 6.23 (s, 1H, CHpyrrole), 7.32-7.34 (m, 4H, 
ArH). 
13
C NMR (62 MHz, acetone-d6): δ = 35.5 (NCH3), 98.7, 
106.5 (CBr), 111.9 (CH), 129.6 (2CH), 131.2 (2CH), 131.7, 134.2, 136.0 (C). IR (KBr, cm
−1
): 
v = 3103, 2922, 2851 (w), 1593, 1562, 1463 (m), 1425, 1385 (w), 1307 (m), 1260, 1164, 1095 
(w), 1078, 995 (m), 877, 766, 737, 682 (s), 636 (m).. GC-MS (EI, 70 eV): m/z (%) = 354(10) 
[M
+
 (
8¹
Br, 
8¹
Br,
37
Cl)], 352(66) [M
+
 (
8¹
Br, 
8¹
Br, Cl); (Br, 
8¹
Br, 
37
Cl)], 350(100) [M
+
 (Br, 
8¹
Br,Cl); (Br, Br,
37
Cl)], 348(37) [M
+
 (Br, Br,
 
Cl)],  273(39), 272(11), 271(33), 230(11), 
175(10). HRMS (EI, 70 eV): calcd for C11H8Br2ClNS [M
+
 (
8¹
Br, 
8¹
Br, 
35
Cl)]: 350.86656; 
found: 350.87303; [M
+
 (Br, 
8¹
Br, 
37
Cl)]: 350.86566; found: 350.81418. 
 
 
Synthesis of unsymmetrical 2,4,5-triarylmethyl-1H-pyrroles (20): 
 
5-(4-tert-Butylphenyl)-2,3-bis(4-methoxyphenyl)-1-methyl-1H-pyrrole (20): 
 
Starting with 19c (0.093 g, 0.25 mmol) and 4-
methoxyphenylboronic acid (0.114 g, 0.75 mmol) 
, 20a was isolated (0.077 g, 74%) as a yellowish 
oil. 
1
H NMR (300 MHz, CDCl3): δ = 1.29 (s, 9H,
 
3CH3), 3.30 (s, 3H,
 
NCH3), 3.68 (s, 3H,
 
OCH3), 
3.76 (s, 3H,
 
OCH3),  6.33 (s, 1H, CHpyrrole), 6.67 
(dd, 2H, J = 2.1, 6.8 Hz, ArH), 6.85 (dd, 2H, J = 2.1, 6.7 Hz, ArH), 7.07 (dd, 2H, J = 2.2, 
6.7 Hz, ArH), 7.20 (dd, 2H, J = 2.2, 6.7 Hz, ArH), 7.36 (br, 4H, ArH). 
13
C NMR (75 MHz, 
CDCl3): δ = 31.4 (3CH3), 33.6 (NCH3), 34.6 (C), 55.1, 55.2 (OCH3), 108.2 (CH), 113.6 
(2CH), 114.0 (2CH), 122.1 (C), 125.3 (2CH), 125.6 (C), 128.5 (2CH), 128.8 (2CH), 129.3, 
130.6, 131.4 (C), 132.4 (2CH), 135.2, 149.8, 157.3, 159.0 (C). IR (KBr, cm
−1
): v = 2951, 
2903, 2831, 1606, 1574, 1554 (w), 1514, 1496, 1455, 1439, 1287 (m), 1247, 1239, 1170 (s), 
1105, 1037, 1011 (m), 831, 807, 801 (s), 766, 584, 558 (m). GC-MS (EI, 70 eV): m/z (%) 
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 = 425(100) [M
+
], 411(10), 410(36). HRMS (EI, 70 eV):  calcd for C29H31NO2 [M
+
]: 
425.23493; found: 425.23416. 
 
Synthesis of 2,5-diaryl-3-bromo-N-methylpyrroles (21): 
 
To a mixture of 18 (0.159 g, 0.5 mmol), aryl boronic acid (1.15 mmol) and Pd(PPh3)4 (29 mg, 
5 mol-%) was added a mixture of 1,4-dioxane and toluene (1:1; 5 mL) and K3PO4 (4.0 equiv, 
424 mg) under an argon atmosphere. The reaction mixture was stirred at 100 °C for 12 h and 
was subsequently allowed to cool to 20 °C. The solution was poured into H2O and EtOAc 
(25 mL each) and the organic and the aqueous layers were separated. The latter was extracted 
with EtOAc (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The residue 
was purified by flash column chromatography (flash silica gel, eluent: heptanes/EtOAc).  
 
3-Bromo-2,5-bis(3,5-dimethylphenyl)-1-methyl-1H-pyrrole (21a): 
Starting with 18 (0.159 g, 0.5 mmol) and 3,5-dimethyl 
phenyl boronic acid (0.172 g, 1.15 mmol), 21a was 
isolated (0.077 g , 42%) as a colorless oil.  
1
H NMR 
(300 MHz, acetone-d6): δ = 2.34 (s, 3H, CH3),  2.34 (s, 
3H, CH3), 2.35 (s, 3H, CH3), 2.36 (s, 3H, CH3), 3.48 
(s, 3H, NCH3), 6.26 (s, 1H, CHpyrrole), 7.00 (s, 1H, ArH), 7.04 (s, 1H, ArH), 7.10 (s, 4H, ArH). 
13
C NMR (75 MHz, acetone-d6): δ = 21.3 (2CH3), 21.4 (2CH3), 35.0 (NCH3), 95.9 (CBr), 
111.4 (CH), 127.4 (2CH), 129.1 (2CH), 129.8, 130.2 (CH), 132.2, 133.3, 134.1, 136.9 (C), 
138.6 (2C), 138.8 (2C). IR (KBr, cm
−1
): v = 3005, 2918, 2856, 1711, 1679, 1663 (w), 1600, 
1462 (m), 1376, 1330, 1270, 1191, 1038, 900 (w), 854, 841 (m), 780, 696, 659 (w). GC-MS 
(EI, 70 eV): m/z (%) = 369(100) [M
+
 (
8¹
Br)], 367(99) [M
+
 (Br)], 272(10). HRMS (EI, 70 eV): 
m/z [M
+
 (Br)] calcd for C21H22BrN: 367.09301; found: 367.09300. 
 
3-Bromo-2,5-bis(4-tert-butylphenyl)-1-methyl-1H-pyrrole (21b): 
Starting with 18 (0.159 g, 0.5 mmol) and 4-tert-
butylphenyl boronic acid (0.204 g, 1.15 mmol), 
 21b  was isolated (0.078 g, 37%) as brownish 
oil. 
1
H NMR (250 MHz, acetone-d6): δ = 1.20 (s, 
9H, 3CH3), 1.21 (s, 9H, 3CH3), 3.34 (s, 3H, NCH3), 
6.15 (s, 1H, CHpyrrole), 7.26 (d, 2H, J = 8.7 Hz, ArH), 7.27 (d, 2H, J = 8.7 Hz, ArH), 7.29 (m, 
2H, ArH), 7.39 (d, 2H, J = 8.7 Hz, ArH). 
13
C NMR (62 MHz, acetone-d6): δ = 31.7 (6CH3), 
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35.1 (NCH3), 35.3 (2C), 96.1 (CBr), 111.4 (CH), 126.1 (2CH), 126.3 (2CH), 129.3 (2CH), 
129.4, 130.6 (C), 131.0 (2CH), 133.8, 136.6, 151.1, 151.4 (C). IR (KBr, cm
−1
): v = 2957 (m), 
2902, 2866, 1736 (w), 1496, 1460, 1361, 1322, 1264 (m), 1241, 1226, 1201 (w), 1111, 1016, 
944 (m), 836 (s), 780 (m), 736 (s), 704 (m), 679, 632, 614 (w), 562 (s). GC-MS (EI, 70 eV): 
m/z (%) = 425(98) [M
+
 (
8¹
Br)], 423(100) [M
+ 
(Br)], 410(60), 409(17), 408(59), 314(12). 
HRMS (EI, 70 eV): calcd for C25H30BrN [M
+ 
(Br)]: 423.15561; found: 423.15524. 
 
3-Bromo-2,5-bis(4-methoxyphenyl)-1-methyl-1H-pyrrole (21c): 
Starting with 18 (0.159 g, 0.5 mmol) and 4-
methoxyphenylboronic acid (0.204 g, 1.15 mmol), 
21c was isolated (0.107 g, 58%) as brownish 
oil. 
1
H NMR (250 MHz, acetone-d6): δ = 3.31 (s, 
3H, NCH3), 3.70 (s, 3H, OCH3), 3.72 (s, 3H, 
OCH3), 6.08 (s, 1H, CHpyrrole), 6.87 (d, 2H, J = 8.9 Hz, ArH), 6.90 (d, 2H, J = 8.9 Hz, ArH), 
7.25 (d, 2H, J = 8.9 Hz, ArH), 7.26 (d, 2H, J = 8.9 Hz, ArH). 
13
C NMR (62 MHz, acetone-d6): 
δ = 34.7 (NCH3), 55.6 (2OCH3), 95.8 (CBr), 110.8 (CH), 114.7 (2CH), 114.8 (2CH), 124.5, 
125.9 (C), 130.9 (2CH), 132.6 (2CH), 133.2, 136.1, 160.2, 160.4 (C). IR (KBr, cm
−1
): v = 
3117, 2934, 2834 (w), 1609, 1552 (m), 1494 (s), 1463, 1439 (m), 1411, 1320, 1320 (w), 1284, 
1245, 1172 (s), 1107 (m), 1028 (s), 998, 940 (m), 831 (s), 797, 776, 665, 644, 593, 535 (m). 
MS (EI, 70 eV): m/z (%) = 373(100) [M
+
 (
8¹
Br)], 371(199) [M
+ 
(Br)], 358(44), 356(44), 
293(19), 278(14). HRMS (EI, 70 eV): calcd for C19H18BrNO2 [M
+ 
(Br)]: 371.05154; found: 
371.05125. 
 
Synthesis of unsymmetrical 2,4,5-triarylmethyl-1H-pyrroles (22): 
 
3-(4-Chlorophenyl)-2,5-bis(4-methoxyphenyl)-1-methyl-1H-pyrrole (22a): 
Starting with 21c (0.093 g, 0.25 mmol) and 4-
chlorophenylboronic acid (0.074 g, 0.50 mmol), 
 22a was isolated (0.072 g, 72%) as a yellowish 
solid, mp.= 165-166 °C. 
1
H NMR (300 MHz, 
CDCl3): δ = 3.32 (s, 3H,
 
NCH3), 3.74 (s, 3H,
 
OCH3), 3.75 (s, 3H,
 
OCH3),  6.29 (s, 1H, 
CHpyrrole), 6.83 (dd, J = 2.1, 6.7 Hz, 2H, ArH), 6.88 (dd, J = 2.1, 6.7 Hz, 2H, ArH), 7.04 (br, 
4H, ArH), 7.15 (dd, J = 2.1, 6.7 Hz, 2H, ArH), 7.31 (dd, J = 2.1, 6.9 Hz, 2H, ArH). 
13
C NMR 
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(62 MHz, CDCl3): δ = 33.4 (NCH3), 55.2, 55.3 (OCH3), 107.7 (CH), 113.9 (2CH), 114.2 
(2CH), 121.1, 125.2, 125.8 (C), 128.2 (2CH), 128.8 (2CH), 130.1 (2CH), 130.6, 131.8 (C), 
132.3 (2CH), 135.2 (2C), 158.9, 159.2 (C). IR (KBr, cm
−1
): v = 2955, 2924, 2852, 1721 (w), 
1668 (m), 1595 (s), 1572, 1509, 1490, 1461, 1422, 1307, 1286 (m), 1238, 1165 (s), 1114, 
1014, 833, 821, 758, 607, 590 (m). GC-MS (EI, 70 eV): m/z (%) = 403(100) [M
+
], 390(13), 
388(34).  HRMS (ESI): calcd for C25H23ClNO2 [M+H]
+
: 404.1412; found: 404.1410. 
 
2,5-Bis(4-tert-butylphenyl)-3-(2-ethoxyphenyl)-1-methyl-1H-pyrrole (22b): 
Starting with 21b (0.106 g, 0.25 mmol) and 2-
ethoxyphenylboronic acid (0.083 g, 0.50 mmol), 
 22b was isolated (0.096 g, 83%) as a yellowish 
semi solid. 
1
H NMR (300 MHz, CDCl3): δ = 1.08 
(t, 3H, J = 7.0 Hz, CH3), 1.23 (s, 9H, 3CH3), 1.28 
(s, 9H, 3CH3), 3.46 (s, 3H,
 
NCH3), 3.75 (q, 2H, 
J = 7.0 Hz, OCH2),  6.43 (s, 1H, CHpyrrole), 6.67-6.74 (m, 2H, ArH), 6.99-7.06 (m, 2H, ArH), 
7.13 (dd, 2H, J = 1.9, 6.6 Hz, ArH), 7.23 (dd, 2H, J = 2.0, 6.6 Hz, ArH), 7.37 (br, 4H, ArH). 
13
C NMR (75 MHz, CDCl3): δ = 14.6 (CH3), 31.3 (3CH3), 31.4 (3CH3), 34.4 (NCH3), 34.5, 
34.6 (C), 63.3 (OCH2), 110.7, 111.9 (CH), 119.0 (C), 120.1 (CH), 125.0 (2CH), 125.3 (2CH), 
126.0 (C), 126.6 (CH), 128.5 (2CH), 130.0 (2CH), 130.8, 130.9 (C), 131.9 (CH), 133.5, 
135.1, 149.4, 149.5, 155.9 (C). IR (KBr, cm
−1
): v = 3085, 2960, 2866, 1659, 1597, 1552, 
1461, 1455, 1391, 1361 (w), 1267, 1237, 1121, 1109, 1040 (m), 1014, 920 (w), 837, 746, 566 
(m). GC-MS (EI, 70 eV): m/z (%) = 465(100) [M
+
], 450(20). HRMS (ESI): calcd for 
C33H40NO [M+H]
+
: 466.3104; found: 466.3108. 
 
Synthesis of 2,3,5-triaryl-N-methylpyrroles (23): 
 
 In a pressure tube (glass bomb) a suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 5 mol-%) and 
P(Cy)3 (10 mol-%) in toluene (5 mL) was purged with Argon and stirred at 20 °C to give a 
brownish solution. To the stirred solution were added 18 (0.159 g, 0.5 mmol), arylboronic 
acid (2.0 mmol), and K3PO4 (4.0 equiv, 424 mg) under argon atmosphere. The reaction 
mixture was stirred at 110 °C for 36 h and was subsequently allowed to cool to 20 °C. The 
solution was poured into H2O and EtOAc (25 mL each) and the organic and the aqueous layer 
were separated. The latter was extracted with EtOAc (3 × 25 mL), dried (Na2SO4), filtered, 
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and concentrated in vacuo. The residue was purified by flash column chromatography (flash 
silica gel, eluent: heptanes/EtOAc).  
 
1-Methyl-2,3,5-tri-p-tolyl-1H-pyrrole (23a): 
Starting with 18 (0.159 g, 0.5 mmol) and 4-methyl 
phenylboronic acid (0.272 g, 2.0 mmol), 23a was 
isolated (0.119 g, 68%) as a brownish oil. 
1
H NMR 
(300 MHz, acetone-d6): δ =  2.09 (s, 3H,
 
CH3), 2.23 
(s, 6H,
 
2CH3), 3.30 (s, 3H,
 
NCH3), 6.26 (s, 1H, 
CHpyrrole), 6.82 (d, 2H, J = 8.0 Hz, ArH), 6.95 (dd, 
2H, J = 1.8, 6.4 Hz, ArH), 7.09 (br, 4H, ArH), 7.11 
(d, 2H, J = 7.9 Hz, ArH), 7.23 (dd, 1H, J = 1.9, 6.3 Hz, ArH), 7.28 (dd, 1H, J = 1.8, 6.2 Hz, 
ArH). 
13
C NMR (75 MHz, acetone-d6): δ = 21.0, 21.2, 21.3 (CH3), 34.0 (NCH3), 109.6 (CH), 
128.4 (2CH), 129.3 (2CH), 129.5 (2CH), 130.0 (2CH), 130.1 (2CH), 131.2, 131.5, 131.7 (C), 
131.8 (2CH), 132.8, 134.9. 135.0, 136.1, 137.2, 138.0 (C). IR (KBr, cm
−1
): v = 3019, 2918, 
2855, 1699, 1606, 1555 (w), 1519, 1497, 1444, 1376, 1179, 1109, 1018 (m), 942 (w), 820, 
788 (s), 762 (m), 672, 612, 563 (w). GC-MS (EI, 70 eV): m/z (%) = 351(100) [M
+
]. HRMS 
(EI, 70 eV): calcd for C26H25N [M
+
]: 351.19815; found: 351.19776. 
 
2,3,5-Tris(4-methoxyphenyl)-1-methyl-1H-pyrrole (23b): 
Starting with 18 (0.159 g, 0.5 mmol) and 4-
methoxyphenylboronic acid (0.304 g, 2.0 mmol), 
23b was isolated (0.177 g, 89%) as a brownish 
oil. 
1
H NMR (300 MHz, acetone-d6): δ = 3.30 (s, 
3H,
 
NCH3), 3.59 (s, 3H,
 
OCH3), 3.71 (s, 6H,
 
2OCH3),  6.19 (s, 1H, CHpyrrole), 6.60 (dd, 2H, 
J = 2.1, 6.7 Hz, ArH), 6.84 (dd, 2H, J = 2.1, 
6.7 Hz, ArH), 6.88 (dd, 2H, J = 2.2, 6.8 Hz, ArH), 6.98 (dd, 2H, J = 2.1, 6.7 Hz, ArH), 7.12 
(dd, 2H, J = 2.1, 6.7 Hz, ArH), 7.31 (dd, 2H, J = 2.1, 6.7 Hz, ArH). 
13
C NMR (62 MHz, 
acetone-d6): δ = 33.7 (NCH3), 55.4, 55.5, 55.5 (OCH3), 108.5 (CH), 114.3 (2CH), 114.7 
(2CH), 114.8 (2CH), 122.7, 126.7, 127.1 (C), 129.3 (2CH), 130.4 (C), 130.7 (2CH), 131.8 
(C), 133.1 (2CH), 135.5, 158.4, 159.8, 160.1 (C). IR (KBr, cm
−1
): v = 3004, 2952, 2930, 
2833, 1608, 1600, 1574, 1562 (w), 1517, 1497, 1461, 1440 (m), 1373, 1343, 1304 (w), 1285 
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(m), 1239, 1170 (s), 1108 (m), 1026, 832 (s), 806, 790 (m), 752, 650 (w), 585, 534 (m). GC-
MS (EI, 70 eV): m/z (%) = 399(100) [M
+
], 384 (35). HRMS (EI, 70 eV): calcd for C26H25NO3 
[M
+
]: 399.18290; found: 399.18262. 
 
2,3,5-Tris(3-methoxyphenyl)-1-methyl-1H-pyrrole (23c): 
Starting with 18 (0.159 g, 0.5 mmol) and 2-methoxy 
phenyl boronic acid (0.304 g, 2.0 mmol), 23c was 
isolated (0.152 g, 76%) as brown oil. 
1
H NMR 
(300 MHz, acetone-d6): δ = 3.33 (s, 3H,
 
NCH3), 3.42 
(s, 3H,
 
OCH3), 3.59 (s, 3H,
 
OCH3), 3.69 (s, 3H,
 
OCH3), 
6.37 (s, 1H, CHpyrrole), 6.45-6.49 (m, 1H, ArH), 6.61-
6.63 (m, 1H, ArH), 6.67-6.71 (m, 1H, ArH), 6.72-6.81 
(m, 4H, ArH), 6.90 (d, 1H, J = 8.0 Hz, ArH), 6.94-6.97 (m, 2H, ArH), 7.15-7.22 (m, 2H, 
ArH). 
13
C NMR (62 MHz, acetone-d6): δ = 34.1 (NCH3), 55.1, 55.5, 55.6 (OCH3), 109.5, 
111.7, 113.4, 111.8, 114.3, 114.9, 117.4, 120.8, 121.7 (CH), 123.3 (C), 124.2, 129.8, 130.4, 
130.5 (CH), 133.3, 135.5, 135.6, 136.1, 138.9, 160.5, 160.8, 160.9 (C). IR (KBr, cm
−1
): v = 
3010, 2954, 2932, 2834, 1605, 1603, 1574, 1562 (w), 1517, 1497, 1461, 1440 (m), 1373, 
1343, 1307 (w), 1285 (m), 1243, 1170 (s), 1108 (m), 1028, 832 (s), 806, 790 (m), 752, 650 
(w), 585, 534 (m). GC-MS (EI, 70 eV): m/z (%) = 399(100) [M
+
]. HRMS (EI, 70 eV): calcd 
for C26H25NO3 [M
+
]: 399.18290; found: 399.18281. 
 
2,3,5-Tris(4-tert-butylphenyl)-1-methyl-1H-pyrrole (23d): 
Starting with 18 (0.159 g, 0.5 mmol) and 4-tert-
butylphenylboronic acid (0.356 g, 2.0 mmol), 
23d was isolated (0.171 g, 72%) as a brownish oil. 
1
H NMR (300 MHz, acetone-d6): δ =  1.20 (s, 27H,
 
9CH3), 3.44 (s, 3H,
 
NCH3), 6.07 (s, 1H, CHpyrrole), 
7.26 (dd, 5H, J = 2.3, 6.4 Hz, ArH), 7.30-7.33 (m, 
7H, ArH). 
13
C NMR (62 MHz, acetone-d6): 
δ = 31.7 (9CH3), 34.7 (NCH3), 35.1 (3C), 109.2 (CH), 126.2 (6CH), 129.0 (6CH), 131.9 (3C), 
137.4 (3C), 150.2 (3C). IR (KBr, cm
−1
): v = 2951 (m), 2901, 2863, 1495, 1444 (w), 1362, 
1266 (m), 1246, 1184 (w), 1110, 1014 (m), 834 (s), 794 (m), 767 (s), 733, 697 (m), 673, 622 
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(w). GC-MS (EI, 70 eV): m/z (%) = 477(100) [M
+
], 463(11), 462(40). HRMS (EI, 70 eV): 
calcd for C35H43N [M
+
]: 477.33900; found: 477.33899. 
 
1-Methyl-2,3,5-tris(2,3,4-trimethoxyphenyl)-1H-pyrrole (23e): 
Starting with 18 (0.160 g, 0.5 mmol) and 2,3,4-
trimethoxyphenyl boronic acid (0.424 g, 
2.0 mmol) , 23e was isolated (0.266 g, 92%) as a 
brownish oil. 
1
H NMR (300 MHz, acetone-d6): 
δ = 3.10 (s, 3H, NCH3), 3.52, 3.53, 3.54, 3.60, 
3.61, 3.67, 3.68, 3.71, 3.74 (s, 3H,
 
OCH3),  6.20 
(s, 1H, CHpyrrole), 6.39 (d, 1H, J = 8.7 Hz, ArH), 
6.55 (d, 1H, J = 8.7 Hz, ArH), 6.57 (d, 1H, 
J = 8.7 Hz, ArH), 6.66 (d, 1H, J = 8.5 Hz, ArH), 6.70 (d, 1H, J = 8.6 Hz, ArH), 6.92 (d, 1H, 
J = 8.5 Hz, ArH). 
13
C NMR (62 MHz, acetone-d6): δ = 32.9 (NCH3), 56.1, 56.2, 56.4, 60.4, 
60.6, 60.7, 60.8, 61.0, 61.1 (OCH3), 108.1, 108.2, 108.5, 111.0 (CH), 119.2, 120.9, 121.6, 
125.1 (C), 126.0, 127.0, 128.1 (CH), 128.9, 131.2, 143.4, 143.5, 143.6, 152.7, 152.8, 153.1, 
153.6, 154.7, 154.8 (C). IR (KBr, cm
−1
): v = 2931, 2871, 2835, 1737, 1600, 1558 (w), 1499, 
1484, 1459, 1430, 1405 (w), 1346 (w), 1286 (s), 1252, 1227, 1203, 1166 (m), 1094, 1079 (s), 
1054 (m), 1009 (s), 985 (m), 914, 878, 855, 834 w), 793 (m), 744, 720 (w), 689 (m). MS (EI, 
70 eV): m/z (%) = 579(100) [M
+
], 208(12). HRMS (EI, 70 eV): calcd for C32H37NO9 [M
+
]: 
579.24628; found: 579.24647. 
 
One-pot Synthesis of unsymmetrical 2,4,5-triarylmethyl-1H-pyrroles (24): 
 
To a mixture of 19 (0.5 mmol), aryl boronic acid (0.55 mmol), and Pd(PPh3)4 (29 mg, 5 mol-
%) was added a mixture of 1,4-dioxane and toluene (1:1; 5 mL) and K3PO4 (424 mg, 2.0 
mmol) under an argon atmosphere. The reaction mixture was stirred at 100 °C. After for 6 h, 
was added the second aryl boronic acid (1.0 mmol) and K3PO4 (212mg, 1.0 mmol). The 
mixture was heated at 110 °C under Argon atmosphere for 24 h. The solution was poured into 
H2O and EtOAc (25 mL each) and the organic and the aqueous layers were separated. The 
latter was extracted with EtOAc (3 × 25 mL), dried (Na2SO4), filtered, and concentrated in 
vacuo. The residue was purified by flash column chromatography (flash silica gel, eluent: 
heptanes/EtOAc).  
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5-(4-tert-Butylphenyl)-3-(4-ethylphenyl)-2-(2-methoxyphenyl)-1-methyl-1H-pyrrole 
(24a): 
 Starting with 19c (0.186 g, 0.5 mmol), 2-methoxy 
phenyl boronic acid (0.084 g, 0.55 mmol) and 4-
ethylphenyl boronic acid (0.150 g, 1.0 mmol), 24a was 
isolated (0.091 g, 43%) as a brownish oil. 
1
H NMR 
(250 MHz, acetone-d6): δ = 0.99 (t, 3H, J = 7.6 Hz, 
CH3), 1.19 (s, 9H, 3CH3), 2.36 (q, 2H, J = 7.6 Hz, 
CH2), 3.20 (s, 3H, NCH3), 3.63 (s, 3H, OCH3), 6.32 (s, 1H, CHpyrrole), 6.80 (d, 2H, J = 8.0 Hz, 
ArH), 6.92-7.00 (m, 5H, ArH), 7.20-7.24 (m, 1H, ArH), 7.26-7.32 (m, 4H, ArH). 
13
C NMR 
(62 MHz, acetone-d6): δ = 16.1 (CH3), 29.0 (CH2), 31.7 (3CH3), 33.1 (NCH3), 35.1 (C), 55.8 
(OCH3), 108.6, 112.4, 121.5 (CH), 123.3, 123.4 (C), 126.2 (2CH), 127.9 (2CH), 128.3 (2CH), 
129.1 (2CH), 129.5 (C), 130.7 (CH), 131.8 (C), 134.2 (CH), 135.3, 135.4, 141.3, 150.3, 159.6 
(C). IR (KBr, cm
−1
): v = 2958, 2930 (m), 2867, 2833, 1611, 1578, 1555, 1511 (w), 1491, 
1460, 1431 (m), 1407, 1373, 1361, 1341, 1289 (w), 1240 (s), 1178, 1116, 1052, 1022 (m), 
1004, 944 (w), 835, 792, 750 (s), 716, 676, 621, 598 (w), 559, 537 (m). GC-MS (EI, 70 eV): 
m/z (%) = 423(100) [M
+
], 409 (11), 408(33), 183(14). HRMS (ESI): calcd for C30H34NO 
[M+H]
+
: 424.26349; found: 424.26434. 
 
2-(2,6-Dimethoxyphenyl)-5-(3,5-dimethylphenyl)-3-(4-ethylphenyl)-1-methyl-1H-pyrrole 
(24b): 
Starting with 19e  (0.171 g, 0.5 mmol), 2,6-dimethoxy 
phenyl boronic acid (0.100 g, 0.55 mmol) and 4-ethyl 
phenyl boronic acid (0.150 g, 1.0 mmol), 24b was isolated 
(0.102 g, 48%) as a brownish oil. 
1
H NMR (300 MHz, 
acetone-d6): δ = 1.09 (t, 3H, J = 7.6 Hz, CH3), 2.28 (s, 6H, 
2CH3), 2.47 (q, 2H, J = 7.6 Hz, CH2),  3.28 (s, 3H, NCH3), 
3.52 (s, 6H, 2OCH3), 6.45 (s, 1H, CHpyrrole),  6.52 (d, 2H, J = 8.3 Hz, ArH), 6.84 (br, 1H, 
ArH), 7.89 (d, 2H, J = 8.2 Hz, ArH), 7.05-7.07 (m, 4H, ArH), 7.18-7.27 (m, 1H, ArH). 
13
C 
NMR (62 MHz, acetone-d6): δ = 15.6 (CH3), 21.4 (2CH3), 28.6 (CH2), 32.5 (NCH3), 55.9 
(2OCH3), 104.5 (2CH), 107.9 (CH), 111.4, 123.0, 123.8 (C), 126.3 (2CH),  126.7 (2CH), 
127.3 (2CH), 128.1, 130.0 (CH), 133.8, 134.9, 135.0 (C), 137.6 (2C), 140.4 (C), 159.7 (2C). 
IR (KBr, cm
−1
): v = 2999, 2959, 2929, 2834 (w), 1599, 1583, 1469, 1430 (m),  1406, 1372, 
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1340, 1294 (w), 1247 (s), 1182 (w), 1103 (s), 1028, 833, 784, 735, 698, 650, 630, 595, 537 
(m). GC-MS (EI, 70 eV): m/z (%) = 425(100) [M
+
]. HRMS (ESI): calcd for C29H32NO2 
[M+H]
+
: 426.24276; found: 426.24233. 
 
General procedure A for the di(alkenyl)thiophene (27), (32), (33) and (35):  
 
In a pressure tube (glass bomb) a suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 5 mol-%) and 
L [XPhos, SPhos or P(Cy)3] (10 mol-%) in DMF (5 mL) was purged with Argon and stirred at 
20 °C to give a yellowish or brownish clear solution. To the stirred solution were added 2,3-
dibromothiophene (25), 31a,b or 5-Aryl-2,3-dibromothiophene (2b,c,d,f) (1.0 mmol), 
NEt3 (1.1 mL, 8.0 mmol) and an alkene (1.25 equiv per Br). The reaction mixture was stirred 
at 100-120 °C for 24-48 h. The solution was cooled to 20 °C, poured into H2O and 
CH2Cl2 (25 mL each), and the organic and the aqueous layer were separated. The latter was 
extracted with CH2Cl2 (3 × 25 mL). The combined organic layers were washed with H2O 
(3 × 20 mL), dried (Na2SO4), and concentrated in vacuo. The residue was purified by 
chromatography (flash silica gel, heptanes/EtOAc). 
 
(2E,2'E)-Dimethyl-3,3'-(thiophene-2,3-diyl)diacrylate (27a): 
Product 27a was prepared starting with 25 (242 mg, 1.0 mmol),  
methyl acrylate (0.23 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-%), 
XPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 
120 °C for 48 h following general procedure A, as a brown oil 
(204 mg, 81%). 
1
H NMR (300 MHz, CDCl3):  = 3.74 (s, 3H, 
OCH3), 3.75 (s, 3H, OCH3), 6.22 (d, 1H, J = 15.5 Hz, CH), 6.24 (d, 1H, J = 15.8 Hz, 
CH), 7.18 (d, 1H, J = 5.5 Hz, ArH), 7.25 (d, 1H, J = 5.3 Hz, ArH), 7.79 (d, 1H, J = 15.8 Hz, 
CH), 7.94 (d, 1H, J = 15.6 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 51.8, 51.9 (OCH3), 
118.8, 120.0, 126.4, 127.8, 133.7, 134.7 (CH), 138.2, 139.8 (C), 166.7, 167.1 (CO). IR (KBr, 
cm
1
): v = 3110, 2950, 2923 (w), 1705 (s), 1631 (m), 1513 (w), 1427, 1308, 1270 (m), 1190, 
1170, 1159 (s), 1110, 1009 (m), 972, 805 (s), 724, 709, 612, 575, 535 (m).  GC-MS (EI, 70 
eV): m/z (%) = 252(30) [M]
+
, 221(13), 193(45), 192(22), 177(22), 161(58), 149(26), 135(13), 
134(100), 133(18), 89(19), 67(13). HRMS (EI, 70 eV): calcd for C12H12O4S [M]
+
: 252.04508; 
found: 252.04533. 
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(2E,2'E)-Diethyl-3,3'-(thiophene-2,3-diyl)diacrylate (27b): 
Product 27b was prepared starting with 25 (242 mg, 1.0  mmol), 
ethyl acrylate (0.27 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol  %), 
SPhos (10 mol %), NEt3(1.10 mL, 8.0 mmol), DMF (5 mL) at 120 °C 
for 48 h following general procedure A, as a brown semi solid 
(252 mg, 90%). 
1
H NMR (300 MHz, CDCl3):  = 1.26 (t, 3H, J =  7.1 
Hz, CH3), 1.27 (t, 3H, J =  7.1 Hz, CH3), 4.20 (q, 2H, J = 7.1 Hz, CH2O), 4.21 (q, 2H, J = 7.1 
Hz, CH2O), 6.23 (d, 1H, J = 15.5 Hz, CH), 6.24 (d, 1H, J = 15.8 Hz, CH), 7.18 (d, 1H, J = 5.6 
Hz, ArH), 7.24 (d, 1H, J = 5.3 Hz, ArH), 7.79 (d, 1H, J = 15.8 Hz, CH), 7.93 (d, 1H, J = 15.5 
Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 14.3 (2CH3), 60.6, 60.7 (CH2O),  119.2, 120.4, 
126.4, 127.7, 133.5, 134.5 (CH), 138.2, 139.8 (C), 166.3, 166.7 (CO). IR (KBr, cm
1
): v = 
3095, 2985, 2939, 2872 (w), 1697 (s), 1621 (m),  1505, 1471, 1443, 1394 (w), 1369, 1315, 
1298, 1278, 1254, 1212 (m), 1176 (s), 1110, 1028, 976, 956, 868, 851 (m), 831, 808 (w),  
771, 764, 718, 701, 664, 627, 582 (m). GC-MS (EI, 70 eV): m/z (%) = 280(24) [M]
+
, 235(11), 
207(31), 206(15), 179(21), 178(08), 163(45), 162(07), 161(34), 136(12), 135(100), 134(44), 
91(16), 89(13), 29(19). HRMS (EI, 70 eV): calcd for C14H16O4S [M]
+
: 280.07638; found: 
280.07680. 
 
(2E,2'E)-Isobutyl-3,3'-(thiophene-2,3-diyl)diacrylate (27c): 
Product 27c was prepared starting with 25 (242 mg, 1.0 mmol), 
iso-butyl acrylate (0.36 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 
5 mol %), XPhos (10 mol %), NEt3(1.10 mL, 8.0 mmol), DMF 
(5 mL) at 120 °C for 48 h following general procedure A, as a 
brown oil (288 mg, 86%). 
1
H NMR (250 MHz, CDCl3):  = 
0.92 (d, 12H, J = 6.7 Hz, 4CH3), 1.89-1.98 (m, 2H, CH), 3.92 
(d, 2H, J = 6.7 Hz, CH2O), 3.93 (d, 2H, J = 6.7 Hz, CH2O), 6.23 (d, 1H, J = 15.5 Hz, 
CH), 6.25 (d, 1H, J = 15.7 Hz, CH), 7.19 (d, 1H, J = 5.4 Hz, ArH), 7.25 (d, 1H, J = 5.4 Hz, 
ArH), 7.79 (d, 1H, J = 15.8 Hz, CH), 7.93 (d, 1H, J = 15.6 Hz, CH)). 
13
C NMR (75 MHz, 
CDCl3):  = 19.1 (4CH3), 27.8 (2CH), 70.8, 70.9 (CH2O), 119.2, 120.4, 126.4, 127.7, 133.5, 
134.5 (CH), 138.2, 139.8 (C), 166.4, 166.8 (CO). IR (KBr, cm
1
): v = 3106, 2959, 2873 (w), 
1704, 1619 (s), 1508, 1468, 1393, 1375, 1342 (w), 1311, 1266, 1237, 1201 (m), 1154 (s), 
1018, 967, 852 (m), 832, 750 (w), 709 (m), 665, 620, 586, 533 (w). GC-MS (EI, 70 eV): m/z 
(%) = 336(25) [M]
+
, 263(19), 180(15), 179(100), 178(36), 163(82), 162(12), 161(42), 
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135(83), 134(59), 91(13), 57(80), 41(34). HRMS (EI, 70 eV): calcd for C18H24O4S [M]
+
: 
336.13898; found: 336.13894. 
 
 
(2E,2'E)-Dibutyl-3,3'-(thiophene-2,3-diyl)diacrylate (27d): 
Product 27d was prepared starting with 25 (242 mg, 1.0  
mmol), n-butyl acrylate (0.36 mL, 2.5 mmol), Pd(OAc)2  
(11 mg, 5 mol %), SPhos (10 mol %), NEt3 (1.10 mL, 8.0  
mmol), DMF (5 mL) at 120 °C for 48 h following general 
procedure A, as a brown oil (312 mg, 93%). 
1
H NMR (300 
MHz, CDCl3):  = 0.90 (t, 6H, J =  7.4 Hz, 2CH3), 1.32-1.40 
(m, 4H, 2CH2), 1.59-1.64 (m, 4H, 2CH2), 4.14 (t, 2H, J = 6.7 Hz, CH2O), 4.15 (t, 2H, J = 6.7 
Hz, CH2O), 6.21 (d, 1H, J = 15.5 Hz, CH), 6.24 (d, 1H, J = 15.8 Hz, CH), 7.18 (d, 1H, J = 5.3 
Hz, ArH), 7.24 (d, 1H, J = 5.4 Hz, ArH), 7.78 (d, 1H, J = 15.8 Hz, CH), 7.93 (d, 1H, J = 15.6 
Hz, CH)). 
13
C NMR (62 MHz, CDCl3):  = 13.7 (2CH3), 19.2 (2CH2), 30.7 (2CH2), 64.5, 64.6 
(CH2O),  119.3, 120.4, 126.4, 127.7, 133.5, 134.4 (CH), 138.2, 139.8 (C), 166.4, 166.8 (CO). 
IR (KBr, cm
1
): v = 2957, 2931, 2872 (w), 1704 (s), 1619 (m), 1509, 1463, 1433, 1383, 1354 
(w), 1309, 1276, 1238, 1202 (m), 1159 (s), 1061, 1024, 968, 853, 751, 710 (m), 665, 619, 584 
(w). GC-MS (EI, 70 eV): m/z (%) = 336(26) [M]
+
, 263(11), 235(15), 234(10), 180(12), 
179(94), 178(32), 163(62), 162(11), 161(45), 135(100), 134(50), 91(14), 57(56), 41(33), 
29(21). HRMS (EI, 70 eV): calcd for C18H24O4S [M]
+
: 336.13898; found: 336.13896. 
 
 
(2E,2'E)-Dihexyl-3,3'-(thiophene-2,3-diyl)diacrylate (27e): 
Product 27e was prepared starting with 25 (242 mg, 
1.0 mmol),  hexyl acrylate (2.5 mmol), Pd(OAc)2  
(11 mg, 5 mol %), SPhos (10 mol %), NEt3(1.10 mL, 
8.0 mmol), DMF (5 mL) at 120 °C for 48 h following 
general procedure A, as a brown oil (360 mg, 92%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.83 (t, 6H, J =  6.9 Hz, 
2CH3), 1.22-1.37 (m, 12H, 6CH2), 1.58-1.68 (m, 4H, 
2CH2), 4.13 (t, 2H, J = 6.8 Hz, CH2O), 4.14 (t, 2H, J = 6.8 Hz, CH2O), 6.22 (d, 1H, J = 15.5 
Hz, CH), 6.24 (d, 1H, J = 15.8 Hz, CH), 7.18 (d, 1H, J = 5.3 Hz, ArH), 7.24 (d, 1H, J = 5.4 
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Hz, ArH), 7.78 (d, 1H, J = 15.8 Hz, CH), 7.93 (d, 1H, J = 15.5 Hz, CH)). 
13
C NMR (62 MHz, 
CDCl3):  = 14.0 (2CH3), 22.5 (2CH2), 25.6 (2CH2), 28.7 (2CH2), 31.4 (2CH2), 64.9, 65.0 
(CH2O),  119.3, 120.4, 126.4, 127.6, 133.5, 134.4 (CH), 138.2, 139.8 (C), 166.4, 166.8 (CO). 
IR (KBr, cm
1
): v = 2954, 2927, 2857 (w), 1707 (s), 1620 (m), 1510, 1465, 1434, 1379 (w), 
1309, 1267, 1240, 1201 (m), 1160 (s), 1058, 1013, 970 (m), 906 (w), 854 (m), 834, 750 (w), 
710 (m), 665, 620, 586 (w). GC-MS (EI, 70 eV): m/z (%) = 392(07) [M]
+
, 263(32), 262(18),  
205(16), 180(14), 179(100), 178(29), 161(44), 135(35), 134(16), 91(07), 57(07), 41(46). 
HRMS (EI, 70 eV): calcd for C22H32O4S [M]
+
: 392.20158; found: 392.20182. 
 
(2E,2'E)-tert-Butyl-3,3'-(thiophene-2,3-diyl)diacrylate (27f): 
Product 27f was prepared starting with 25 (242 mg, 1.0  mmol), 
tert-butyl acrylate (0.36 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 
5 mol %), XPhos (10 mol %), NEt3(1.10 mL, 8.0 mmol), DMF 
(5 mL) at 120 °C for 48 h following general procedure A, as 
yellowish solid (299 mg, 89%), mp. = 85-87 °C. 
1
H NMR (300 
MHz, CDCl3):  = 1.45 (s, 9H, 3CH3), 1.46 (s, 9H, 3CH3), 6.13 
(d, 1H, J = 15.5 Hz, CH), 6.16 (d, 1H, J = 15.7 Hz, CH), 7.15 (d, 1H, J = 5.3 Hz, ArH), 7.20 
(d, 1H, J = 5.4 Hz, ArH), 7.68 (d, 1H, J = 15.7 Hz, CH), 7.84 (d, 1H, J = 15.6 Hz, CH)). 
13
C 
NMR (75 MHz, CDCl3):  = 28.2 (6CH3), 80.1, 80.7 (C-O), 121.1, 122.2, 126.4, 127.3, 132.7, 
133.6 (CH), 138.0, 139.6 (C), 165.6, 166.1 (CO). IR (KBr, cm
1
): v = 2976, 2932, 2872 (w), 
1700 (s), 1617 (m),  1506, 1474, 1456, 1432, 1390 (w), 1364, 1313, 1275, 1249, 1199 (m), 
1137 (s), 1039 (m), 999 (w), 971, 960, 911, 849 (m), 787 (w), 754, 727, 712, 694, 662, 621, 
582 (m). GC-MS (EI, 70 eV): m/z (%) = 336(05) [M]
+
, 263(04), 224(41), 180(14), 179(50), 
178(30), 163(19), 162(10), 161(34), 136(10), 135(100), 134(42), 91(23), 57(64), 41(72), 
29(21). HRMS (ESI): calcd for C18H24NaO4S [M+Na]
+
: 359.12875; found: 359.12877. 
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(2E,2'E)-Bis(2-ethylhexyl)-3,3'-(thiophene-2,3-diyl)diacrylate (27g): 
Product 27g was prepared starting with 25 (242 mg, 
1.0 mmol), 2-ethylhexyl acrylate (0.52 mL, 2.5 mmol), 
Pd(OAc)2 (11 mg, 5 mol %), SPhos (10 mol %), NEt3  
(1.10 mL, 8.0 mmol), DMF (5 mL) at 120 °C for 48 h 
following general procedure A, as a brown oil (380 mg, 
85%). 
1
H NMR (300 MHz, CDCl3):  = 0.85 (t, 12H, J = 
7.1 Hz, 4CH3), 1.17-1.38 (m, 16H, CH-Aliphatic),  1.55-
1.61 (m, 2H, CH), 4.02-4.07 (m, 4H, 2CH2O),  6.22 (d, 1H, J = 15.5 Hz, CH), 6.24 (d, 1H, J = 
15.8 Hz, CH), 7.19 (d, 1H, J = 5.4 Hz, ArH), 7.24 (d, 1H, J = 5.3 Hz, ArH), 7.78 (d, 1H, J = 
15.8 Hz, CH), 7.93 (d, 1H, J = 15.5 Hz, CH)). 
13
C NMR (75 MHz, CDCl3):  = 11.0 (2CH3), 
14.0 (2CH3), 23.0 (2CH2), 23.8, 23.9 (CH2), 28.9 (2CH2), 30.4, 30.5 (CH2), 38.8 (2CH),  67.2 
(2CH2O), 119.3, 120.5, 126.4, 127.6, 133.5, 134.4 (CH), 138.2, 139.8 (C), 166.5, 166.9 (CO). 
IR (KBr, cm
1
): v = 2957, 2927, 2858 (w), 1708 (s), 1621 (m), 1510, 1461, 1379 (w), 1308, 
1267, 1241 (m), 1161 (s), 1028, 970 (m), 854, 833, 750, 710, 665, 620, 586 (w). GC-MS (EI, 
70 eV): m/z (%) = 448(04) [M]
+
, 207(24), 180(17), 179(100), 178(31), 161(30), 135(19), 
134(11), 71(23), 57(31), 43(20). HRMS (EI, 70 eV): calcd for C26H40O4S [M]
+
: 448.26418; 
found: 448.26485. 
 
2,3-Bis(4-tert-butylstyryl)thiophene (27h): 
Product 27h was prepared starting with 25 (242 mg, 1.0 mmol), 
4-tert-butyl styrene (0.45 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 
5 mol %), SPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF 
(5 mL) at 120 °C for 48 h following general procedure A, as a 
brown solid (376 mg, 94%), mp.= 171-174 °C. 
1
H NMR 
(300MHz, CDCl3):  = 1.25 (s, 9H, 3CH3), 1.26 (s, 9H, 3CH3), 
6.83 (d, 1H, J = 15.9 Hz, CH), 6.88 (d, 1H, J = 16.1 Hz, CH), 
7.04 (d, 1H, J = 5.3 Hz, ArH), 7.15-7.22 (m, 3H, ArH), 7.28-7.32 (m, 4H, ArH), 7.35-7.39 
(m, 4H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 31.3 (6CH3),  34.6, 34.7 (C), 119.0, 120.3, 
123.6 (CH), 125.7 (4CH), 126.0 (CH), 126.2 (4CH), 129.0, 129.5 (CH), 134.4, 134.8, 136.8, 
138.4, 150.8, 150.9 (C). IR (KBr, cm
1
): v = 3028 (w), 2957 (m), 2864, 1903, 1605, 1515, 
1504, 1462, 1409, 1391 (w), 1361, 1268 (m), 1246, 1199, 1107, 1015 (w), 953, 940, 852, 827, 
809 (m), 741 (w), 714 (m), 665 (w), 635 (m), 610 (w), 558 (s). GC-MS (EI, 70 eV): m/z (%) = 
129 
 
400(100) [M]
+
, 385(27), 343(15), 287(10), 254(11), 253(42), 209(14), 185(36), 157(20), 
147(20), 91(12), 57(47). HRMS (EI, 70 eV): calcd for C28H32S [M]
+
: 400.22192; found: 
400.22190. 
 
2,3-Bis(4-methoxystyryl)thiophene (27i): 
Product 27i was prepared starting with 25 (242 mg, 1.0 mmol), 
4-methoxy styrene (0.33 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 
5 mol %), SPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF 
(5 mL) at 120 °C for 48 h following general procedure A, as a 
brown oil (289 mg, 83%). 
1
H NMR (300 MHz, CDCl3):  = 
3.69 (s, 6H, 2OCH3), 6.74-6.80 (m, 6H, 4ArH and 2CH), 6.97 (d, 1H, J = 5.3 Hz, ArH), 7.06 
(d, 1H, J = 16.1 Hz, CH), 7.12 (d, 1H, J = 5.4 Hz, ArH), 7.21 (d, 1H, J = 15.9 Hz, CH), 7.33 
(dd, 4H, J = 2.8, 8.8 Hz, ArH). 
13
C NMR (62 MHz, CDCl3):  = 55.3 (2OCH3), 114.2 (2CH), 
114.3 (2CH), 117.7, 119.0, 123.3, 125.9 (CH), 127.6 (2CH), 127.7 (2CH), 128.6, 129.0 (CH), 
130.0, 130.3, 136.5, 138.2, 159.3, 159.4 (C). IR (KBr, cm
1
): v = 3030, 2963, 2834 (w), 1597 
(m), 1573 (w), 1510, 1505 (m), 1462, 1455, 1440, 1435, 1410, 1303, 1283 (w), 1246, 1172 
(s), 1107, 1093 (w), 1024, 967, 957, 946, 931, 849, 812, 804, 778, 765, 726, 704, 631 (m). 
GC-MS (EI, 70 eV): m/z (%) = 348(100) [M]
+
, 347(10), 240(10), 227(39), 225(10), 121(51). 
HRMS (EI, 70 eV): calcd for C22H20O2S [M]
+
: 348.11785; found: 348.11778. 
 
2,3-Bis(4-methylstyryl)thiophene (27j): 
Product 27j was prepared starting with 25 (242 mg, 1.0 mmol),  
4-methyl styrene (2.5 mmol), Pd(OAc)2 (11 mg, 5 mol %), 
XPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 
120 °C for 48 h following general procedure A, as a brown semi 
solid (278 mg, 88 %). 
1
H NMR (250 MHz, CDCl3):  = 2.28 (s, 
6H, 2CH3), 6.83 (d, 1H, J = 15.9 Hz, CH), 6.85 (d, 1H, J = 16.1 
Hz, CH), 7.03 (d, 1H, J = 5.4 Hz, ArH), 7.09 (d, 4H, J = 7.8 Hz, ArH), 7.16-7.22 (m, 2H, 
ArH), 7.30-7.37 (m, 5H, 3ArH and 2CH). 
13
C NMR (62 MHz, CDCl3):  = 21.2 (2CH3), 
118.8, 119.9, 123.6, 125.9 (CH), 126.4 (4CH), 129.1 (CH), 129.4 (4CH), 129.6 (CH), 134.4, 
134.7, 136.7, 137.6, 137.7, 138.4 (C). IR (KBr, cm
1
): v = 3123, 2916, 2853, 1609, 1511, 
1440, 1377, 1259, 1180, 1091, 1017 (w), 957 (s), 938, 905, 850, 829 (m), 800, 729 (s), 707, 
637 (m). GC-MS (EI, 70 eV): m/z (%) = 316(100) [M]
+
, 315(11), 301(22), 225(17), 224(12), 
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212(10), 211(62), 209(12). HRMS (EI, 70 eV): calcd for C22H20S [M]
+
: 316.12802; found: 
316.12823. 
 
2,3-Bis(4-chlorostyryl)thiophene (27k): 
Product 27k was prepared starting with 25 (242 mg, 1.0 mmol),  
4-chloro styrene (0.32 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-
%), SPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 
120 °C for 48 h following general procedure A, as a brown solid 
(292 mg, 82%), mp.= 106-108 °C. 
1
H NMR (300 MHz, CDCl3):  
= 6.80 (d, 1H, J = 15.7 Hz, CH), 6.81 (d, 1H, J = 16.1 Hz, CH), 
7.07 (d, 1H, J = 5.2 Hz, ArH), 7.14-7.29 (m, 7H, 5ArH and 2CH), 7.33-7.36 (dd, 4H, J = 3.2, 
8.3 Hz, ArH). 
13
C NMR (75 MHz, CDCl3):  = 119.9, 121.1, 124.3, 125.9 (CH), 127.6 (4CH), 
128.0, 128.6 (CH), 128.9 (2CH), 129.0 (2CH), 133.3, 133.4, 135.5, 135.9, 136.8, 138.5 (C). 
IR (KBr, cm
1
): v = 3093, 3037, 2990, 2851, 1622, 1613, 1565, 1510 (w), 1488 (m), 1439, 
1401, 1328, 1255, 1245, 1178, 1103 (w), 1087, 1009, 957, 939, 852, 829 (m), 806 (s), 729, 
705, 690, 636 (m), 592 (w). GC-MS (EI, 70 eV): m/z (%) = 356 (70) [M
+
 (
37
Cl, 
37
Cl)], 356 
(100) [M
+
 (
35
Cl,
37
Cl)], 321(15), 320(13), 286(12), 252(13), 245(24), 231(99), 210(27), 
142(14), 125(19). HRMS (EI, 70 eV): calcd for C20H14Cl2S [M
+
 (Cl, 
37
Cl)]: 354.00313; found: 
354.00225. 
 
General procedure B for the synthesis of Benzothiophenes (28) and (36): 
 
 A xylene or diphenylether solution (3 mL) of 27a-e, h-l or 35a-d (0.5 mmol) was stirred at 
200 °C for 24 h in a pressure tube. The solution was allowed to cool to 20 °C and Pd/C 
(30 mg, 10 mol %) was added. The solution was stirred at 200 °C for 48 h under argon 
atmosphere. The reaction mixture was filtered and the filtrate was concentrated in vacuo. The 
residue was purified by chromatography (flash silica gel, heptanes/EtOAc).  
 
Dimethyl benzo[b]thiophene-5,6-dicarboxylate (28a): 
Compound 28a was prepared starting with 27a (100 mg, 0.39 
mmol), following the general procedure B, as a brown highly 
viscous oil (99 mg, 100%). 
1
H NMR (300 MHz, CDCl3):  = 3.86 
(s, 6H, OCH3), 7.34 (d, 1H, J = 5.4 Hz, ArH), 7.59 (d, 1H, J = 5.5 
Hz, ArH), 8.10 (s, 1H, ArH), 8.20 (s, 1H, ArH)). 
13
C NMR (75 
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MHz, CDCl3):  = 51.7, 51.7 (OCH3), 122.9, 124.1, 123.5 (CH), 126.2, 127.4 (C), 129.8 
(CH), 139.9, 140.6 (C), 167.0, 167.4 (CO). IR (KBr, cm
1
): v =  2950, 2925, 2852, 1840, 1780 
(w),  1716 (s), 1601, 1545, 1491 (w), 1433 (m), 1400, 1356 (w), 1316, 1277, 1263, 1246, 
1220, 1198, 1124, 1099, 1075 (m), 1009, 968, 893, 836, 787, 777, 759, 736, 703, 651, 628, 
604, 530 (w). GC-MS (EI, 70 eV): m/z (%) = 250(40) [M]
+
, 220(13), 219(100), 133(12). 
HRMS (EI, 70 eV): calcd for C12H10O4S [M]
+
: 250.02943; found: 250.02983. 
 
Diethyl benzo[b]thiophene-5,6-dicarboxylate (28b): 
Compound 28b was prepared starting with 27b (100 mg, 0.36 mmol), 
following the general procedure B, as a brown highly viscous oil (99 
mg, 100%). 
1
H NMR (300 MHz, CDCl3):  = 1.32 (t, 6H, J = 7.1 Hz, 
2CH3), 1.32 (q, 4H, J = 7.1 Hz, 2OCH2), 7.34 (d, 1H, J = 5.4 Hz, 
ArH), 7.58 (d, 1H, J = 5.4 Hz, ArH), 8.10 (s, 1H, ArH), 8.20 (s, 1H, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.1 (2CH3), 61.6, 61.7 (OCH2), 123.8, 124.1, 124.5 
(CH), 127.7, 128.8 (C), 130.6 (CH), 140.8, 141.5 (C), 167.5, 168.0 (CO). IR (KBr, cm
1
): v =  
2979, 2933, 2903, 2871 (w),  1714 (s), 1622, 1600, 1544, 1490, 1463, 1449, 1388 (w), 1365, 
1313 (m), 1273, 1241 (s), 1191, 1173, 1120, 1095, 1073, 1018 (m),  972, 907, 854, 804 (w), 
774, 755, 701 (m), 649, 607, 545 (w). GC-MS (EI, 70 eV): m/z (%) = 278(30) [M]
+
, 233(20), 
206(15), 205(100), 121(12). HRMS (EI, 70 eV): calcd for C14H14O4S [M]
+
: 278.06073; found: 
278.06090. 
 
Diisobutyl benzo[b]thiophene-5,6-dicarboxylate (28c): 
Compound 28c was prepared starting with 27c (100 mg, 0.30 
mmol), following the general procedure B, as a brown oil (99 
mg, 100%). 
1
H NMR (300 MHz, CDCl3):  = 0.93 (d, 6H, J = 6.7 
Hz, 2CH3), 0.94 (d, 6H, J = 6.7 Hz, 2CH3), 1.91-2.06 (m, 2H, 
CH), 4.05 (d, 4H, J = 6.8 Hz, 2CH2O), 7.35 (dd, 1H, J = 0.7, 5.6 
Hz, ArH), 7.58 (d, 1H, J = 5.5 Hz, ArH), 8.10 (s, 1H, ArH), 8.20 (s, 1H, ArH). 
13
C NMR (62 
MHz, CDCl3):  = 19.1 (2CH3), 19.2 (2CH3), 27.7, 27.8 (CH), 71.8, 71.9 (CH2O), 123.8, 
124.0, 124.4 (CH), 127.8, 128.9 (C), 130.6 (CH), 140.8, 141.5 (C), 167.6, 168.3 (CO). IR 
(KBr, cm
1
): v = 3106, 2958, 2873 (w), 1716 (s), 1626, 1601, 1545, 1490, 1468 (w), 1448, 
1452, 1405, 1392, 1392, 1375, 1341 (m), 1314, 1271, 1239, 1190, 1167, 1119, 1097, 1073 (s), 
1005,  982, 945, 904, 785, 775, 754, 702 (m), 682, 653, 626 (w). GC-MS (EI, 70 eV): m/z (%) 
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= 334(8) [M]
+
, 222(57), 206(17), 205(100), 178(15), 160(06). HRMS (EI, 70 eV): calcd for 
C18H22O4S [M]
+
: 334.12388; found: 334.12360. 
 
Dibutyl benzo[b]thiophene-5,6-dicarboxylate (28d): 
Compound 28d was prepared starting with 27d (100 mg, 
0.30 mmol), following the general procedure B, as a brown 
oil (99 mg, 100%). 
1
H NMR (300 MHz, CDCl3):  = 0.90 (t, 
6H, J =  7.4 Hz, 2CH3), 1.32-1.42 (m, 4H, 2CH2), 1.62-1.71 
(m, 4H, 2CH2), 4.26 (t, 4H, J = 6.7 Hz, 2CH2O), 7.35 (dd, 
1H, J = 0.6, 5.4 Hz, ArH), 7.57 (d, 1H, J = 5.4 Hz, ArH), 8.09 (s, 1H, ArH), 8.19 (s, 1H, 
ArH)). 
13
C NMR (62 MHz, CDCl3):  = 13.7 (2CH3), 19.2 (2CH2), 30.6 (2CH2), 65.5, 65.6 
(CH2O), 123.8, 124.1, 124.4 (CH), 127.8, 128.8 (C), 130.6 (CH), 140.8, 141.5 (C), 167.6, 
168.1 (CO). IR (KBr, cm
1
): v = 2957, 2930, 2871 (w), 1717 (s), 1625, 1600, 1543, 1490, 
1452, 1405, 1381 (w), 1314 (m), 1273 (s), 1241, 1190, 1119, 1096, 1074 (m), 1018, 961, 942, 
903, 840 (w), 775, 754, 736, 700 (m), 651, 545 (w). GC-MS (EI, 70 eV): m/z (%) = 334(11) 
[M]
+
, 222(27), 206(13), 205(100), 178(11). HRMS (EI, 70 eV): calcd for C18H22O4S [M]
+
: 
334.12333; found: 334.12338. 
 
Dihexyl benzo[b]thiophene-5,6-dicarboxylate (28e): 
Compound 28e was prepared starting with 27e (100 
mg, 0.26 mmol), following the general procedure B, as 
a brown oil (99 mg, 100%). 
1
H NMR (300 MHz, 
CDCl3):  = 0.80-0.85 (m, 6H, 2CH3), 1.18-1.40 (m, 
12H, 6CH2), 1.63-1.72 (m, 4H, 2CH2), 4.25 (q, 4H, J 
= 6.8 Hz, 2OCH2), 7.35 (dd, 1H, J = 0.5, 5.5 Hz, ArH), 7.58 (d, 1H, J = 5.5 Hz, ArH), 8.10 (s, 
1H, ArH), 8.20 (s, 1H, ArH)). 
13
C NMR (62 MHz, CDCl3):  = 14.0 (2CH3), 22.5 (2CH2), 
25.6 (2CH2), 28.5 (2CH2), 31.5 (2CH2) 65.8, 65.9 (OCH2), 123.8, 124.1, 124.4 (CH), 127.8, 
128.8 (C), 130.5 (CH), 140.8, 141.5 (C), 167.6, 168.0 (CO). IR (KBr, cm
1
): v = 2953, 2926, 
2856 (w), 1720 (s), 1624, 1601, 1544, 1490, 1465, 1455, 1378, 1314 (w), 1272, 1241, 1189, 
1167, 1120, 1097, 1074 (m), 993, 904, 837, 776, 755, 724, 701, 652 (w). GC-MS (EI, 70 eV): 
m/z (%) = 390(7) [M]
+
, 222(23), 206(13), 205(100). HRMS (EI, 70 eV): calcd for C22H30O4S 
[M]
+
: 390.18593; found: 390.18607. 
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Bis(2-ethylhexyl) benzo[b]thiophene-5,6-dicarboxylate (28g): 
Compound 28g was prepared starting with 27g (100 
mg, 0.26 mmol), following the general procedure B, as 
a brown oil (99 mg, 100%). 
1
H NMR (300 MHz, 
CDCl3):  = 0.77-0.88 (m, 12H, 4CH3), 1.25-1.41 (m, 
16H, CH-Aliphatic),  1.59-1.65 (m, 2H, CH), 4.15-4.18 
(m, 4H, 2CH2O), 7.33 (d, 1H, J = 5.4 Hz, ArH), 7.56 
(d, 1H, J = 5.4 Hz, ArH), 8.07 (s, 1H, ArH), 8.17 (s, 
1H, ArH)). 
13
C NMR (62 MHz, CDCl3):  = 11.0 (2CH3), 14.1 (2CH3), 23.0 (2CH2), 23.8 
(2CH2), 29.0 (2CH2), 30.4 (2CH2), 38.7, 38.8 (CH), 68.1, 68.2 (CH2O), 123.7, 124.1, 124.4 
(CH), 127.9, 129.0 (C), 130.5 (CH), 140.8, 141.5 (C), 167.7, 168.1 (CO). IR (KBr): v = 2956, 
2927 (m), 2858 (w), 1720 (s), 1625, 1459, 1379, 1313 (w), 1270 (s), 1240, 1190, 1167, 1120, 
1097, 1073, 774, 701 (m), 654, 544 (w) cm
1
. GC-MS (EI, 70 eV): m/z (%) = 446(02) [M]
+
, 
223(27), 222(41), 205(100), 57(10). HRMS (EI, 70 eV): calcd for C26H38O4S [M]
+
: 
446.24853; found: 446.24915. 
 
5,6-Bis(4-tert-butylphenyl)benzo[b]thiophene (28h): 
Compound 28h was prepared starting with 27h (100 mg, 0.25 
mmol), following the general procedure B, as a brown highly 
viscous oil (99 mg, 100%). 
1
H NMR (300 MHz, CDCl3):  = 
1.21 (s, 18H, 6CH3), 7.01 (d, 4H, J = 8.3 Hz, ArH), 7.13 (d, 
4H, J = 8.1 Hz, ArH), 7.26 (d, 1H, J = 5.3 Hz, ArH), 7.36 (d, 
1H, J = 5.4 Hz, ArH), 7.77 (s, 1H, ArH), 7.83 (s, 1H, ArH). 
13
C 
NMR (62 MHz, CDCl3):  = 31.4 (6CH3), 34.4 (2C),  123.7, 
123.9 (CH), 124.6 (4CH), 125.1, 126.9 (CH), 129.6 (2CH), 129.7 (2CH), 137.6, 137.7, 138.6, 
138.7, 138.8, 138.9 (C), 149.2, 149.3 (C). ). IR (KBr, cm
1
): v = 3026, 2958, 2902, 2864, 
2245, 1906, 1602, 1514, 1449, 1408, 1390 (w), 1361 (m), 1320, 1307 (w), 1267 (m), 1200, 
1181, 1111, 1085, 1085, 1058, 1038, 1014, 960, 907, 894, 876 (w), 834 (s), 776, 762 (w), 
731, 719 (m), 683, 661, 646, 633 (w), 602, 562 (m). GC-MS (EI, 70 eV): m/z (%) = 398(100) 
[M]
+
, 384(25), 383(84), 184(12), 156(16), 57(29). HRMS (EI, 70 eV): calcd for C28H30S 
[M]
+
: 398.20627; found: 398.20642. 
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5,6-Bis(4-methoxyphenyl)benzo[b]thiophene (28i): 
Compound 28i was prepared starting with 27i (100 mg, 0.29 
mmol), following the general procedure B, as a brown highly 
viscous oil (99 mg, 100%). 
1
H NMR (300 MHz, CDCl3):  = 
3.69 (s, 6H, 2OCH3), 6.7 (dd, 4H, J = 1.3, 8.6 Hz, ArH), 7.01 
(dd, 4H, J = 1.9, 8.7 Hz, ArH), 7.25 (d, 1H, J = 5.4 Hz, ArH), 
7.35 (d, 1H, J = 5.4 Hz, ArH), 7.72 (s, 1H, ArH), 7.78 (s, 1H, 
ArH). 
13
C NMR (75 MHz, CDCl3):  = 55.2 (2OCH3), 113.4 (4CH), 123.7, 123.9, 125.1, 
126.9 (CH), 131.0 (2CH), 131.1 (2CH), 134.1, 134.3, 137.2, 137.3, 138.8, 138.9 (C), 158.2, 
158.3 (C-O). IR (KBr, cm
1
): v = 3132, 2952, 2929, 2833, 2540, 1712 (w), 1607 (m), 1574 
(w), 1484, 1449, 1439 (m), 1415, 1390, 1319 (w), 1286 (m), 1240, 1173 (s), 1107 (m), 1087, 
1085 (w), 1044, 1025 (m), 958 (w), 905 (m), 830 (s), 801, 759, 730, 716 (m), 683, 670, 657, 
628, 603 (w), 585, 546, 534 (m). GC-MS (EI, 70 eV): m/z (%) = 346(100) [M]
+
, 271(12). 
HRMS (EI, 70 eV): calcd for C22H18O2S [M]
+
: 346.10220; found: 346.10260. 
 
5,6-Di-p-tolylbenzo[b]thiophene (28j): 
Compound 28j was prepared starting with 27j (100 mg, 0.32 
mmol), following the general procedure B, as a brown highly 
viscous oil (99 mg, 100%). 
1
H NMR (250 MHz, CDCl3):  = 
2.23 (s, 6H, 2CH3), 6.94 (d, 4H, J = 7.3 Hz, ArH), 6.99 (d, 4H, 
J = 8.2 Hz, ArH), 7.25 (d, 1H, J = 5.4 Hz, ArH), 7.35 (d, 1H, J 
= 5.5 Hz, ArH), 7.74 (s, 1H, ArH), 7.79 (s, 1H, ArH). 
13
C 
NMR (62 MHz, CDCl3):  = 21.2 (2CH3), 123.7, 124.0, 125.3, 127.0 (CH), 128.6 (4CH), 
129.9 (2CH), 130.0 (2CH), 135.9, 136.0, 137.5, 137.6, 138.7 (C), 138.8 (2C), 138.9 (C). IR 
(KBr, cm
1
.): v = 3020, 2916, 2848 (w), 1512 (m), 1484 (w), 1448 (m), 1409, 1319, 1181, 
1110, 1087, 1057, 1036, 1018, 943, 894, 875 (m), 814 (s), 758, 724, 657, 583, 526 (w). GC-
MS (EI, 70 eV): m/z (%) = 314(100) [M]
+
, 299(42), 298(19), 285(10), 284(28). HRMS (EI, 
70 eV): calcd for C22H18S [M]
+
: 314.11237; found: 314.11245. 
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Synthesis of 2-alknylthiophene (29): 
 
(E)-Methyl-3-(thiophen-2-yl)acrylate (29a): 
Product 29a was prepared starting with 25 (242 mg, 1.0 mmol),  
methyl acrylate (0.09 mL, 1.0 mmol), Pd(OAc)2 (11 mg, 5 mol %), 
XPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 
120 °C for 24 h following general procedure A, as a brown oil (126 mg, 75%). 
1
H NMR (230) 
MHz, CDCl3):  = 3.71 (s, 3H, OCH3), 6.18 (d, 1H, J = 15.9 Hz, CH), 7.18-7.27 (m, 2H, 
ArH), 7.40-7.42 (m, 1H, ArH), 7.60 (d, 1H, J = 15.9 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  
= 51.6 (OCH3), 117.4, 125.1, 126.9, 128.1 (CH), 137.5 (C), 138.3 (CH),  167.6 (CO). IR 
(KBr, cm
1
): v = 3098, 29993, 2946, 2841 (w), 1703, 1699, 1632 (s),  1515 (w), 1435 (m), 
1392, 1370 (w), 1306, 1275, 1247, 1197 (m), 1168 (s), 1054, 1043, 1012, 979, 922, 865, 842, 
828 (m), 793 (s), 754, 736, 725, 666, 608, 590 (m). GC-MS (EI, 70 eV): m/z (%) = 168(62) 
[M]
+
, 138(10), 137(100), 110(08), 109(42), 65(16). HRMS (EI, 70 eV): calcd for C8H8O2S 
[M]
+
: 168.02395; found: 168.02367. 
 
(E)-Ethyl-3-(thiophen-2-yl)acrylate (29b): 
 Product 29b was prepared starting with 25 (242 mg, 1.0 mmol),  ethyl 
acrylate (0.11 mL, 1.0 mmol), Pd(OAc)2 (11 mg, 5 mol %), SPhos 
(10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 120 °C for 
24 h following general procedure A, as a brown oil (141 mg, 78%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.26 (t, 3H, J = 7.1 Hz, CH3), 4.18 (q, 2H, J = 7.1 Hz, CH2O), 6.18 (d, 1H, J = 
15.9 Hz, CH), 7.19-7.26 (m, 2H, ArH), 7.40-7.42 (m, 1H, ArH), 7.59 (d, 1H, J = 15.9 Hz, 
CH). 
13
C NMR (62 MHz, CDCl3):  = 14.3 (CH3), 60.4 (CH2O), 117.9, 125.1, 126.9, 127.9, 
138.0 (CH), 137.6 (C),  167.2 (CO). IR (KBr, cm
1
): v = 3098, 2978, 2927, 2853 (w), 1703 
(s), 1632 (m), 1518, 1463, 1444, 1392, 1365 (w), 1302, 1276, 1244, 1204 (m), 1152 (s), 1094, 
1033, 975, 863, 828, 783, 700, 666, 605, 592 (m). GC-MS (EI, 70 eV): m/z (%) = 182(46) 
[M]
+
, 154(11), 138(12), 137(100), 110(20), 109(37), 65(16). HRMS (EI, 70 eV): calcd for 
C9H10O2S [M]
+
: 182.03960; found: 182.03963. 
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(E)-Isobutyl-3-(thiophen-2-yl)acrylate (29c): 
Product 29c was prepared starting with 25 (242 mg, 1.0 mmol),  
iso-butyl acrylate (0.14 mL, 1.0 mmol), Pd(OAc)2 (11 mg, 
5 mol %) , XPhos (10 mol %), NEt3(1.10 mL, 8.0 mmol), DMF 
(5 mL) at 120 °C for 24 h following general procedure A, as a 
brown highly viscous oil (155 mg, 74%).  
1
H NMR (250 MHz, CDCl3):  = 0.90 (d, 6H, J = 
6.7 Hz, 2CH3), 1.85-2.01 (m, 1H, CH), 3.91 (d, 2H, J = 6.7 Hz, CH2O), 6.20 (d, 1H, J = 15.9 
Hz, CH), 7.18-7.25 (m, 2H, ArH), 7.40-7.42 (m, 1H, ArH), 7.59 (d, 1H, J = 15.9 Hz, CH). 
13
C 
NMR (75 MHz, CDCl3):  = 19.2 (2CH3), 27.9 (CH), 70.6 (CH2O), 117.9, 125.2, 126.9, 
127.9 (CH), 137.6 (C), 138.0 (CH), 167.3 (CO). IR (KBr): v = 3098, 2958, 2931, 2872 (w), 
1704 (s), 1632 (m), 1518, 1468, 1426, 1394, 1375, 1342 (w), 1305, 1276, 1203 (m), 1151 (s), 
1084 (w),  1013, 974 (m), 867, 859, 828 (w), 783 (m), 699, 667 (w), 605 (m), 569, 537 (w) 
cm
1
. GC-MS (EI, 70 eV): m/z (%) = 210 ([M]
+
, 12), 154 (71), 138 (10), 137 (100), 112 (12), 
109 (31), 65 (13), 39 (08). HRMS (EI, 70 eV): calcd for C11H14O2S [M]
+
: 210.07090; found: 
210.07110. 
 
(E)-tert-Butyl-3-(thiophen-2-yl)acrylate (29d): 
Product 29d was prepared starting with 25 (242 mg, 1.0 mmol),  
tert-butyl acrylate (0.14 mL, 1.0 mmol), Pd(OAc)2  (11 mg, 
5 mol %), XPhos (10 mol %), NEt3 (1.10 mL, 8.0  mmol), DMF 
(5 mL) at 120 °C for 24 h following general procedure A, as a brown oil (182 mg, 87%). 
1
H 
NMR (300 MHz, CDCl3):  = 1.45 (s, 9H, 3CH3),  6.12 (d, 1H, J = 15.9 Hz, CH), 7.18-7.25 
(m, 2H, ArH), 7.36-7.39 (m, 1H, ArH), 7.59 (d, 1H, J = 16.0 Hz, CH). 
13
C NMR (75 MHz, 
CDCl3):  = 28.2 (3CH3), 80.4 (C-O), 119.9, 125.2, 126.8, 127.4, 137.1 (CH), 137.8 (C), 
166.6 (CO). IR (KBr, cm
1
): v = 3098, 2976, 2927, 2855 (w), 1705 (s), 1633 (m), 1518, 1455, 
1392 (w), 1366, 1309, 1281 (m), 1248, 1219 (w), 1148 (s), 1085, 1041, 978, 855, 829, 787, 
702, 665, 606, 529 (w). GC-MS (EI, 70 eV): m/z (%) = 210(16) [M]
+
, 154(100), 137(57), 
126(10), 112(30), 109(21), 65(12), 57(20), 41(14). HRMS (EI, 70 eV): calcd for C11H14O2S 
[M]
+
: 210.07090; found: 210.07071. 
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(E)-Hexyl-3-(thiophen-2-yl)acrylate (29e): 
Product 29e was prepared starting with 25 (242 mg, 
1.0 mmol),  hexyl acrylate (1.0 mmol), Pd(OAc)2 
 (11 mg, 5 mol %), SPhos (10 mol %), NEt3 (1.10 mL, 
8.0 mmol), DMF (5 mL) at 120 °C for 24 h following 
general procedure A, as a brown oil (180 mg, 76%). 
1
H NMR (300 MHz, CDCl3):  = 0.83 (t, 
3H, J = 6.8 Hz, CH3), 1.21-1.29 (m, 6H, 3CH2), 1.54-1.64 (m, 2H, CH2), 4.11 (t, 2H, J = 6.8 
Hz, CH2O), 6.19 (d, 1H, J = 15.9 Hz, CH), 7.18-7.25 (m, 2H, ArH), 7.40-7.42 (m, 1H, ArH), 
7.59 (d, 1H, J = 15.9 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 (CH3), 22.5, 25.6, 28.7, 
31.4 (CH2), 64.7 (CH2O), 118.0, 125.1, 126.9, 127.9 (CH), 137.6 (C), 138.0 (CH),  167.3 
(CO). IR (KBr, cm
1
): v = 3098, 2953, 2927, 2856 (w), 1707 (s), 1632 (m), 1518, 1465, 1391, 
1379 (w), 1302, 1276, 1245, 1203 (m), 1162 (s), 1112, 1082, 976 (m), 908, 867, 860, 829 (w), 
784, 711 (m), 668 (w), 605 (m). GC-MS (EI, 70 eV): m/z (%) = 238(12) [M]
+
, 155(16), 
154(100), 138(10), 137(81), 112(13), 110(12), 109(32), 65(14). HRMS (EI, 70 eV): calcd for 
C13H18O2S [M]
+
: 238.10220; found: 238.10245 
 
Synthesis of (E)-N-[(4,5-dibromothiophen-2-yl)methylene]-4-methoxyaniline (31): 
A mixture of  4,5-dibromothiophene-2-carbaldehyde 
(30)  (269 mg, 1.0 mmol), 4-methoxy aniline (184 mg, 
1.5 mmol) in glacial acetic acid  (5 mL) was stirred at 
room temperature for 15 min to give a greenish 
precipitate. Then it was filtered and washed with ethanol to give the pure imine 31 (365 mg, 
98.00 %), mp. = 136-137 °C. 
1
H NMR (300 MHz, CDCl3):  = 3.75 (s, 3H, OCH3), 6.83 (dd, 
2H, J = 2.1, 6.8 Hz, ArH), 7.12 (s, 1H, ArH), 7.14 (dd, 2H, J = 2.1, 6.8 Hz, ArH), 8.33 (s, 1H, 
N=CH). 
13
C NMR (62 MHz, CDCl3):  = 55.5 (OCH3), 114.5 (2CH), 122.5 (2CH), 132.8 
(CH), 143.1 (2C-Br), 144.0 (2C), 148.2 (CH), 158.9 (C-O). IR (KBr, cm
1
): v = 2932, 2834 
(w), 1614, 1579, 1519, 1502, 1463, 1427, 1417, 1287 (m), 1239 (s), 1200, 1183, 1159, 1118 
(m), 1030 (s), 991, 950 (m), 827 (s), 770, 665, 636, 582 (m), 546 (w). GC-MS (EI, 70 eV): 
m/z (%) = 377(53) [M
+
 (
8¹
Br, 
8¹
Br)], 375(100) [M
+ 
(Br, 
8¹
Br)], 373(52) [M
+ 
(Br, Br)], 360(93), 
358(47), 172(19), 92(12), 77(12), 64(11). HRMS (EI, 70 eV): calcd for C12H9Br2NOS [M
+ 
(Br, 
8¹
Br)]
+
: 374.87456; found: 374.87422. 
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Synthesis of 2,3-di(alkenyl)thiophenes (32): 
 
(2E,2'E)-Dimethyl-3,3'-{5-[(E)-(4-methoxyphenylimino)methyl]thiophene-2,3-diyl} 
diacrylate (32a): 
Product 32a was prepared starting with 31 
(186 mg, 0.5 mmol), methyl acrylate (0.12 
mL, 1.25 mmol), Pd(OAc)2 (6 mg, 5 mol-%), 
P(Cy)3 (10 mol-%), NEt3 (0.55 mL, 4.0 
mmol) , DMF (5 mL) at 90 °C for 12 h 
following general procedure A, as a brown 
oil (119 mg, 62%). 
1
H NMR (300 MHz, CDCl3):  =  3.75 (s, 9H, 3OCH3), 6.25 (d, 1H, J = 
16.4 Hz, CH), 6.31 (d, 1H, J = 16.4 Hz, CH), 6.85 (d, 2H, J = 9.0 Hz, ArH), 7.15 (d, 2H, J = 
9.0 Hz, ArH), 7.46 (s, 1H, ArH), 7.76 (d, 1H, J = 15.7 Hz, CH), 7.92 (d, 1H, J = 15.3 Hz, 
CH), 8.44 (s, 1H, N=CH). 
13
C NMR (75 MHz, CDCl3):  = 51.9, 52.0, 55.5 (OCH3), 114.5 
(2CH), 120.2, 120.3 (CH), 122.6 (2CH), 129.1, 133.4, 134.3 (CH), 138.5 (C), 142.2 (C-N), 
143.2, 144.4 (C) 149.0 (CH), 159.1 (C-O), 166.6, 167.0 (CO). IR (KBr, cm
1
): v =  2957, 
2935, 2830 (w), 1709, 1637 (m), 1614 (s), 1574, 1508, 1453, 1440, 1386, 1367, 1304, 1291 
(m), 1243, 1171, 1162 (s), 1120, 1108 (m),1022, 970 (s), 864 (m), 832 (s), 795, 780, 732, 705, 
678, 599, 554, 537 (m). GC- MS (EI, 70 eV): m/z (%) = 385(60) [M
+
], 383(19), 326(79), 
327(100), 310(35), 294(60), 267(16), 252(27), 162(12), 147(20), 134(35). HRMS (EI, 70 eV): 
calcd for C20H19NO5S [M]
+
: 385.09784; found: 385.09850. 
 
(2E,2'E)-Isobutyl-3,3'-{5-[(E)-(4-methoxyphenylimino)methyl]thiophene-2,3-diyl} 
diacrylate (32b): 
Product 32b was prepared starting with 31 
(186 mg, 0.5 mmol), iso-butyl acrylate  
(0.18 mL, 1.25 mmol), Pd(OAc)2 (6 mg, 
5 mol %), P(Cy)3 (10 mol %), NEt3 (0.55  
mL, 4.0 mmol), DMF (5 mL) at 90 °C for 
12 h following general procedure A, as a 
brown oil (178 mg, 76%). 
1
H NMR (300 MHz, CDCl3):  =  0.92 (dd, 12H, J = 0.8, 6.7 Hz, 
4CH3), 1.92-1.98 (m, 2H, CH), 3.76 (s, 3H, OCH3),  3.92 (dd, 4H, J = 1.9, 6.7 Hz, 2CH2O), 
6.31 (t, 2H, J = 15.8 Hz, CH), 6.85 (dd, 2H, J = 2.1, 6.8 Hz, ArH), 7.18 (dd, 2H, J = 2.2, 6.8 
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Hz, ArH), 7.49 (s, 1H, ArH), 7.76 (d, 1H, J = 15.8 Hz, CH), 7.92 (d, 1H, J = 15.5 Hz, CH), 
8.45 (s, 1H, N=CH). 
13
C NMR (75 MHz, CDCl3):  = 18.1 (4CH3), 26.8 (2CH), 54.5 (OCH3), 
69.9, 70.0 (CH2O), 113.5 (2CH), 119.7, 119.8 (CH), 121.6 (2CH), 128.2, 132.2, 133.1 (CH), 
137.4 (C), 141.2 (C-N), 142.2, 143.3 (C) 148.0 (CH), 158.0 (C-O), 165.2, 165.6 (CO). IR 
(KBr, cm
1
): v =  2960, 2873, 2835 (w), 1692 (s), 1608, 1574, 1501, 1465, 1393, 1377, 1367 
(m), 1343, 1305 (w), 1282, 1268 (m), 1246, 1234 (s), 1199, 1178 (m), 1166, 1156 (s), 1109 
(m), 1024, 1014 (s), 967, 951, 930, 908, 856, 843 (m), 827 (s), 779, 735, 712, 664, 636, 617, 
599, 553, 535 (m). MS (EI, 70 eV): m/z (%) = 469(100) [M
+
], 343(15), 312(21), 296(16), 
294(10), 268(26), 252(10), 134(17), 78(12), 63(14), 57(32). HRMS (EI, 70 eV): calcd for 
C26H31NO5S [M]
+
: 469.19175; found: 469.19242. 
 
 (2E,2'E)-Dibutyl-3,3'-{5-[(E)-(4-methoxyphenylimino)methyl]thiophene-2,3-diyl}diacrylate 
(32c): 
Product 32c was prepared starting 
with 31 (186 mg, 0.5 mmol), n-butyl 
acrylate (0.18 mL, 1.25  mmol) , 
Pd(OAc)2 (6 mg, 5 mol %), P(Cy)3 
(10 mol %), NEt3 (0.55 mL, 4.0 
 mmol), DMF (5 mL) at 90 °C for 12 h following general procedure A, as a brown oil (128 
mg, 55%). 
1
H NMR (300 MHz, CDCl3):  =  0.90 (t, 6H, J = 7.4 Hz, 2CH3), 1.30-1.43 (m, 
4H, 2CH2), 1.57-1.68 (m, 4H, 2CH2), 3.76 (s, 3H, OCH3), 4.15 (t, 2H, J = 6.7 Hz, 
CH2O), 4.16 (t, 2H, J = 6.7 Hz, CH2O), 6.27 (d, 1H, J = 15.9 Hz, CH), 6.32 (d, 1H, J = 15.6 
Hz, CH), 6.85 (dd, 2H, J = 2.8, 9.0 Hz, ArH), 7.14-7.20 (m, 2H, ArH), 7.51 (s, 1H, ArH), 
7.76 (d, 1H, J = 15.8 Hz, CH), 7.92 (d, 1H, J = 15.5 Hz, CH), 8.45 (s, 1H, N=CH). 
13
C NMR 
(75 MHz, CDCl3):  = 13.7 (2CH3), 19.2 (2CH2), 30.7 (2CH2), 55.5 (OCH3), 64.7, 64.8 
(CH2O), 114.4 (2CH), 120.8, 122.4 (CH), 122.6 (2CH), 129.2, 133.2, 134.1 (CH), 138.4 (C), 
142.3 (C-N), 143.3, 144.3 (C) 149.1 (CH), 159.1 (C-O), 166.3, 166.7 (CO). IR (KBr, cm
1
): 
v =  2956, 2869, 2835 (w), 1698, 1613 (s), 1557, 1529 (w), 1503, 1455, 1392 (m), 1281, 1242 
(s), 1202 (m), 1164 (s), 1108, 1064, 1031 (m), 963 (s), 933, 858 (m), 833 (s), 800, 780, 739, 
713, 666, 601, 555, 531 (m). MS (EI, 70 eV): m/z (%) = 469(100) [M
+
], 343(15), 312(20), 
296(15), 294(10), 268(27), 252(10), 134(19), 78(14), 63(15), 57(15). HRMS (EI, 70 eV): 
calcd for C26H31NO5S [M]
+
: 469.19175; found: 469.19256. 
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(2E,2'E)-dihexyl 3,3'-{5-[(E)-(4-methoxyphenylimino)methyl]thiophene-2,3-diyl}diacrylate 
(32d): 
 
Product 32d was prepared 
starting  with 31 (186 mg, 
0.5 mmol), n-hexyl acrylate 
(0.22 mL, 1.25  mmol), 
Pd(OAc)2  (6 mg, 5 mol %), 
P(Cy)3 (10 mol %), NEt3 (0.55 mL, 4.0  mmol), DMF (5 mL) at 90 °C for 12 h following 
general procedure A, as a brown oil (176 mg, 67%). 
1
H NMR (300 MHz, CDCl3):  =  0.83 (t, 
6H, J = 6.7 Hz, 2CH3), 1.23-1.35 (m, 12H, 6CH2), 1.59-1.67 (m, 4H, 2CH2), 3.76 (s, 3H, 
OCH3), 4.14 (t, 2H, J = 6.8 Hz, CH2O), 4.15 (t, 2H, J = 6.8 Hz, CH2O), 6.27 (d, 1H, J = 16.4 
Hz, CH), 6.33 (d, 1H, J = 15.7 Hz, CH), 6.85 (d, 2H, J = 8.9 Hz, ArH), 7.17-7.20 (m, 2H, 
ArH), 7.48 (s, 1H, ArH), 7.75 (d, 1H, J = 15.8 Hz, CH), 7.92 (d, 1H, J = 15.5 Hz, CH), 8.45 
(s, 1H, N=CH). 
13
C NMR (75 MHz, CDCl3):  = 14.0 (2CH3), 22.5 (2CH2), 25.6 (2CH2), 
28.6, 28.7 (CH2), 31.4 (2CH2), 55.5 (OCH3), 65.0, 65.1 (CH2O), 114.5 (2CH), 120.8 (2CH), 
122.6 (2CH), 129.2, 133.2, 134.1 (CH), 138.4 (C), 142.3 (C-N), 143.3, 144.3 (C) 149.1 (CH), 
159.0 (C-O), 166.3, 166.7 (CO). IR (KBr, cm
1
): v = 2954, 2927, 2857 (w), 1695, 1612 (s), 
1575, 1529 (w), 1502, 1454 (m), 1268, 1237, 1165, 1158 (s), 1015, 969, 827, 779 (m), 711, 
662, 601 (w), 553, 533 (m). MS (EI, 70 eV): m/z (%) = 525(100) [M
+
], 312(22), 296(19), 
294(10), 268(29), 252(10), 134(22), 43(44), 41(12). HRMS (EI, 70 eV): calcd for 
C30H39NO5S [M]
+
: 525.25435; found: 525.25419. 
 
General procedure C for the synthesis of 2,3-di(alkenyl)-5-formylthiophene (33): 
 
In a pressure tube (glass bomb), to a mixture of compounds 32a-e (0.5 mmol) and 
dichloromethane (1mL) were added H2SO4 (4mL, 2.5M). The reaction mixture was stirred at 
room temperature for 20 h. The solution was poured into H2O and CH2Cl2 (25 mL each) and 
the organic and the aqueous layer were separated. The latter was extracted with CH2Cl2 (3 × 
25 mL), dried (Na2SO4), filtered, and concentrated in vacuo. 
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(2E,2'E)-Dimethyl-3,3'-(5-formylthiophene-2,3-diyl)diacrylate (33a): 
Compound 33a was prepared starting with 32a (192 mg, 
0.50 mmol), following the general procedures C, as a brown 
solid (137 mg, 98%), mp.= 142-145 °C. 
1
H NMR (300 MHz, 
CDCl3):  =  3.77 (s, 6H, 2CH3O), 6.32 (d, 1H, J = 15.8 Hz, 
CH), 6.40 (d, 1H, J = 15.6 Hz, CH), 7.75 (d, 1H, J = 15.9 
Hz, CH), 7.82 (s, 1H, ArH), 7.92 (d, 1H, J = 15.7 Hz, CH), 9.85 (s, 1H, O=CH). 
13
C NMR (62 
MHz, CDCl3):  = 51.1, 51.2 (CH3O), 120.4, 121.5, 131.9, 132.8, 133.1 (CH), 137.3, 142.4, 
145.3 (C), 165.0, 165.6 (CO), 181.6 (O=CH). IR (KBr, cm
1
): v = 3084, 2958, 2922, 2850 
(w), 1708, 1668, 1620 (s), 1442, 1472, 1302, 1276, 1242, 1212 (m), 1191, 1160 (s), 1031, 
1015 (m), 966 (s), 915, 863, 853, 730, 685, 663, 607, 538 (m). GC-MS (EI, 70 eV): m/z (%) = 
280(47) [M
+
], 249(23), 221(100), 220(47), 205(47), 189(80), 177(46), 161(75), 149(23), 
134(64), 89(39), 67(17), 59(41). HRMS (EI, 70 eV): calcd for C13H12O5S [M]
+
: 280.04000; 
found: 280.04067. 
 
(2E,2'E)-Isobutyl-3,3'-(5-formylthiophene-2,3-diyl)diacrylate (33b): 
Compound 33c was prepared starting with 32b (234 mg, 
0.50 mmol), following the general procedures C, as a 
brown oil (172 mg, 95%). 
1
H NMR (300 MHz, CDCl3):  
=  0.92 (d, 12H, J = 6.7 Hz, 4CH3), 1.88-2.02 (m, 2H, 
CH), 3.95 (d, 4H, J = 6.7 Hz, 2CH2O), 6.33 (d, 1H, J = 
15.8 Hz, CH), 6.41 (d, 1H, J = 15.6 Hz, CH), 7.74 (d, 1H, 
J = 15.8 Hz, CH), 7.84 (s, 1H, ArH), 7.92 (d, 1H, J = 15.6 Hz, CH), 9.85 (s, 1H, O=CH). 
13
C 
NMR (75 MHz, CDCl3):  = 19.1 (4CH3), 27.8 (2CH), 71.1, 71.3 (CH2O), 121.9, 122.9, 
132.7, 133.6, 134.3 (CH), 138.3, 143.3, 146.3 (C), 165.6, 166.2 (CO), 182.6 (O=CH). IR 
(KBr, cm
1
): v = 2978, 2926, 2848 (w), 1708, 1671 (s), 1625, 1449, 1375, 1279, 1240 (m), 
1176, 1157, 1031 (s), 968, 954, 854, 677 (m). GC-MS (EI, 70 eV): m/z (%) = 364(20) [M
+
], 
291(18), 208 (22), 207 (100), 191(72), 163(61), 135(33), 91(11), 89(15), 57(75), 41(37), 
29(18). HRMS (EI, 70 eV): calcd for C19H24O5S [M]
+
: 364.13390; found: 364.13470. 
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(2E,2'E)-Dibutyl-3,3'-(5-formylthiophene-2,3-diyl)diacrylate (33c): 
Compound 33c was prepared starting with 32c (234 
mg, 0.50 mmol), following the general procedures C, 
as a brown oil (167 mg, 92%). 
1
H NMR (300 MHz, 
CDCl3):  =  0.90 (t, 6H, J = 7.4 Hz, 2CH3), 1.33-
1.40 (m, 4H, 2CH2), 1.59-1.66 (m, 4H, 2CH2), 4.15 
(t, 2H, J = 6.8 Hz, CH2O), 4.17 (t, 2H, J = 6.7 Hz, CH2O), 6.32 (d, 1H, J = 15.8 Hz, CH), 6.39 
(d, 1H, J = 15.6 Hz, CH), 7.74 (d, 1H, J = 15.9 Hz, CH), 7.82 (s, 1H, ArH), 7.90 (d, 1H, J = 
15.6 Hz, CH), 9.84 (s, 1H, O=CH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 (2CH3), 19.0, 19.1 
(CH2), 30.6, 30.7 (CH2), 64.9, 65.1 (CH2O), 121.9, 123.0, 132.7, 133.6, 134.2 (CH), 138.3, 
143.2, 146.3 (C), 165.7, 166.3 (CO), 182.5 (O=CH). IR (KBr, cm
1
): v =  2957, 2930, 2871 
(w), 1705, 1671 (s), 1621, 1443, 1308, 1274, 1242 (m), 1162 (s), 1061, 1025, 967, 856, 661, 
600 (m). GC-MS (EI, 70 eV): m/z (%) = 364(06) [M
+
], 263(35), 262(19), 207(100), 189(40), 
163(15), 161(15), 135(28), 91(11), 57(23), 41(25), 29(21). HRMS (EI, 70 eV): calcd for 
C19H24O5S [M]
+
: 364.13390; found: 364.13398. 
 
  (2E,2'E)-Dihexyl-3,3'-(5-formylthiophene-2,3-diyl)diacrylate (33d): 
Compound 33d was prepared starting with 32d 
(262 mg, 0.50 mmol), following the general 
procedures C, as a brown oil (201 mg, 96%). 
1
H NMR (300 MHz, CDCl3):  =  0.29 (t, 6H, 
J = 6.8 Hz, 2CH3), 0.69-0.81 (m, 12H, 6CH2), 
1.07-1.12 (m, 4H, 2CH2), 3.61 (t, 4H, J = 6.8 
Hz, 2CH2O), 5.78 (d, 1H, J = 15.8 Hz, CH), 5.85 (d, 1H, J = 15.6 Hz, CH), 7.20 (d, 1H, J = 
15.8 Hz, CH), 7.29 (s, 1H, ArH), 7.37 (d, 1H, J = 15.6 Hz, CH), 9.30 (s, 1H, O=CH). 
13
C 
NMR (62 MHz, CDCl3):  = 14.0 (2CH3), 22.5 (2CH2), 25.5 (2CH2), 28.5, 28.6 (CH2), 31 
(2CH2), 65.2, 65.4 (CH2O), 121.9, 123.0, 132.7, 133.6, 134.2 (CH), 138.3, 143.2, 146.3 (C), 
165.6, 166.2 (CO), 182.5 (O=CH). IR (KBr, cm
1
): v =  2953, 2926, 2855 (w), 1707, 1670 (s), 
1622, 1443, 1305, 1271, 1243 (m), 1163 (s), 966, 857 (m), 725, 684 (w), 661 (m), 601 (w). 
GC-MS (EI, 70 eV): m/z (%) = 420(04) [M
+
], 291(32), 233(20), 207(100), 189(37), 163(11), 
135(18), 43(49), 41(16). HRMS (EI, 70 eV): calcd for C23H32O5S [M]
+
: 420.19650; found: 
420.19703. 
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Synthesis of 2,3-di(alkenyl)-5-arylthiophene (35): 
 
(2E,2'E)-Isobutyl-3,3'-(5-(4-ethylphenyl)thiophene-2,3-diyl)diacrylate (35a): 
Product 35a was prepared starting with 2b (173 
mg, 0.5 mmol),  iso-butyl acrylate (0.18 mL, 1.25 
mmol), Pd(OAc)2  (6 mg, 5 mol %), P(Cy)3 
(10 mol %), NEt3 (0.55 mL, 4.0 mmol), DMF 
(5 mL) at 100 °C for 24 h following general 
procedure A, as a brown oil (196 mg, 89%). 
1
H NMR (300 MHz, CDCl3):  = 0.90 (d, 6H, J = 
6.7 Hz, 2CH3), 0.91 (d, 6H, J = 6.7 Hz, 2CH3), 1.17 (t, 3H, J = 7.6 Hz, CH3), 1.87-2.01 (m, 
2H, 2CH), 2.58 (q, 2H, J = 7.6 Hz, CH2), 3.92 (d, 2H, J = 6.7 Hz, CH2O), 3.93 (d, 2H, J = 6.7 
Hz, CH2O), 6.20 (d, 1H, J = 15.4 Hz, CH), 6.29 (d, 1H, J = 15.7 Hz, CH), 7.15 (d, 2H, J = 8.2 
Hz, ArH), 7.37 (s, 1H, ArH), 7.42 (d, 2H, J = 8.2 Hz, ArH), 7.76 (d, 1H, J = 16.0 Hz, CH), 
7.91 (d, 1H, J = 15.4 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 14.3 (CH3), 18.1 (4CH3), 
26.8 (2CH), 27.6 (CH2), 69.8 (2CH2O), 117.4, 119.4, 120.1(CH), 125.0 (2CH), 127.6 (2CH), 
129.2 (C), 132.4, 133.4 (CH), 137.5, 138.2, 144.4, 145.3 (C), 165.5, 165.8 (CO). IR (KBr, 
cm
1
): v = 2960, 2933, 2872 (w), 1702 (s), 1622 (m), 1504, 1468, 1417, 1392, 1375 (w), 
1303, 1271, 1246, 1220 (m), 1156 (s), 1019, 969, 823 (m), 774, 713, 680, 614, 550 (w). MS 
(EI, 70 eV): m/z (%) = 440(51) [M
+
], 367(16), 283(53), 265(46), 239(57), 223(23), 221(12), 
207(21), 169(13), 149(12), 133(15), 111(18), 97(26), 83(28), 69(69), 57(100), 44(68).  HRMS 
(EI, 70 eV): calcd for C26H32O4S [M]
+
: 440.20158; found: 440.20124. 
 
 (2E,2'E)-Dibutyl-3,3'-[5-(4-tert-butylphenyl)thiophene-2,3-diyl]diacrylate (35b): 
Product 35b was prepared starting with 2c 
 (187 mg, 0.5 mmol),  n-butyl acrylate (0.18 
mL, 1.25 mmol), Pd(OAc)2 (6 mg, 5 mol %), 
P(Cy)3 (10 mol %), NEt3 (0.55 mL, 4.0 
 mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure A, as a brown oil (176 mg, 75%). 
1
H NMR (300 MHz, CDCl3):  
= 0.89 (t, 6H, J = 6.8 Hz, 2CH3), 1.26 (s, 9H, 3CH3), 1.32-1.40 (m, 4H, 2CH2), 1.57-1.67 (m, 
4H, 2CH2), 4.14 (t, 2H, J = 6.8 Hz, CH2O),  4.16 (t, 2H, J = 6.7 Hz, CH2O), 6.20 (d, 1H, J = 
15.6 Hz, CH), 6.29 (d, 1H, J = 15.8 Hz, CH), 7.33-7.36 (m, 3H, ArH), 7.45 (d, 2H, J = 8.4 
Hz, ArH), 7.77 (d, 1H, J = 15.9 Hz, CH), 7.92 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (75 MHz, 
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CDCl3):  = 13.8 (2CH3), 19.2 (2CH2), 30.8 (2CH2), 31.2 (3CH3), 34.8 (C), 64.6, 64.7 
(CH2O), 118.5, 120.5, 121.2 (CH), 125.8 (2CH), 126.1 (2CH), 130.0 (C), 133.5, 134.5 (CH), 
138.6, 139.3, 146.2, 152.4 (C), 166.6, 166.9 (CO). IR (KBr, cm
1
): v = 2957, 2932, 2871 (w), 
1714 (m), 1695 (s), 1613 (m), 1504, 1456, 1391, 1361 (w), 1271, 1251, 1228 (m), 1163 (s), 
1113, 1064, 1026, 968, 823 (m), 739, 607, 529 (w). MS (EI, 70 eV): m/z (%) = 468(26) [M]
+
, 
367(10), 366(18), 351(16), 322(12), 311(36), 293(23), 267(47), 251(22), 237(15), 223(12), 
211(13), 91(27), 69(15), 66(12), 57(100), 44(48), 41(68). HRMS (ESI): calcd for C28H37O4S 
[M+H]
+
: 469.2407; found: 469.2405 
 
(2E,2'E)-Isobutyl 3,3'-[5-(3,5-dimethylphenyl)thiophene-2,3-diyl]diacrylate (35c): 
Product 35c was prepared starting with 2d (173 
mg, 0.5  mmol),  iso-butyl acrylate (0.18 mL, 
1.25 mmol), Pd(OAc)2 (6 mg, 5 mol %), P(Cy)3 
(10 mol %), NEt3 (0.55 mL, 4.0 mmol), DMF 
(5 mL) at 100 °C for 24 h following general 
procedure A, as a brown oil (171 mg, 78%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.91 (d, 6H, J = 6.7 
Hz, 2CH3), 0.92 (d, 6H, J = 6.7 Hz, 2CH3), 1.88-2.02 (m, 2H, 2CH), 2.28 (s, 6H, 2 CH3), 3.93 
(d, 2H, J = 6.7 Hz, CH2O), 3.94 (d, 2H, J = 6.7 Hz, CH2O), 6.22 (d, 1H, J = 15.5 Hz, CH), 
6.32 (d, 1H, J = 15.8 Hz, CH), 6.92 (s, 1H, ArH), 7.15 (s, 2H, ArH), 7.37 (s, 1H, ArH), 7.78 
(d, 1H, J = 15.8 Hz, CH), 7.93 (d, 1H, J = 15.5 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  = 
19.2 (4CH3), 21.3 (2CH3), 27.9 (2CH), 70.8 (CH2O), 70.9 (CH2O), 118.5, 120.4, 121.5 (CH), 
123.9 (2CH), 130.7 (CH), 132.6 (C), 133.5 134.5 (CH), 138.7 (C), 138.8 (2C), 139.2, 146.5 
(C), 166.5, 166.8 (CO). IR (KBr, cm
1
): v = 2958 (m), 2872 (w), 1705 (s), 1615, 1602 (m), 
1530 (w), 1467, 1375, 1309, 1265, 1240, 1213 (m), 1155 (s), 1021, 967, 829, 687 (m), 598, 
541 (w). GC- MS (EI, 70 eV): m/z (%) = 440(34) [M]
+
, 339(14), 338(16), 309(11), 283(65), 
265(51), 240(18), 239(100), 238(30), 224(18), 91(16), 57(94), 44(63), 41(51). HRMS (ESI): 
calcd for C26H33O4S [M+H]
+
: 441.2094; found: 441.2090. 
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(2E,2'E)-Isobutyl-3,3'-[5-(2-methoxyphenyl)thiophene-2,3-diyl]diacrylate (35d): 
Product 35d was prepared starting with 2f (174 mg, 
0.5 mmol),  iso-butyl acrylate (0.18 mL, 1.25 mmol), 
Pd(OAc)2 (6 mg, 5 mol %), P(Cy)3 (10 mol %), NEt3 
(0.55 mL, 4.0 mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure A, as a brown oil (168 mg, 
76%). 
1
H NMR (300 MHz, CDCl3):  = 0.91 (d, 12H, J 
= 6.8 Hz, 4CH3), 1.86-2.01 (m, 2H, 2CH), 3.86 (s, 3H, OCH3), 3.92 (d, 2H, J = 6.6 Hz, 
CH2O), 3.93 (d, 2H, J = 6.6 Hz, CH2O), 6.23 (d, 1H, J = 15.3 Hz, CH), 6.28 (d, 1H, J = 15.3 
Hz, CH), 6.88-6.94 (m, 2H, ArH), 7.20-7.26 (m, 1H, ArH), 7.52-7.58 (m, 2H, ArH), 7.78 (d, 
1H, J = 15.7 Hz, CH), 7.93 (d, 1H, J = 15.6 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  = 18.2 
(4CH3), 26.8 (2CH), 54.6 (OCH3), 69.7, 69.8 (CH2O), 110.7,  117.0, 118.9, 120.0 (CH), 120.6 
(C), 122.8, 127.2, 128.9, 132.7, 133.7 (CH), 136.9, 138.1, 140.6, 154.9 (C), 165.6, 165.9 
(CO). IR (KBr, cm
1
): v = 3099, 2957, 2844 (w), 1692 (s), 1605, 1462 (m), 1441, 1393, 1375, 
1342 (w), 1268, 1253, 1240, 1210 (s), 1179, 1162, 1115 (m), 1024, 970 (s), 950, 846 (m), 744 
(s), 717, 683, 603 (w). MS (EI, 70 eV): m/z (%) = 442(11) [M]
+
, 285(57), 269(13), 267(25), 
243(11), 241(54), 57(100), 41(42). HRMS (ESI): calcd for C25H31O5S [M+H]
+
: 443.1887; 
found: 443.1876. 
 
Synthesis of benzothiophenes (36): 
 
Diisobutyl-2-(4-ethylphenyl)benzo[b]thiophene-5,6-dicarboxylate (36a): 
Compound 36a was prepared starting with 35a 
(100 mg, 0.23 mmol), following the general 
procedure B, as a brown semi solid (92 mg, 93%). 
1
H NMR (300 MHz, CDCl3):  = 0.92 (d, 6H, J = 
6.8 Hz, 2CH3), 0.93 (d, 6H, J = 6.7 Hz, 2CH3), 
1.18 (t, 3H, J = 7.6 Hz, CH3), 1.92-2.05 (m, 2H, 2CH), 2.60 (q, 2H, J = 7.6 Hz, CH2), 4.03 (d, 
2H, J = 6.7 Hz, CH2O), 4.04 (d, 2H, J = 6.7 Hz, CH2O), 7.18 (d, 2H, J = 8.8 Hz, ArH), 7.47 
(s, 1H, ArH), 7.54 (dd, 2H, J = 1.7, 6.6 Hz, ArH), 7.98 (s, 1H, ArH), 8.13 (s, 1H, ArH). 
13
C 
NMR (62 MHz, CDCl3):  = 15.4 (CH3), 19.2 (4CH3), 27.7, 27.8 (CH), 28.7 (CH2), 71.8 
(2CH2O), 118.7, 123.5, 123.9 (CH), 126.6 (2CH), 127.3 (C), 128.6 (2CH), 129.4, 130.8, 
140.9, 142.2, 145.6, 149.0 (C), 167.5, 168.2 (CO). IR (KBr, cm
1
): v = 2958, 2873 (m), 1721, 
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1708 (s), 1593, 1552, 1526 (w), 1495, 1469 (m), 1419, 1403, 1392 (w), 1371, 1303 (m), 1281, 
1254, 1229, 1179, 1119, 1090 (s), 1013, 982, 945, 898, 888, 832 (m), 818 (s), 780, 719, 691 
(m), 657, 634, 590, 549 (w). GC- MS (EI, 70 eV): m/z (%) = 438(69) [M]
+
, 382(16), 326(24), 
310(22), 309(100), 221(13). HRMS (EI, 70 eV): calcd for C26H30O4S [M]
+
: 438.18593; found: 
438.18532. 
 
Dibutyl-2-(4-tert-butylphenyl)benzo[b]thiophene-5,6-dicarboxylate (36b): 
Compound 36b was prepared starting with 
35b (100 mg, 0.21 mmol), following the 
general procedure B, as a yellowish solid 
(81 mg, 82%), mp. 56-58 °C. 
1
H NMR (250 
MHz, CDCl3):  = 0.89 (t, 6H, J = 7.3 Hz, 
2CH3), 1.28 (s, 9H, 3CH3), 1.34-1.43 (m, 4H, 2CH2), 1.61-1.72 (m, 4H, 2CH2), 4.25 (t, 2H, J 
= 6.7 Hz, CH2O), 4.26 (t, 2H, J = 6.7 Hz, CH2O), 7.39 (dd, 2H, J = 1.9, 6.6 Hz ArH), 7.48 (s, 
1H, ArH), 7.58 (dd, 2H, J = 1.9, 6.6 Hz, ArH), 7.99 (s, 1H, ArH), 8.13 (s, 1H, ArH). 
13
C 
NMR (62 MHz, CDCl3):  = 13.7 (2CH3), 19.2 (2CH2), 30.6, 30.7 (CH2), 31.2 (3CH3), 34.8 
(C), 65.6 (2CH2O), 118.7, 123.6, 123.9 (CH), 126.1 (2CH), 126.4 (2CH), 127.2, 129.3, 130.6, 
140.9, 142.2, 148.9, 152.5 (C), 167.5, 168.2 (CO). IR (KBr, cm
1
): v = 2955, 2927, 2869 (m), 
1709 (s), 1650, 1625, 1595, 1497, 1460, 1390, 1359 (w), 1330 (m), 1306, 1284, 1258, 1239 
(s), 1189, 1122 (m), 1094 (s), 1060, 1017, 834, 819, 778 (m), 729, 719, 578 (w), 532 (m). 
GC- MS (EI, 70 eV): m/z (%) = 466(100) [M]
+
, 452(20), 451(67), 410(11), 395(23), 337(62), 
321(14), 250(13). HRMS (ESI): calcd for C28H35O4S [M+H]
+
: 467.2251; found: 467.2256. 
Anal. calcd for C28H34O4S: C, 72.07; H, 7.34; S, 6.87. Found: C, 72.08; H, 7.52; S, 6.88. 
 
Diisobutyl-2-(3,5-dimethylphenyl)benzo[b]thiophene-5,6-dicarboxylate (36c): 
Compound 36c was prepared starting with 35c 
(100 mg, 0.23 mmol), following the general 
procedure B, as a white solid (84 mg, 85%), mp. 
66-68 °C. 
1
H NMR (300 MHz, CDCl3):  = 0.93 
(d, 6H, J = 6.7 Hz, 2CH3), 0.94 (d, 6H, J = 6.7 Hz, 
2CH3), 1.92-2.08 (m, 2H, 2CH), 2.29 (s, 6H, 
2CH3), 4.03 (d, 2H, J = 6.7 Hz, CH2O), 4.04 (d, 2H, J = 6.7 Hz, CH2O), 6.94 (s, 1H, ArH), 
7.17 (s, 2H, ArH), 7.49 (s, 1H, ArH), 7.99 (s, 1H, ArH), 8.13 (s, 1H, ArH). 
13
C NMR (62 
147 
 
MHz, CDCl3):  = 18.2 (4CH3), 20.3 (2CH3), 26.7, 26.8 (CH), 70.8 (2CH2O), 118.0, 122.5, 
123.0 (CH), 123.5 (2CH), 126.3, 128.3 (C), 129.8 (CH), 132.2 (C), 137.7 (2C), 140.0, 141.0, 
148.2 (C), 166.5, 167.1 (CO). IR (KBr, cm
1
): v = 2957, 2924, 2871 (m), 1716 (s), 1600, 
1514, 1487 (w), 1468 (m), 1405, 1392, 1376, 1344 (w), 1305, 1273, 1261 (m), 1236 (s), 1180, 
1163, 1120, 1091, 1012, 979, 946, 899, 843, 816, 781, 748, 721, 690, 681, 603 (m). GC-MS 
(EI, 70 eV): m/z (%) = 438(57) [M]
+
, 382(12), 326(26), 310(22), 309(100), 236(14). HRMS 
(ESI): calcd for C26H31O4S [M+H]
+
: 439.1938; found: 439.1944. Anal. calcd for C26H30O4S: 
C, 71.20; H, 6.89; S, 7.31. Found: C, 71.08; H, 7.13; S, 7.47. 
 
Diisobutyl-2-(2-methoxyphenyl)benzo[b]thiophene-5,6-dicarboxylate (36d): 
Compound 36d was prepared starting with 35d (100 
mg, 0.23 mmol), following the general procedure B, as 
yellowish solid (87 mg, 88%), mp. 96-98 °C. 
1
H NMR 
(300 MHz, CDCl3):  = 0.93 (d, 12H, J = 6.7 Hz, 
4CH3), 1.92-2.06 (m, 2H, 2CH), 3.89 (s, 3H, OCH3), 
4.03 (d, 2H, J = 6.7 Hz,CH2O), 4.04 (d, 2H, J = 6.7 Hz, 
CH2O), 6.93-6.99 (m, 2H, ArH), 7.24-7.29 (m, 1H, ArH), 7.63 (dd, 1H, J = 1.5, 7.7 Hz, ArH), 
7.73 (s, 1H, ArH), 8.02 (s, 1H, ArH), 8.14 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 19.2 
(4CH3), 27.8 (2CH), 55.6 (OCH3), 71.8 (2CH2O), 111.8, 121.1, 122.0 (CH), 122.3 (C), 123.2, 
124.0 (CH), 127.2, 128.9 (C), 129.3, 130.1 (CH), 141.3, 141.5, 144.6, 156.4 (C), 167.7, 168.3 
(CO). IR (KBr, cm
1
): v = 2955, 2928, 2872 (w), 1707 (s), 1627, 1594, 1579, 1547, 1509, 
1481 (w), 1468, 1458 (m), 1435, 1408, 1376, 1341 (w), 1307, 1283, 1267 (m), 1252, 1242 (s), 
1167, 1125, 1101, 1025, 982, 906, 833, 772 (m), 755 (s), 735, 690 (m), 594, 548 (w). GC- MS 
(EI, 70 eV): m/z (%) = 440(63) [M]
+
, 384(12), 328(13), 312(20), 311(100). HRMS (ESI): 
calcd for C25H29O5S [M+H]
+
: 441.1730; found: 441.1738. Anal. calcd for C25H28O5S: C, 
68.16; H, 6.41; S, 7.28. Found: C, 68.15; H, 6.55; S, 7.48. 
 
General procedure D for the synthesis of compounds 39, 43 and 47: 
 
In a pressure tube (glass bomb) a suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 5 mol%) and 
P(Cy)3 (28.04 mg, 0.10 mmol, 10 mol%) in DMF (5 mL) was purged with Argon and stirred 
at 20 °C to give a yellowish or brownish clear solution. To the stirred solution were added 38, 
42a-d or 46a,b (1.0 mmol), Et3N (1.1 mL, 8.0 mmol) and the alkene (1.25 equiv. per bromine 
atom of the substrate). The reaction mixture was stirred at 100 °C for 24 h. The solution was 
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cooled to 20 °C, poured into a mixture of H2O and CH2Cl2 (25 mL each), and the organic and 
the aqueous layer were separated. The latter was extracted with CH2Cl2 (3 × 25 mL). The 
combined organic layers were washed with H2O (3 × 20 mL), dried (Na2SO4), and 
concentrated in vacuo. The residue was purified by chromatography (flash silica gel, 
heptanes-EtOAc). 
 
(2E,2'E,2''E)-Tributyl-3,3',3''-(1-methyl-1H-imidazole-2,4,5-triyl)triacrylate (39a): 
Product 39a was prepared starting with 
38 (318 mg,1.0 mmol),  n-butyl acrylate 
 (0.47 mL, 3.3 mmol), Pd(OAc)2  (11  
mg, 5 mol %), P(Cy)3 (10 mol %), NEt3 
(1.10 mL, 8.0  mmol), DMF (5 mL) at 
100 °C for 24 h following general procedure D, as a brown oil (395 mg, 86%). 
1
H NMR (250 
MHz, CDCl3):  = 0.88 (t, 6H, J = 7.3 Hz, 2CH3), 0.90 (t, 3H, J = 7.2 Hz, CH3), 1.32-1.41 (m, 
6H, 3CH2), 1.55-1.66 (m, 6H, 3CH2), 3.69 (s, 3H, NCH3), 4.14 (t, 2H, J = 6.5 Hz, CH2O), 
4.15 (t, 2H, J = 6.6 Hz, CH2O), 4.16 (t, 2H, J = 6.4 Hz, CH2O), 6.23 (d, 1H, J = 16.1 Hz, CH), 
6.78 (d, 1H, J = 15.3 Hz, CH), 6.95 (d, 1H, J = 15.4 Hz, CH), 7.43 (d, 1H, J = 15.3 Hz, CH), 
7.55 (d, 1H, J = 16.2 Hz, CH), 7.62 (d, 1H, J = 15.4 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  
= 13.7 (3CH3), 19.1 (CH2), 19.2 (2CH2), 30.6, 30.7, 30.8 (CH2), 31.6 (NCH3), 64.4, 64.8, 64.9 
(OCH2), 120.5, 121.5, 124.6, 127.2, 128.3 (CH), 130.7 (C), 133.0 (CH), 140.3, 146.1 (C), 
166.2, 166.4, 167.2 (CO). IR (KBr, cm
1
): v = 2957, 2932, 2872 (w), 1705 (s), 1625, 1457 
(m), 1392 (w), 1299 (m), 1272, 1160 (s), 1062, 1022, 964 (m), 867, 739, 661 (w). GC-MS 
(EI, 70 eV): m/z (%) = 460(18) [M]
+
, 387(19), 359(45), 329(14), 303(100), 285(74), 259(38), 
229(21), 185(40), 157(28), 57(14), 44(34). HRMS (EI, 70 eV): m/z calcd for C25H36N2O6 
[M]
+
: 460.25679; found: 460.25633. 
 
(2E,2'E,2''E)-Isobutyl-3,3',3''-(1-methyl-1H-imidazole-2,4,5-triyl)triacrylate (39b):  
Product 39b was prepared starting with 38  
(318 mg, 1.0 mmol),  iso-butyl acrylate 
(0.47 mL, 3.3 mmol), Pd(OAc)2 (11 mg, 
5 mol %), P(Cy)3 (10 mol %), NEt3 
(1.10 mL, 8.0  mmol), DMF (5 mL) at 
100 °C for 24 h following general 
procedure D, as a brown oil (386 mg, 84%). 
1
H NMR (250 MHz, CDCl3):  = 0.90 (d, 12H, J 
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= 6.7 Hz, 4CH3), 0.91 (d, 6H, J = 6.7 Hz, 2CH3), 1.88-1.98 (m, 3H, 3CH), 3.69 (s, 3H, 
NCH3), 3.91 (d, 2H, J = 6.3 Hz, CH2O), 3.93 (d, 2H, J = 6.6 Hz, CH2O), 3.94 (d, 2H, J = 6.3 
Hz, CH2O), 6.24 (d, 1H, J = 16.0 Hz, CH), 6.77 (d, 1H, J = 15.5 Hz, CH), 6.97 (d, 1H, J = 
15.4 Hz, CH), 7.43 (d, 1H, J = 15.4 Hz, CH), 7.56 (d, 1H, J = 16.2 Hz, CH), 7.63 (d, 1H, J = 
15.4 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 19.0 (2CH3), 19.1 (4CH3), 27.7 (2CH), 27.8 
(CH), 31.6 (NCH3), 70.6,  70.0, 71.1 (OCH2), 120.5, 121.4, 124.6, 127.2, 128.3 (CH), 130.7 
(C), 133.0 (CH), 140.2, 146.1 (C), 166.2, 166.3, 167.1 (CO). IR (KBr, cm
1
): v = 2959, 2874 
(w), 1706 (s), 1625, 1463 (m), 1394, 1370, 1342 (w), 1303 (m), 1272, 1242, 1154 (s), 1009, 
964 (m), 867, 744, 704, 553 (w). GC-MS (EI, 70 eV): m/z (%) = 460(15) [M]
+
, 387(18), 
359(16), 303(100), 285(47), 259(20), 229(12), 203(18), 185(23), 157(17), 57(11), 41(11). 
HRMS (ESI): m/z calcd for C25H37N2 O6 [M+H]
+
: 461.2646; found: 461.2648. 
 
(2E,2'E,2''E)-tert-butyl-3,3',3''-(1-methyl-1H-imidazole-2,4,5-triyl)triacrylate (39c): 
Product 39c was prepared starting with 38 (318 
mg, 1.0 mmol),  tert-butyl acrylate (0.47 mL, 
3.3 mmol), Pd(OAc)2 (11 mg, 5 mol %), P(Cy)3 
(10 mol %), NEt3 (1.10 mL, 8.0  mmol), DMF 
(5 mL) at 100 °C for 24 h following general 
procedure D, as a brown oil (372 mg, 81%). 
1
H 
NMR (250 MHz, CDCl3):  = 1.44 (s, 18H, 6CH3), 1.46 (s, 9H, 3CH3), 3.65 (s, 3H, NCH3), 
6.15 (d, 1H, J = 16.1 Hz, CH), 6.70 (d, 1H, J = 15.3 Hz, CH), 6.85 (d, 1H, J = 15.3 Hz, CH), 
7.33 (d, 1H, J = 15.4 Hz, CH), 7.44 (d, 1H, J = 16.1 Hz, CH), 7.55 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 28.0 (3CH3), 28.1 (3CH3), 28.2 (3CH3), 31.4 (NCH3), 80.3, 
81.1, 81.2 (C-O), 122.1, 123.3, 126.0, 126.4, 127.4 (CH), 130.5 (C), 132.3 (CH), 139.9, 145.9 
(C), 165.4, 166.5, 166.5 (CO). IR (KBr, cm
1
): v = 2975, 2931 (w), 1701 (s), 1627, 1456 (m), 
1392 (w), 1366, 1304, 1279, 1255 (m), 1139 (s), 956, 855, 848 (m), 760, 744, 708, 630, 539 
(w). MS (EI, 70 eV): m/z (%) = 460(23) [M]
+
, 404(10), 247(11), 204(14), 203(100), 185(26), 
157(16), 56(34), 41(62). HRMS (EI, 70 eV): m/z calcd for C25H36N2 O6 [M]
+
: 460.25679; 
found: 460.25587. 
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(2E,2'E,2''E)-Trihexyl-3,3',3''-(1-methyl-1H-imidazole-2,4,5-triyl)triacrylate (39d): 
 
 
 
 
 
 
 
Product 39d was prepared starting with 38 (318 mg, 1.0 mmol),  n-hexyl acrylate  (0.58 mL, 
3.3 mmol), Pd(OAc)2 (11 mg, 5 mol %) , P(Cy)3 (10 mol %), NEt3 (1.10 mL, 8.0  mmol), 
DMF (5 mL) at 100 °C for 24 h following general procedure D, as a brown oil (402 mg, 
74%). 
1
H NMR (250 MHz, CDCl3):  = 0.83 (t, 9H, J = 6.6 Hz, 3CH3), 1.24-1.34 (m, 18H, 
9CH2), 1.56-1.65 (m, 6H, 3CH2), 3.69 (s, 3H, NCH3), 4.09-4.17 (m, 6H, 3OCH2), 6.22 (d, 1H, 
J = 16.1 Hz, CH), 6.78 (d, 1H, J = 15.3 Hz, CH), 6.94 (d, 1H, J = 15.3 Hz, CH), 7.42 (d, 1H, 
J = 15.3 Hz, CH), 7.55 (d, 1H, J = 16.5 Hz, CH), 7.57 (d, 1H, J = 15.5 Hz, CH).  
13
C NMR 
(62 MHz, CDCl3):  = 13.9 (3CH3), 22.5 (3CH2), 25.5 (CH2), 25.6 (2CH2), 28.5, 28.6, 28.7 
(CH2), 31.3 (CH2), 31.4 (2CH2), 31.6 (NCH3), 64.6, 65.1, 65.2 (OCH2), 120.5, 121.4, 124.6, 
127.2, 128.3 (CH), 130.7 (C), 133.0 (CH), 140.3, 146.1 (C), 166.2, 166.3, 167.1 (CO). IR 
(KBr, cm
1
): v = 2954, 2928, 2857 (w), 1707 (s), 1695, 1457, 1299 (m), 1272, 1161 (s), 1060 
(w), 964 (m), 910, 867, 728, 663, 611 (w). MS (EI, 70 eV): m/z (%) = 544(49) [M]
+
, 443(17), 
417(100), 389(10), 331(41), 315(24), 287 (58), 231(14), 203(30), 185(35), 55(20), 44(43). 
HRMS (ESI): m/z calcd for C31H49N2O6 [M+H]
+
: 545.3585; found: 545.3591. 
 
(2E,2'E,2''E)-Triethyl-3,3',3''-(1-methyl-1H-imidazole-2,4,5-triyl)triacrylate (39e): 
Product 39e was prepared starting with 38 (318 mg, 
1.0 mmol),  ethyl acrylate (0.36 mL, 3.3 mmol), 
Pd(OAc)2 (11 mg, 5 mol %), P(Cy)3 (10 mol %), 
NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) at 100 °C 
for 24 h following general procedure D, as a yellow 
solid (275 mg, 73%), mp. 129-131 °C. 
1
H NMR (250 
MHz, CDCl3):  =  1.25 (t, 3H, J = 7.1 Hz, CH3), 1.26 (t, 3H, J = 7.1 Hz, CH3), 1.27 (t, 3H, J 
= 7.2 Hz, CH3),  3.68 (s, 3H, NCH3), 4.15-4.22 (m, 6H, OCH2), 6.20 (d, 1H, J = 16.2 Hz, 
CH), 6.74 (d, 1H, J = 15.3 Hz, CH), 6.91 (d, 1H, J = 15.3 Hz, CH), 7.41 (d, 1H, J = 15.3 Hz, 
151 
 
CH), 7.54 (d, 1H, J = 16.1 Hz, CH), 7.60 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (62 MHz, 
CDCl3):  = 14.1, 14.2, 14.3 (CH3), 31.6 (NCH3), 60.4, 60.9, 61.0 (OCH2), 120.4, 121.4, 
124.5, 127.2, 128.2 (CH), 130.7 (C), 133.0 (CH), 140.3, 146.1 (C), 166.1, 166.2, 167.0 (CO). 
IR (KBr, cm
1
): v = 3046, 2980, 2938, 2873, 1733 (w), 1695, 1619 (s), 1514 (w), 1461, 1391, 
1363 (m), 1298, 1270, 1170, 1151 (s), 1115, 1095 (m), 1025, 962 (s), 932, 871, 850, 743, 709 
(m), 676, 662, 613 (w). GC-MS (EI, 70 eV): m/z (%) = 376(90) [M]
+
, 332(11),  333(51), 
303(50), 275(14), 257(50), 231(83), 229(21), 185(100), 184(11), 157(52), 156(19). HRMS 
(ESI): m/z calcd for C19H25N2O6 [M+H]
+
: 377.1707; found: 377.1711. 
 
(2E,2'E,2''E)-Trimethyl-3,3',3''-(1-methyl-1H-imidazole-2,4,5-triyl)triacrylate (39f): 
Product 39f was prepared starting with 38 (318 mg, 
1.0 mmol),  methyl acrylate (0.30 mL, 3.3 mmol), 
Pd(OAc)2 (11 mg, 5 mol %), P(Cy)3 (10 mol-%), 
NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) at 100 °C 
for 24 h following general procedure D, as a yellow 
clear highly viscous oil (254 mg, 76%). 
1
H NMR (250 MHz, CDCl3):  = 3.70 (s, 3H, NCH3), 
3.72, 3.75, 3.76 (s, 3H, OCH3), 6.20 (d, 1H, J = 16.2 Hz, CH), 6.74 (d, 1H, J = 15.4 Hz, CH), 
6.91 (d, 1H, J = 15.3 Hz, CH), 7.41 (d, 1H, J = 15.3 Hz, CH), 7.53 (d, 1H, J = 16.2 Hz, CH), 
7.57 (d, 1H, J = 15.4 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  = 31.7 (NCH3), 51.7 (OCH3), 
52.0 (2OCH3), 120.0, 121.0, 124.1, 127.4, 128.4 (CH), 130.7 (C), 133.1 (CH), 140.3, 146.1 
(C), 166.5, 166.6, 167.4 (CO). IR (KBr, cm
1
): v = 3041, 2991, 2948, 2847 (w), 1708, 1695, 
1622 (s), 1519 (w), 1431, 1411, 1306 (m), 1279, 1261, 1193, 1165 (s), 1065, 1034, 1014, 984 
(m), 959 (s), 931, 879, 869, 811, 748, 713, 700, 665, 611 (m). GC-MS (EI, 70 eV): m/z (%) = 
334(74) [M]
+
, 303(41), 276(13), 275(82), 244(16), 243(100), 231(27), 216(12), 215(18), 
199(17), 185(28), 184(10), 171(25), 157(44), 156(21). HRMS (EI, 70 eV): m/z calcd for 
C16H18N2O6 [M]
+
: 334.11594; found: 334.11621. 
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(2E,2'E,2''E)-Tris(2-ethylhexyl)-3,3',3''-(1-methyl-1H-imidazole-2,4,5-triyl)triacrylate 
(39g): 
 
 
 
 
 
 
Product 39g was prepared starting with 38 (318 mg, 1.0  mmol), 2-ethylhexyl acrylate  (0.69 
mL, 3.3 mmol), Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  mol %), NEt3 (1.10 mL, 8.0  mmol), 
DMF (5 mL) at 100 °C for 24 h following general procedure D, as a brown oil (515 mg, 
82%). 
1
H NMR (250 MHz, CDCl3):  = 0.81-0.89 (m, 18H, 6CH3), 1.25-1.39 (m, 24H, 
12CH2), 1.53-1.62 (m, 3H, 3CH), 3.69 (s, 3H, NCH3), 4.03-4.09 (m, 6H, 3OCH2), 6.23 (d, 
1H, J = 16.1 Hz, CH), 6.80 (d, 1H, J = 15.4 Hz, CH), 6.97 (d, 1H, J = 15.3 Hz, CH), 7.44 (d, 
1H, J = 15.4 Hz, CH), 7.55 (d, 1H, J = 16.1 Hz, CH), 7.63 (d, 1H, J = 15.4 Hz, CH).  
13
C 
NMR (75 MHz, CDCl3):  = 10.9, 11.0, 11.1 (CH3), 14.1 (3CH3), 22.9 (3CH2), 23.7, 23.8, 
23.9 (CH2), 28.9 (2CH2), 29.0 (CH2), 30.3, 30.4, 30.5 (CH2), 31.6 (NCH3), 38.8, 38.8, 38.9 
(CH), 66.9, 67.4, 67.6 (OCH2), 120.6, 121.6, 124.7, 127.2, 128.3 (CH), 130.7 (C), 133.0 
(CH), 140.3, 146.1 (C), 166.4, 166.6, 167.3 (CO). IR (KBr, cm
1
): v = 2957, 2928, 2858 (w), 
1708, 1625, 1458 (m), 1379 (w), 1299, 1271 (m), 1162 (s), 964 (m), 868, 729, 704, 663 (w). 
MS (EI, 70 eV): m/z (%) = 628(100) [M]
+
, 501(20), 499(22), 475(13), 473(74), 471(18), 
446(18), 361(13), 359(22), 343(19), 333(24), 317(65), 315(44), 231(18), 203(27), 118(11), 
185(20), 133(16), 117(14), 83(24), 81(11), 70(25), 66(11), 55(44), 44(89), 41(40). HRMS (EI, 
70 eV): m/z calcd for C37H60N2O6 [M]
+
: 628.44459; found: 628.44336. 
 
General procedure E for the synthesis of Benzimidazoles 40, 41, 44, 45 and 48: 
 
 A diphenylether solution (3 mL) of 39a-g, 43a-r, 47a-d (0.5 mmol) was stirred at 200 °C for 
24 h in a pressure tube. The solution was allowed to cool to 20 °C and Pd/C (30 mg, 
10 mol %) was added. The solution was stirred at 200 °C for 48 h under argon atmosphere. 
The reaction mixture was filtered and the filtrate was concentrated in vacuo. The residue was 
purified by chromatography (flash silica gel, heptanes/EtOAc).  
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(E)-Dibutyl-2-(3-butoxy-3-oxoprop-1-enyl)-1-methyl-1H-benzo[d]imidazole-5,6-
dicarboxylate (40a): 
Compound 40a was prepared starting 
with 39a (100 mg, 0.22 mmol), 
following the general procedures E, as 
a brown oil (89 mg, 90%). 
1
H NMR 
(300 MHz, CDCl3):  = 0.89 (t, 9H, J 
= 7.3 Hz, 3CH3), 1.33-1.41 (m, 6H, 3CH2), 1.61-1.70 (m, 6H, 3CH2), 3.86 (s, 3H, NCH3), 
4.19 (t, 2H, J = 6.7 Hz, CH2O), 4.26 (t, 4H, J = 6.5 Hz, 2CH2O), 7.15 (d, 1H, J = 15.5 Hz, 
CH), 7.62 (d, 1H, J = 15.5 Hz, CH), 7.66 (s, 1H, ArH), 8.06 (s, 1H, ArH). 
13
C NMR (62 MHz, 
CDCl3):  = 13.6 (CH3), 13.7 (2CH3), 19.0, 19.1, 19.2 (CH2), 30.4 (NCH3), 30.5 (CH2), 30.6 
(2CH2), 65.0, 65.5, 65.7 (CH2O), 111.2, 121.6 (CH), 127.7 (2CH), 127.7, 128.2, 136.9, 143.9, 
151.3 (C), 165.9, 167.7, 168.0 (CO). IR (KBr, cm
1
): v = 2957 (m), 2932, 2872 (w), 1710 (s), 
1634, 1618, 1463, 1388, 1340, 1294 (m), 1252, 1209, 1170, 1102 (s), 1060, 1033, 1020, 964, 
949, 899, 870, 843, 786, 746, 737 (m), 697, 608 (w). GC-MS (EI, 70 eV): m/z (%) = 458(18) 
[M]
+
, 385(19), 330(12), 329(100), 328(33), 273(27), 272(12). HRMS (EI, 70 eV): m/z calcd 
for C25H34N2O6 [M]
+
: 458.24114; found: 458.24011. 
 
(E)-Diisobutyl-2-(3-isobutoxy-3-oxoprop-1-enyl)-1-methyl-1H-benzo[d]imidazole-5,6-
dicarboxylate (40b): 
Compound 40b was prepared starting with 
39b (100 mg, 0.22 mmol), following the 
general procedures E, as a brown oil (89 
mg, 90%). 
1
H NMR (300 MHz, CDCl3):  
= 0.92 (d, 6H, J = 6.5 Hz, 2CH3), 0.93 (d, 
6H, J = 6.7 Hz, 2CH3), 0.94 (d, 6H, J = 6.5 
Hz, 2CH3), 1.94-2.02 (m, 3H, 3CH), 3.87 (s, 3H, NCH3), 3.97 (d, 2H, J = 6.6 Hz, CH2O), 
4.04 (d, 2H, J = 6.6 Hz, CH2O), 4.05 (d, 2H, J = 6.6 Hz, CH2O), 7.19 (d, 1H, J = 15.5 Hz, 
CH), 7.64 (d, 1H, J = 15.5 Hz, CH), 7.67 (s, 1H, ArH), 8.10 (s, 1H, ArH). 
13
C NMR (75 MHz, 
CDCl3):  = 18.0 (2CH3), 18.1 (2CH3), 18.2 (2CH3), 26.7 (CH), 26.8 (2CH), 29.4 (NCH3), 
70.3, 70.7, 71.0 (CH2O), 110.2 (2CH), 120.7, 126.7 (CH), 126.7, 127.5, 136.0, 142.9, 150.3 
(C), 164.9, 166.6, 167.1 (CO). IR (KBr, cm
1
): v = 2959 (m), 2930, 2873 (w), 1713 (s), 1634, 
1620 (w), 1468, 1377, 1341, 1289 (m), 1252, 1210, 1170, 1101 (s), 1034, 1009, 983, 947, 
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900, 786 (m). GC-MS (EI, 70 eV): m/z (%) = 458(18) [M]
+
, 385(19), 330(12), 329(100), 
328(33), 273(27), 272(12). HRMS (EI, 70 eV): m/z calcd for C25H34N2O6 [M]
+
: 458.24114; 
found: 458.24011. 
 
(E)-Dihexyl-2-(3-(hexyloxy)-3-oxoprop-1-enyl)-1-methyl-1H-benzo[d]imidazole-5,6-
dicarboxylate (40d): 
Compound 40d was prepared 
starting with 39d (100 mg, 
0.18 mmol), following the 
general procedures E, as a 
brown oil (59 mg, 60%). 
1
H 
NMR (250 MHz, CDCl3):  
= 0.80-0.86 (m, 9H, 3CH3), 1.25-1.33 (m, 18H, 9CH2), 1.59-1.71 (m, 6H, 3CH2), 3.87 (s, 3H, 
NCH3), 4.15-4.28 (m, 6H, 3CH2O), 7.17 (d, 1H, J = 15.4 Hz, CH), 7.63 (d, 1H, J = 15.5 Hz, 
CH), 7.68 (s, 1H, ArH), 8.08 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 (3CH3), 
22.5 (3CH2), 25.5, 25.6, 25.7 (CH2), 28.5 (CH2), 28.6 (2CH2), 29.7, 30.4, 31.4 (CH2), 30.5 
(NCH3), 65.4, 65.8, 66.1 (CH2O), 111.2, 121.7 (CH), 127.7 (2C),  127.8, 128.3 (CH), 137.0, 
143.9, 151.4 (C), 166.0, 167.7, 168.1 (CO). IR (KBr, cm
1
): v = 2956, 2932, 2872 (w), 1712 
(s), 1636, 1616, 1463, 1389, 1290 (m), 1254, 1170, 1103 (s), 1060, 1035, 1020, 962, 949, 
899, 870, 845, 786, 746, 733 (m), 697 (w). MS (EI, 70 eV): m/z (%) = 542(09) [M]
+
, 441(11), 
415(20), 358(58), 357(100), 273(18), 69(18), 57(10), 55(13), 44(24), 41(13). HRMS (ESI): 
m/z calcd for C31H47N2O6 [M+H]
+
: 543.3429; found: 543.3431. 
 
(E)-Diethyl-2-(3-ethoxy-3-oxoprop-1-enyl)-1-methyl-1H-benzo[d]imidazole-5,6-
dicarboxylate (40e): 
Compound 40e was prepared starting with 39e (100 
mg, 0.27 mmol), following the general procedures E, 
as a brown oil (47 mg, 48%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.29 (t, 3H, J = 7.1 Hz, CH3), 1.32 (t, 
6H, J = 7.1 Hz, 2CH3), 3.87 (s, 3H, NCH3), 4.25 (q, 
2H, J = 7.1 Hz, CH2O), 4.28-4.37 (m, 4H, 2CH2O), 
7.16 (d, 1H, J = 15.5 Hz, CH), 7.63 (d, 1H, J = 15.5 Hz, CH), 7.69 (s, 1H, ArH), 8.08 (s, 1H, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.1 (CH3), 14.2 (2CH3), 30.4 (NCH3), 61.2, 61.6, 
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61.8 (CH2O), 111.3, 121.7 (CH), 127.8 (2CH), 128.1 (2C), 137.0, 144.0, 151.3 (C), 165.8, 
167.7, 167.9 (CO). IR (KBr, cm
1
): v = 2956, 2932, 2872 (w), 1712 (s), 1636, 1616, 1463, 
1389, 1290 (m), 1254, 1170, 1103 (s), 1060, 1035, 1020, 962, 949, 899, 870, 845, 786, 746, 
733 (m), 697 (w). GC-MS (EI, 70 eV): m/z (%) = 374(40) [M]
+
, 329(18), 302(35), 303(100), 
273(29), 207(23), 32(12). HRMS (EI, 70 eV): m/z calcd for C19H22N2O6 [M]
+
: 374.14724; 
found: 374.14642. 
 
(E)-Dimethyl-2-(3-methoxy-3-oxoprop-1-enyl)-1-methyl-1H-benzo[d]imidazole-5,6-
dicarboxylate (40f): 
Compound 40f was prepared starting with 39f (100 
mg, 0.30 mmol), following the general procedures E, 
as a brown oil (39 mg, 40%). 
1
H NMR (300 MHz, 
CDCl3):  = 3.79 (s, 3H, NCH3), 3.87 (s, 9H, 
3CH3O), 7.17 (d, 1H, J = 15.3 Hz, CH), 7.64 (d, 1H, 
J = 15.5 Hz, CH), 7.70 (s, 1H, ArH), 8.07 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  =  
30.4 (NCH3), 52.3, 52.7, 52.8 (CH3O), 111.4, 121.7 (CH), 126.3 (C), 127.3 (CH), 125.5 (C), 
128.0 (CH), 134, 144.1, 151.4 (C), 165.4, 166.3, 168.3 (CO). IR (KBr, cm
1
): v = 2954, 2923, 
2851 (w), 1725, 1707 (s), 1643, 1621, 1429, 1393, 1359, 1345, 1306 (m), 1257, 1226, 1170, 
1101, 1037, 968 (s), 892, 877, 815, 776, 744, 733 (m), 692, 619, 578 (w). GC-MS (EI, 70 
eV): m/z (%) = 332(48) [M]
+
, 310(100), 273(32). HRMS (EI, 70 eV): m/z calcd for 
C16H16N2O6 [M]
+
: 332.10029; found: 332.09953. 
 
(E)-Bis(2-ethylhexyl)-2-[3-(2-ethylhexyloxy)-3-oxoprop-1-enyl]-1-methyl-1H-benzo[d] 
imidazole-5,6-dicarboxylate (40g): 
Compound 40g was prepared 
starting with 39g (100 mg, 
0.16 mmol), following the 
general procedures E, as a 
brown oil (87 mg, 88%). 
1
H 
NMR (300 MHz, CDCl3):  
= 0.82-.088 (m, 18H, 6CH3), 1.25-1.40 (m, 24H, 12CH2), 1.57-1.66 (m, 3H, 3CH), 3.87 (s, 
3H, NCH3), 4.09-4.19 (m, 6H, 3CH2O), 7.19 (d, 1H, J = 15.4 Hz, CH), 7.63 (s, 1H, ArH), 
7.64 (d, 1H, J = 15.8 Hz, CH), 8.09 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 10.9 
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(CH3), 11.0 (2CH3), 14.0 (3CH3), 23.0 (3CH2), 23.8 (3CH2), 28.9 (3CH2), 30.3 (NCH3), 30.4 
(3CH2), 38.7 (CH), 38.8 (2CH) 67.6, 68.0, 68.4 (OCH2), 111.1, 121.7 (CH), 127.7, 127.8 
(CH), 127.8, 128.7, 137.0, 143.8, 151.3 (C), 166.1, 167.5, 168.3 (CO). IR (KBr, cm
1
): v = 
2956, 2926, 2858 (m), 1712 (s), 1630 (w), 1459, 1380, 1339, 1296 (m), 1255, 1208, 1113, 
1100 (s), 1032, 965, 785 (m), 745, 727 (w). MS (EI, 70 eV): m/z (%) = 626(06) [M]
+
, 
515(13), 471(17), 402(45), 385(100), 290(11), 273(30), 69(15), 57(22), 43(17), 41(15). 
HRMS (ESI): m/z calcd for C37H59N2O6 [M+H]
+
: 627.4368; found: 627.4372. 
 
Synthesis of Benzimidazoles (41): 
 
Dihexyl-2-(3-(hexyloxy)-3-oxopropyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate 
(41d): 
Compound 41d was prepared 
starting with 39d (100 mg, 
0.18 mmol), following the 
general procedures E, as a 
brown oil (31 mg, 32%). 
1
H 
NMR (250 MHz, CDCl3):  = 0.80 (t, 3H, J = 6.7 Hz, CH3), 0.83 (t, 6H, J = 6.7 Hz, 2CH3), 
1.19-1.34 (m, 18H, 9CH2), 1.47-1.59 (m, 2H, CH2), 1.61-1.72 (m, 4H, 2CH2), 2.97 (t, 2H, J = 
6.5 Hz, CH2), 3.11 (t, 2H, J = 6.6 Hz, CH2),  3.74 (s, 3H, NCH3), 4.00 (t, 2H, J = 6.7 Hz, 
OCH2), 4.22 (t, 2H, J = 6.7 Hz, OCH2), 4.24 (t, 2H, J = 6.7 Hz, OCH2), 7.59 (s, 1H, ArH), 
7.99 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 13.9 (CH3), 14.0 (2CH3), 22.4 (CH2), 
22.5 (3CH2), 25.5, 25.6, 25.7 (CH2), 28.5 (2CH2), 28.6 (CH2), 30.1 (NCH3), 31.2, 31.4 (CH2), 
31.5 (2CH2), 65.0, 65.6, 65.9 (OCH2), 110.4, 120.6 (CH), 126.5, 127.0, 136.8, 143.5, 157.3 
(C), 168.0, 168.4, 172.5 (CO). IR (KBr, cm
1
): v = 2954, 2928 (m), 2857 (w), 1715 (s), 1622, 
1511 (w), 1465, 1334 (m), 1252, 1204, 1173, 1151 (s), 1024, 984, 785 (m), 725, 612 (w). GC-
MS (EI, 70 eV): m/z (%) = 544(21) [M]
+
, 416(38), 415(100), 359(39), 331(13), 229(13). 
HRMS (EI, 70 eV): m/z calcd for C31H48N2O6 [M]
+
: 544.35069; found: 544.34919. 
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Diethyl-2-(3-ethoxy-3-oxopropyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate 
(41e): 
Compound 41e was prepared starting with 39e (100 
mg, 0.27 mmol), following the general procedures E, as 
a brown oil (39 mg, 40%). 
1
H NMR (250 MHz, 
CDCl3):  = 1.16 (t, 3H, J = 7.1 Hz, CH3), 1.29 (t, 3H, 
J = 7.1 Hz, CH3), 1.30 (t, 3H, J = 7.1 Hz, CH3), 2.94 (t, 
2H, J = 6.6 Hz, CH2), 3.09 (t, 2H, J = 6.4 Hz, CH2),  3.72 (s, 3H, NCH3), 4.06 (q, 2H, J = 7.0 
Hz, CH2O), 4.24-4.34 (m, 4H, 2CH2O), 7.59 (s, 1H, ArH), 7.96 (s, 1H, ArH). 
13
C NMR (62 
MHz, CDCl3):  = 14.1 (3CH3), 22.4 (CH2), 30.0 (NCH3), 31.1 (CH2), 60.7, 61.3, 61.5 
(OCH2), 110.5, 120.5 (CH), 126.4, 126.6, 136.7, 143.5, 157.3 (C), 168.0, 168.2, 172.3 (CO). 
IR (KBr, cm
1
): v = 2956, 2929 (m), 2858 (w), 1716 (s), 1513 (w), 1467, 1334 (m), 1255, 
1206, 1173, 1152 (s), 1024, 984, 786 (m), 725, 612 (w). GC-MS (EI, 70 eV): m/z (%) = 
376(40) [M]
+
, 329(18), 302(35), 303(100), 273(29), 207(23), 32(12). HRMS (EI, 70 eV): m/z 
calcd for C19H24N2O6 [M]
+
: 376.16344; found: 376.16442. 
 
Dimethyl-2-(3-methoxy-3-oxopropyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate 
(41f): 
Compound 41f was prepared starting with 39f (100 
mg, 0.30 mmol), following the general procedures E, 
as a white semi solid (33 mg, 34%). 
1
H NMR (300 
MHz, CDCl3):  = 2.98 (t, 2H, J = 7.0 Hz, CH2 ), 
3.12 (t, 2H, J = 7.0 Hz, CH2 ), 3.63 (s, 3H, NCH3), 
3.75 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 7.62 (s, 1H, ArH), 7.98 (s, 1H, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 22.4 (CH2), 30.1 (NCH3), 30.9 (CH2), 52.0 (OCH3), 
52.5 (OCH3), 52.6 (OCH3), 110.6, 120.7 (CH), 126.24, 126.28, 136.8, 143.7, 157.3 (C), 
168.5, 168.6, 172.8 (CO). IR (KBr, cm
1
): v = 2997, 2948, 2843 (w), 1727, 1713 (s), 1622, 
1581, 1510, 1488 (w), 1431, 1368, 1339 (m), 1254 (s), 1229, 1219, 1190, 1153, 1101, 1041, 
970 (m), 888, 887, 830, (w), 783 (m), 680, 669, 620, 570 (w). GC-MS (EI, 70 eV): m/z (%) = 
334(12) [M]
+
, 303(24), 276(18), 275(100). HRMS (EI, 70 eV): m/z calcd for C16H18N2O6 
[M]
+
: 334.11594; found: 334.11537. 
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Synthesis of 4,5-di(alkenyl)-2-aryl-N-methyl imidazol (43): 
 
(2E,2'E)-Dibutyl-3,3'-(2-(4-methoxyphenyl)-1-methyl-1H-imidazole-4,5-diyl)diacrylate 
(43a): 
Product 43a was prepared starting with  
42a (346 mg, 1.0  mmol),  n-butyl acrylate 
 (0.36 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 
5 mol %), P(Cy)3 (10 mol %), NEt3 (1.10  
mL, 8.0  mmol), DMF (5 mL) at 100 °C 
for 24 h following general procedure D, as a yellow highly viscous oil (400 mg, 91%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.87 (t, 3H, J = 7.4 Hz, CH3), 0.90 (t, 3H, J = 7.3 Hz, CH3), 
1.31-1.41 (m, 4H, 2CH2), 1.55-1.65 (m, 4H, 2CH2), 3.64 (s, 3H, NCH3), 3.78 (s, 3H, OCH3), 
4.12 (t, 2H, J = 6.6 Hz, CH2O), 4.16 (t, 2H, J = 6.7 Hz, CH2O), 6.20 (d, 1H, J = 16.1 Hz, CH), 
6.77 (d, 1H, J = 15.3 Hz, CH), 6.92 (dd, 2H, J = 2.0, 6.8 Hz, ArH), 7.48 (dd, 2H, J = 2.1, 6.8 
Hz, ArH), 7.62 (d, 1H, J = 16.1 Hz, CH), 7.69 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (75 MHz, 
CDCl3):  = 13.7 (2CH3), 19.2 (2CH2), 30.7, 30.8 (CH2), 33.9 (NCH3), 55.4 (OCH3), 64.2, 
64.8 (CH2O), 114.2 (2CH), 119.1, 119.4 (CH), 121.6 (C), 129.1 (CH), 130.0 (C), 130.7 
(2CH), 133.5 (CH),  139.7, 152.1, 160.8 (C), 166.7, 167.5 (CO). IR (KBr, cm
1
): v = 2957, 
2933, 2871 (w), 1694 (s), 1622, 1612 (m), 1578, 1531 (w), 1456, 1443 (m), 1387, 1338 (w), 
1278 (m), 1249, 1158 (s), 1114, 1065, 1024, 965, 835 (m), 815, 793 (w), 741 (m), 695, 638, 
620, 536 (w). GC-MS (EI, 70 eV): m/z (%) = 440(30) [M]
+
, 339(25), 338(20), 284(22), 
283(100), 281(12), 266(14), 265(71), 240(18), 239(96), 237(17), 41(11). HRMS (EI, 70 eV): 
m/z calcd for C25H32N2O5 [M]
+
: 440.23057; found: 440.22968. 
 
(2E,2'E)-Isobutyl-3,3'-(2-(4-methoxyphenyl)-1-methyl-1H-imidazole-4,5-diyl)diacrylate 
(43b): 
Product 43b was prepared starting with  
42a (346 mg, 1.0  mmol),  iso-butyl acrylate 
 (0.36 mL, 2.5 mmol) , Pd(OAc)2  (11 mg, 
5 mol %), P(Cy)3 (10  mol %), NEt3 (1.10 mL, 
8.0  mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure D, as a brown oil 
(374 mg, 85%). 
1
H NMR (300 MHz, CDCl3):  = 0.90 (d, 6H, J = 6.8 Hz, 2CH3), 0.92 (d, 6H, 
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J = 6.8 Hz, 2CH3), 1.88-2.00 (m, 2H, 2CH), 3.65 (s, 3H, NCH3), 3.79 (s, 3H, OCH3), 3.91 (d, 
2H, J = 6.6 Hz, CH2O), 3.94 (d, 2H, J = 6.7 Hz, CH2O), 6.23 (d, 1H, J = 16.1 Hz, CH), 6.80 
(d, 1H, J = 15.3 Hz, CH), 6.94 (dd, 2H, J = 1.9, 6.8 Hz, ArH), 7.49 (dd, 2H, J = 2.1, 6.8 Hz, 
ArH), 7.64 (d, 1H, J = 16.1 Hz, CH), 7.71 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (75 MHz, 
CDCl3):  = 19.1 (2CH3), 19.2 (2CH3), 27.8, 27.9 (CH), 33.8 (NCH3), 55.4 (OCH3), 70.5, 
71.0 (CH2O), 114.2 (2CH), 119.2, 119.4 (CH), 121.6 (C), 129.2 (CH), 130.0 (C), 130.7 
(2CH), 133.5 (CH), 139.7, 152.1, 160.8 (C), 166.7, 167.5 (CO). IR (KBr, cm
1
): v = 2958 (m), 
2873, 2838 (w), 1703 (s), 1624, 1611 (m), 1577, 1533 (w), 1481, 1454, 1440, 1392, 1376 (m), 
1279 (m), 1249, 1154 (s), 1111, 1059, 1024, 1009, 967, 835, 791, 741, 699 (m), 614, 603, 536 
(w). GC-MS (EI, 70 eV): m/z (%) = 440(30) [M]
+
, 338(13), 284(18), 283(100), 281(11), 
265(52), 240(16), 239(70). HRMS (ESI): m/z calcd for C25H33N2O5 [M+H]
+
: 441.2384; 
found: 441.2392. 
 
(2E,2'E)-Dihexyl-3,3'-[2-(4-methoxyphenyl)-1-methyl-1H-imidazole-4,5-diyl]diacrylate 
(43c): 
Product 43c was prepared starting 
with  42a (346 mg, 1.0  mmol),  n-
hexyl acrylate  (0.44 mL, 2.5 mmol) , 
Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 
(10 mol %), NEt3 (1.10 mL, 8.0 
 mmol), DMF (5 mL) at 100 °C for 
24 h following general procedure D, as yellowish solid (385 mg, 78%), mp. 95-97 °C. 
1
H 
NMR (250 MHz, CDCl3):  = 0.81 (t, 3H, J = 6.6 Hz, CH3), 0.83 (t, 3H, J = 6.5 Hz, CH3), 
1.18-1.34 (m, 12H, 6CH2), 1.55-1.67 (m, 4H, 2CH2), 3.64 (s, 3H, NCH3), 3.78 (s, 3H, OCH3), 
4.11 (t, 2H, J = 6.7 Hz, CH2O), 4.14 (t, 2H, J = 6.8 Hz, CH2O), 6.20 (d, 1H, J = 16.1 Hz, CH), 
6.77 (d, 1H, J = 15.4 Hz, CH), 6.92 (dd, 2H, J = 2.1, 6.8 Hz, ArH), 7.48 (dd, 2H, J = 1.9, 6.9 
Hz, ArH), 7.63 (d, 1H, J = 16.1 Hz, CH), 7.69 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (75 MHz, 
CDCl3):  = 14.0 (2CH3), 22.5 (2CH2), 25.6 (2CH2), 28.7 (2CH2), 31.4, 31.5 (CH2), 33.9 
(NCH3), 55.4 (OCH3), 64.5, 65.1 (CH2O), 114.2 (2CH), 119.1, 119.4 (CH), 121.6 (C), 129.1 
(CH), 130.0 (C), 130.7 (2CH), 133.5 (CH), 139.7, 152.1, 160.8 (C), 166.7, 167.5 (CO). IR 
(KBr, cm
1
): v = 2953, 2928, 2856, 1716 (w), 1695, 1624 (s), 1578, 1531 (w), 1474, 1463 
(m), 1388, 1338 (w), 1294 (m), 1283, 1251, 1170 (s), 1112, 1021, 964, 868, 835 (m), 815, 
792, 742, 698, 602, 539 (w). GC-MS (EI, 70 eV): m/z (%) = 494(33) [M]
+
, 326(12), 310(19), 
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309(100), 281(10). HRMS (EI, 70 eV): m/z calcd for C29H40N2O5 [M]
+
: 496.29317; found: 
496.29374. 
 
2-(4-Methoxyphenyl)-1-methyl-4,5-bis(4-methylstyryl)-1H-imidazole (43d): 
Product 43d was prepared starting with  
42a (346 mg, 1.0  mmol),  4-methyl styrene 
(0.33 mL, 2.5 mmol) , Pd(OAc)2  (11 mg, 
5 mol %), P(Cy)3 (10 mol %), NEt3 (1.10 mL, 
8.0  mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure D, as a brown 
oil (264 mg, 63%). 
1
H NMR (300 MHz, 
CDCl3):  = 2.25 (s, 3H, CH3), 2.31 (s, 3H, CH3), 3.58 (s, 3H, NCH3), 3.78 (s, 3H, OCH3), 
6.80 (d, 1H, J = 16.3 Hz, CH), 6.86-6.95 (m, 4H, ArH and CH), 7.04 (d, 2H, J = 8.0 Hz, 
ArH), 7.12 (d, 2H, J = 7.1 Hz, ArH), 7.33-7.38 (m, 4H, ArH and CH),  7.44 (dd, 1H, J = 2.2, 
6.4 Hz, ArH), 7.52 (dd, 2H, J = 2.0, 6.8 Hz, ArH). 
13
C NMR (75 MHz, CDCl3):  = 21.2, 21.3 
(CH3), 33.2 (NCH3), 55.4 (OCH3), 114.0 (CH), 114.1 (2CH), 114.4, 118.5 (CH), 122.9 (C), 
126.3 (3CH), 127.9 (CH), 129.2 (2CH), 129.5 (2CH), 130.6 (2CH), 131.9 (CH), 134.5, 135.3, 
136.8, 137.9 (C), 138.0 (2C), 149.2, 160.3 (C). IR (KBr, cm
1
): v = 2955 (w), 1608, 1509, 
1465 (w), 1394, 1362, 1305 (w), 1248 (s), 1173, 1111, 1031, 948, 838, 816, 805 (m), 728, 
623, 541 (w). GC-MS (EI, 70 eV): m/z (%) = 420(100) [M]
+
, 419(35), 329(11), 253(10), 
207(65), 148(15), 44(13), 32(12). HRMS (ESI): m/z calcd for C29H29N2O [M+H]
+
: 421.2274; 
found: 421.2274. 
 
4,5-Bis(4-tert-butylstyryl)-2-(4-methoxyphenyl)-1-methyl-1H-imidazole (43e): 
Product 43e was prepared starting with  
42a (346 mg, 1.0  mmol),  4-tert-butyl 
styrene (0.45 mL, 2.5 mmol) , Pd(OAc)2  
(11 mg, 5 mol %), P(Cy)3 (10 mol %), NEt3 
(1.10 mL, 8.0  mmol), DMF (5 mL) at 
100 °C for 24 h following general procedure 
D, as a brown oil (262 mg, 52%). 
1
H NMR 
(300 MHz, CDCl3):  = 1.24 (s, 9H, 3CH3), 1.27 (s, 9H, 3CH3), 3.58 (s, 3H, NCH3), 3.77 (s, 
3H, OCH3), 6.86 (d, 2H, J = 16.3 Hz, CH), 6.92 (d, 2H, J = 8.8 Hz, ArH), 7.12 (d, 2H, J = 
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16.0 Hz, CH), 7.26 (d, 2H, J = 8.3 Hz, ArH), 7.34 (d, 2H, J = 8.5 Hz, ArH), 7.37-7.41 (m, 4H, 
ArH), 7.51 (d, 2H, J = 8.8 Hz, ArH). 
13
C NMR (62 MHz, CDCl3):  = 30.2 (3CH3), 30.3 
(3CH3), 32.0 (NCH3), 33.5, 33.7 (C), 54.3 (OCH3), 113.0 (2CH), 113.6, 117.8 (CH), 121.9 
(C), 124.4 (2CH), 124.7 (2CH), 125.0 (2CH), 125.1 (2CH), 126.7 (CH), 129.3 (C), 129.5 
(2CH), 130.9 (CH), 133.5, 134.3, 136.9, 148.1, 149.0, 150.2, 159.2 (C). IR (KBr, cm
1
): v = 
2959 (w), 1611, 1508, 1465 (m), 1394, 1362, 1305 (w), 1248 (s), 1173, 1111, 1031, 948, 838, 
816, 805 (m), 728, 623, 541 (w). HRMS (ESI): m/z calcd for C35H41N2O [M+H]
+
: 505.3213; 
found: 505.3212. 
 
(2E,2'E)-Dihexyl-3,3'-(1-methyl-2-p-tolyl-1H-imidazole-4,5-diyl)diacrylate (43g): 
Product 43g was prepared starting 
with  42b (330 mg, 1.0  mmol),  n-
hexyl acrylate  (0.44 mL, 2.5 mmol) , 
Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 
(10 mol %), NEt3 (1.10 mL, 8.0 
 mmol), DMF (5 mL) at 100 °C for 
24 h following general procedure D, as a brown oil (360 mg, 75%). 
1
H NMR (300 MHz, 
CDCl3):  = 0.82 (t, 3H, J = 6.8 Hz, CH3), 0.84 (t, 3H, J = 6.7 Hz, CH3), 1.21-1.33 (m, 12H, 
6CH2), 1.58-1.67 (m, 4H, 2CH2), 2.35 (s, 3H, CH3), 3.65 (s, 3H, NCH3), 4.11 (t, 2H, J = 6.7 
Hz, CH2O), 4.15 (t, 2H, J = 6.8 Hz, CH2O), 6.22 (d, 1H, J = 16.1 Hz, CH), 6.79 (d, 1H, J = 
15.3 Hz, CH), 7.22 (d, 2H, J = 7.9 Hz, ArH), 7.44 (dd, 2H, J = 1.7, 6.5 Hz, ArH), 7.64 (d, 1H, 
J = 16.2 Hz, CH), 7.70 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 
(2CH3), 21.4 (CH3), 22.5 (2CH2), 25.6 (2CH2), 28.7 (2CH2), 31.4 (2CH2), 33.8 (NCH3), 64.5, 
65.1 (CH2O), 119.3, 119.5 (CH), 126.4 (C), 129.1 (3CH), 129.5 (2CH), 130.1 (C), 133.5 
(CH), 139.7, 140.0, 152.2 (C), 166.6, 167.5 (CO). IR (KBr, cm
1
): v = 2953, 2925, 2855 (m), 
1705 (s), 1624, 1452, 1277 (m), 1163 (s), 1056, 1018, 970 (m), 913, 865, 848 (w), 823 (m), 
790, 734, 611 (w). GC-MS (EI, 70 eV): m/z (%) = 480(18) [M]
+
, 351(21), 268(14), 267(100), 
265(10), 249(54), 224(15), 223(80), 221(15), 207(28), 43(13). HRMS (ESI): m/z calcd for 
C29H41N2O4 [M+H]
+
: 481.3061; found: 481.3064. 
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(2E,2'E)-Isobutyl-3,3'-(1-methyl-2-p-tolyl-1H-imidazole-4,5-diyl)diacrylate (43h): 
Product 43h was prepared starting with  42b (330 
mg, 1.0  mmol),  iso-butyl acrylate  (0.36 mL, 2.5 
mmol) , Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  
mol %), NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) 
at 100 °C for 24 h following general procedure D, 
as a brown oil (347 mg, 82%). 
1
H NMR (300 
MHz, CDCl3):  = 0.89 (d, 6H, J = 6.9 Hz, 2CH3), 0.91 (d, 6H, J = 7.0 Hz, 2CH3), 1.86-1.97 
(m, 2H, 2CH), 2.33 (s, 3H, CH3), 3.64 (s, 3H, NCH3), 3.90 (d, 2H, J = 6.6 Hz, CH2O), 3.94 
(d, 2H, J = 6.8 Hz, CH2O), 6.23 (d, 1H, J = 16.1 Hz, CH), 6.80 (d, 1H, J = 15.3 Hz, CH), 7.21 
(d, 2H, J = 7.8 Hz, ArH), 7.42 (d, 2H, J = 8.0 Hz, ArH), 7.63 (d, 1H, J = 16.1 Hz, CH), 7.70 
(d, 1H, J = 15.3 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 19.0 (2CH3), 19.1 (2CH3), 21.4 
(CH3), 27.7, 27.8 (CH), 33.8 (NCH3), 70.4, 71.0 (CH2O), 119.3, 119.4 (CH), 126.1 (C), 129.0 
(2CH), 129.1 (CH), 129.4 (2CH), 130.1 (C), 133.5 (CH), 139.6, 140.0, 152.1 (C), 166.6, 
167.4 (CO). IR (KBr, cm
1
): v = 2958, 2873 (w), 1704 (s), 1624, 1467, 1453, 1376, 1276, 
1244 (m), 1149 (s), 1111, 967, 822 (m), 734, 700, 615 (w). GC-MS (EI, 70 eV): m/z (%) = 
424(18) [M]
+
, 323(11), 268(19), 267(100), 249(45), 223 (71), 221(14), 207(12). HRMS (EI, 
70 eV): m/z calcd for C25H32N2O4 [M]
+
: 424.23566; found: 424.23506. 
 
(2E,2'E)-Dibutyl-3,3'-(1-methyl-2-p-tolyl-1H-imidazole-4,5-diyl)diacrylate (43i): 
Product 43i was prepared starting with  
42b (330 mg, 1.0  mmol),  n-butyl acrylate 
 (0.36 mL, 2.5 mmol) , Pd(OAc)2  (11 mg, 
5 mol %), P(Cy)3 (10  mol %), NEt3 (1.10 mL, 
8.0  mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure D, as a brown oil 
(369 mg, 87%). 
1
H NMR (300 MHz, CDCl3):  = 0.88 (t, 3H, J = 7.4 Hz, CH3), 0.90 (t, 3H, J 
= 7.3 Hz, CH3), 1.31-1.41 (m, 4H, 2CH2), 1.55-1.66 (m, 4H, 2CH2), 2.34 (s, 3H, CH3), 3.65 
(s, 3H, NCH3), 4.13 (t, 2H, J = 6.6 Hz, CH2O), 4.16 (t, 2H, J = 6.6 Hz, CH2O), 6.22 (d, 1H, J 
= 16.2 Hz, CH), 6.78 (d, 1H, J = 15.3 Hz, CH), 7.22 (d, 2H, J = 7.9 Hz, ArH), 7.44 (dd, 2H, J 
= 1.8, 6.3 Hz, ArH), 7.64 (d, 1H, J = 16.2 Hz, CH), 7.70 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR 
(62 MHz, CDCl3):  = 13.7 (2CH3), 19.2 (2CH2), 21.4 (CH3), 30.7, 30.8 (CH2), 33.8 (NCH3), 
64.2, 64.8 (CH2O), 119.3, 119.5 (CH), 126.4 (C), 129.1 (3CH), 129.5 (2CH), 130.1 (C), 133.5 
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(CH), 139.7, 140.0, 152.2 (C), 166.6, 167.5 (CO). IR (KBr, cm
1
): v = 2956, 2931, 2871 (w), 
1701, 1623 (s), 1451 (m), 1381 (w), 1276 (s), 1258 (m), 1159, 1148 (s), 1118, 1059, 1018, 
967 (m), 864, 847 (w), 822, 734 (m), 700, 610 (w). GC-MS (EI, 70 eV): m/z (%) = 424(26) 
[M]
+
, 323(35), 322(13), 268(17), 267(100), 265(14), 250(10), 249(59), 224(14), 223(94), 
221(17). HRMS (ESI): m/z calcd for C25H33 N2O4 [M+H]
+
: 425.2435; found: 425.2443. 
 
(2E,2'E)-tert-Butyl-3,3'-(1-methyl-2-p-tolyl-1H-imidazole-4,5-diyl)diacrylate (43j): 
Product 43j was prepared starting with  42b (330 
mg, 1.0  mmol),  tert-butyl acrylate  (0.36 mL, 2.5 
mmol) , Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  
mol %), NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) 
at 100 °C for 24 h following general procedure D, 
as whitish solid (381 mg, 90%), mp. = 126-126 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.44 (s, 9H, 3CH3), 1.47 (s, 9H, 3CH3), 2.34 (s, 3H, CH3), 
3.63 (s, 3H, NCH3), 6.16 (d, 1H, J = 16.1 Hz, CH), 6.72 (d, 1H, J = 15.4 Hz, CH), 7.22 (d, 
2H, J =  8.0 Hz, ArH), 7.43 (d, 2H, J =  8.1 Hz, ArH), 7.53 (d, 1H, J =  16.2 Hz, CH), 7.62 (d, 
1H, J = 15.3 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  = 21.4 (CH3), 28.2 (6CH3), 33.6 
(NCH3), 80.1, 81.1 (C), 121.3, 121.6 (CH), 126.5 (C), 128.3 (CH), 129.1 (2CH), 129.4 (2CH), 
130.0 (C), 132.7 (CH), 139.3, 139.9, 151.8 (C), 166.9, 166.9 (CO). IR (KBr, cm
1
): v = 2974, 
2928, 2869 (w), 1698, 1623 (m), 1520, 1480 (w), 1452 (m), 1391 (w), 1365, 1299, 1278, 
1255 (m), 1136 (s), 1057, 969, 886, 854, 822, 761, 733 (m). MS (EI, 70 eV): m/z (%) = 
424(16) [M]
+
, 267(15), 224(19), 223(100), 221(16), 56(12), 41(22). HRMS (ESI): m/z calcd 
for C25H33N2O4 [M+H]
+
: 425.24348; found: 425.24384. 
 
2-(4-tert-Butylphenyl)-4,5-bis(4-methoxystyryl)-1-methyl-1H-imidazole (43k): 
Product 43k was prepared starting with  
42c (372 mg, 1.0  mmol),  4-methoxy 
styrene (0.33 mL, 2.5 mmol) , Pd(OAc)2  
(11 mg, 5 mol %), P(Cy)3 (10 mol %), 
NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) 
at 100 °C for 24 h following general 
procedure D, as a brown oil (305 mg, 
64%). 
1
H NMR (300 MHz, CDCl3):  = 1.27 (s, 9H, 3CH3), 3.60 (s, 3H, NCH3), 3.72 (s, 3H, 
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OCH3), 3.76 (s, 3H, OCH3), 6.77-6.79 (m, 5H, ArH and CH), 6.85 (d, 1H, J = 8.6 Hz, ArH), 
7.02 (d, 2H, J = 16.0 Hz, CH), 7.37-7.42 (m, 6H, ArH and CH), 7.51 (d, 2H, J = 8.3 Hz, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 31.2 (3CH3), 33.1 (NCH3), 34.8 (C), 55.3, 55.4 
(OCH3), 113.3 (CH), 114.0 (2CH), 114.3 (3CH), 125.5 (CH), 125.6 (2CH), 127.5 (2CH), 
127.6 (2CH), 128.8 (2CH), 129.7, 130.1 (C), 131.0 (2C), 131.6 (CH), 137.8, 149.1, 152.2, 
158.8, 159.6 (C). IR (KBr, cm
1
): v = 2954 (w), 1603, 1509, 1462 (m), 1394, 1362, 1303 (w), 
1246 (s), 1173, 1111, 1031, 948, 837, 816, 802 (m), 728, 623, 540 (w). GC-MS (EI, 70 eV): 
m/z (%) = 478(100) [M]
+
, 476(48), 461(11), 371(13), 174(16), 44(10). HRMS (ESI): m/z 
calcd for C32H35N2O2 [M+H]
+
: 479.2693; found: 479.2693. 
 
(2E,2'E)-Diethyl-3,3'-(2-(4-tert-butylphenyl)-1-methyl-1H-imidazole-4,5-diyl)diacrylate 
(43l): 
Product 43l was prepared starting with  42c (372 mg, 
1.0  mmol),  ethyl acrylate  (0.27 mL, 2.5 mmol) , 
Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  mol %), 
NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) at 100 °C 
for 24 h following general procedure D, as a brown 
oil (301 mg, 81%). 
1
H NMR (300 MHz, CDCl3):  = 1.23 (t, 6H, J = 7.2 Hz, 2CH3), 1.27 (s, 
9H, 3CH3), 3.66 (s, 3H, NCH3), 4.17 (q, 2H, J = 7.2 Hz, CH2O), 4.20 (q, 2H, J = 7.2 Hz, 
CH2O), 6.21 (d, 1H, J = 16.3 Hz, CH), 6.77 (d, 1H, J = 15.4 Hz, CH), 7.42 (d, 2H, J = 8.0 Hz, 
ArH), 7.47 (d, 2H, J = 8.4 Hz, ArH), 7.64 (d, 1H, J = 16.2 Hz, CH), 7.69 (d, 1H, J = 15.3 Hz, 
CH). 
13
C NMR (62 MHz, CDCl3):  = 14.3 (2CH3), 31.1 (3CH3), 33.9 (NCH3), 34.8 (C), 60.3, 
60.8 (CH2O), 119.1, 119.4 (CH), 125.7 (2CH), 126.3 (C), 128.9 (2CH), 129.1 (CH), 130.0 
(C), 133.5 (CH), 139.8, 152.2, 153.1 (C), 166.5, 167.4 (CO). IR (KBr, cm
1
): v = 2958, 2903, 
2868 (w), 1701, 1624 (s), 1479, 1451 (m), 1391 (w), 1364 (m), 1277, 1261, 1151 (s), 1111, 
1094, 1028, 1015, 967 (m), 917, 892 (w), 839, 728 (m), 671, 645 (w), 610, 558 (m). GC-MS 
(EI, 70 eV): m/z (%) = 410(46) [M]
+
, 338(25), 337(100), 336(24), 321(15), 309(21), 293(63), 
291(88), 277(17), 265(73), 249(52). HRMS (EI, 70 eV): m/z calcd for C24H30N2O4 [M]
+
: 
410.22001; found: 410.21940. 
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2-(4-tert-Butylphenyl)-1-methyl-4,5-bis(4-methylstyryl)-1H-imidazole (43m): 
Product 43m was prepared starting with  
42c (372 mg, 1.0  mmol),  4-methylstyrene 
(0.33 mL, 2.5 mmol), Pd(OAc)2  (11 mg, 
5 mol %), P(Cy)3 (10 mol %), NEt3 (1.10 mL, 
8.0  mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure D, as a brown oil 
(249 mg, 56%). 
1
H NMR (300 MHz, CDCl3): 
 = 1.27 (s, 9H, 3CH3), 2.25 (s, 3H, CH3), 2.30 (s, 3H, CH3), 3.60 (s, 3H, NCH3), 6.86 (d, 2H, 
J = 14.3 Hz, CH), 7.03 (d, 2H, J = 8.0 Hz, ArH), 7.08-7.15 (m, 3H, ArH and CH), 7.34 (dd, 
4H, J = 1.4, 8.0 Hz, ArH), 7.39-7.46 (m, 3H, ArH and CH), 7.51 (dd, 2H, J = 1.9, 6.6 Hz, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 21.2, 21.3 (CH3), 31.3 (3CH3), 33.1 (NCH3), 34.8 (C), 
114.4, 118.6 (CH), 125.5 (CH), 125.6 (2CH), 126.3 (3CH), 127.6 (C), 128.0 (CH), 128.8 
(2CH), 129.3 (2CH), 129.5 (2CH), 129.9 (C), 131.9 (CH), 134.5, 135.3, 136.8, 137.9, 138.1, 
149.3, 152.2 (C). IR (KBr, cm
1
): v = 3019, 2957, 2864, 1510, 1477, 1446, 1362, 1266 (w), 
1111, 1014, 954, 838, 802, 728 (m), 624, 612, 556 (w). GC-MS (EI, 70 eV): m/z (%) = 
446(09) [M]
+
, 444(100), 429(28), 215(13). HRMS (ESI): m/z calcd for C32H35N2 [M+H]
+
: 
447.2795; found: 447.2801. 
 
(2E,2'E)-Dibutyl-3,3'-(2-(4-tert-butylphenyl)-1-methyl-1H-imidazole-4,5-diyl)diacrylate 
(43o): 
Product 43o was prepared starting with  
42c (372 mg, 1.0  mmol),  n-butylacrylate 
 (0.36 mL, 2.5 mmol) , Pd(OAc)2  (11 mg, 
5 mol %), P(Cy)3 (10  mol %), NEt3 
(1.10 mL, 8.0  mmol), DMF (5 mL) at 
100 °C for 24 h following general 
procedure D, as a brown oil (405 mg, 87%). 
1
H NMR (300 MHz, CDCl3):  = 0.86 (t, 3H, J = 
7.4 Hz, CH3), 0.89 (t, 3H, J = 7.4 Hz, CH3), 1.27 (s, 9H, 3CH3), 1.31-1.43 (m, 4H, 2CH2), 
1.55-1.67 (m, 4H, 2CH2), 3.66 (s, 3H, NCH3), 4.12 (t, 2H, J = 6.5 Hz, CH2O), 4.15 (t, 2H, J = 
6.7 Hz, CH2O), 6.22 (d, 1H, J = 16.2 Hz, CH), 6.78 (d, 1H, J = 15.3 Hz, CH), 7.42 (d, 2H, J = 
8.5 Hz, ArH), 7.47 (d, 2H, J = 8.6 Hz, ArH), 7.64 (d, 1H, J = 16.2 Hz, CH), 7.70 (d, 1H, J = 
15.3 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 (2CH3), 19.2 (2CH2), 30.7, 30.8 (CH2), 
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31.2 (3CH3), 33.8 (NCH3), 34.8 (C), 64.2, 64.7 (CH2O), 119.2, 119.4 (CH), 125.7 (2CH), 
126.3 (C), 128.9 (2CH), 129.1 (CH), 130.0 (C), 133.5 (CH), 139.7, 152.2, 153.1 (C), 166.6, 
167.5 (CO). IR (KBr, cm
1
): v = 2956, 2934, 2870 (w), 1705, 1624 (s), 1480, 1453 (m), 1383, 
1362 (w), 1277, 1159 (s), 1113, 1061, 1014, 969, 840 (m), 728, 613, 559 (w). GC-MS (EI, 70 
eV): m/z (%) = 466(20) [M]
+
, 365(32), 309(100), 291(65), 265(64), 249(133). HRMS (EI, 70 
eV): m/z calcd for C28H38 N2O4 [M]
+
: 466.28261; found: 466.28365. 
 
(2E,2'E)-Dibutyl-3,3'-(2-(3,5-dimethylphenyl)-1-methyl-1H-imidazole-4,5-diyl)diacrylate 
(43p): 
Product 43p was prepared starting with  
42d (344 mg, 1.0  mmol),  n-butyl acrylate 
 (0.36 mL, 2.5 mmol) , Pd(OAc)2  (11 mg, 
5 mol %), P(Cy)3 (10  mol %), NEt3 (1.10 mL, 
8.0  mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure D, as a brown oil 
(324 mg, 74%). 
1
H NMR (250 MHz, CDCl3):  = 0.87 (t, 3H, J = 7.2 Hz, CH3), 0.90 (t, 3H, J 
= 7.2 Hz, CH3), 1.30-1.41 (m, 4H, 2CH2), 1.54-1.66 (m, 4H, 2CH2), 2.29 (s, 6H, 2CH3), 3.64 
(s, 3H, NCH3), 4.11 (t, 2H, J = 6.6 Hz, CH2O), 4.16 (t, 2H, J = 6.7 Hz, CH2O), 6.22 (d, 1H, J 
= 16.2 Hz, CH), 6.79 (d, 1H, J = 15.4 Hz, CH), 7.03 (s, 1H, ArH), 7.14 (s, 2H, ArH), 7.63 (d, 
1H, J = 15.8 Hz, CH), 7.69 (d, 1H, J = 15.2 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 
(2CH3), 19.2 (2CH2), 21.3 (2CH3), 30.7 (2CH2), 33.8 (NCH3), 64.2, 64.7 (CH2O), 119.3, 
119.5 (CH), 126.9 (2CH), 129.0 (C), 129.1 (CH), 130.0 (C), 131.5, 133.5 (CH), 138.4 (2C), 
139.6, 152.4 (C), 166.6, 167.5 (CO). IR (KBr, cm
1
): v = 2956 (m), 2931, 2871 (w), 1703 (s), 
1624, 1605 (m), 1514, (w), 1456 (m), 1381, 1387 (w), 1292, 1274, 1256, 1197 (m), 1160 (s), 
1097, 1063, 1023 (w), 969, 854 (m), 783, 757, 735, 695, 666, 620, 545 (w). GC-MS (EI, 70 
eV): m/z (%) = 438(24) [M]
+
, 337(29), 336(11), 282(19), 281(100), 279(14), 264(13), 
263(65), 238(17), 237(94), 235(18). HRMS (ESI): m/z calcd for C26H35 N2O4 [M+H]
+
: 
439.2591; found: 439.2595. 
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4,5-Bis(4-tert-butylstyryl)-2-(3,5-dimethylphenyl)-1-methyl-1H-imidazole (43q): 
Product 43q was prepared starting with  42q  
(344 mg, 1.0  mmol),  4-tert-butylstyrene (0.45 
mL, 2.5 mmol) , Pd(OAc)2  (11 mg, 5 mol %), 
P(Cy)3 (10 mol %), NEt3 (1.10 mL, 8.0  mmol), 
DMF (5 mL) at 100 °C for 24 h following 
general procedure D, as a brown oil (326 mg, 
65%). 
1
H NMR (300 MHz, CDCl3):  = 1.23 (s, 
9H, 3CH3), 1.26 (s, 9H, 3CH3), 2.28 (s, 6H, 
2CH3), 3.58 (s, 3H, NCH3), 6.86 (d, 2H, J = 15.1 Hz, CH), 6.94-6.97 (m, 3H, ArH), 7.09-7.11 
(m, 2H, ArH), 7.14-7.19 (m, 2H, ArH and CH), 7.22-7.28 (m, 2H, ArH), 7.35-7.40 (m, 5H, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 21.2 (2CH3), 31.3 (6CH3), 33.1 (NCH3), 34.5, 34.7 
(C), 114.6, 118.8 (CH), 125.5 (2CH), 125.8 (2CH), 126.1 (2CH), 126.2 (2CH), 126.4 (CH), 
126.9 (2CH), 127.8 (CH), 130.0, 130.3 (C), 130.7 (CH), 132.0, 134.5, 135.4, 138.0 (C), 138.2 
(2C), 150.0, 151.3 (C). IR (KBr, cm
1
): v = 2952, 2921 (m), 2863 (w), 1602, 1462, 1455, 
1361, 1107, 955 (m), 852, 817 (s), 791, 690 (m), 559 (s). MS (EI, 70 eV): m/z (%) = 502(100) 
[M]
+
, 501(49), 448(19), 433(14), 371(40), 357(10), 343(20), 161(13), 146(23), 133(12), 
97(11), 69(18), 57(25), 44(12). HRMS (ESI): m/z calcd for C36H43N2 [M+H]
+
: 503.3421; 
found: 503.3422. 
 
(2E,2'E)-Isobutyl-3,3'-[2-(3,5-dimethylphenyl)-1-methyl-1H-imidazole-4,5-diyl] 
diacrylate (43r): 
Product 43r was prepared starting with  42d (344 
mg, 1.0  mmol),  iso-butyl acrylate  (0.36 mL, 2.5 
mmol) , Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  
mol %), NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) at 
100 °C for 24 h following general procedure D, as a 
brown oil (328 mg, 75%). 
1
H NMR (300 MHz, 
CDCl3):  = 0.88 (d, 6H, J = 6.7 Hz, 2CH3), 0.91 (d, 
6H, J = 6.7 Hz, 2CH3), 1.86-1.99 (m, 2H, 2CH), 2.28 (s, 6H, 2CH3), 3.64 (s, 3H, NCH3), 3.89 
(d, 2H, J = 6.6 Hz, CH2O), 3.93 (d, 2H, J = 6.7 Hz, CH2O), 6.23 (d, 1H, J = 16.2 Hz, CH), 
6.80 (d, 1H, J = 15.4 Hz, CH), 7.02 (s, 1H, ArH), 7.14 (s, 2H, ArH), 7.63 (d, 1H, J = 16.2 Hz, 
CH), 7.70 (d, 1H, J = 15.4 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 19.0 (2CH3), 19.1 
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(2CH3), 21.2 (2CH3), 27.7, 27.8 (CH), 33.7 (NCH3), 70.4, 70.9 (CH2O), 119.3, 119.4 (CH), 
126.9 (2CH), 129.0 (C), 129.1 (CH), 130.0 (C), 131.5, 133.5 (CH), 138.4 (2C), 139.6, 152.4 
(C), 166.6, 167.4 (CO). IR (KBr, cm
1
): v = 2958, 2873 (w), 1704 (s), 1624, 1604, 1468 (m), 
1392 (w), 1376 (m), 1340 (w), 1288, 1274, 1258, 1240, 1197 (m), 1154 (s), 1111, 969, 854 
(m), 785, 735, 695, 547 (w). GC-MS (EI, 70 eV): m/z (%) = 438(18) [M]
+
, 282(19), 281(100), 
263(44), 238(11), 237(62), 235(11). HRMS (ESI): m/z calcd for C26H35N2O4 [M+H]
+
: 
439.2591; found: 439.2594. 
 
Synthesis of Benzimidazoles (44) 
 
Dibutyl-2-(4-methoxyphenyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44a): 
Compound 44a was prepared starting with 
43a (100 mg, 0.23 mmol), following the 
general procedure E, as a brown highly 
viscous oil (80 mg, 81%). 
1
H NMR (300 
MHz, CDCl3):  = 0.89 (t, 6H, J = 7.3 Hz, 
2CH3),  1.31-1.43 (m, 4H, 2CH2), 1.61-1.70 (m, 4H, 2CH2), 3.79 (s, 3H, OCH3), 3.80 (s, 3H, 
NCH3), 4.25 (t, 4H, J = 6.7 Hz, 2CH2O), 6.96 (dd, 2H, J = 2.0, 6.9 Hz, ArH), 7.64 (dd, 2H, J 
= 2.0, 6.5 Hz, ArH), 7.65 (s, 1H, ArH), 8.05 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 
12.7 (2CH3), 18.1, 18.2 (CH2), 29.5, 29.6 (CH2), 31.1 (NCH3), 54.4 (OCH3), 64.3, 64.6 
(CH2O), 111.0 (CH), 113.3 (2CH), 119.9 (CH), 120.5, 125.9, 126.1 (C), 129.9 (2CH), 136.5, 
143.0, 156.0, 160.3 (C), 167.1, 167.3 (CO). IR (KBr, cm
1
): v = 2957, 2932, 2872 (w), 1713 
(s), 1609 (m), 1577, 1532 (w), 1478, 1463, 1438 (m), 1381, 1358 (w), 1327, 1306, 1271 (m), 
1245, 1174 (s), 1099, 1059, 1024, 962, 943, 836, 782, 740 (m), 661, 638, 588, 549 (w). GC-
MS (EI, 70 eV): m/z (%) = 438(45) [M]
+
, 310(19), 309(100), 308(12). HRMS (EI, 70 eV): 
m/z calcd for C25H30N2O5 [M]
+
: 438.21492; found: 438.21393. 
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Diisobutyl-2-(4-methoxyphenyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate 
(44b): 
Compound 44b was prepared starting with 43b 
(100 mg, 0.23 mmol), following the general 
procedure E, as a brown oil (77 mg, 77%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.93 (d, 6H, J = 
6.7 Hz, 2CH3), 0.94 (d, 6H, J = 6.7 Hz, 2CH3), 
1.93-2.03 (m, 2H, 2CH), 3.82 (s, 3H, NCH3), 3.83 (s, 3H, OCH3), 4.04 (d, 2H, J = 6.6 Hz, 
CH2O), 4.05 (d, 2H, J = 6.7 Hz, CH2O), 6.99 (dd, 2H, J = 2.0, 6.8 Hz, ArH), 7.65-7.68 (m, 
3H, ArH), 8.1 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 18.1 (2CH3), 18.2 (2CH3), 26.7, 
26.8 (CH), 31.1 (NCH3), 54.4 (OCH3), 70.6, 70.9 (CH2O), 110.0 (CH), 113.3 (2CH), 119.9 
(CH), 120.5, 126.0, 126.2 (C), 129.9 (2CH), 136.6, 142.9, 156.0, 160.3 (C), 167.0, 167.4 
(CO). IR (KBr, cm
1
): v = 2957 (m), 2927, 2872 (w), 1714 (s), 1609 (m), 1578, 1533 (w), 
1479, 1465, 1438, 1376, 1327 (m), 1248, 1175, 1099, 1027 (s), 984, 836, (m), 782 (s), 741 
(m), 699, 661, 589 (w). GC-MS (EI, 70 eV): m/z (%) = 438(46) [M]
+
, 326(17), 310(20), 
309(100). HRMS (EI, 70 eV): m/z calcd for C25H30N2 O5 [M]
+
: 438.21492; found: 438.21400. 
 
Dihexyl-2-(4-methoxyphenyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44c): 
Compound 44c was prepared 
starting with 43c (100 mg, 0.20 
mmol), following the general 
procedure E, as a brown highly 
viscous oil (83 mg, 84%). 
1
H NMR 
(300 MHz, CDCl3):  = 0.83 (t, 6H, J = 6.9 Hz, 2CH3), 1.20-1.36 (m, 12H, 6CH2), 1.63-1.73 
(m, 4H, 2CH2), 3.81 (s, 3H, OCH3), 3.82 (s, 3H, NCH3), 4.24 (t, 2H, J = 6.6 Hz, CH2O), 4.25 
(t, 2H, J = 6.8 Hz, CH2O), 6.98 (dd, 2H, J = 2.0, 6.8 Hz, ArH), 7.64-7.67 (m, 3H, ArH), 8.07 
(s, 1H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 14.0 (2CH3), 22.6 (2CH2), 25.6, 25.7, 28.5, 
28.6 (CH2), 31.5 (2CH2), 32.1 (NCH3), 55.4 (OCH3), 65.7, 65.9 (CH2O), 111.0 (CH), 114.3 
(2CH), 120.9 (CH), 121.5, 127.0, 127.1 (C), 131.0 (2CH), 137.6, 144.0, 157.0, 161.3 (C), 
168.1, 168.4 (CO). IR (KBr, cm
1
): v = 2953, 2927, 2856 (w), 1713 (s), 1609 (m), 1577, 1532 
(w), 1479, 1465, 1438, 1379, 1358, 1327, 1269 (m), 1246, 1220, 1174, 1024 (s), 981, 836, 
783, 741 (m), 661, 606, 588 (w). GC-MS (EI, 70 eV): m/z (%) = 494(36) [M]
+
, 326(12), 
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309(100), 308(20), 281(11), 207(14). HRMS (EI, 70 eV): m/z calcd for C29H38N2O5 [M]
+
: 
494.27752; found: 494.27654. 
 
2-(4-Methoxyphenyl)-1-methyl-5,6-di-p-tolyl-1H-benzo[d]imidazole (44d): 
Compound 44d was prepared starting with 
43d (100 mg, 0.24 mmol), following the 
general procedure E, as a brown semi solid 
(78 mg, 79%). 
1
H NMR (300 MHz, CDCl3): 
 = 2.25 (s, 3H, CH3), 2.26 (s, 3H, CH3), 
3.80 (s, 3H, OCH3), 3.82 (s, 3H, NCH3), 
6.94-7.04 (m, 10H, ArH), 7.29 (s, 1H, ArH), 7.67 (dd, 2H, J = 2.0, 6.8 Hz, ArH), 7.75 (s, 1H, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 21.1 (2CH3), 31.8 (NCH3), 55.4 (OCH3), 111.2 (CH), 
114.2 (2CH), 121.0 (CH), 122.4 (C), 128.5 (2CH), 128.6 (2CH), 130.0 (2CH), 130.1 (2CH), 
130.8 (2CH), 135.5, 135.8, 135.9, 136.1, 139.3 (C), 139.5 (2C), 142.2, 154.5, 160.9 (C). IR 
(KBr, cm
1
): v = 3019, 2918, 2950, 1715, 1659 (w), 1608 (m), 1576, 1531 (w), 1514, 1466, 
1434, 1415, 1377, 1291 (m), 1249, 1173 (s), 1109, 1023 (m), 963, 946, 907, 882 (w), 835 (m), 
818 (s), 789 (m), 724 (s), 678, 646, 625 (w), 608 (m), 566, 539 (w). GC-MS (EI, 70 eV): m/z 
(%) = 418(100) [M]
+
, 417(31), 403(10). HRMS (ESI): calcd for C29H27N2O [M+H]
+
: 
419.2118; found: 419.2119. 
 
5,6-Bis(4-tert-butylphenyl)-2-(4-methoxyphenyl)-1-methyl-1H-benzo[d]imidazole (44e): 
Compound 44e was prepared starting with 
43e (100 mg, 0.20 mmol), following the 
general procedure E, as a brown solid (70 
mg, 71%), mp. 152-154 °C. 
1
H NMR (300 
MHz, CDCl3):  = 1.22 (s, 9H, 3CH3), 1.23 
(s, 9H, 3CH3), 3.79 (s, 3H, OCH3), 3.81 (s, 
3H, NCH3), 6.98 (dd, 2H, J = 1.9, 6.9 Hz, 
ArH), 7.03 (dd, 2H, J = 1.6, 6.6 Hz, ArH), 7.04 (s, 1H, ArH), 7.11-7.17 (m, 5H, ArH), 7.32 (s, 
1H, ArH), 7.66 (dd, 2H, J = 2.0, 6.8 Hz, ArH), 7.78 (s, 1H, ArH). 
13
C NMR (75 MHz, 
CDCl3):  = 31.4 (6CH3), 31.8 (NCH3), 34.3, 34.4 (C), 55.4 (OCH3), 111.1 (CH), 114.2 
(2CH), 120.9 (CH), 122.5 (C), 124.5 (2CH), 124.6 (2CH), 129.8 (2CH), 130.0 (2CH), 130.9 
(2CH), 136.1 (2C), 136.3, 139.2, 139.5, 142.3, 148.8, 149.0, 154.5, 160.9 (C). IR (KBr, 
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cm
1
): v = 2955 (m), 2902, 2864, 1609, 1576, 1511 (w), 1467, 1435 (m), 1379, 1361, 1291 
(w), 1250 (s), 1174, 1110, 1025 (m), 907, 883 (w), 832 (s), 790, 728, 666, 622, 572, 564, 554 
(m). HRMS (ESI): calcd for C35H39N2O [M+H]
+
: 503.3057; found: 503.3058. 
 
5,6-Bis(4-methoxyphenyl)-1-methyl-2-p-tolyl-1H-benzo[d]imidazole (44f): 
Compound 44f was prepared starting with 
43f (100 mg, 0.23 mmol), following the 
general procedure E, as a a browm oil (82 
mg, 83%). 
1
H NMR (300 MHz, CDCl3):  = 
2.35 (s, 3H, CH3), 3.69 (s, 3H, OCH3), 3.70 
(s, 3H, OCH3), 3.77 (s, 3H, NCH3), 6.68 (d, 
2H, J = 8.9 Hz, ArH), 6.69 (d, 2H, J = 8.9 Hz, ArH), 7.02 (d, 2H, J = 8.7 Hz, ArH), 7.23-7.26 
(m, 3H, ArH), 7.59 (d, 2H, J = 8.1 Hz, ArH), 7.73 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3): 
 = 21.4 (CH3), 31.8 (NCH3), 55.1, 55.2 (OCH3), 111.1 (CH), 113.2 (2CH), 113.3 (2CH), 
121.0 (CH), 125.3 (C), 129.3 (2CH), 129.4 (2CH), 131.2 (2CH), 131.3 (2CH), 134.8, 134.9, 
135.6, 135.8, 136.1, 139.9, 142.3, 154.7, 158.0, 158.1 (C). IR (KBr, cm
1
): v = 2953, 2922, 
2852 (w), 1606, 1513, 1464, 1435, 1379, 1286 (m), 1243, 1173 (s), 1106, 1080, 1032, 921, 
880 (m), 826 (s), 773, 655, 606, 547 (m). GC-MS (EI, 70 eV): m/z (%) = 434(12) [M]
+
, 
433(100), 201(23), 173(24), 166(24). HRMS (EI, 70 eV): calcd for C29H26N2O2 [M]
+
: 
434.19888; found: 434.19812. 
 
Dihexyl-1-methyl-2-p-tolyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44g): 
Compound 44g was prepared 
starting with 43g (100 mg, 0.21 
mmol), following the general 
procedure E, as a brown oil (86 
mg, 87%). 
1
H NMR (300 MHz, 
CDCl3):  = 0.82 (t, 3H, J = 6.9 Hz, CH3), 0.83 (t, 3H, J = 6.8 Hz, CH3), 1.25-1.38 (m, 12H, 
6CH2), 1.63-1.73 (m, 4H, 2CH2), 2.37 (s, 3H, CH3), 3.83 (s, 3H, NCH3), 4.24 (t, 2H, J = 6.7 
Hz, CH2O), 4.25 (t, 2H, J = 6.9 Hz, CH2O),  7.27 (d, 2H, J = 7.9 Hz, ArH), 7.60 (d, 2H, J = 
8.1 Hz, ArH), 7.68 (s, 1H, ArH), 8.08 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 
(2CH3), 21.5 (CH3), 22.5 (2CH2), 25.6, 25.7 (CH2), 28.5, 28.6 (CH2), 31.5 (2CH2), 32.1 
(NCH3), 65.7, 65.9 (CH2O), 111.1, 121.1 (CH), 126.3, 127.0, 127.1 (C), 129.3 (2CH), 129.5 
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(2CH), 137.5, 140.7, 144.0, 157.2 (C), 168.1, 168.4 (CO). IR (KBr, cm
1
): v = 2952, 2925, 
2856 (m), 1713 (s), 1615, 1577 (w), 1466, 1379, 1357, 1326 (m), 1270, 1243, 1220 (s), 1194, 
1117 (m), 1099 (s), 1018 (m), 982, 951, 892 (w), 823, 783, 730 (m), 627, 583 (w). GC-MS 
(EI, 70 eV): m/z (%) = 478(61) [M]
+
, 394(21), 310(44), 294(43), 293(100), 292(46), 265(13). 
HRMS (EI, 70 eV): m/z calcd for C29H38N2O4 [M]
+
: 478.28261; found: 478.28202. Anal. 
calcd for C29H38N2O4: C, 72.77; H, 8.00; N, 5.85. Found: C, 72.42; H, 8.49; N, 5.58. 
 
 
Diisobutyl-1-methyl-2-p-tolyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44h): 
Compound 44h was prepared starting with 43h 
(100 mg, 0.24 mmol), following the general 
procedure E, as a brown oil (85 mg, 86%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.93 (d, 6H, J = 6.7 
Hz, 2CH3), 0.94 (d, 6H, J = 6.7 Hz, 2CH3), 1.95-
2.04 (m, 2H, 2CH), 2.38 (s, 3H, CH3), 3.84 (s, 3H, NCH3), 4.04 (d, 2H, J = 6.6 Hz, 
CH2O), 4.05 (d, 2H, J = 6.8 Hz, CH2O), 7.28 (d, 2H, J = 8.0 Hz, ArH), 7.60 (d, 3H, J = 8.1 
Hz, ArH), 7.7 (s, 1H, ArH), 8.1 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 19.1 (2CH3), 
19.2 (2CH3), 21.5 (CH3), 27.7, 27.8 (CH), 30.9 (NCH3), 71.6, 71.9 (CH2O), 111.0, 121.2 
(CH), 126.3, 127.0, 127.1 (C), 129.3 (2CH), 129.5 (2CH), 137.5, 140.7, 144.0, 157.1 (C), 
168.1, 168.3 (CO). IR (KBr, cm
1
): v = 2957, 2927 (m), 2872 (w), 1716 (s), 1603, 1511, 1465, 
1376, 1327 (m), 1246, 1175, 1100, 1032, 1017 (s), 985, 823, 783, 731 (m). GC-MS (EI, 70 
eV): m/z (%) = 422(27) [M]
+
, 310(30), 293(100), 265(11). HRMS (EI, 70 eV): m/z calcd for 
C25H30N2 O4 [M]
+
: 422.22001; found: 422.22021. 
 
Dibutyl-1-methyl-2-p-tolyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44i): 
Compound 44i was prepared starting with 43i 
(100 mg, 0.24 mmol), following the general 
procedure E, as a yellow solid (80 mg, 81%), 
mp. 88-90 °C. 
1
H NMR (300 MHz, CDCl3):  
= 0.88 (t, 6H, J = 7.4 Hz, 2CH3),  1.31-1.45 
(m, 4H, 2CH2), 1.61-1.71 (m, 4H, 2CH2), 2.35 (s, 3H, CH3), 3.80 (s, 3H, NCH3), 4.25 (t, 4H, 
J = 6.7 Hz, 2CH2O), 7.24 (d, 2H, J = 8.1 Hz, ArH), 7.57 (d, 2H, J = 8.1 Hz, ArH), 7.66 (s, 
1H, ArH), 8.07 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 (2CH3), 19.1, 19.2 (CH2), 
21.4 (CH3), 30.5, 30.6 (CH2), 32.1 (NCH3), 65.3, 65.6 (CH2O), 111.1, 121.0 (CH), 126.3, 
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127.0, 127.1 (C), 129.3 (2CH), 129.5 (2CH), 137.5, 140.7, 144.0, 157.1 (C), 168.1, 168.3 
(CO). IR (KBr, cm
1
): v = 2957 (m), 2933, 2872 (w), 1715, 1700 (s), 1614, 1479, 1464, 1441, 
1391, 1380, 1357 (m), 1329, 1275, 1257, 1239, 1219, 1209, 1197, 1122, 1098 (s), 1061, 1037, 
1018, 963, , 902, 887, 832, 822, 783, 730 (m), 703, 673, 602, 586, 552 (w). GC-MS (EI, 70 
eV): m/z (%) = 422(31) [M]
+
, 310(13), 294(19), 295(100), 292(14). HRMS (EI, 70 eV): m/z 
calcd for C25H30N2O4 [M]
+
: 422.22001; found: 422.22049. Anal. calcd for C25H30N2O4: C, 
71.07; H, 7.16; N, 6.63. Found: C, 70.42; H, 7.25; N, 6.26. 
 
2-(4-tert-Butylphenyl)-5,6-bis(4-methoxyphenyl)-1-methyl-1H-benzo[d]imidazole (44k): 
Compound 44k was prepared starting with 
43k (100 mg, 0.21 mmol), following the 
general procedure E, as a yellow solid (64 
mg, 65%), mp. 190-192 °C. 
1
H NMR (300 
MHz, CDCl3):  = 1.30 (s, 9H, 3CH3), 3.70 
(s, 3H, OCH3), 3.71 (s, 3H, OCH3), 3.81 (s, 
3H, NCH3), 6.69 (d, 2H, J = 8.7 Hz, ArH), 6.70 (d, 2H, J = 8.7 Hz, ArH), 7.03 (d, 2H, J = 8.6 
Hz, ArH), 7.04 (d, 2H, J = 8.6 Hz, ArH), 7.28 (s, 1H, ArH), 7.47 (d, 2H, J = 8.5 Hz, ArH), 
7.65 (d, 2H, J = 8.4 Hz, ArH), 7.74 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 31.2 
(3CH3), 31.8 (NCH3), 34.9 (C), 55.1, 55.2 (OCH3), 111.1 (CH), 113.2 (2CH), 113.3 (2CH), 
121.1 (CH), 125.7 (2CH), 127.3 (C), 129.1 (2CH), 131.2 (2CH), 131.3 (2CH), 134.8, 134.9, 
135.5, 135.8, 136.1, 142.4, 153.0, 154.7, 158.0, 158.1 (C). IR (KBr, cm
1
): v = 2952, 2961, 
2833, 1607, 1556 (w), 1513, 1462, 1456, 1435 (m), 1404, 1380, 1361, 1287, 1266 (w), 1243, 
1172 (m), 1110 (w), 1041, 1032, 1023, 1014 (w), 829 (s), 807 (m), 776, 730, 713, 699, 655, 
646, 626 (w), 577, 547, 535 (m). GC-MS (EI, 70 eV): m/z (%) = 476(100) [M]
+
, 461(14), 
365(31), 185(15), 183(20), 44(30), 43(13). HRMS (ESI): calcd for C32H33N2O2 [M+H]
+
: 
477.2537; found: 477.2540. 
 
 
Diethyl-2-(4-tert-butylphenyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44l): 
Compound 44l was prepared starting with 43l (100 
mg, 0.24 mmol), following the general procedure E, 
as a brown oil (92 mg, 93%). 
1
H NMR (250 MHz, 
CDCl3):  = 1.29 (s, 9H, 3CH3), 1.30 (t, 6H, J = 7.2 
Hz, 2CH3), 3.83 (s, 3H, NCH3), 4.31 (q, 2H, J = 7.1 
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Hz, CH2O), .432 (q, 2H, J = 7.1 Hz, CH2O), 7.48 (d, 2H, J = 8.5 Hz, ArH), 7.63 (d, 2H, J = 
8.4 Hz, ArH), 7.69 (s, 1H, ArH), 8.07 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.1 
(2CH3), 31.2 (3CH3), 32.1 (NCH3), 34.9 (C), 61.4, 61.6 (CH2O), 111.1, 121.0 (CH), 125.8 
(2CH), 126.3, 126.8, 127.1 (C), 129.2 (2CH), 137.5, 144.1, 153.8, 157.1 (C), 168.1, 168.2 
(CO). IR (KBr, cm
1
): v = 2956 (m), 2903, 2867 (w), 1712 (s), 1614 (m), 1578 (w), 1475, 
1463, 1443, 1391, 1367 (m), 1326, 1266, 1246, 1219, 1200 (s), 1172 (m), 1116, 1098, 1039, 
1014 (s), 893, 843, 823, 784, 728, 711 (m), 676, 640, 613, 590, 558 (w). GC-MS (EI, 70 eV): 
m/z (%) = 408(100) [M]
+
, 394(13), 393(49), 363(13), 336(15), 335(62), 248(11), 146(15). 
HRMS (EI, 70 eV): m/z calcd for C24H28N2O4 [M]
+
: 408.20436; found: 408.20359. 
 
2-(4-tert-Butylphenyl)-1-methyl-5,6-di-p-tolyl-1H-benzo[d]imidazole (44m): 
Compound 44m was prepared starting with 
43m (100 mg, 0.22 mmol), following the 
general procedure E, as a brown oil (76 mg, 
77%). 
1
H NMR (300 MHz, CDCl3):  = 1.29 
(s, 9H, 3CH3), 2.22 (s, 3H, CH3), 2.23 (s, 3H, 
CH3), 3.79 (s, 3H, NCH3), 6.92-6.97 (m, 4H, 
ArH), 7.01( d, 4H, J = 7.9 Hz, ArH), 7.28 (s, 1H, ArH), 7.46 (d, 2H, J = 8.4 Hz, ArH), 7.64 
(d, 2H, J = 8.4 Hz, ArH), 7.75 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 21.1 (2CH3), 
31.2 (3CH3), 31.8 (NCH3), 34.9 (C), 111.3, 121.3 (CH), 125.7 (2CH), 127.3 (C), 128.5 
(2CH), 128.6 (2CH), 129.1 (2CH), 130.1 (2CH), 130.2 (2CH), 135.5, 135.7, 135.9 (C), 136.2 
(2C), 139.4, 139.6, 142.5, 153.1, 154.7 (C). IR (KBr, cm
1
): v = 2957, 2928 (m), 2871 (w), 
1716 (s), 1598 (w), 1495, 1455, 1300 (m), 1283, 1283, 1238, 1177, 1117, 1091 (s), 1060, 
1018, 961, 941, 898, 819, 778, 695 (m), 633, 635, 577 (w). MS (EI, 70 eV): m/z (%) = 
444(100) [M]
+
, 429(20), 91(19). HRMS (EI, 70 eV): calcd for C32H32N2 [M]
+
: 444.25600; 
found: 444.25609. 
 
 
Dibutyl-2-(4-tert-butylphenyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44o): 
Compound 44o was prepared starting with 
43o (100 mg, 0.21 mmol), following the 
general procedure E, as colorless oil (84 mg, 
85%). 
1
H NMR (300 MHz, CDCl3):  = 0.89 
(t, 6H, J = 7.3 Hz, 2CH3), 1.29 (s, 9H, 
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3CH3), 1.33-1.42 (m, 4H, 2CH2), 1.61-1.71 (m, 4H, 2CH2), 3.83 (s, 3H, NCH3), 4.25 (t, 4H, J 
= 6.7 Hz, 2CH2O), 7.47 (d, 2H, J = 8.3 Hz, ArH), 7.63 (d, 2H, J = 8.3 Hz, ArH), 7.67 (s, 1H, 
ArH), 8.07 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 (2CH3), 19.1, 19.2 (CH2), 
30.5, 30.6 (CH2), 31.2 (3CH3), 32.1 (NCH3), 34.9 (C), 65.3, 65.6 (CH2O), 111.1, 121.0 (CH), 
125.8 (2CH), 126.3, 127.0, 127.1 (C), 129.2 (2CH), 137.5, 144.0, 153.8, 157.1 (C), 168.1, 
168.3 (CO). IR (KBr, cm
1
): v = 2956 (m), 2934, 2870 (w), 1713 (s), 1616, 1578, 1555 (w), 
1463, 1435, 1386, 1359 (m), 1326, 1267, 1244, 1218, 1220, 1117, 1098 (s), 1060, 1033, 1013 
(w), 961, 943, 893 (w), 840, 784 (m), 752, 711, 614, 560 (w). MS (EI, 70 eV): m/z (%) = 
464(45) [M]
+
, 408(13), 352(11), 337 (13), 336(21), 335(100), 334(18), 319(21), 248(13), 
247(12). HRMS (ESI): calcd for C28H37N2O4 [M+H]
+
: 465.2748; found: 465.2750. Anal. 
calcd for C28H36N2O4: C, 72.39; H, 7.81; N, 6.03. Found: C, 72.45; H, 7.80; N, 5.45. 
 
Dibutyl-2-(3,5-dimethylphenyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate (44p): 
Compound 44p was prepared starting with 43p 
(100 mg, 0.23 mmol), following the general 
procedure E, as whitish solid (89 mg, 90%), 
mp. 80-81 °C. 
1
H NMR (250 MHz, CDCl3):  
= 0.89 (t, 6H, J = 7.3 Hz, 2CH3), 1.33-1.47 (m, 
4H, 2CH2), 1.61-1.72 (m, 4H, 2CH2), 2.32 (s, 
6H, 2CH3), 3.82 (s, 3H, NCH3), 4.25 (t, 4H, J = 6.6 Hz, 2CH2O), 7.08 (s, 1H, ArH), 7.29 (s, 
2H, ArH), 7.67 (s, 1H, ArH), 8.07 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 
(2CH3), 19.1, 19.2 (CH2), 21.3 (2CH3), 30.5, 30.6 (CH2), 32.1 (NCH3), 65.3, 65.6 (CH2O), 
111.1, 121.1 (CH), 127.1 (C), 127.1 (2CH), 129.0 (C), 132.0 (CH), 137.5 (C), 138.5 (3C), 
144.0, 157.3 (C), 168.1, 168.3 (CO). IR (KBr, cm
1
): v = 2954, 2931, 2871 (m), 1710 (s), 
1619, 1602, 1577, 1504 (w), 1467, 1457, 1442, 1394, 1359, 1331 (m), 1265, 1249, 1237, 
1224 (s), 1108, 1061, 1037 (m), 1018, 946, 906 (w), 888, 850, 784, 728 (m), 688, 658, 591 
(w). GC-MS (EI, 70 eV): m/z (%) = 436(32) [M]
+
, 324(13), 308(20), 307(100), 306(13). 
HRMS (EI, 70 eV): m/z calcd for C26H32N2 O4 [M]
+
: 436.23566; found: 436.23489. Anal. 
calcd for C26H32N2O4: C, 71.53; H, 7.39; N, 6.42. Found: C, 71.01; H, 7.51; N, 5.73. 
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Diisobutyl-2-(3,5-dimethylphenyl)-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate 
(44r): 
Compound 44r was prepared starting with 43r 
(100 mg, 0.23 mmol), following the general 
procedure E, as whistish solid (82 mg, 83%), mp. 
100-101 °C. 
1
H NMR (300 MHz, CDCl3):  = 0.92 
(d, 6H, J = 6.7 Hz, 2CH3), 0.93 (d, 6H, J = 6.7 Hz, 
2CH3), 1.92-2.05 (m, 2H, 2CH), 2.32 (s, 6H, 
2CH3), 3.83 (s, 3H, NCH3), 4.03 (d, 4H, J = 6.2 Hz, 2CH2O), 7.09 (s, 1H, ArH), 7.30 (s, 2H, 
ArH), 7.68 (s, 1H, ArH), 8.1 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 19.1 (2CH3), 19.2 
(2CH3), 21.3 (2CH3), 27.7, 27.8 (CH), 32.1 (NCH3), 71.6, 71.9 (CH2O), 110.1, 121.1 (CH), 
127.0 (C), 127.1 (2CH), 127.3, 129.0 (C), 132.1 (CH), 137.5 (C), 138.5 (2C), 143.9, 157.3 
(C), 167.9, 168.4 (CO). IR (KBr, cm
1
): v = 2960 (m), 2916, 2873 (w), 1712 (s), 1621, 1604, 
1578, 1516, 1483 (w), 1468, 1392, 1371, 1321 (m), 1256, 1200 (s), 1134, 1120 (m), 1100, 
1093, 1034 (s), 982, 947, 927, 900, 853, 786, 774, 728, 696 (m), 681, 645, 620, 529 (w). MS 
(EI, 70 eV): m/z (%) = 436(71) [M]
+
, 380(27), 325(15), 324(76), 323(18), 308(40), 307(100), 
280(13), 279(24), 263(12), 57(14). HRMS (ESI): calcd for C26H33N2O4 [M+H]
+
: 437.2435; 
found: 437.2435. Anal. calcd for C26H32N2O4: C, 71.53; H, 7.39; N, 6.42. Found: C, 71.33; H, 
7.56; N, 5.76. 
 
Synthesis of Benzimidazol (45): 
 
1-Methyl-2-p-tolyl-1H-benzo[d]imidazole (45j): 
Compound 45j was prepared starting with 43j (100 mg, 0.24 
mmol), following the general procedure E, as a brown solid 
(42 mg, 82%), mp. 108-110 °C. 
1
H NMR (300 MHz, CDCl3): 
 = 2.37 (s, 3H, CH3), 3.79 (s, 3H, NCH3), 7.22-7.27 (m, 4H, 
ArH), 7.29-7.34 (m, 1H, ArH), 7.59 (dd, 2H, J = 1.7, 6.5 Hz, ArH), 7.73-7.79 (m, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 21.4 (CH3), 31.7 (NCH3), 109.6, 119.6, 122.5, 122.7 (CH), 
126.9 (C), 129.3 (2CH), 129.4 (2CH), 136.4, 140.0, 142.4, 153.8 (C). IR (KBr, cm
1
): v = 
3039, 2923, 2855, 1481 (w), 1453, 1437, 1322, 1288, 1248 (m), 1181, 1097, 1052, 1018, 899 
(w), 819 (m), 747 (s), 729 (m), 640, 590, 570, 528 (w). GC-MS (EI, 70 eV): m/z (%) = 
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222(72) [M]
+
, 221(100) 206(11). HRMS (EI, 70 eV): m/z calcd for C15H14N2 [M]
+
: 
222.11570; found: 222.11534. 
 
2-(4-tert-Butylphenyl)-1-methyl-1H-benzo[d]imidazole (45n): 
Compound 45n was prepared starting with 43n (100 mg, 0.21 
mmol), following the general procedure E, as a brown semi 
solid (36 mg, 65%). 
1
H NMR (250 MHz, CDCl3):  = 1.30 (s, 
9H, 3CH3), 3.81 (s, 3H, NCH3), 7.22-7.34 (m, 3H, ArH), 7.47 
(d, 2H, J = 8.4 Hz, ArH), 7.64 (d, 2H, J = 8.4 Hz, ArH), 7.72-7.78 (m, 1H, ArH). 
13
C NMR 
(62 MHz, CDCl3):  = 30.2 (3CH3), 30.7 (NCH3), 33.8 (C), 108.5, 118.6, 121.4, 121.7 (CH), 
124.6 (2CH), 126.0 (C), 128.2 (2CH), 135.5, 141.7, 152.1, 152.8 (C). IR (KBr, cm
1
): v = 
2955 (w), 2922 (m), 2854, 1487 (w), 1467, 1458, 1434, 1408, 1379, 1324, 1247, 1112, 1005, 
836, 817, 743 (m), 731 (s), 723, 598, 544 (m). GC-MS (EI, 70 eV): m/z (%) = 264(64) [M]
+
, 
263(19), 250(19), 249(100). HRMS (EI, 70 eV): m/z calcd for C18H20N2 [M]
+
: 264.16210; 
found: 264.16199. 
 
General procedure for 2-alkenyl-4,5-dibromo-N-methylimidazol (46): 
 
To a THF solution (15 mL) of nBuLi (2.5 M in n-hexane, 0.5 mL, 1.2 mmol) was added and 
tribromo-N-methylimidazol (38) (0.319 g, 1.0 mmol) at -78 °C under Argon atmosphere and 
the mixture was stirred for 1 h. To the stirred solution were added (2.0 mmol) of 1-
iodoalkane. After stirring for 16 h, a saturated aqueous solution of Na2SO4 (10 mL) was 
added to the solution. The aqueous and the organic layer were separated. The organic layer 
was dried (Na2SO4), filtered and concentrated in vacuo. The residue was purified by flash 
column chromatography (fine flash silica gel, n-heptane). 
 
4,5-Dibromo-1-methyl-2-propyl-1H-imidazole (46a): 
Compound 46b was prepared starting with 38 (319 mg, 1.0 mmol), 
nBuLi (0.5mL , 1.2 mmol)and 1-Iodopropane (0.19 mL, 2.0 mmol), as 
a brown oil (220 mg, 78 %). 
1
H NMR (300 MHz, CDCl3):  = 0.92 (t, 
3H, J = 7.4 Hz, CH3), 1.60-1.73 (m, 2H, CH2), 2.60 (t, 2H, J = 7.8 Hz, 
CH2), 3.46 (s, 3H, NCH3). 
13
C NMR (75 MHz, CDCl3):  = 13.8 
(CH3), 21.0, 29.9 (CH2), 32.6 (NCH3), 103.0, 114.9 (CBr), 149.4 (C). IR (KBr, cm
1
): v = 
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2962, 2932 (m), 2872 (w), 1501, 1451, 1432, 1400, 1382 (m), 1351, 1277 (w), 1223 (s), 1098, 
1079 (m), 972 (s), 908, 812 (w), 750, 666 (m), 566 (w). GC-MS (EI, 70 eV): m/z (%) = 
284(16) [M
+
 (
8¹
Br, 
8¹
Br)], 282(28) [M
+
 (Br, 
8¹
Br)], 280(15) [M
+
 (Br, Br)], 267(16), 256(49), 
254(100), 251(25), 212(13), 134(16), 132(20), 122(15), 120(14). HRMS (ESI): m/z calcd for 
C7H11Br2N2 [M+H]
+
: 282.92632; found: 282.92588. 
 
4,5-Dibromo-2-butyl-1-methyl-1H-imidazole (46b): 
Compound 46b was prepared starting with 38 (319 mg, 1.0 mmol), 
nBuLi (0.5 mL , 1.1 mmol)and 1-Iodobutane (0.23 mL, 2.0 mmol), 
as a brown oil (263 mg, 89 %). 
1
H NMR (300 MHz, CDCl3):  = 
0.87 (t, 3H, J = 7.3 Hz, CH3), 1.26-1.39 (m, 2H, CH2), 1.56-1.67 
(m, 2H, CH2), 2.60 (t, 2H, J = 7.8 Hz, CH2), 3.47 (s, 3H, NCH3). 
13
C NMR (75 MHz, CDCl3):  = 13.7 (CH3), 22.3, 27.7, 29.6 (CH2), 32.5 (NCH3), 102.9, 
114.9 (CBr), 149.5 (C). IR (KBr, cm
1
): v = 2954, 2929 (m), 2869 (w), 1505, 1452, 1399 (m), 
1378, 1324, 1282 (w), 1226 (s), 1077 (m), 971 (s), 932, 809, 730, 715, 666, 644, 572 (w). 
GC-MS (EI, 70 eV): m/z (%) = 298(08) [M
+
 (
8¹
Br, 
8¹
Br)], 296(19) [M
+
 (Br, 
8¹
Br)], 294(09) 
[M
+
 (Br, Br)], 267(18), 265(10), 254(100), 252(51), 134(11), 132(12). HRMS: m/z calcd for 
C8H12Br2N2 [M
+
 (Br, 
8¹
Br)]
+
: 295.93413; found: 295.93371. 
 
Synthesis of tri(alkenyl)imidazol (47): 
 
(2E,2'E)-Dibutyl-3,3'-(1-methyl-2-propyl-1H-imidazole-4,5-diyl)diacrylate (47a): 
Product 47a was prepared starting with  46a (282 
mg, 1.0  mmol),  n-butyl acrylate  (0.36 mL, 2.5 
mmol), Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  
mol %), NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) at 
100 °C for 24 h following general procedure D, as a 
brown oil (343 mg, 91%). 
1
H NMR (300 MHz, CDCl3):  = 0.88 (t, 3H, J = 7.3 Hz, CH3), 
0.89 (t, 3H, J = 7.3 Hz, CH3), 0.95 (t, 3H, J = 7.4 Hz, CH3), 1.31-1.43 (m, 4H, 2CH2), 1.57-
1.77 (m, 6H, 3CH2), 2.62 (t, 2H, J = 7.4 Hz, CH2), 3.55 (s, 3H, NCH3), 4.12 (t, 2H, J = 6.6 
Hz, CH2O), 4.15 (t, 2H, J = 6.7 Hz, CH2O), 6.15 (d, 1H, J = 16.2 Hz, CH), 6.67 (d, 1H, J = 
15.3 Hz, CH), 7.56 (d, 1H, J = 16.1 Hz, CH), 7.63 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (75 
MHz, CDCl3):  = 12.7 (2CH3), 12.9 (CH3), 18.2 (2CH2), 20.1, 28.2, 29.7, 29.8 (CH2), 30.7 
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(NCH3), 63.2, 63.7 (OCH2), 117.8, 117.9 (CH), 127.9 (C), 128.1, 132.6 (CH), 137.8, 151.9 
(C), 165.7, 166.6 (CO). IR (KBr, cm
1
): v = 2956, 2931, 2872 (w), 1703 (s), 1624 (m), 1514 
(w), 1459 (m), 1392, 1379, 1343 (w), 1294, 1275, 1257 (m), 1148 (s), 1062, 1022, 968 (m), 
865, 849, 735, 701 (w). GC-MS (EI, 70 eV): m/z (%) = 376(32) [M]
+
, 303(19), 275(21), 
219(44), 203(29), 201(22), 176(11), 175(100), 174(11), 146(13), 145(13). HRMS (ESI): m/z 
calcd for C21H33O4N2 [M+H]
+
: 377.24348; found: 377.24365. 
 
(2E,2'E)-Isobutyl-3,3'-(2-butyl-1-methyl-1H-imidazole-4,5-diyl)diacrylate (47b): 
Product 47b was prepared starting with  46b (296 mg, 
1.0  mmol), iso-butyl acrylate  (0.36 mL, 2.5 mmol), 
Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  mol %), 
NEt3 (1.10 mL, 8.0  mmol), DMF (5 mL) at 100 °C for 
24 h following general procedure D, as a brown oil 
(331 mg, 85%). 
1
H NMR (250 MHz, CDCl3):  = 
0.85-0.92 (m, 15H, 5CH3), 1.29-1.44 (m, 2H, CH2), 1.59-1.71 (m, 2H, CH2), 1.83-1.99 (m, 
2H, 2CH), 2.64 (t, 2H, J = 7.5 Hz, CH2), 3.55 (s, 3H, NCH3), 3.90 (d, 2H, J = 6.8 Hz, CH2O), 
3.92 (d, 2H, J = 6.9 Hz, CH2O), 6.16 (d, 1H, J = 16.2 Hz, CH), 6.69 (d, 1H, J = 15.4 Hz, CH), 
7.57 (d, 1H, J = 16.1 Hz, CH), 7.65 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  
= 13.7 (CH3), 19.0 (2CH3), 19.1 (2CH3), 22.5, 27.1 (CH2), 27.7, 27.8 (CH), 29.8 (CH2), 31.7 
(NCH3), 70.4, 70.9 (OCH2), 118.7 (2CH), 128.9 (C), 129.1, 133.6 (CH) 138.8, 153.0 (C), 
166.7, 166.5 (CO). IR (KBr, cm
1
): v = 2960, 2929, 2873 (w), 1710 (s), 1626, 1460 (m), 1395, 
1369, 1342 (w), 1276, 1245 (m), 1145 (s), 1011, 967 (m), 895, 702 (w). GC-MS (EI, 70 eV): 
m/z (%) = 390(44) [M]
+
, 361(15), 348(94), 317(41), 289(21), 274(13), 233(49), 217(39), 
215(22), 189(100), 173(21), 159(13), 145(20), 131(11), 57(13), 41(15). HRMS (EI, 70 eV): 
m/z calcd for C22H34N2O4 [M]
+
: 390.25131; found: 390.25087. 
 
(2E,2'E)-Isobutyl-3,3'-(1-methyl-2-propyl-1H-imidazole-4,5-diyl)diacrylate (47c): 
Product 47c was prepared starting with  46a (282 mg, 
1.0  mmol), iso-butyl acrylate  (0.36 mL, 2.5 mmol), 
Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  mol %), NEt3 
(1.10 mL, 8.0  mmol), DMF (5 mL) at 100 °C for 24 h 
following general procedure D, as a brown oil (335 
mg, 89%). 
1
H NMR (250 MHz, CDCl3):  = 0.89 (d, 
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6H, J = 6.6 Hz, 2CH3), 0.91 (d, 6H, J = 6.8 Hz, 2CH3), 0.96 (t, 3H, J = 7.2 Hz, CH3), 1.64-
1.76 (m, 2H, CH2), 1.84-1.99 (m, 2H, 2CH), 2.63 (t, 2H, J = 7.6 Hz, CH2), 3.55 (s, 3H, 
NCH3), 3.90 (d, 2H, J = 6.8 Hz, CH2O), 3.93 (d, 2H, J = 7.0 Hz, CH2O), 6.16 (d, 1H, J = 16.2 
Hz, CH), 6.69 (d, 1H, J = 15.3 Hz, CH), 7.57 (d, 1H, J = 16.6 Hz, CH), 7.65 (d, 1H, J = 15.4 
Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 12.9 (CH3), 18.1 (2CH3), 18.2 (2CH3), 20.2 (CH2), 
26.7, 26.8 (CH), 28.3 (CH2), 30.7 (NCH3), 69.4, 70.0 (OCH2), 117.8 (2CH), 127.9 (C), 128.1, 
132.6 (CH), 137.8, 151.9 (C), 165.7, 166.5 (CO). IR (KBr, cm
1
): v = 2958, 2928, 2872 (w), 
1705 (s), 1625, 1461 (m), 1394, 1369, 1342 (w), 1276, 1242 (m), 1148 (s), 1010, 967 (m), 
895, 702, 533 (w). GC-MS (EI, 70 eV): m/z (%) = 376(29) [M]
+
, 303(25), 275(20), 219(41), 
203(29), 201(18), 175(100), 174(12), 146(15), 145(11), 57(13), 41(10). HRMS (ESI): m/z 
calcd for C21H33N2O4 [M+H]
+
: 377.24348; found: 377.24422. 
 
(2E,2'E)-Dibutyl-3,3'-(2-butyl-1-methyl-1H-imidazole-4,5-diyl)diacrylate (47d): 
Product 47d was prepared starting with  46b (296 
mg, 1.0  mmol),  n-butyl acrylate  (0.36 mL, 2.5 
mmol), Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10  
mol %), NEt3 (1.10 mL, 8.0  mmol), DMF 
(5 mL) at 100 °C for 24 h following general 
procedure D, as a brown oil (319 mg, 82%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.87 (t, 3H, J = 7.3 Hz, CH3), 0.88 (t, 3H, J = 7.3 Hz, CH3), 
0.89 (t, 3H, J = 7.3 Hz, CH3), 1.30-1.40 (m, 6H, 3CH2), 1.54-1.68 (m, 6H, 3CH2), 2.63 (t, 2H, 
J = 7.5 Hz, CH2), 3.54 (s, 3H, NCH3), 4.12 (t, 2H, J = 6.6 Hz, CH2O), 4.15 (t, 2H, J = 6.7 Hz, 
CH2O), 6.14 (d, 1H, J = 16.1 Hz, CH), 6.67 (d, 1H, J = 15.3 Hz, CH), 7.55 (d, 1H, J = 16.1 
Hz, CH), 7.63 (d, 1H, J = 15.3 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 13.6 (2CH3), 13.7 
(CH3), 19.1 (2CH2), 22.5, 27.1, 29.7, 30.7, 30.8 (CH2), 31.7 (NCH3), 64.1, 64.7 (OCH2), 
118.7, 118.8 (CH), 128.9 (C), 129.1, 133.6 (CH), 138.8, 153.0 (C), 166.7, 167.5 (CO). IR 
(KBr, cm
1
): v = 2956, 2931, 2872 (w), 1703 (s), 1624 (m), 1514 (w), 1459 (m), 1392, 1379, 
1343 (w), 1294, 1275, 1257 (m), 1148 (s), 1062, 1022, 968 (m), 865, 849, 735, 701 (w). GC-
MS (EI, 70 eV): m/z (%) = 390(43) [M]
+
, 361(15), 359(14), 349(13), 348(64), 347(21), 
346(77), 317(27), 289(24), 259(24), 246(11), 233(53), 217(31), 215(23), 190(18), 189(100), 
187(10), 174(12), 173(19), 159(12), 146(22), 145(20), 131(11), 57(11), 41(17). HRMS (EI, 
70 eV): m/z calcd for C22H34N2O4 [M]
+
: 390.25131; found: 390.25143. 
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Synthesis of Benzimidazol (48): 
 
Dibutyl-1-methyl-2-propyl-1H-benzo[d]imidazole-5,6-dicarboxylate (48a): 
Compound 48a was prepared starting with 47a (100 
mg, 0.26 mmol), following the general procedure E, 
as a brown oil (80 mg, 81%). 
1
H NMR (300 MHz, 
CDCl3):  = 0.89 (t, 6H, J = 7.3 Hz, 2CH3), 1.00 (t, 
3H, J = 7.1 Hz, CH3), 1.33-1.42 (m, 4H, 2CH2), 
1.61-1.71 (m, 4H, 2CH2), 1.82-1.90 (m, 2H, CH), 2.86 (t, 2H, J = 7.4 Hz, CH2), 3.72 (s, 3H, 
NCH3), 4.24 (t, 2H, J = 6.6 Hz, CH2O), 4.25 (t, 2H, J = 6.7 Hz, CH2O), 7.61 (s, 1H, ArH), 
8.03 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 12.7 (2CH3), 12.9 (CH3), 18.2 (2CH2), 
19.8, 28.7 (CH2), 29.5 (NCH3), 29.5, 29.6 (CH2), 64.4, 64.7 (CH2O), 109.6, 119.2 (CH), 
126.0, 126.1, 135.4, 141.5, 157.6 (C), 166.9, 167.3 (CO). IR (KBr, cm
1
): v = 2958, 2929 (m), 
2872 (w), 1714 (s), 1620, 1579, 1510 (w), 1455, 1388, 1359, 1330 (m), 1252, 1205, 1009 (s), 
1060, 1032, 961, 943, 894, 784, 746 (m), 682, 613, 543 (w). GC-MS (EI, 70 eV): m/z (%) = 
374(08) [M]
+
, 347(22), 346(100), 290(23), 245(63). HRMS (ESI): m/z calcd for C21H31N2O4 
[M+H]
+
: 375.22783; found: 375.22849. 
 
Diisobutyl-2-butyl-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate (48b): 
Compound 48b was prepared starting with 47b (100 mg, 
0.29 mmol), following the general procedure E, as a 
brown solid (68 mg, 69%), mp.= 96-98 °C. 
1
H NMR 
(300 MHz, CDCl3):  = 0.91 (t, 3H, J = 7.4 Hz, CH3), 
0.92 (d, 6H, J = 6.7 Hz, 2CH3), 0.93 (d, 6H, J = 6.7 Hz, 
2CH3), 1.34-1.47 (m, 2H, CH2), 1.74-1.85 (m, 2H, CH2), 1.91-2.05 (m, 2H, 2CH), 2.83 (t, 2H, 
J = 7.6 Hz, CH2), 3.70 (s, 3H, NCH3), 4.02 (d, 2H, J = 6.7 Hz, CH2O), 4.03 (d, 2H, J = 6.7 
Hz, CH2O), 7.58 (s, 1H, ArH), 8.03 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 13.8 
(CH3), 19.1 (2CH3), 19.2 (2CH3), 22.5, 27.3 (CH2), 27.7, 27.8 (CH), 29.4 (CH2), 30.1 
(NCH3), 71.5, 71.8 (CH2O), 110.3, 120.6 (CH), 126.4, 126.9, 136.8, 143.6, 159.0 (C), 168.0, 
168.6 (CO). IR (KBr, cm
1
): v = 2957, 2927 (m), 2872 (w), 1713 (s), 1620, 1578, 1504, 1482 
(w), 1467, 1456, 1444, 1396, 1377, 1367, 1339 (m), 1256, 1233, 1216, 1103 (s), 1033, 985 
(m), 946, 888 (w), 781 (m), 733, 639, 611, 575 (w). GC-MS (EI, 70 eV): m/z (%) = 388(3) 
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[M]
+
, 359(13), 347(19), 346(100), 259(32). HRMS (EI, 70 eV): m/z calcd for C22H32N2O4 
[M]
+
: 388.23566; found: 388.23532. 
 
Diisobutyl-1-methyl-2-propyl-1H-benzo[d]imidazole-5,6-dicarboxylate (48c): 
Compound 48c was prepared starting with 47c (100 mg, 
0.26 mmol), following the general procedure E, as 
whitish semi solid (84 mg, 85%).
1
H NMR (300 MHz, 
CDCl3):  = 0.91 (d, 6H, J = 6.7 Hz, 2CH3), 0.92 (d, 6H, 
J = 6.7 Hz, 2CH3), 0.98 (t, 3H, J = 7.4 Hz, CH3), 1.77-
1.90 (m, 2H, CH2), 1.93-2.04 (m, 2H, CH), 2.81 (t, 2H, J 
= 7.4 Hz, CH2), 3.69 (s, 3H, NCH3), 4.01 (d, 2H, J = 6.6 Hz, CH2O), 4.02 (d, 2H, J = 6.7 Hz, 
CH2O), 7.58 (s, 1H, ArH), 8.02 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 13.9 (CH3), 
19.1 (2CH3), 19.2 (2CH3), 20.7 (CH2), 27.7, 27.8 (CH), 29.4 (CH2), 30.1 (NCH3), 71.5, 71.8 
(CH2O), 110.3, 120.5 (CH), 126.5, 126.9, 136.7, 143.4, 158.8 (C), 167.9, 168.5 (CO). IR 
(KBr, cm
1
): v = 2958 (m), 2872 (w), 1726, 1708 (s), 1620, 1574, 1504, 1484 (w), 1463, 
1440, 1377, 1360, 1332, 1278 (m), 1250, 1229, 1208, 1101 (s), 1035, 990 (m), 948, 875 (w), 
784 (m), 736, 636, 576 (w). MS (EI, 70 eV): m/z (%) = 374(10) [M]
+
, 347(22), 346(100), 
290(74), 246(22), 245(96), 234(27), 231(20), 217(10), 216(19). HRMS (EI, 70 eV): m/z calcd 
for C21H30N2 O4 [M]
+
: 374.22001; found: 374.21979. 
 
Dibutyl-2-butyl-1-methyl-1H-benzo[d]imidazole-5,6-dicarboxylate (48d): 
Compound 48d was prepared starting with 47d 
(100 mg, 0.26 mmol), following the general 
procedure E, as a brown oil (73 mg, 74%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.89 (t, 6H, J = 7.3 
Hz, 2CH3), 0.91 (t, 3H, J = 7.3 Hz, CH3), 1.30-
1.45 (m, 6H, 3CH2), 1.60-1.70 (m, 4H, 2CH2), 1.73-1.83 (m, 2H, CH2), 2.81 (t, 2H, J = 7.5 
Hz, CH2), 3.69 (s, 3H, NCH3), 4.23 (t, 2H, J = 6.5 Hz, CH2O), 4.24 (t, 2H, J = 6.8 Hz, CH2O), 
7.58 (s, 1H, ArH), 7.99 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 (3CH3), 19.1, 
19.2, 22.5, 27.3, 29.4 (CH2), 30.0 (NCH3), 30.5, 30.6 (CH2), 65.3, 65.5 (CH2O), 110.3, 120.4 
(CH), 126.5, 12679, 136.7, 143.5, 158.9 (C), 168.1, 168.4 (CO). IR (KBr, cm
1
): v = 2959, 
2928 (m), 2872 (w), 1716 (s), 1620, 1579, 1511 (w), 1455, 1388, 1360, 1331 (m), 1252, 1205, 
1010 (s), 1061, 1032, 961, 944, 894, 784, 747 (m), 682, 614, 543 (w). GC-MS (EI, 70 eV): 
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m/z (%) = 388(3) [M]
+
, 359(13), 347(19), 346(100). HRMS (EI, 70 eV): m/z calcd for 
C22H32N2O4 [M]
+
: 388.23566; found: 388.23512. 
 
General procedure F for synthesis of 2,3-Di(alkenyl)pyrroles 49: 
 
 In a pressure tube (glass bomb) a suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 5 mol%) and 
P(Cy)3 (28.04 mg, 0.10 mmol, 10 mol%) in DMF (5 mL) was purged with Argon and stirred 
at 20 °C to give a yellowish or brownish clear solution. To the stirred solution were 
added 19b,c,e,g (1.0 mmol), Et3N (1.1 mL, 8.0 mmol) and the alkene 26 (2.5 equiv). The 
reaction mixture was stirred at 100 °C for 24 h. The solution was cooled to 20 °C, poured into 
H2O and CH2Cl2 (25 mL each), and the organic and the aqueous layers were separated. The 
latter was extracted with CH2Cl2 (3 × 25 mL). The combined organic layers were washed with 
H2O (3 × 20 mL), dried (Na2SO4), and concentrated in vacuo. The residue was purified by 
chromatography (flash silica gel, eluent: heptanes-EtOAc). 
 
(2E,2'E)-Isobutyl-3,3'-(1-methyl-5-p-tolyl-1H-pyrrole-2,3-diyl)diacrylate (49a): 
Compound 49a was prepared starting with 19g 
(329 mg, 1.0 mmol) and iso-butyl acrylate 26 
(0.36 mL, 2.5 mmol), following the general 
procedure F, as a brown oil (304 mg, 72%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.91 (d, 6H, J = 6.7 
Hz, 2CH3), 0.92 (d, 6H, J = 6.7 Hz, 2CH3), 1.91-
1.97 (m, 2H, 2CH), 2.33 (s, 3H, CH3), 3.57 (s, 3H, NCH3), 3.91 (d, 2H, J = 6.8 Hz, 
CH2O), 3.93 (d, 2H, J = 6.9 Hz, CH2O), 6.10 (d, 1H, J = 16.0 Hz, CH), 6.18 (d, 1H, J = 15.6 
Hz, CH), 6.42 (s, 1H, CHpyrrole), 7.18-7.20 (m, 4H, ArH), 7.71 (d, 1H, J = 16.0 Hz, CH), 7.78 
(d, 1H, J = 15.7 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 19.2 (4CH3), 21.3 (CH3), 27.8, 
27.9 (CH), 33.8 (NCH3), 70.4, 70.8 (CH2O), 107.7, 116.5, 117.5 (CH), 123.7, 128.6 (C), 
129.0 (2CH), 129.4 (2CH), 130.9 (C), 131.0, 136.3 (CH), 138.3, 140.7 (C), 167.2, 167.5 
(CO). IR (KBr, cm
1
): v = 2959, 2872 (w), 1703, 1615 (m), 1565 (w), 1468, 1454, 1375, 
1283, 1243, 1222 (m), 1151 (s), 1016, 969 (m), 852, 824, 798, 657 (w). MS (EI, 70 eV): m/z 
(%) = 423(48) [M]
+
, 350(16), 322(28), 266(100), 250(39), 248(32), 222(89), 57(34), 4 (18). 
HRMS (ESI): calcd for C26H34NO4 [M+H]
+
: 424.2482; found: 424.2475. 
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(2E,2'E)-Dibutyl-3,3'-(5-(4-ethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl)diacrylate (49c): 
Compound 49c was prepared starting with 19b 
(343mg, 1.0 mmol) and n-butyl acrylate 26 
(0.36 mL, 2.5 mmol), following the general 
procedure F, as a brown oil (275 mg, 63%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.89 (t, 3H, J = 
7.3 Hz, CH3), 0.90 (t, 3H, J = 7.3 Hz, CH3), 1.21 (t, 3H, J = 7.6 Hz, CH3),  1.33-1.41 (m, 4H, 
2CH2), 1.57-1.65 (m, 4H, 2CH2), 2.63 (q, 2H, J = 7.6 Hz, CH2), 3.57 (s, 3H, NCH3), 4.13 (t, 
4H, J = 6.8 Hz, 2CH2O), 6.09 (d, 1H, J = 16.0 Hz, CH), 6.17 (d, 1H, J = 15.6 Hz, CH), 6.41 
(s, 1H, CHpyrrole), 7.18-7.22 (m, 4H, ArH), 7.70 (d, 1H, J = 16.0 Hz, CH), 7.77 (d, 1H, J = 
15.7 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  = 13.8 (2CH3), 15.4 (CH3), 19.1, 19.2 (CH2), 
28.6, 30.8, 30.9 (CH2), 33.9 (NCH3), 64.2, 64.5 (CH2O), 107.7, 116.5, 117.5 (CH), 123.8 (C), 
128.2 (2CH), 128.8 (C), 129.1 (2CH), 130.9 (C), 131.0, 136.3 (CH), 140.8, 144.6 (C), 167.3, 
167.6 (CO). IR (KBr, cm
1
): v = 3003, 2964, 2872 (w), 1711, 1691 (s), 1610 (m), 1502 (w), 
1470, 1452, 1432, 1374, 1282 (m), 1254, 1241, 1217, 1163, 1033, 966, 848, 835, 802 (s), 775, 
722, 689, 670, 632, 609, 535 (m). GC-MS (EI, 70 eV): m/z (%) = 437(84) [M]
+
, 364(22), 
336(100), 306(28), 280(89), 262(77), 235(67), 207(46), 124(15), 41(20). HRMS (EI, 70 eV): 
calcd for C27H35NO4 [M]
+
: 437.25606; found: 437.25602. 
 
 (2E,2'E)-Isobutyl-3,3'-[5-(4-ethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate (49d): 
Compound 49d was prepared starting with 19b 
(343mg, 1.0 mmol) and iso-butyl acrylate 26 (0.36 
mL, 2.5 mmol), following the general procedure F, 
as a brown oil (301 mg, 69%). 
1
H NMR (300 
MHz, CDCl3):  = 0.90 (d, 6H, J = 6.7 Hz, 2CH3), 
0.91 (d, 6H, J = 6.7 Hz, 2CH3), 1.20 (t, J = 7.6 Hz, 
3H, CH3), 1.87-1.99 (m, 2H, 2CH), 2.62 (q, 2H, J = 7.6 Hz, CH2), 3.57 (s, 3H, NCH3), 3.90 
(d, 2H, J = 6.8 Hz, CH2O), 3.92 (d, 2H, J = 6.8 Hz, CH2O), 6.10 (d, 1H, J = 16.0 Hz, 
CH), 6.18 (d, 1H, J = 15.6 Hz, CH), 6.42 (s, 1H, CHpyrrole), 7.20-7.25 (m, 4H, ArH), 7.71 (d, 
1H, J =  16.0 Hz, CH), 7.78 (d, 1H, J = 15.7 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  = 15.4 
(CH3), 19.2 (4CH3), 27.8, 27.9 (CH), 28.6 (CH2), 33.9 (NCH3), 70.4, 70.8 (CH2O), 107.7, 
116.5, 117.5 (CH), 123.7 (C), 128.2 (2CH), 129.0 (C), 129.1 (2CH), 130.9 (C), 131.1, 136.3 
(CH), 140.7, 144.6 (C), 167.2, 167.5 (CO). IR (KBr, cm
1
): v = 2959 (m), 2932, 2872 (w), 
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1699, 1615 (s), 1548, 1504 (w), 1468, 1453 (m), 1424, 1392 (w), 1368, 1284, 1260, 1241, 
1220 (m), 1148 (s), 1015, 966, 839, 799 (m), 773, 723, 703, 672, 610, 533 (w). MS (EI, 70 
eV): m/z (%) = 437(07) [M]
+
, 280(14), 236(11), 66(13), 44(16), 43(100), 42(30), 41(55). 
HRMS (EI, 70 eV): calcd for C27H35NO4 [M]
+
: 437.25606; found: 437.25529. 
 
(2E,2'E)-Dihexyl-3,3'-[5-(4-ethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate (49e): 
Compound 49e was prepared starting 
with 19b (343mg, 1.0 mmol) and n-
hexyl acrylate 26 (0.44 mL, 2.5 mmol), 
following the general procedure F, as a 
brown oil (296 mg, 60%). 
1
H NMR (250 
MHz, CDCl3):  = 0.82 (t, 3H, J = 7.9 
Hz, CH3), 0.83 (t, 3H, J = 7.1 Hz, CH3), 1.17-1.32 (m, 15H, 6CH2 and CH3),  1.56-1.67 (m, 
4H, 2CH2), 2.63 (q, 2H, J = 7.6 Hz, CH2), 3.57 (s, 3H, NCH3), 4.11 (t, 2H, J = 6.7 Hz, 
CH2O), 4.13 (t, 2H, J = 6.7 Hz, CH2O), 6.09 (d, 1H, J = 16.0 Hz, CH),  6.17 (d, 1H, J = 15.6 
Hz, CH), 6.41 (s, 1H, CHpyrrole), 7.18-7.23 (m, 4H, ArH), 7.70 (d, 1H, J = 16.1 Hz, CH), 7.77 
(d, 1H, J = 15.8 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 (2CH3), 15.4 (CH3), 22.5 
(2CH2), 25.6 (2CH2), 28.6 (CH2), 28.7 (2CH2), 31,5 (2CH2), 33.9 (NCH3), 64.4, 64.8 (CH2O), 
107.7, 116.5, 117.5 (CH), 123.7 (C), 128.2 (2CH), 128.8 (C), 129.1 (2CH), 129.1 (C), 131.0, 
136.3 (CH), 140.7, 144.6 (C), 167.2, 167.6 (CO). IR (KBr, cm
1
): v = 2954 (w), 2927 (m), 
2856 (w), 1701, 1615 (m), 1549, 1504 (w), 1454 (m), 1377 (w), 1273, 1244, 1220 (m), 1150 
(s), 1060, 1012, 969, 837, 798 (m), 725, 672, 606, 533 (w). MS (EI, 70 eV): m/z (%) = 
493(84) [M]
+
, 392(12), 365(12), 364(53), 281(16), 280(100), 264(35), 262(37), 237(11), 
236(72), 235(30), 220(17), 43(28). HRMS (EI, 70 eV): calcd for C31H43NO4 [M]
+
: 493.31866; 
found: 493.31916. 
 
(2E,2'E)-Diethyl-3,3'-[5-(4-ethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate (49f): 
Compound 49f was prepared starting with 19b 
(343mg, 1.0 mmol) and ethyl acrylate 26 (0.27 mL, 
2.5 mmol), following the general procedure F, as a 
brown oil (179 mg, 47%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.21 (t, 3H, J = 7.6 Hz, CH3), 1.26 (t, 
3H, J = 7.1 Hz, CH3), 1.27 (t, 3H, J = 7.2 Hz, CH3),  2.63 (q, 2H, J = 7.6 Hz, CH2), 3.57 (s, 
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3H, NCH3), 4.19 (q, 2H, J = 7.2 Hz, OCH2), 4.20 (q, 2H, J = 7.1 Hz, OCH2), 6.09 (d, 1H, J = 
16.0 Hz, CH), 6.17 (d, 1H, J = 15.6 Hz, CH), 6.41 (s, 1H, CHpyrrole), 7.18-7.21 (m, 4H, ArH), 
7.71 (d, 1H, J = 16.1 Hz, CH), 7.77 (d, 1H, J = 15.7 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  
= 14.4 (2CH3), 15.4 (CH3), 28.6 (CH2), 34.0 (NCH3), 60.2, 60.6 (OCH2), 107.7, 116.5, 117.5 
(CH), 123.8 (C), 128.2 (2CH), 128.8 (C), 129.1 (2CH), 129.1 (C), 131.0, 136.3 (CH), 140.8, 
144.7 (C), 167.2, 167.5 (CO). IR (KBr, cm
1
): v = 2964, 2931, 2872 (w), 1698, 1614 (s), 1504 
(w), 1453, 1365, 1260, 1220 (m), 1149 (s), 1094, 1034, 967, 838, 797 (m), 771, 724, 603, 532 
(w). MS (EI, 70 eV): m/z (%) = 381(64) [M]
+
, 336(14), 309(21), 308(90), 307(13), 280(24),  
262(77), 235(100), 220(67), 204(20). HRMS (EI, 70 eV): calcd for C23H27NO4 [M]
+
: 
381.19346; found: 381.19387. 
 
(2E,2'E)-Bis(2-ethylhexyl)-3,3'-[5-(4-ethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]  
diacrylate  (49g): 
Compound 49g was prepared starting 
with 19b (343mg, 1.0 mmol) and 2-
ethylhexyl acrylate 26 (0.52 mL, 2.5 
mmol), following the general 
procedure F, as a brown oil (334 mg, 
61%). 
1
H NMR (300 MHz, CDCl3):  
= 0.81-0.89 (m, 15H, 5CH3), 1.25-1.37 (m, 16H, 8CH2), 1.52-1.62 (m, 2H, 2CH), 2.63 (q, 2H, 
J = 7.6 Hz, CH2), 3.58 (s, 3H, NCH3), 4.00-4.07 (m, 4H, 2CH2O), 6.10 (d, 1H, J = 16.0 Hz, 
CH), 6.18 (d, 1H, J = 15.6 Hz, CH), 6.42 (s, 1H, CHpyrrole), 7.21-7.24 (m, 4H, ArH), 7.71 (d, 
1H, J = 16.0 Hz, CH), 7.78 (d, 1H, J = 15.7 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  = 11.0, 
11.1 (CH3), 14.1 (2CH3), 15.4 (CH3), 23.0 (2CH2), 23.9, 24.0 (CH2), 28.6 (CH2), 30.0 (2CH2), 
30.4, 30.5 (CH2), 33.8 (NCH3), 38.9 (2CH),  66.7, 67.2 (CH2O), 107.7, 116.6, 117.6 (CH), 
123.7 (C), 128.2 (2CH), 128.8 (C), 129.1 (2CH), 130.3 (CH), 131.0 (C), 136.2 (CH), 140.7, 
144.6 (C), 167.4, 167.7 (CO). IR (KBr, cm
1
): v = 2956, 2926, 2857, 1727, 1704, 1616, 1456 
(m), 1378 (w), 1273, 1222 (m), 1152 (s), 1031, 1015, 970, 837 (m), 795, 772, 726, 529 (w). 
MS (EI, 70 eV): m/z (%) = 549(24) [M]
+
, 392(19), 368(14), 367(54), 280(54), 255(63), 
238(100), 211(33), 198(14), 71(21), 57(40). HRMS (EI, 70 eV): calcd for C35H51NO4 [M]
+
: 
549.38181; found: 549.38164. 
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(2E,2'E)-Dimethyl-3,3'-[5-(4-ethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate 
(49h): 
Compound 49h was prepared starting with 19b 
(343mg, 1.0 mmol) and methyl acrylate 26 (0.23 mL, 
2.5 mmol), following the general procedure F, as a 
yellow solid (204 mg, 58%), mp. = 125-127 °C. 
1
H 
NMR (300 MHz, CDCl3):  = 1.20 (t, 3H, J = 7.6 Hz, 
CH3), 2.62 (q, 2H, J = 7.6 Hz, CH2), 3.57 (s, 3H, NCH3), 3.71 (s, 3H, OCH3), 3.74 (s, 3H, 
OCH3), 6.08 (d, 1H, J = 16.0 Hz, CH), 6.16 (d, 1H, J = 15.6 Hz, CH), 6.41 (s, 1H, CHpyrrole), 
7.18-7.21 (m, 4H, ArH), 7.71 (d, 1H, J = 16.3 Hz, CH), 7.76 (d, 1H, J = 16.2 Hz, CH). 
13
C 
NMR (75 MHz, CDCl3):  = 14.4 (CH3), 27.6 (CH2), 33.0 (NCH3), 50.5 (OCH3), 50.7 
(OCH3), 106.7, 115.1, 116.0 (CH), 122.8 (C), 127.2 (2CH), 127.7 (C), 128.1 (2CH), 129.9 
(C), 130.1, 135.4 (CH), 139.9, 143.7 (C), 166.5, 166.9 (CO). IR (KBr, cm
1
): v = 3003, 2964, 
2928 (w), 1711, 1691 (s), 1622, 1611 (m), 1502 (w), 1471, 1452, 1432, 1425, 1374, 1282 (m), 
1254, 1241, 1217, 1162 (s), 1117, 1063, 1052 (m), 1033, 956, 848, 835, 802 (s), 775, 722, 
702, 652, 608, 535 (m). GC-MS (EI, 70 eV): m/z (%) = 353(49) [M]
+
, 322(16), 320(10), 
295(14), 294(99), 293(11), 281(15), 279(12), 278(11), 263(20), 262(100), 236(11), 135(48), 
234(24), 232(12), 221(14), 220(49), 209(12), 208(18), 207(71), 205(12), 204(21), 178(10), 
44(23), 32(18). HRMS (EI, 70 eV): calcd for C21H23NO4 [M]
+
: 353.16216; found: 353.16297. 
 
(2E,2'E)-Dimethyl-3,3'-[5-(4-tert-butylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate 
(49i): 
Compound 49i was prepared starting with 19c (371 
mg, 1.0 mmol) and methyl acrylate 26 (0.23 mL, 2.5 
mmol), following the general procedure F, as a 
brown oil (202 mg, 53%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.28 (s, 9H, 3CH3), 3.58 (s, 3H, NCH3), 
3.71 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 6.08 (d, 1H, J = 16.0 Hz, CH), 6.17 (d, 1H, J = 15.7 
Hz, CH),  6.41 (s, 1H, CHpyrrole), 7.23 (dd, 2H, J = 2.1, 6.5 Hz, ArH), 7.39 (dd, 2H, J = 1.8, 
6.6 Hz, ArH), 7.71 (d, 1H, J = 16.1 Hz, CH), 7.77 (d, 1H, J = 16.0 Hz, CH). 
13
C NMR (62 
MHz, CDCl3):  = 31.3 (3CH3), 34.0 (NCH3), 34.7 (C), 51.5, 51.7 (OCH3), 107.7, 116.1, 
117.0 (CH), 123.8 (C), 125.6 (2CH), 128.6 (C), 128.8 (2CH), 131.0 (C), 131.2, 136.4 (CH), 
140.9, 151.5 (C), 167.5, 167.9 (CO). IR (KBr, cm
1
): v = 2950, 2905, 2868 (w), 1708, 1616 
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(s), 1550, 1502 (w), 1455, 1432 (m), 1364 (w), 1303, 1266, 1222, 1191 (m), 1156 (s), 1037, 
1014 (w), 969 (m), 936 (w), 841, 800 (m), 729, 605, 558 (w). MS (EI, 70 eV): m/z (%) = 
381(49) [M
+
], 323(20), 322(100), 290(46), 263(10), 248(23), 234(28), 69(18), 57(22), 44(48), 
41(11). HRMS (EI, 70 eV): calcd for C23H27NO4 [M]
+
: 381.19346; found: 381.19290. 
 
(2E,2'E)-Isobutyl-3,3'-[5-(4-tert-butylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate 
(49j): 
Compound 49j was prepared starting with 19c 
(371 mg, 1.0 mmol) and iso-butyl acrylate 26 
(0.36 mL, 2.5 mmol), following the general 
procedure F, as a brown oil (353 mg, 76%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.91 (d, 6H, J = 
6.8 Hz, 2CH3), 0.92 (d, 6H, J = 6.7 Hz, 2CH3), 
1.29 (s, 9H, 3CH3), 1.87-1.99 (m, 2H, 2CH), 3.56 (s, 3H, NCH3), 3.91 (d, 2H, J = 6.9 Hz, 
CH2O), 3.93 (d, 2H, J = 6.8 Hz, CH2O), 6.11 (d, 1H, J = 16.0 Hz, CH), 6.18 (d, 1H, J = 15.6 
Hz, CH),  6.43 (s, 1H, CHpyrrole), 7.25 (d, 2H, J = 8.5 Hz, ArH), 7.40 (d, 2H, J = 8.5 Hz, ArH), 
7.72 (d, 1H, J = 16.0 Hz, CH), 7.79 (d, 1H, J = 15.7 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  
= 19.2 (4CH3), 27.8, 27.9 (CH), 31.3 (3CH3), 33.9 (NCH3), 34.7 (C), 70.4, 70.8 (CH2O), 
107.8, 116.5, 117.5 (CH), 123.7 (C), 125.6 (2CH), 128.6 (C), 128.8 (2CH), 131.0 (C), 131.1, 
136.3 (CH), 140.7, 151.5 (C), 167.3, 167.6 (CO). IR (KBr, cm
1
): v = 2957 (m), 2871 (w), 
1704, 1616 (m), 1462, 1455, 1375, 1367, 1267, 1243, 1222 (m), 1149 (s), 1110, 1013, 968, 
839, 794 (m), 742, 722, 666, 610, 558 (w). MS (EI, 70 eV): m/z (%) = 465(41) [M
+
], 364(38), 
309(18), 310(100), 292(18), 290(23), 266(15), 264(37), 248(15), 57(18). HRMS: m/z calcd 
for C29H39NO4 [M
+
]: 465.28736; found: 465.28617. 
 
(2E,2'E)-Dibutyl-3,3'-[5-(4-tert-butylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate 
(49k): 
Compound 49k was prepared starting with 
19c (371 mg, 1.0 mmol) and n-butyl acrylate 
26 (0.36 mL, 2.5 mmol), following the 
general procedure F, as a brown oil (260 mg, 
56%). 
1
H NMR (300 MHz, CDCl3):  = 0.89 
(t, 3H, J = 7.3 Hz, CH3), 0.90 (t, 3H, J = 7.2 Hz, CH3), 1.28 (s, 9H, 3CH3),  1.33-1.40 (m, 4H, 
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2CH2), 1.57-1.65 (m, 4H, 2CH2), 3.58 (s, 3H, NCH3), 4.12 (t, 2H, J = 6.8 Hz, CH2O), 4.15 (t, 
2H, J = 6.8 Hz, CH2O), 6.09 (d, 1H, J = 16.0 Hz, CH), 6.17 (d, 1H, J = 15.6 Hz, CH),  6.41 
(s, 1H, CHpyrrole), 7.24 (dd, 2H, J = 1.8, 6.5 Hz, ArH), 7.39 (dd, 2H, J = 2.0, 6.4 Hz, ArH), 
7.71 (d, 1H, J = 16.0 Hz, CH), 7.76 (d, 1H, J = 15.7 Hz, CH). 
13
C NMR (75 MHz, CDCl3):  
= 12.7 (2CH3), 18.1, 18.2 (CH2), 29.7, 29.8 (CH2), 30.3 (3CH3), 32.9 (NCH3), 33.7 (C), 63.1, 
63.5 (CH2O), 106.7, 115.5, 116.5 (CH), 122.7 (C), 124.6 (2CH), 127.5 (C), 127.8 (2CH), 
130.0 (C), 130.1, 135.3 (CH), 139.7, 150.5 (C), 166.3, 166.6 (CO). IR (KBr, cm
1
): v = 2956 
(m), 2932, 2870 (w), 1700, 1616 (s), 1454, 1363, 1267, 1245, 1221 (m), 1150 (s), 1063, 1023, 
968, 839, 799, 730 (m), 647, 605, 557 (w). GC-MS (EI, 70 eV): m/z (%) = 465(45) [M]
+
, 
463(11), 364(47), 308(100), 290(77), 264(22), 248(24), 234(10), 57(10). HRMS (EI, 70 eV): 
calcd for C29H39NO4 [M]
+
: 465.28736; found: 465.28768. Anal. calcd for C29H39NO4: C, 
75.13; H, 8.04; N, 3.02. Found: C, 75.53; H, 8.18; S, 2.70. 
 
(2E,2'E)-Dihexyl-3,3'-[5-(4-tert-butylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate 
(49l): 
Compound 49l was prepared starting 
with 19c (371mg, 1.0 mmol) and n-
hexyl acrylate 26 (0.44 mL, 2.5 
mmol), following the general proce- 
dure F, as a brown oil (369 mg, 71%). 
1
H NMR (500 MHz, CDCl3):  = 
0.80-0.85 (m, 6H, 2CH3), 1.17-1.33 (m, 17H, 4CH2 and 3CH3), 1.50-1.58 (m, 4H, 2CH2), 
1.59-1.67 (m, 4H, 2CH2), 3.58 (s, 3H, NCH3), 4.10-4.16 (m, 4H, 2CH2O), 6.09 (d, 1H, J = 
16.0 Hz, CH),  6.17 (d, 1H, J = 15.6 Hz, CH), 6.42 (s, 1H, CHpyrrole), 7.24 (d, 2H, J = 8.4 Hz, 
ArH), 7.39 (d, 2H, J = 8.4 Hz, ArH), 7.70 (d, 1H, J = 16.0 Hz, CH), 7.78 (d, 1H, J = 15.6 Hz, 
CH). 
13
C NMR (125 MHz, CDCl3):  = 13.9, 14.00 (CH3), 22.5 (2CH2), 25.7 (2CH2), 28.7 
(CH2), 31.3 (CH3), 31.5 (2CH2), 33.9 (NCH3), 34.7 (C), 64.5, 64.8 (CH2O), 107.7, 116.5, 
117.5 (CH), 123.8, 125.4 (C), 125.6 (2CH), 128.8 (2CH), 130.9 (C), 131.0, 136.3 (CH), 
140.7, 151.5 (C), 167.6, 167.6 (CO). IR (KBr, cm
1
): v = 2953, 2927, 2857 (w), 1703, 1617 
(m), 1548, 1502 (w), 1454, 1267, 1245 (m), 1153 (s), 1057, 1010, 970, 840, 800 (m), 724, 
607, 558 (w). MS (EI, 70 eV): m/z (%) = 519(10) [M]
+
, 392(69), 309(19), 308(100), 292(23), 
290(33), 282(15), 264(43), 248(19), 236(14), 234(11), 157(10), 69(21), 66(15), 57(18), 
44(24), 41(16). HRMS (EI, 70 eV): calcd for C33H45NO4 [M]
+
: 519.33431; found: 519.33507. 
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 (2E,2'E)-diethyl-3,3'-(5-(4-tert-butylphenyl)-1-methyl-1H-pyrrole-2,3-diyl)diacrylate 
(49m): 
Compound 49m was prepared starting with 19c (371 
mg, 1.0 mmol) and ethyl acrylate 26 (0.27 mL, 2.5 
mmol), following the general procedure F, as a 
brown oil (196 mg, 48%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.27-1.30 (m, 15H, 5CH3), 3.58 (s, 3H, 
NCH3), 4.14-4.23 (m, 4H, 2CH2O), 6.09 (d, 1H, J = 15.9 Hz, CH), 6.17 (d, 1H, J = 15,6 Hz, 
CH), 6.41 (s, 1H, CHpyrrole), 7.24 (d, 2H, J = 8,5 Hz, ArH), 7.39 (d, 2H, J = 8,4 Hz, ArH), 7.71 
(d, 1H, J = 16.0 Hz, CH), 7.78 (d, 1H, J = 15,6 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  = 
13.4 (2CH3), 30.2 (3CH3), 33.0 (NCH3), 33.7 (C), 59.2, 59.5 (CH2O), 106.7, 115.4, 116.4 
(CH), 122.8, 124.4 (C), 124.6 (2CH), 127.5 (C), 127.8 (2CH), 130.0, 135.3 (CH), 139.7, 
150.5 (C), 166.2, 166.5 (CO). IR (KBr, cm
1
): v = 2958, 2903, 2867 (w), 1700, 1615 (s), 
1453, 1364, 1299, 1260 (m), 1149 (s), 1110, 1094, 1034, 968, 839, 798, 728 (m), 603, 556 
(w). MS (EI, 70 eV): m/z (%) = 409(43) [M
+
], 337(20), 336(100), 308(13), 292(20), 290(38), 
264(17), 263(32), 248(29), 234(12). HRMS: m/z calcd for C25H31NO4 [M
+
]: 409.22476; 
found: 409.222406. 
 
(2E,2'E)-Dibutyl-3,3'-(5-(3,5-dimethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl)diacrylate 
(49o): 
Compound 49o was prepared starting with 19e 
(343 mg, 1.0 mmol) and n-butyl acrylate 26 
(0.36 mL, 2.5 mmol), following the general 
procedure F, as a brown oil (288 mg, 66%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.89 (t, 3H, J = 
7.4 Hz, CH3), 0.90 (t, 3H, J = 7.3 Hz, CH3), 
1.30-1.41 (m, 4H, 2CH2), 1.57-1.65 (m, 4H, 2CH2), 2.29 (s, 6H, 2CH3), 3.57 (s, 3H, NCH3), 
4.12 (t, 2H, J = 6.8 Hz, CH2O), 4.15 (t, 2H, J = 6.6 Hz, CH2O), 6.09 (d, 1H, J = 16.0 Hz, CH), 
6.17 (d, 1H, J = 15.6 Hz, CH), 6.41 (s, 1H, CHpyrrole), 6.92 (br, 2H, ArH), 6.95 (br, 1H, ArH), 
7.70 (d, 1H, J = 16.0 Hz, CH), 7.77 (d, 1H, J = 15.7 Hz, CH). 
13
C NMR (62 MHz, CDCl3):  
= 13.8 (2CH3), 19.2 (2CH2), 21.3 (2CH3), 30.8 (2CH2), 33.9 (NCH3), 64.1, 64.5 (CH2O), 
107.8, 116.5, 117.5 (CH), 123.7 (C), 126.9 (2CH), 130.0, 130.9 (CH), 131.0, 131.4 (C), 136.3 
(CH), 138.3 (2C), 140.9 (C), 167.3, 167.6 (CO). IR (KBr, cm
1
): v = 2956, 2931, 2871 (w), 
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1700, 1615, 1456 (m), 1378 (w), 1300, 1274, 1257, 1238 (m), 1149 (s), 1160, 1023, 968, 851, 
799 (m), 738 (w), 701 (m), 670, 632, 545 (w). GC-MS (EI, 70 eV): m/z (%) = 437(38) [M]
+
, 
336(44), 335(33), 281(19), 280(100), 279(13), 263(17), 262(84), 236(34), 235(26), 234(13), 
221(15). HRMS (EI, 70 eV): calcd for C27H35NO4 [M]
+
: 437.25606; found: 437.25671. 
 
(2E,2'E)-tert-butyl-3,3'-[5-(4-ethylphenyl)-1-methyl-1H-pyrrole-2,3-diyl]diacrylate 
(49q): 
Compound 49q was prepared starting with 19b 
(343mg, 1.0 mmol) and tert-butyl acrylate 26 (0.36 
mL, 2.5 mmol), following the general procedure F, 
as a brown oil (284 mg, 65%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.20 (t, 3H, J = 7.6 Hz, CH3),  1.46 (s, 
9H, 3CH3), 1.47 (s, 9H, 3CH3), 2.62 (q, 2H, J = 7.6 Hz, CH2), 3.55 (s, 3H, NCH3), 6.04 (d, 
1H, J = 15.9 Hz, CH), 6.10 (d, 1H, J = 15.6 Hz, CH), 6.40 (s, 1H, CHpyrrole), 7.18-7.22 (m, 
4H, ArH), 7.60 (d, 1H, J = 16.0 Hz, CH), 7.71 (d, 1H, J = 15.6 Hz, CH). 
13
C NMR (75 MHz, 
CDCl3):  = 15.4 (CH3), 28.2 (3CH3), 28.3 (3CH3), 28.6 (CH2), 33.7 (NCH3), 80.0, 80.5 (C), 
107.6, 118.1, 119.5 (CH), 123.4 (C), 128.2 (2CH), 129.0 (C), 129.1 (2CH), 130.2 (CH), 131.0 
(C), 135.6 (CH), 140.3, 144.5 (C), 166.5, 167.0 (CO). IR (KBr, cm
1
): v = 2970, 2930, 2873 
(w), 1696, 1615 (s), 1470, 1453 (m), 1390 (w), 1365, 1305, 1277, 1253 (m), 1134 (s), 969, 
839, 799, 763, 730 (m), 692, 614, 531 (w). MS (EI, 70 eV): m/z (%) = 437(30) [M]
+
, 
280(100), 264(11), 236(37), 220(14). HRMS (EI, 70 eV): calcd for C27H35NO4 [M]
+
: 
437.25606; found: 437.25616. 
 
(2E,2'E)-tert-butyl-3,3'-(1-methyl-5-p-tolyl-1H-pyrrole-2,3-diyl)diacrylate (49r): 
Compound 49r was prepared starting with 19g 
(329 mg, 1.0 mmol) and tert-butyl acrylate 26 
(0.36 mL, 2.5 mmol), following the general 
procedure F, as a brown oil (304 mg, 72%). 
1
H 
NMR (300 MHz, CDCl3):  = 1.46 (s, 9H, 3CH3), 
1.47 (s, 9H, 3CH3), 2.33 (s, 3H, CH3), 3.55 (s, 3H, 
NCH3), 6.04 (d, 1H, J = 16.0 Hz, CH), 6.10 (d, 1H, J = 15.7 Hz, CH), 6.39 (s, 1H, CHpyrrole), 
7.18 (br, 4H, ArH), 7.60 (d, 1H, J =  16.0 Hz, CH), 7.70 (d, 1H, J = 15.6 Hz, CH). 
13
C NMR 
(62 MHz, CDCl3):  = 21.2 (CH3), 28.2 (6CH3), 33.7 (NCH3), 80.0, 81.0 (C), 107.5, 118.1, 
192 
 
119.5 (CH), 123.4, 128.8 (C), 129.0 (2CH), 129.3 (2CH), 130.1 (CH), 131.0 (C), 135.5 (CH), 
138.2, 140.2 (C), 166.5, 167.0 (CO). IR (KBr, cm
1
): v = 2974, 2926, 2868 (w), 1696, 1614 
(m), 1503, 1471 (w), 1453 (m), 1424, 1390 (w), 1365, 1305, 1277, 1254 (m), 1225, 1201 (w), 
1134 (s), 969, 853, 823, 797 (m), 764, 734, 594 (w). MS (EI, 70 eV): m/z (%) = 423(20) [M]
+
, 
267(20), 266(100), 250(13), 248(13), 222(45), 221(15), 207(12), 57(22), 41(21). HRMS (EI, 
70 eV): calcd for C26H33NO4 [M]
+
: 423.24041; found: 423.24040. 
 
General procedure G for synthesis of Indoles 50 and 51: 
 
 A diphenyl ether solution (3 mL) of 49a-o,q,r  (0.25 mmol) was stirred at 200 °C for 24 h in 
a pressure tube. The solution was allowed to cool to 20 °C and Pd/C (30 mg, 10 mol %) was 
added. The solution was stirred at 200 °C for 48 h under an argon atmosphere. The reaction 
mixture was filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (flash silica gel, eluent: heptanes-EtOAc). 
 
Diisobutyl-1-methyl-2-p-tolyl-1H-indole-5,6-dicarboxylate (50a): 
Compound 50a was prepared starting with 49a 
(100 mg, 0.24 mmol), following the general 
procedure G, as a brown oil (90 mg, 91%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.92 (d, 6H, J = 6.7 
Hz, 2CH3), 0.93 (d, 6H, J = 6.7 Hz, 2CH3), 1.92-
2.05 (m, 2H, 2CH), 2.36 (s, 3H, CH3), 3.70 (s, 
3H, NCH3), 4.02 (d, 2H, J = 6.7 Hz, CH2O), 4.03 (d, 2H, J = 6.7 Hz, CH2O), 6.53 (s, 1H, 
CHpyrrole), 7.22 (d, 2H, J = 7.9 Hz, ArH), 7.31 (dd, 2H, J = 1.8, 6.5 Hz, ArH), 7.66 (s, 1H, 
ArH), 7.94 (s, 1H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 19.3 (4CH3), 21.3 (CH3), 27.8, 27.9 
(CH), 31.4 (NCH3), 71.4, 71.6 (CH2O), 102.6, 111.2, 122.1 (CH), 124.3, 125.7, 128.8, 129.1 
(C), 129.3 (2CH), 129.4 (2CH), 138.3, 138.6, 145.1 (C), 168.8, 169.0 (CO). IR (KBr, cm
1
): v 
= 2958, 2930, 2872 (w), 1710 (s), 1610, 1495 (w), 1469 (m), 1429, 1394 (w), 1376, 1359, 
1340 (m), 1260, 1233 (s), 1214, 1157 (m), 1104 (s), 1037, 1023, 986, 907, 823, 784, 779, 729 
(m), 672, 646, 569, 545 (w). GC-MS (EI, 70 eV): m/z (%) = 421(80) [M]
+
, 309(13), 293(22), 
292(100), 219(14). HRMS (EI, 70 eV): calcd for C26H31NO4 [M]
+
: 421.22476; found: 
421.22551. 
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Dihexyl-1-methyl-2-p-tolyl-1H-indole-5,6-dicarboxylate (50b): 
Compound 50b was prepared starting 
with 49b (100 mg, 0.21 mmol), 
following the general procedure G, as a 
brown oil (79 mg, 80%). 
1
H NMR (300 
MHz, CDCl3):  = 0.82 (t, 6H, J = 7.0 
Hz, 2CH3), 1.22-1.37 (m, 12H, 6CH2),  1.63-1.72 (m, 4H, 2CH2), 2.34 (s, 3H, CH3), 3.69 (s, 
3H, NCH3), 4.22 (t, 2H, J = 6.8 Hz, CH2O), 4.24 (t, 2H, J = 6.8 Hz, CH2O), 6.51 (s, 1H, 
CHpyrrole), 7.20 (d, 2H, J = 8.0 Hz, ArH), 7.31 (d, 2H, J = 8.1 Hz, ArH), 7.65 (s, 1H, ArH), 
7.92 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 (2CH3), 21.3 (CH3), 22.6 (2CH2), 
25.7 (2CH2), 28.6, 28.7 (CH2), 31.5 (NCH3), 31,4 (2CH2), 65.5, 65.7 (CH2O), 102.6, 111.1, 
122.1 (CH), 124.2, 125.6, 128.8, 129.1 (C), 129.2 (2CH), 129.4 (2CH), 138.2, 138.6, 145.1 
(C), 168.9, 169.0 (CO). IR (KBr, cm
1
): v = 2952, 2924 (m), 2855 (w), 1711 (s), 1610, 1547 
(w), 1495, 1456, 1379, 1360, 1339 (m), 1254, 1234, 1156, 1104 (s), 1033, 1021, 984, 894, 
823, 780, 741, 720 (m), 671, 625, 600, 572, 543 (w). GC-MS (EI, 70 eV): m/z (%) = 477(78) 
[M]
+
, 293(22), 294(100), 219(18), 41(11). HRMS (ESI): calcd for C30H40NO4 [M+H]
+
: 
478.2952; found: 478.2958. 
 
Dibutyl-2-(4-ethylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50c): 
Compound 50c was prepared starting with 49c 
(100 mg, 0.23 mmol), following the general 
procedure G, as a brown oil (75 mg, 76%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.90 (t, 6H, J = 
7.4 Hz, 2CH3), 1.23 (t, 3H, J = 7.6 Hz, CH3),  
1.35-1.43 (m, 4H, 2CH2), 1.62-1.72 (m, 4H, 2CH2), 2.66 (q, 2H, J = 7.6 Hz, CH2), 3.72 (s, 
3H, NCH3), 4.24 (t, 2H, J = 6.7 Hz, CH2O), 4.26 (t, 2H, J = 6.7 Hz, CH2O), 6.53 (s, 1H, 
CHpyrrole), 7.25 (d, 2H, J = 8.3 Hz, ArH), 7.35 (dd, 2H, J = 1.8, 6.5 Hz, ArH), 7.66 (s, 1H, 
ArH), 7.93 (s, 1H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 13.8 (2CH3), 15.5 (CH3), 19.3 
(2CH2), 28.7, 30.7, 30.8 (CH2), 31.5 (NCH3), 65.2, 65.4 (CH2O), 102.6, 111.2, 122.1 (CH), 
124.2, 125.6 (C), 128.2 (2CH), 129.1 (C), 129.3 (2CH), 129.3, 138.0, 144.9, 145.2 (C), 168.9, 
169.0 (CO). IR (KBr, cm
1
): v = 2957 (m), 2871 (w), 1711 (s), 1611, 1562, 1494 (w), 1456 
(m), 1430, 1382 (w), 1360, 1340 (m), 1254, 1233 (s), 1209, 1157 (m), 1103 (s), 1060, 1036, 
1021 (m), 962, 944, 897 (w), 837, 784, 740 (m), 700, 671, 599, 543 (w). GC-MS (EI, 70 eV): 
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m/z (%) = 435(100) [M]
+
, 307(17), 306(78). HRMS (EI, 70 eV): calcd for C27H33NO4 [M]
+
: 
435.24041; found: 435.23989. 
 
Diisobutyl-2-(4-ethylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50d): 
Compound 50d was prepared starting with 49d 
(100 mg, 0.23 mmol), following the general 
procedure G, as a yellow oil (71 mg, 72%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.92 (d, 6H, J = 6.7 
Hz, 2CH3), 0.93 (d, 6H, J = 6.7 Hz, 2CH3), 1.22 
(d, 3H, J = 7.6 Hz, CH3), 1.92-2.05 (m, 2H, 2CH), 
2.65 (q, 2H, J = 7.6 Hz, CH2), 3.71 (s, 3H, NCH3), 4.01 (d, 2H, J = 6.6 Hz, CH2O), 4.03 (d, 
2H, J = 6.7 Hz, CH2O), 6.53 (s, 1H, CHpyrrole), 7.24 (d, 2H, J = 8.1 Hz, ArH), 7.34 (d, 2H, J = 
8.1 Hz, ArH), 7.66 (s, 1H, ArH), 7.94 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 15.4 
(CH3), 19.3 (4CH3), 27.7, 27.8 (CH), 28.7 (CH2), 31.4 (NCH3), 71.4, 71.6 (CH2O), 102.6, 
111.1, 122.1 (CH), 124.2, 125.7, 128.2 (C), 128.2 (2CH), 129.0 (C), 129.3 (2CH), 138.2, 
144.9, 145.2 (C), 168.8, 169.0 (CO). IR (KBr, cm
1
): v = 2959, 2930, 2872 (w), 1711 (s), 
1610, 1494 (w), 1469 (m), 1429, 1394 (w), 1376, 1360, 1340 (m), 1254, 1232 (s), 1209, 1156 
(m), 1104 (s), 1037, 1024, 986, 837, 783, 731 (m), 671, 626, 586, 546 (w). GC-MS (EI, 70 
eV): m/z (%) = 435(84) [M]
+
, 323(12), 307(20), 306(100), 233(14), 218(10). HRMS (EI, 70 
eV): calcd for C27H33NO4 [M]
+
: 435.24041; found: 435.24055. 
 
Dihexyl-2-(4-ethylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50e): 
Compound 50e was prepared starting 
with 49e (100 mg, 0.20 mmol), 
following the general procedure G, as a 
brown oil (89 mg, 90%). 
1
H NMR (300 
MHz, CDCl3):  = 0.82 (t, 6H, J = 7.0 
Hz, 2CH3), 1.18-1.38 (m, 15H, 6CH2 and 
CH3),  1.63-1.72 (m, 4H, 2CH2), 2.65 (q, 2H, J = 7.6 Hz, CH2), 3.71 (s, 3H, NCH3), 4.22 (t, 
2H, J = 6.8 Hz, CH2O), 4.24 (t, 2H, J = 6.8 Hz, CH2O), 6.53 (s, 1H, CHpyrrole), 7.24 (d, 2H, J 
= 8.2 Hz, ArH), 7.35 (dd, 2H, J = 1.8, 6.6 Hz, ArH), 7.66 (s, 1H, ArH), 7.92 (s, 1H, ArH). 
13
C 
NMR (62 MHz, CDCl3):  = 14.0 (2CH3), 15.4 (CH3), 22.6 (2CH2), 25.6, 25.7, 28.6 (CH2), 
28.7 (2CH2), 31.4 (NCH3), 31,5 (2CH2), 65.5, 65.7 (CH2O), 102.6, 111.1, 122.1 (CH), 124.2, 
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125.6 (C), 128.2 (2CH), 129.1 (C), 129.3 (2CH), 129.3, 138.2, 144.9, 145.1 (C), 168.9, 169.0 
(CO). IR (KBr, cm
1
): v = 2957, 2927 (m), 2856 (w), 1712 (s), 1611, 1494 (w), 1456 (m), 
1430, 1379 (w), 1360, 1340 (m), 1253, 1233 (s), 1209, 1157 (m), 1104 (s), 1034, 1021 (m), 
894 (w), 837, 784 (m), 726, 671, 586, 546 (w). GC-MS (EI, 70 eV): m/z (%) = 491(58) [M]
+
, 
407(13), 323(10), 307(18), 306(100), 305(42), 233(26), 218(11), 56(19), 55(15). HRMS (EI, 
70 eV): calcd for C31H41NO4 [M]
+
: 491.30301; found: 491.30315. 
 
Bis(2-ethylhexyl)-2-(4-ethylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50g): 
Compound 50g was prepared starting 
with 49g (100 mg, 0.18 mmol), 
following the general procedure G, as a 
brown oil (93 mg, 94%). 
1
H NMR (300 
MHz, CDCl3):  = 0.82 (t, 9H, J = 6.9 
Hz, 3CH3), 0.86 (t, 6H, J = 7.5 Hz, 
2CH3), 1.26-1.40 (m, 16H, 8CH2), 1.59-1.68 (m, 2H, 2CH), 2.65 (q, 2H, J = 7.6 Hz, CH2), 
3.71 (s, 3H, NCH3), 4.14-4.18 (m, 4H, 2CH2O), 6.54 (s, 1H, CHpyrrole), 7.24 (d, 2H, J = 8.1 
Hz, ArH), 7.34 (d, 2H, J = 8.1 Hz, ArH), 7.65 (s, 1H, ArH), 7.92 (s, 1H, ArH). 
13
C NMR (62 
MHz, CDCl3):  = 11.0 (2CH3), 14.1 (2CH3), 15.4 (CH3), 23.0 (2CH2), 23.8 (2CH2), 28.7 
(CH2), 29.0 (2CH2), 30.5 (2CH2), 31.4 (NCH3), 38.7, 38.8 (CH), 67.8, 68.0 (CH2O), 102.6, 
111.1, 122.1 (CH), 124.3, 125.8 (C), 128.2 (2CH), 129.0, 129.1 (C), 129.3 (2CH), 138.2, 
144.9, 145.1 (C), 168.8, 169.1 (CO). IR (KBr, cm
1
): v = 2957, 2926 (m), 2857 (w), 1712 (s), 
1611, 1563, 1494 (w), 1458, 1378, 1361, 1340 (m), 1257, 1232 (s), 1209, 1157 (m), 1104 (s), 
1037, 1023 (m), 960, 896 (w), 837, 785 (m), 741, 671, 586, 547 (w). MS (EI, 70 eV): m/z (%) 
= 547(78) [M]
+
, 435(17), 323(31), 307(22), 306(100), 305(31), 234(14), 233(30), 218(12), 
70(16), 57(35). HRMS (ESI): calcd for C35H50NO4 [M+H]
+
: 548.3734; found: 548.3739. 
 
Dimethyl-2-(4-tert-butylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50i): 
Compound 50i was prepared starting with 49i (100 
mg, 0.26 mmol), following the general procedure G, 
as a brown oil (69 mg, 70%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.31 (s, 9H, 3CH3), 3.73 (s, 3H, NCH3), 
3.84 (s, 3H, CH3O), 3.86 (s, 3H, CH3O), 6.54 (s, 1H, 
CHpyrrole), 7.37 (d, 2H, J = 8.5 Hz, ArH), 7.44 (d, 2H, J = 8.5 Hz, ArH), 7.66 (s, 1H, ArH), 
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7.94 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 31.3 (3CH3), 31.5 (NCH3), 34.8 (C), 52.4, 
52.5 (CH3O), 102.7, 111.3, 122.2 (CH), 123.8, 124.9 (C), 125.6 (2CH), 128.7 (C), 129.1 
(2CH), 129.2, 138.3, 145.3, 151.8 (C), 169.2, 169.3 (CO). IR (KBr, cm
1
): v = 3141, 3033 
(w), 2949 (m), 1714 (s), 1611, 1558, 1493 (w), 1432, 1404, 1361, 1340 (m), 1260, 1236 (s), 
1190, 1157 (m), 1106 (s), 1042, 972 (m), 888 (w), 839, 783, 738 (m), 670,599, (w), 564 (m). 
GC-MS (EI, 70 eV): m/z (%) = 379(100) [M]
+
, 365(12), 364(46), 348(31), 334(54), 153(13). 
HRMS (EI, 70 eV): calcd for C23H25NO4 [M]
+
: 379.17781; found: 379.17794. 
 
Diisobutyl-2-(4-tert-butylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50j): 
Compound 50j was prepared starting with 49j 
(100 mg, 0.22 mmol), following the general 
procedure G, as a yellow oil (76 mg, 77%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.92 (d, 6H, J = 
6.7 Hz, 2CH3), 0.93 (d, 6H, J = 6.7 Hz, 2CH3), 
1.30 (s, 9H, 3CH3),  1.92-2.05 (m, 2H, 2CH), 
3.72 (s, 3H, NCH3), 4.02 (d, 2H, J = 6.7 Hz, CH2O), 4.04 (d, 2H, J = 6.7 Hz, CH2O), 6.54 (s, 
1H, CHpyrrole), 7.36 (d, 2H, J = 8.6 Hz, ArH), 7.44 (d, 2H, J = 8.6 Hz, ArH), 7.67 (s, 1H, 
ArH), 7.94 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 19.3 (4CH3), 27.7, 27.8 (CH), 31.3 
(3CH3), 31.5 (NCH3), 34.7 (C), 71.4, 71.6 (CH2O), 102.6, 111.1, 122.1 (CH), 124.2 (C), 
125.6 (2CH), 125.7, 128.8 (C), 129.1 (2CH), 129.1, 138.3, 145.1, 151.8 (C), 168.8, 169.0 
(CO). IR (KBr, cm
1
): v = 2957 (m), 2871 (w), 1712 (s), 1611, 1558, 1495 (w), 1468 (m), 
1429, 1394 (w), 1376, 1361, 1340 (m), 1260, 1233 (s), 1210, 1157 (m), 1105 (s), 1037, 987 
(m), 907 (w), 839, 783, 732 (m), 673, 626, 608 (w), 565 (m). GC-MS (EI, 70 eV): m/z (%) = 
463(100) [M]
+
,  407(12), 335(26), 334(64), 333(23), 247(12). HRMS (EI, 70 eV): calcd for 
C29H37NO4 [M]
+
: 463.27171; found: 463.27044. 
 
Dibutyl-2-(4-tert-butylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50k): 
Compound 50k was prepared starting with 
49k (100 mg, 0.22 mmol), following the 
general procedure G, as a yellow oil (88 mg, 
89%). 
1
H NMR (250 MHz, CDCl3):  = 0.89 
(t, 6H, J = 8.7 Hz, 2CH3), 1.29 (s, 9H, 3CH3),  
1.33-1.42 (m, 4H, 2CH2), 1.61-1.72 (m, 4H, 2CH2), 3.71 (s, 3H, NCH3), 4.23 (t, 2H, J = 6.7 
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Hz, CH2O), 4.25 (t, 2H, J = 6.7 Hz, CH2O), 6.52 (s, 1H, CHpyrrole), 7.36 (d, 2H, J = 8.4 Hz, 
ArH), 7.43 (d, 2H, J = 8.5 Hz, ArH), 7.65 (s, 1H, ArH), 7.92 (s, 1H, ArH). 
13
C NMR (75 
MHz, CDCl3):  = 12.8 (2CH3), 18.2 (2CH2), 29.6, 29.7 (CH2), 30.3 (3CH3), 30.5 (NCH3), 
33.7 (C), 64.1, 64.3 (CH2O), 101.5, 110.1, 121.1 (CH), 123.2, 124.5 (C), 124.6 (2CH), 127.8 
(C), 128.0 (2CH), 128.0, 137.2, 144.1, 150.7 (C), 167.8, 168.0 (CO). IR (KBr, cm
1
): v = 
2956 (m), 2870 (w), 1711 (s), 1611, 1562, 1494 (w), 1475, 1461 (m), 1430, 1390 (w), 1360, 
1339 (m), 1256, 1243 (s), 1209, 1157 (m), 1103 (s), 1060, 1036, 1004 (m), 962, 944, 896 (w), 
839, 783, 736 (m), 672, 625, 602, 565 (w). GC-MS (EI, 70 eV): m/z (%) = 463(100) [M]
+
, 
448(13), 407(10), 355(14), 334(54), 318(13), 290(11). HRMS (EI, 70 eV): calcd for 
C29H37NO4 [M]
+
: 463.27171; found: 463.27286. 
 
Dihexyl-2-(4-tert-butylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50l): 
Compound 50l was prepared starting 
with 49l (100 mg, 0.19 mmol), 
following the general procedure G, as 
a brown oil (80 mg, 81%). 
1
H NMR 
(300 MHz, CDCl3):  = 0.83 (t, 6H, J 
= 6.7 Hz, 2CH3), 1.24-1.31 (m, 21H, 6CH2 and 3CH3),  1.63-1.73 (m, 4H, 2CH2), 3.73 (s, 3H, 
NCH3), 4.23 (t, 2H, J = 6.8 Hz, CH2O), 4.25 (t, 2H, J = 6.8 Hz, CH2O), 6.54 (s, 1H, CHpyrrole), 
7.37 (dd, 2H, J = 2.0, 6.6 Hz, ArH), 7.44 (dd, 2H, J = 2.1, 6.5 Hz, ArH), 7.67 (s, 1H, ArH), 
7.93 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 (2CH3), 22.6 (2CH2), 25.7 (2CH2), 
28.6, 28.7 (CH2), 31.3 (3CH3), 31.4 (NCH3), 31.5 (2CH2), 34.7 (C), 65.5, 65.7 (CH2O), 102.7, 
111.1, 122.1 (CH), 124.2, 125.6 (C), 125.6 (2CH), 128.8, 129.1 (C), 129.1 (2CH), 138.3, 
145.1, 151.8 (C), 168.9, 169.0 (CO). IR (KBr, cm
1
): v = 2953, 2927 (m), 2856 (w), 1712 (s), 
1611, 1494 (w), 1458, 1361, 1340 (m), 1255, 1234 (s), 1157 (m), 1106 (s), 1077, 1021 (m), 
894 (w), 839, 784 (m), 697, 565 (w). MS (EI, 70 eV): m/z (%) = 519(100) [M
+
], 335(10), 
334(49), 69(15), 69(15), 43(28). HRMS (EI, 70 eV): calcd for C33H45NO4 [M]
+
: 519.33431; 
found: 519.33467. 
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Diethyl-2-(4-tert-butylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50m): 
Compound 50m was prepared starting with 49m (100 
mg, 0.24 mmol), following the general procedure G, 
as brownish solid (74 mg, 75%), mp. 113-115 °C. 
1
H 
NMR (250 MHz, CDCl3):  = 1.29-1.34 (m, 15H, 
5CH3), 3.73 (s, 3H, NCH3), 4.29 (q, 2H, J = 7.0 Hz, 
CH2O), 4.30 (q, 2H, J = 7.1 Hz, CH2O), 6.53 (s, 1H, CHpyrrole), 7.37 (d, 2H, J = 8,4 Hz, ArH), 
7.44 (d, 2H, J = 8,4 Hz, ArH), 7.68 (s, 1H, ArH), 7.94 (s, 1H, ArH). 
13
C NMR (62 MHz, 
CDCl3):  = 13.2 (2CH3), 30.2 (3CH3), 30.5 (NCH3), 33.7 (C), 60.2, 61.3 (CH2O), 101.6, 
110.2, 121.1 (CH), 123.2, 124.4 (C), 124.6 (2CH), 127.8 (C), 128.0 (2CH), 128.1, 137.3, 
144.1, 150.8 (C), 167.8, 167.9 (CO). IR (KBr, cm
1
): v = 2956 (m), 2853 (w), 1713 (s), 1611, 
1560, 1494 (w), 1475, 1463 (m), 1430, 1392 (w), 1370, 1338 (m), 1255, 1235 (s), 1209, 1157 
(m), 1103 (s), 1042, 1021 (m), 841, 784 (m), 737, 646, 604 (w), 566 (m). GC-MS (EI, 70 eV): 
m/z (%) = 407(100) [M]
+
, 392(24), 334(30), 144(13). HRMS (EI, 70 eV): calcd for 
C25H29NO4 [M]
+
: 407.20911; found: 407.20967. 
 
Bis(2-ethylhexyl)-2-(3,5-dimethylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50n): 
Compound 50n was prepared starting 
with 49n (100 mg, 0.18 mmol), 
following the general procedure G, as a 
brown oil (76 mg, 77%). 
1
H NMR (300 
MHz, CDCl3):  = 0.82 (t, 6H, J = 7.0 
Hz, 2CH3), 0.86 (t, 6H, J = 7.5 Hz, 
2CH3), 1.26-1.43 (m, 16H, 8CH2), 1.58-1.66 (m, 2H, 2CH), 2.31 (s, 6H, 2CH3), 3.70 (s, 3H, 
NCH3), 4.13-4.18 (m, 4H, 2CH2O), 6.52 (s, 1H, CHpyrrole), 7.00 (s, 1H, ArH), 7.03 (s, 2H, 
ArH), 7.65 (s, 1H, ArH), 7.92 (s, 1H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 11.0 (2CH3), 
14.1 (2CH3), 21.3 (2CH3), 23.0 (2CH2), 23.8 (2CH2), 28.9 (2CH2), 30.5 (2CH2), 31.4 (NCH3), 
38.7, 38.8 (CH), 67.8, 68.0 (CH2O), 102.6, 111.1, 122.1 (CH), 124.3, 125.8 (C), 127.2 (2CH), 
129.0 (C), 130.3 (CH), 131.6, 138.2 (C), 138.3 (2C), 145.3 (C), 168.8, 169.1 (CO). IR (KBr, 
cm
1
): v = 2955, 2925 (m), 2857 (w), 1712 (s), 1602, 1536 (w), 1460, 1379, 1361, 1338 (m), 
1257, 1228 (s), 1155 (m), 1104 (s), 1076, 1032 (m), 995, 959, 897 (w), 853, 785, 785, 731, 
703 (m), 670, 642, 543 (w). GC-MS (EI, 70 eV): m/z (%) = 547(64) [M]
+
, 324(21), 323(100), 
307(88), 306(99), 290 (13), 279(19), 261(21), 250(13), 234(49), 222(18), 218(23), 208(15), 
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191(15), 116(10), 83(13), 70(26), 57(71), 43(21). HRMS (ESI): calcd for C35H50NO4 [M+H]
+
: 
548.3734; found: 548.3744. 
 
Dibutyl-2-(3,5-dimethylphenyl)-1-methyl-1H-indole-5,6-dicarboxylate (50o): 
Compound 50o was prepared starting with 49o 
(100 mg, 0.23 mmol), following the general 
procedure G, as a brown oil (87 mg, 88%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.89 (t, 6H, J = 
7.4 Hz, 2CH3), 1.32-1.44 (m, 4H, 2CH2), 1.60-
1.71 (m, 4H, 2CH2), 2.31 (s, 6H, 2CH3), 3.70 
(s, 3H, NCH3), 4.23 (t, 2H, J = 6.7 Hz, CH2O), 4.25 (t, 2H, J = 6.7 Hz, CH2O), 6.51 (s, 1H, 
CHpyrrole), 6.99 (s, 1H, ArH), 7.03 (s, 2H, ArH), 7.65 (s, 1H, ArH), 7.92 (s, 1H, ArH). 
13
C 
NMR (75 MHz, CDCl3):  = 13.8 (2CH3), 19.3 (2CH2), 21.4 (2CH3), 30.7, 30.8 (CH2), 31.5 
(NCH3), 65.2, 65.4 (CH2O), 102.7, 111.2, 122.1 (CH), 124.2, 125.6 (C), 127.2 (2CH), 129.1 
(C), 130.3 (CH), 131.6, 138.3 (C), 138.3 (2C), 145.3 (C), 168.9, 169.0 (CO). IR (KBr, cm
1
): 
v = 2956, 2930, 2871 (w), 1710 (s), 1601, 1534 (w), 1456, 1383, 1360, 1337 (m), 1255, 1224 
(s), 1155 (m), 1104 (s), 1060, 1032 (m), 944, 897 (w), 852, 784, 733, 703, 669 (m), 642, 543 
(w). GC-MS (EI, 70 eV): m/z (%) = 435(100) [M]
+
, 307(22), 306(97), 305(12), 233(13). 
HRMS (EI, 70 eV): calcd for C27H33NO4 [M]
+
: 435.24041; found: 435.24084. 
 
Synthesis of furo[3,4-f]indole (51): 
 
2-(4-Ethylphenyl)-1-methyl-1H-furo[3,4-f]indole-5,7-dione (51a): 
Compound 51a was prepared starting with 49q (100 mg, 
0.23 mmol), following the general procedure G, as 
yellowish oil (44 mg, 63%). 
1
H NMR (300 MHz, CDCl3): 
 = 1.24 (t, 3H, J = 7.6 Hz, CH3), 2.69 (q, 2H, J = 7.6 Hz, 
CH2), 3.82 (s, 3H, NCH3), 6.73 (s, 1H, CHpyrrole), 7.30 (d, 
2H, J = 8.2 Hz, ArH), 7.38 (dd, 2H, J = 1.8, 6.4 Hz, ArH), 7.88 (s, 1H, ArH), 8.12 (s, 1H, 
ArH). 
13
C NMR (75 MHz, CDCl3):  = 15.4 (CH3), 28.7 (CH2), 31.9 (NCH3), 104.5, 107.6, 
118.8 (CH), 122.2, 123.2, 127.9 (C), 128.5 (2CH), 129.4 (2CH), 133.7, 141.3, 145.9, 148.1 
(C), 164.3, 164.5 (CO). IR (KBr, cm
1
): v = 3032, 2965, 2921, 2851 (w), 1829 (m), 1748 (s), 
1594, 1587 (m), 1565, 1541 (w), 1485, 1459, 1435, 1401, 1357, 1260, 1241, 1209, 1165, 
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1135, 1021 (m), 878, 838, 802,736 (s), 717, 639, 632 (m), 584 (s), 542 (m). GC-MS (EI, 70 
eV): m/z (%) = 305(100) [M]
+
, 234(15), 233(80), 218(27), 109(12). HRMS (ESI): calcd for 
C19H16NO3 [M+H]
+
: 306.11247; found: 306.11168. 
 
1-Methyl-2-p-tolyl-1H-furo[3,4-f]indole-5,7-dione (51b): 
Compound 51b was prepared starting with 49r (100 mg, 
0.24 mmol), following the general procedure G, as 
yellowish solid (51 mg, 72%), mp 240-242 °C. 
1
H NMR 
(300 MHz, CDCl3):  = 2.39 (s, 3H, CH3), 3.81 (s, 3H, 
NCH3), 6.73 (s, 1H, CHpyrrole), 7.28 (d, 2H, J = 8.0 Hz, 
ArH), 7.35 (d, 2H, J = 8.1 Hz, ArH), 7.87 (s, 1H, ArH), 8.11 (s, 1H, ArH). 
13
C NMR (62 
MHz, CDCl3):  = 20.4 (CH3), 30.9 (NCH3), 103.4, 106.6, 117.8 (CH), 121.1, 122.2, 126.7 
(C), 128.3 (2CH), 128.6 (2CH), 132.6, 138.6, 140.2, 147.0 (C), 163.3, 163.5 (CO). IR (KBr, 
cm
1
): v = 3093, 3044, 2946, 2852 (w), 1828, 1805 (m), 1749 (s), 1693, 1588, 1481, 1463, 
1434, 1401, 1359, 1261, 1135, 1059 (m), 889, 814, 785, 734 (s), 723, 712, 677 (m), 637 (s), 
609 (m), 584 (s), 541 (m). GC-MS (EI, 70 eV): m/z (%) = 291(100) [M]
+
, 220(16), 219(90), 
218(15), 109(12). HRMS (ESI): calcd for C18H14NO3 [M+H]
+
: 292.09682; found: 292.09706. 
 
General procedure H for synthesis of 2,3-dihydrocarbazoles (54), 2,3,5,6-tetraalkenyl-N-
methylindole (56) and 2,3,4,5-tetraalkenyl-N-methylpyrrole (59): 
 
In a pressure tube (glass bomb) a suspension of Pd(OAc)2 (12 mg, 0.05 mmol) and SPhos or 
P(Cy)3 (10 mol %) in DMF (5 mL) was purged with argon and stirred at 20 °C to get a 
yellowish or brownish transparent solution. To the stirred solution were added the 
brominated indole 53 or pyrrole 58 (1.0 mmol), NEt3 (1.1 mL, 8.0 mmol) and the alkene 26 
(1.25 equiv per Br). The reaction mixture was stirred at 90-120 °C for 12-48 h. The solution 
was cooled to 20 °C, poured into H2O and CH2Cl2 (25 mL each), and the organic and the 
aqueous layer were separated. The latter was extracted with CH2Cl2 (3×25 mL). The 
combined organic layers were washed with H2O (3×20 mL), dried (Na2SO4), and 
concentrated in vacuo. The residue was purified by chromatography (flash silica gel, 
heptanes/EtOAc). 
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Dimethyl-6,7-bis[(E)-3-methoxy-3-oxoprop-1-enyl]-9-methyl-2,9-dihydro-1H-carbazole-
2,3-dicarboxylate (54a): 
Product 54a was prepared starting with 53 
(446 mg, 1.0 mmol), 2-ethylhexyl acrylate  (0.5 
mL, 5.0 mmol), Pd(OAc)2 (11 mg, 5 mol %), 
SPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), 
DMF (5 mL) at 120 °C for 48 h following 
general procedure H, as a yellow highly viscous 
oil (316 mg, 68%). 
1
H NMR (300 MHz, CDCl3): δ = 3.01-3.61 (m, 2Hα/β, C-1), 3.52 (s, 3H, 
NCH3), 3.62 (s, 3H, OCH3), 3.71 (s, 6H, 2 OCH3), 3.81 (s, 3H, OCH3), 4.01 (br d, 1H, J = 
7.2 Hz, C-2), 6.42 (d, 1H, J = 15.6 Hz, CH), 6.43 (d, 1H, J  = 15.6 Hz, CH), 7.32 (s, 1H, 
ArH), 7.71 (s, 1H, ArH), 7.82 (s, 1H, CH), 8.02 (d, 1H, J = 15.8 Hz, CH), 8.03 (d, 1H, J = 
15.7 Hz, CH). 
13
C NMR (62 MHz, CDCl3): δ = 23.9 (CH2), 30.0 (NCH3), 38.6 (C(4)H), 51.6, 
51.7, 51.8, 52.6 (CH3O), 108.5 (CH), 109.7 (C), 117.1 (CH), 117.3 (C), 119.1, 119.2 (CH), 
126.4, 127.8, 128.3 (C), 131.4 (CH), 138.8 (C), 142.6, 142.7 (CH), 142.9 (C), 167.0, 167.1, 
167.3, 173.4 (CO). IR (KBr, cm
−1
): ν = 2950, 2921, 2851 (w), 1693, 1625, 1602, 1525, 1433, 
1365 (s), 1310, 1271, 1228, 1189, 1162, 1088 (m), 1035, 972, 912, 919, 853, 802, 775, 725 
(s). GC-MS (EI, 70 eV): m/z (%) = 467(75) [M
+
], 434(38), 405(100), 374(59), 347(26), 
316(15). HRMS (ESI): m/z calcd for C25H25NNaO8 [M+Na]
+
: 490.14724; found: 490.14693. 
 
Diethyl-6,7-bis[(E)-3-ethoxy-3-oxoprop-1-enyl]-9-methyl-2,9-dihydro-1H-carbazole-2,3-
dicarboxylate (54b): 
Compound 54b was synthesized starting with 53 
 (446 mg, 1.0 mmol), following general procedure 
H, as a yellow highly viscous oil (450 mg, 
86%). 
1
H NMR (250 MHz, CDCl3): δ = 1.10 (t, 
3H, J = 7.0 Hz, CH3), 1.30 (t, 6H, J = 7.1 Hz, 
2CH3), 1.30 (t, 3H, J = 7.0 Hz, CH3), 3.00 (dd, 
1Hα, J = 8.8, 17.1 Hz, H-1), 3.60 (dd, 1Hβ, J = 2.3, 17.1 Hz, H-1), 3.70 (s, 3H, NCH3), 3.90-
4.00 (m, 2H, CH2O), 4.10 (dd, 1Hα, J = 2.6, 9.0 Hz, H-2), 4.20-4.30 (m, 6H, 3CH2O), 6.20 (d, 
1H, J = 15.7 Hz, CH), 6.30 (d, 1H, J = 15.7 Hz, CH), 7.40 (s, 1H, ArH), 7.70 (s, 1H, ArH), 
7.80 (s, 1H, H-4), 8.00 (d, 1H, J = 15.8 Hz, CH), 8.10 (d, 1H, J = 15.8 Hz, CH). 
13
C NMR 
(62 MHz, CDCl3): δ = 14.0 (CH3), 14.3 (2CH3), 14.5 (CH3), 23.8 (CH2), 30.0 (NCH3), 38.8 
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(CH, C-2), 60.4, 60.5, 60.5, 61.3 (CH2O), 108.6 (CH), 109.8 (C), 117.3 (CH), 118.0 (C), 
119.6, 119.8 (CH), 126.4, 127.9, 128.8 (C), 130.8 (CH), 138.8 (C), 142.5, 142.6 (CH), 142.7 
(C), 166.6, 166.7, 166.9, 172.9 (CO). IR (KBr, cm
−1
): ν = 2989, 2934, 2903 (w), 1694, 1625, 
1604 9 (s), 1528, 1477, 1464, 1446, 1392, 1367 (m), 1274, 1220, 1158 (s), 1111, 1092, 1034, 
973, 914, 855 (m), 777 (w), 727 (m), 660, 646, 612, 558 (w). GC–MS (EI, 70 eV): m/z (%) = 
523(100) [M
+
], 478(18), 450(88), 404(84), 375(23), 332(22), 303(34), 275(25), 231(51), 
217(9). HRMS (EI, 70 eV): calcd for C29H33NO8 [M
+
]: 523.22062; found: 523.22073. 
 
Dibutyl-6,7-bis[(E)-3-butoxy-3-oxoprop-1-enyl]-9-methyl-2,9-dihydro-1H-carbazole-2,3-
dicarboxylate (54c): 
Product 54c was prepared starting 
with 53 (446 mg, 1.0 mmol), n-
butyl acrylate (0.70 mL, 5.0 
 mmol), Pd(OAc)2 (11 mg, 5 mol  
%), SPhos (10 mol %), NEt3 
(1.10 mL, 8.0 mmol), DMF (5  
mL) at 120 °C for 48 h following general procedure H, as a yellow highly viscous oil 
(450 mg, 71%). 
1
H NMR (300 MHz, CDCl3): δ = 0.9 (t, 3H, J = 7.2 Hz, CH3), 0.9 (t, 3H, J = 
7.4 Hz, CH3), 0.9 (t, 6H, J = 7.3 Hz, 2CH3), 1.3-1.4 (m, 8H, 4CH2), 1.6–1.7 (m, 8H, 4CH2), 
3.0 (dd, 1Hα, J = 8.5, 17.3, Hz, C-1), 3.6 (dd, 1Hβ, J = 2.0, 17.2 Hz, C-1), 3.7 (s, 3H, NCH3), 
4.0 (dd, 1H, J = 2.0, 8.8 Hz, C-2), 4.1 (t, 4H, J = 6.7 Hz, 2CH2O), 4.2 (t, 4H, J = 6.7 Hz, 
2CH2O), 6.2 (d, 1H, J = 15.5 Hz, CH), 6.3 (d, 1H, J = 16.4 Hz, CH), 7.4 (s, 1H, ArH), 7.8 (s, 
1H, ArH), 7.8 (s, 1H, C-4), 8.0 (d, 1H, J = 16.4 Hz, CH), 8.0 (d, 1H, J = 15.5 Hz, CH). 
13
C 
NMR (62 MHz, CDCl3): δ = 13.6 (CH3), 13.7 (2CH3), 13.8 (CH3), 18.9 (CH2), 19.2 (2CH2), 
19.3 (CH2), 23.8 (CH2), 30.0 (NCH3), 30.4 (CH2), 30.8 (2CH2), 30.9 (CH2), 38.8 (CH, C-2), 
64.4 (CH2O), 64.5 (2CH2O), 65.2 (CH2O), 108.6 (CH), 109.9 (C), 117.4 (CH), 118.2 (C), 
119.7, 119.9 (CH), 126.4, 128.0, 128.5 (C), 130.7 (CH), 138.8 (C), 142.6, 142.7 (CH) 142.8 
(C), 166.7, 166.8, 167.0, 172.9 (CO). IR (KBr, cm
−1
): ν = 2932 (w), 1698, 1624, 1604, 1528 
(s), 1464 (m), 1700, 1622 (s), 1548, 1380, 1287, 1274, 1243, 1213 (m), 1168 (s), 1062, 1025, 
965, 864 (m), 780, 738, 721, 549 (w). MS (EI, 70 eV): m/z (%) = 635(12) [M]
+
, 591(2), 
531(7), 380(24), 379(100), 304(5), 215(20), 67(12). HRMS: m/z calcd for C37H49NO8 [M]
+
: 
635.34527; found: 635.34556. 
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 Di(isobutyl)-6,7-bis[(E)-3-isobutoxy-3-oxoprop-1-enyl]-9-methyl-2,9-dihydro-1H-
carbazole-2,3-dicarboxylate (54d): 
Compound 54d was synthesized starting 
with 53 (455 mg, 1.0 mmol) and iso-butyl 
 acrylate (0.72 mL, 5.0 mmol) following 
general procedure H, as a yellow highly 
viscous oil (455 mg, 72%). 
1
H NMR 
(250 MHz, CDCl3): δ = 0.70 (d, 6H, J = 
6.9 Hz, 2CH3), 0.90-1.00 (m, 18H, 6CH3) 
, 1.70-1.80 (m, 3H, CH), 1.90-2.00 (m, 1H, CH), 3.00 (dd, 1Hα, J = 8.6, 17.2 Hz, H-1), 3.60 
(dd, 1Hβ, J = 1.8, 17.3 Hz, H-1), 3.60-3.70 (m, 5H, NCH3 and CH2O), 3.90-4.00 (m, 6H, 
3CH2O), 4.00-4.10 (dd, 1Hα, J = 1.6, 8.4 Hz, H-2), 6.20 (d, 1H, J = 15.6 Hz, CH), 6.30 (d, 
1H, J = 15.6 Hz, CH), 7.40 (s, 1H, ArH), 7.70 (s, 1H, ArH), 7.80 (s, 1H, H-4), 8.10 (d, 2H, J 
= 15.6 Hz, CH). 
13
C NMR (75 MHz, CDCl3): δ = 18.7 (CH3), 18.8 (CH3), 19.2 (4CH3), 19.3 
(2CH3), 23.7 (CH2), 27.6 (CH), 27.8 (2CH), 27.9 (CH), 30.0 (NCH3), 38.7 (CH, C-2), 70.5, 
70.6, 70.7, 71.2 (CH2O), 108.6 (CH), 109.8 (C), 117.3 (CH), 118.2 (C), 119.6, 119.8 (CH), 
126.4, 127.9, 128.3 (C), 130.5 (CH), 138.8 (C), 142.5, 142.6 (CH), 142.9 (C), 166.6, 166.7, 
166.9, 172.8 (CO). IR (KBr, cm
−1
): ν = 2958, 2932, 2873 (w), 1702, 1692 (s), 1623, 1605, 
1528, 1483, 1468, 1393, 1375, 1342, 1287, 1271 (m), 1219, 1163 (s), 1084, 1035, 980 (m), 
945, 908, 884, 863, 778, 729, 645, 613, 572 (w). GC-MS (EI, 70 eV): m/z (%) = 635(100) 
[M
+
], 578(27), 498(55), 409(43), 375(32), 333(51), 288(16), 275(33), 196(22), 173(77). 
HRMS (EI, 70 eV): calcd for C37H49NO8 [M
+
]: 635.34582; found: 635.34571. 
 
Di(tert-butyl)-6,7-bis[(E)-3-tert-butoxy-3-oxoprop-1-enyl]-9-methyl-2,9-dihydro-1H-
carbazole-2,3-dicarboxylate (54e): 
Compound 54e was synthesized starting 
with 53 (446 mg, 1.0 mmol), following 
general procedure H, as a yellow highly 
viscous oil (463 mg, 72%). 
1
H NMR 
(250 MHz, CDCl3): δ = 1.30 (s, 9H, 
3CH3), 1.50 (s, 18H, 6CH3), 1.50 (s, 9H, 
3CH3), 3.00 (dd, 1Hα, J = 8.9, 17.2 Hz, H-1), 3.50 (dd, 1Hβ,, J = 2.2, 17.2 Hz, H-1), 3.70 (s, 
3H, NCH3), 3.90 (dd, 1Hα, J = 2.2, 8.6 Hz, H-2), 6.20 (d, 1H, J = 15.5 Hz, CH), 6.30 (d, 1H, J 
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= 15.5 Hz, CH), 7.40 (s, 1H, ArH), 7.70 (s, 1H, ArH), 7.80 (s, 1H, H-4), 7.90 (d, 1H, J = 
15.7 Hz, CH), 8.00 (d, 1H, J = 15.7 Hz, CH). 
13
C NMR (75 MHz, CDCl3): δ = 23.6 (CH2), 
27.9 (3CH3), 28.1 (CH3), 28.3 (6CH3), 28.4 (2CH3), 30.0 (NCH3), 39.5 (C(2)H), 80.1, 80.4, 
80.5, 81.3 (C), 108.4 (CH), 109.7 (C), 117.2 (CH), 120.3 (C), 121.3, 121.6 (CH), 126.4, 
127.9, 128.4 (C), 129.3(CH), 138.7 (C), 141.8, 141.9 (CH), 142.6 (C), 166.0, 166.1, 166.4, 
172.1 (CO). IR (KBr, cm
−1
): ν = 2977, 2929 (w), 1713 (s), 1611, 1530, 1478, 1455, 1392, 
1367, 1285, 1256, 1221 (m), 1152 (s), 1089, 979, 847, 794, 530 (w). MS (EI, 70 eV): m/z (%) 
= 635(15) [M
+
], 634(10), 577(46), 562(100), 259(25), 225(50), 181(97), 63(37). HRMS (EI, 
70 eV): calcd for C37H49NO8 [M
+
]: 635.34582; found: 635.34535. 
 
Dihexyl-6,7-bis[(E)-3-(hexyloxy)-3-oxoprop-1-enyl]-9-methyl-2,9-dihydro-1H-carbazole-
2,3-dicarboxylate (54f): 
 
 
 
 
 
 
 
Product 54f was prepared starting with 53 (446 mg, 1.0 mmol), n-hexyl acrylate (0.9 mL, 
5.0 mmol), Pd(OAc)2 (11 mg, 5 mol %), SPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF 
(5 mL) at 120 °C for 48 h following general procedure H, as a yellow highly viscous oil 
(598 mg, 80%). 
1
H NMR (300 MHz, CDCl3): δ = 0.81-0.93 (m, 12H, CH3), 1.32-1.41 (m, 
16H, 8CH2), 1.61-1.72 (m, 16H, 8CH2), 3.00 (dd, 1Hα, J = 8.5, 17.1 Hz, C-1); 3.61 (dd, 1Hβ, J 
= 2.1, 17.1 Hz, C-1), 3.82 (s, 3H, NCH3), 3.91 (dd, 1Hα, J = 1.7, 6.7 Hz, C-2), 4.12-4.22 (m, 
8H, 4CH2O), 6.31 (d, 2H, J = 16.0 Hz, CH), 7.30 (s, 1H, ArH), 7.49 (s, 1H, ArH), 8.01 (s, 1H, 
C-4), 8.02 (d, 2H, J = 16.0 Hz, CH). 
13
C NMR (62.9 MHz, CDCl3): δ = 14.0 (4CH3), 22.5 
(4CH2), 25.7 (3CH2), 28.4 (CH2), 28.7 (2CH2), 28.8, 29.7 (CH2), 30.1 (NCH3 ), 31.2 (CH2), 
31.5 (3CH2), 31.6 (CH2), 33.3 (C(2)H), 64.5, 64.8, 64.8, 65.4 (CH2O), 108,9 (CH), 109.6, 
112.8 (C), 120.0, 120.4, 120.5 (CH), 127.4, 128.1, 129.6 (C), 136.6 (CH), 138.6, 138.7 (C), 
142,5, 142.6 (CH), 166.6, 166.8, 168.0, 172.8 (CO). IR (KBr, cm
−1
): ν = 2953, 2926, 2856 
(w), 1701, 1622, 1605 (s), 1551, 1527, 1465, 1455, 1378, 1337 (w), 1242 (m), 1159 (s), 973, 
908, 849, 728, 674, 648, 605 (w). MS (EI, 70 eV): m/z (%) = 747(10) [M
+
], 596(11), 595(31), 
205 
 
594(37), 595(100), 492(20), 465(16), 464(33), 463(68), 407(07), 380(30), 362(35), 336(13), 
355(18), 278(13), 251(13), 234(23). HRMS: m/z calcd for C45H65NO8 [M
+
]: 747.47047; 
found: 747.46850. 
 
Bis(2-ethylhexyl)-6,7-bis[(E)-3-(2-ethylhexyloxy)-3-oxoprop-1-enyl]-9-methyl-2,9-
dihydro-1H-carbazole-2,3-dicarboxylate (54g): 
 
 
 
 
 
 
 
Product 54g was prepared starting with 53 (446 mg, 1.0 mmol), 2-ethylhexyl acrylate 
(1.10 mL, 5.0 mmol), Pd(OAc)2 (11 mg, 5 mol %), SPhos (10 mol %), NEt3 (1.10 mL, 8.0 
 mmol), DMF (5 mL) at 120 °C for 48 h following general procedure H, as a yellow highly 
viscous oil (618 mg, 72%). 
1
H NMR (300 MHz, CDCl3): δ = 0.82-0.93 (m, 24H, 8CH3), 1.21-
1.43 (m, 32H, Aliphatic), 1.51-1.62 (m, 4H, CH-aliphatic), 2.98-3.06 (m, 1Hα, C-1), 3.58-3.64 
(m, 1Hβ, C-1), 3.71 (s, 3H, NCH3), 3.82 (m, 1Hα, C-2), 4.12 (dd, 8H, J = 2.4, 5.8 Hz, 4CH2O), 
6.32 (d, 1H, J = 15.7 Hz, CH), 6.33 (d, 1H, J = 15.7 Hz, CH), 7.41 (s, 1H, ArH), 7.72 (s, 1H, 
ArH), 7.83 (s, 1H, C(4)), 8.01 (d, 1H, J = 15.7 Hz, CH), 8.12 (d, 1H, J = 15.7 Hz, CH). 
13
C 
NMR (62 MHz, CDCl3): δ = 10.9 (CH3), 11.0 (3CH3), 14.1 (4CH3), 23.0 (5CH2), 23.9 
(4CH2), 29.0 (4CH2), 29.7 (2CH2), 30.1 (NCH3), 30.5 (2CH2), 31.2, 38.6, 38.7 (CH), 38.9 
(CH(2)), 38.9 (CH), 67.0, 67.1, 67.3, 67.5 (CH2O), 108.6 (CH), 110.0 (C), 117.3 (CH), 118.0 
(C), 119.7, 120.0 (CH),  126.4, 128.0, 128.5 (C), 130.5 (CH), 138.8 (C), 142.5, 142.6 (CH), 
142.8 (C), 166.8, 166.9, 167.0, 173.0 (CO). IR (KBr, cm−1): ν = 2928, 2925, 2858 (w), 1703 
(s), 1631, 1605, 1528, 1460, 1380, 1265, 1220 (m), 1161 (s), 1113, 1085, 1031, 974 (m), 852, 
773, 730, 695, 645, 609 (w). MS (EI, 70 eV): m/z (%) = 859(12) [M
+
], 699(10), 590(11), 
588(11), 572(11), 460(5), 83(20), 71(22), 70(11), 69(16), 57(100), 44(93). HRMS: m/zcalcd 
for C53H81NO8 [M
+
]: 859.596901; found: 859.59567. 
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General procedure I for the transformation of 1,2-dihydrocarbazoles (54)  to carbazoles 
(55): 
 
To solution of xylene (5 mL) were added the 1,2-dihydrocarbazole (54)  (0.25 mmol) and 
Pd/C (10 mg, 10 mol %). The solution was stirred under reflux for 48 h under argon 
atmosphere. The reaction mixture was filtered and the filtrate was concentrated in vacuo. 
 
Dimethyl-6,7-bis[(E)-3-methoxy-3-oxoprop-1-enyl]-9-methyl-9H-carbazole-2,3-
dicarboxylate (55a): 
Compound 55a was synthesized starting with  
54a (100 mg, 0.22 mmol), following general 
procedure I, as a yellow highly viscous oil 
(99 mg, 100%). 
1
H NMR (300 MHz, CDCl3): δ 
= 3.54 (s, 3H, CH3), 3.64 (s, 3H, CH3), 3.74 (s, 
6H, 2CH3), 3.77 (s, 3H, CH3), 6.3 (d, 1H, J = 
15.6 Hz, CH), 6.4 (d, 1H J = 16.3 Hz, CH), 7.4 (s, 1H, ArH), 7.5 (s, 1H, ArH), 8.0 (d, 1H, J = 
15.6 Hz, CH), 8.1 (d, 1H, J = 15.6 Hz, CH), 8.5 (s, 2H, ArH). 
13
C NMR (75 MHz, CDCl3): δ 
= 29.6 (NCH3), 52.5, 52.6, 52.8, 52.9 (CH3O), 107.9, 109.4, 119.6, 120.2, 122.7, 122.9 (CH), 
123.1, 123.8, 124.5, 125.5, 126.0, 126.9, 128.9, 133.7 (C), 142.0, 142.4 (CH), 166.7, 167.1, 
167.8, 169.4 (CO). IR (KBr, cm
−1
): ν = 3089 (w), 1652 (s), 1455, 1277 (m), 1097, 1060 (s), 
912 (w), 845, 798, 699 (s). GC-MS (EI, 70 eV): m/z (%) = 465(53) [M
+
], 434(31), 405(100), 
374(83). HRMS: m/z calcd for C25H23NO8 [M
+
]: 465.14181; found: 465.141506. 
 
Dibutyl-6,7-bis[(E)-3-butoxy-3-oxoprop-1-enyl]-9-methyl-9H-carbazole-2,3-dicarboxylate 
(55c): 
Compound 55c was synthesized 
starting with 54c (100 mg, 0.16 
 mmol), following general 
procedure I, as a yellow highly 
viscous oil (98 mg, 100%). 
1
H 
NMR (300 MHz, CDCl3): δ = 
0.9 (t, 3H, J =7.3 Hz, CH3), 0.9 (t, 3H, J = 7.3 Hz, CH3), 0.9 (t, 3H, J = 7.5 Hz, CH3), 0.9 (t, 
3H, J = 7.3 Hz, CH3), 1.3-1.4 (m, 8H, 4CH2), 1.6-1.7 (m, 8H, 4CH2), 3.7 (s, 3H, NCH3), 4.1 
(t, 4H, J = 6.7 Hz, 2CH2O), 4.2 (t, 2H, J = 7.1 Hz, CH2O), 4.3 (t, 2H, J = 6.9 Hz, CH2O), 6.3 
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(d, 1H, J = 15.9 Hz, CH), 6.4 (d, 1H, J = 15.9 Hz, CH), 7.4 (s, 1H, ArH), 7.4 (s, 1H, ArH), 8.0 
(d, 1H, J = 15.2 Hz, CH), 8.1 (d, 1H, J = 15.8 Hz, CH), 8.1 (s, 1H, ArH), 8.3 (s, 1H, 
ArH). 
13
C NMR (75.5 MHz, CDCl3):  = 13.7 (3CH3), 13.7 (CH3), 19.2 (CH2),  19.2 (2CH2), 
19.3 (CH2), 29.5 (NCH3), 30.6 (CH2), 30.7 (2CH2), 30.8 (CH2), 64.5, 64.6, 65.4, 65.8 (CH2O), 
107.7, 109.2, 119.8, 120.0, 121.8, 122.5 (CH), 122.5, 122.9, 123.6, 126.8, 132.4, 133.6 (C), 
141.6, 142.0 (CH), 142.7 (2C),  166.3, 166.7, 167.2, 168.9 (CO). IR (KBr, cm
−1
): ν = 2957, 
2932, 2872 (w), 1705 (s), 1623, 1596, 1561, 1463 (m), 1387, 1341 (w), 1262, 1226, 1162, 
1107 (s), 1080, 1063, 1021, 967 (m), 906, 856, 774, 737, 713, 659, 618, 594 (w). MS (EI, 
70 eV): m/z (%) = 633(24) [M
+
], 560(09), 531(69), 507(100), 458(29), 378(41), 302(28). 
HRMS (ESI): m/z calcd for C37H48NO8 [M+H]
+
: 634.33744; found: 634.33799. 
 
Bis(2-ethylhexyl)-6,7-bis[(E)-3-(2-ethylhexyloxy)-3-oxoprop-1-enyl]-9-methyl-9H-carbazole-
2,3-dicarboxylate (55g): 
 
 
 
Compound 55g was synthesized starting with 54g (100 mg, 0.12  mmol), follow ing general 
proce dure I, as a yellow highly viscous oil (99 mg, 100%). 
1
H NMR (300 MHz, CDCl3): δ = 
0.8-0.9 (m, 24H, 8CH3), 1.2-1.4 (m, 32H, CH-aliphatic), 1.6-1.7 (m, 4H, aliphatic), 3.9 (s, 3H, 
NCH3), 4.1 (dd, 4H, J = 2.6, 5.7 Hz, 2CH2O), 4.2 (dd, 4H, J = 2.6, 5.7 Hz, 2CH2O), 6.4 (d, 
1H, J = 15.7 Hz, CH), 6.4 (d, 1H, J = 15.7 Hz, CH), 7.5 (s, 1H, ArH), 7.6 (s, 1H, ArH), 8.1 (d, 
1H, J = 15.7 Hz, CH), 8.2 (d, 1H, J = 15.8 Hz, CH), 8.3 (s, 1H, ArH), 8.5 (s, 1H, ArH). 
13
C 
NMR (62.9 MHz, CDCl3): δ = 10.9 (3CH3), 11.0 (CH3), 14.1 (4CH3), 23.0 (2CH2), 23.7 
(2CH2), 23.8 (2CH2), 23.9 (2CH2), 28.9 (2CH2), 29.0 (2CH2), 29.6 (NCH3), 30.4 (2CH2), 30.5 
(2CH2), 30.9, 38.5, 38.7, 38.8, (CH), 67.1, 67.3, 68.1, 68.5 (CH2O), 107.8, 109.4, 120.1, 
120.3, 122.0, 122.7 (CH), 122.9, 123.1, 123.8, 127.0, 132.7, 133.8 (C), 141.8, 142.2 (CH), 
142.8, 142.9 (C), 166.5, 166.8, 167.4, 169.1 (CO). IR (KBr, cm
−1
): ν = 2927(w), 1712, 1624, 
1601, 1562, 1459, 1379, 1260, 1229, 1165, 1108, 1081, 1015, 975, 858, 774, 726, 615 (s). 
GC-MS (EI
+
, 70 eV): m/z (%) = 857(23) [M
+
], 699(23), 588(27), 346(18), 302(29). 
HRMS: m/z calcd for C53H79NO8 [M
+
]: 857.5806; found: 857.5803. 
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Synthesis of 2,3,5,6-tetra(alkenyl)-N-methylindoles (56): 
 
(2E,2′E,2″E,2″′E)-Tetraethyl-3, 3′,3″,3″′-(1-methyl-1H-indole-2,3,5,6-tetrayl) tetraacrylate 
(56b): 
Product 56b was prepared starting with 53  
(446 mg, 1.0 mmol), ethyl acrylate (0.6 mL, 
5.0 mmol), Pd(OAc)2 (11 mg, 5 mol %), SPhos  
(10 mol %), NEt3 (1.10 mL, 8.0 mmol), DMF 
(5 mL) at 90 °C for 36 h following general 
procedure H, as a yellow highly viscous oil 
(397 mg, 76%). 
1
H NMR (300 MHz, CDCl3): δ = 1.3 (t, 6H, J = 6.8 Hz, 2CH3), 1.3 (t, 6H, J = 
7.0 Hz, 2CH3), 3.8 (s, 3H, NCH3), 4.2-4.3 (m, 8H, 4CH2O), 6.2 (d, 1H, J = 15.8 Hz, CH), 6.3 
(d, 1H, J = 15.7 Hz, CH), 6.3 (d, 1H, J = 15.4 Hz, CH), 6.4 (d, 1H, J = 16.0 Hz, CH), 7.4 (s, 
1H, ArH), 7.8 (d, 1H, J = 16.0 Hz, CH), 7.9 (d, 1H, J = 16.0 Hz, CH), 8.0 (s, 1H, ArH), 8.0 
(d, 1H, J = 15.8 Hz, CH), 8.1 (d, 1H, J = 15.8 Hz, CH). 
13
C NMR (62 MHz, CDCl3): δ = 13.2 
(CH3), 13.3 (2CH3), 13.4 (CH3), 30.4 (NCH3), 59.5, 59.6, 59.7, 60.2 (CH2O), 107.9 (CH), 
113.2 (C), 116.7, 119.4, 119.7, 120.1, 125.1, (CH), 125.7, 127.8 (C), 129.3 (CH), 130.0 (C), 
134.7 (CH), 138.1, 138.4 (C), 141.2, 141.3 (CH), 164.7, 165.4, 165.6, 166.5 (CO). IR (KBr, 
cm
−1
): ν = 2979, 2930, 2872 (w), 1704, 1613 (s), 1463, 1445, 1367 (m), 1259, 1160, 1093, 
1028, 974, 855 (s), 809, 785, 770, 727, 702, 607 (m). GC-MS (EI, 70 eV): m/z (%) = 
523(100) [M
+
], 477(18), 452(88), 402(84), 375(23), 350(70). HRMS: m/z calcd for 
C29H33NO8 [M
+
]: 523.22062; found: 523.22073. 
 
 
(2E,2′E,2″E,2″′E)-Tetrabutyl-3,3′,3″,3″′-(1-methyl-1H-indole-2,3,5,6-tetrayl)tetraacrylate 
(56c): 
Product 56c was prepared starting 
with 53 (446 mg, 1.0 mmol), n-
butyl acrylate (0.70 mL, 5.0 
mmol), Pd(OAc)2  (11 mg, 5 mol  
%), SPhos (10 mol %), NEt3 
(1.10 mL, 8.0  mmol), DMF 
(5 mL) at 90 °C for 36 h following general procedure I, as a yellow highly viscous oil 
(450 mg, 71%). 
1
H NMR (300 MHz, CDCl3): δ = 0.8-0.9 (m, 12H, 4CH3), 1.3-1.5 (m, 8H, 
4CH2), 1.6-1.7 (m, 8H, 4CH2), 3.7 (s, 3H, NCH3), 4.1 (t, 4H,  J = 6.9 Hz, 2CH2O), 4.2 (t, 
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4H, J = 6.9 Hz, 2CH2O), 6.2 (d, 1H, J = 16.4 Hz, CH), 6.2 (d, 1H, J = 15.4 Hz, CH), 6.3 (d, 
1H, J = 15.8 Hz, CH), 6.4 (d, 1H, J = 16.2 Hz, CH), 7.4 (s, 1H, ArH), 7.7 (d, 1H, J = 16.2 Hz, 
CH), 7.8 (d, 1H,  J = 16.2 Hz, CH), 7.9 (s, 1H, ArH), 8.0 (d, 1H, J = 15.4 Hz, CH), 8.0 (d, 
1H, J = 15.4 Hz, CH). 
13
C NMR (75.5 MHz, CDCl3): δ = 13.7 (CH3), 13.7 (2CH3), 13.8 
(CH3), 19.1, 19.1, 19.2, 19.2, 30.6, 30.7, 30.8, 30.8 (CH2), 31.4 (NCH3), 64.4, 64.5, 64.5, 65.0 
(CH2O), 108.9 (CH), 114.1 (C), 117.6, 120.3, 120.6, 121.0, 125.9 (CH), 126.6, 128.6 (C), 
130.3 (CH), 130.9 (C), 135.5 (CH), 139.0, 139.3, 142.0, 142.1 (C), 165.7, 166.3, 166.6, 167.4 
(CO). IR (KBr, cm
−1
): ν = 2932 (w), 1699, 1622, 1548 (s), 1463 (m), 1416, 1379, (s), 1273 
(m), 1243, 1212, 1168, 1062, 1025, 956, 864, 780 (s), 738 (m), 694, 647, 588 (s). MS (EI, 
70 eV): m/z (%) = 635(100) [M
+
], 591(18), 562(16), 534(14), 509(14), 507(11), 478(33), 
460(46), 431(11), 360(11), 334(12), 304(13), 260(19), 231(15), 57(21). HRMS: m/z calcd for 
C37H49NO8 [M
+
]: 635.34527; found: 635.34554. 
 
(2E,2'E,2''E,2'''E)-tert-butyl-3,3',3'',3'''-(1-methyl-1H-indole-2,3,5,6-tetrayl) 
tetraacrylate (56e): 
Product 56e was prepared starting with  53 
(446 mg, 1.0 mmol), tert-butyl acrylate 
(0.7 mL, 5.0 mmol), Pd(OAc)2  (11 mg, 
5 mol %), SPhos (10 mol %), NEt3 
(1.10 mL, 8.0 mmol), DMF (5 mL) at 
90 °C for 36 h following general procedure 
H, as a yellow highly viscous oil (559 mg, 88%). 
1
H NMR (300 MHz, CDCl3): δ = 1.5 (s, 9H, 
3CH3), 1.5 (s, 9H, 3CH3), 1.5 (s, 9H, 3CH3), 1.5 (s, 9H, 3CH3), 3.8 (s, 3H, CH3N), 6.2 (d, 
1H, J = 16.1 Hz, CH), 6.3 (d, 1H, J = 15.7 Hz, CH), 6.3 (d, 1H, J = 15.7 Hz, CH), 6.4 (d, 
1H, J = 16.0 Hz, CH), 7.4 (s, 1H, ArH), 7.7 (d, 1H, J = 16.0 Hz, CH), 7.8 (d, 1H, J = 16.0 Hz, 
CH), 7.9 (d, 1H, J = 15.8 Hz, CH), 8.0 (d, 1H, J = 14.2 Hz, CH), 8.0 (s, 1H, ArH). 
13
C NMR 
(62 MHz, CDCl3): δ = 28.1 (3CH3), 28.2 (6CH3), 28.3 (3CH3), 30.9 (NCH3), 80.4, 80.6, 80.7, 
81.5 (CO), 108.7 (CH), 114,1 (C), 119.3, 120.5, 122.6, 122.7 (CH), 126.6 (C), 127.7 (CH), 
128.8 (C), 129.6 (CH), 131.0 (C), 134.9 (CH) 139.0, 139.3 (C), 141.5 (2CH), 165.0, 165.7, 
165.9, 166.9 (CO). IR (KBr, cm−1): ν = 2976, 2931 (w), 1694, 1621, 1548, 1475, 1455, 1390, 
1365, 1289, 1254, 1217, 1140, 965, 846, 764 (s). MS (EI, 70 eV):  m/z (%) = 635(15) [M
+
], 
579(04), 523(07), 478(17), 766(20), 304(28). HRMS:  m/z calcd for C37H49NO8 [M
+
]: 
635.34582; found: 635.34532. 
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(2E,2′E,2″E,2″′E)-Tetrakis(2-ethylhexyl)-3,3′,3″,3″′-(1-methyl-1H-indole-2,3,5,6-tetrayl) 
tetraacrylate (56g): 
 
 
Product 56g was prepared starting with  53   (446 mg, 1.0  mmol), 2-ethylhexyl acrylate  (1.10 
 mL, 5.0 mmol),  Pd(OAc)2 (11 mg, 5 mol %), SPhos (10 mol %), NEt3 (1.10 mL, 8.0 mmol), 
DMF (5 mL) at 90 °C for 36 h following general procedure H, as a yellow highly viscous oil 
(645 mg, 75%). 
1
H NMR (300 MHz, CDCl3): δ = 0.81-0.92 (m, 24H, 8CH3), 1.23-1.44 (m, 
32H, CH2-aliphatic), 1.52-1.61 (m, 4H, CH), 3.83 (s, 3H, NCH3), 4.01-4.12 (m, 8H, 4CH2O), 
6.21 (d, 1H, J = 16.1 Hz, CH), 6.32 (d, 1H, J = 15.6 Hz, CH), 6.33 (d, 1H, J = 15.7 Hz, CH), 
6.41 (d, 1H, J = 16.0 Hz, CH), 7.52 (s, 1H, ArH), 7.74 (d, 1H, J = 16.0 Hz, CH), 7.81 (d, 
1H, J = 16.0 Hz, CH), 8.01 (s, 1H, ArH), 8.02 (d, 2H, J = 16.0 Hz, CH). 
13
C NMR 
(75.5 MHz, CDCl3): δ = 10.9 (CH3), 11.0 (3CH3), 14.0 (4CH3), 22.9 (4CH2), 23.7 (CH2), 23.8 
(2CH2), 23.9, 28.1, 28.9 (CH2), 29.0 (2CH2), 30.3 (CH2), 30.4 (2CH2), 30.5 (CH2), 31.3 
(NCH3), 38.8 (CH), 38.9 (3CH), 66.9, 67.0, 67.1, 67.6 (CH2O), 108.9 (CH), 114.1 (C), 117.8, 
120.4, 120.7, 121.0, 125.9 (CH), 126.7, 128.8 (C), 130.4 (CH), 131.0 (C), 135.5 (CH), 139.0, 
139.4 (C), 142.1, 142.2 (CH), 165.8, 166.4, 166.6, 167.5 (CO). IR (KBr, cm
−1
): ν = 2957, 
2927, 2872, 2858 (w), 1706, 1691, 1624 (s), 1600, 1548, 1460, 1379, 1283, 1254, 1215 (w), 
1164 (s), 1029, 970, 864 (m), 769, 727, 695, 639, 595 (w). MS (EI, 70 eV): m/z (%) = 859(46) 
[M
+
], 703(11), 701(14), 591(13), 590(32), 571(11), 572(28), 543(15), 460(14), 432(21), 
431(13), 416(10), 414(13), 304(19), 276(19), 71(31), 70(20), 57(100), 44(19), 43(44). HRMS 
(ESI): m/z calcd for C53H82NO8 [M
+
+H]: 860.6035; found: 860.6029. 
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Synthesis of 2,3,4,5-tetra(alkenyl)-N-methyl pyrrole (59): 
 
(2E,2'E,2''E,2'''E)-Tetrabutyl-3,3',3'',3'''-(1-methyl-1H-pyrrole-2,3,4,5-tetrayl)tetraacrylate 
(59a): 
Product 59a was prepared starting with 
 58 (392 mg, 1.0 mmol), n-butyl acrylate  
(0.72 mL, 5.0 mmol), Pd(OAc)2  (11 mg, 
5 mol %) , P(Cy)3 (10 mol %), NEt3  
(1.10 mL, 8.0 mmol), DMF (5 mL) at 
90 °C for 12 h following general procedure H, as a brown oil (380 mg, 65%). 
1
H NMR (300 
MHz, CDCl3):  = 0.89 (t, 12H, J = 7.4 Hz, 4CH3), 1.30-1.40 (m, 8H, 4CH2), 1.58-1.65 (m, 
8H, 4CH2), 3.71 (s, 3H, NCH3), 4.14 (t, 4H, J = 6.7 Hz, 2CH2O), 4.16 (t, 4H, J = 6.7 Hz, 
2CH2O), 6.02 (d, 2H, J = 16.0 Hz, 2CH), 6.12 (d, 2H, J = 16.1 Hz, 2CH), 7.58 (d, 2H, J =  
16.1 Hz, 2CH), 7.65 (d, 2H, J = 16.0 Hz, 2CH). 
13
C NMR (62 MHz, CDCl3):  = 13.7 
(2CH3), 13.8 (2CH3), 19.1 (2CH2), 19.2 (2CH2), 30.6 (2CH2), 30.7 (2CH2), 34.2 (NCH3), 64.5 
(2CH2O), 64.8 (2CH2O), 121.9 (2CH), 122.2 (2C), 122.5 (2CH), 130.5 (2CH), 132.8 (2C), 
135.7 (2CH), 166.4 (2CO), 166.6 (2CO). IR (KBr, cm
1
): v = 2957, 2933 (m), 2872 (w), 1705 
(s), 1618 (m), 1453, 1383 (w), 1278, 1247 (m), 1161 (s), 1062, 1023, 964, 858, 735 (m), 653, 
611 (w). MS (EI, 70 eV): m/z (%) = 585(44) [M]
+
,  512 (12), 484(21), 428(12), 410(100), 
354(14), 310(30), 254(22), 252(15), 226( 17), 182(17), 173(11), 57(23), 41(17). HRMS (EI, 
70 eV): calcd for C33H47NO8 [M
+
]: 585.32962; found: 585.32935. 
 
(2E,2'E,2''E,2'''E)-Isobutyl-3,3',3'',3'''-(1-methyl-1H-pyrrole-2,3,4,5-tetrayl) 
tetraacrylate (59b): 
Product 59b was prepared starting with  58  
(392 mg, 1.0 mmol), iso-butyl acrylate  (0.72 
mL, 5.0  mmol), Pd(OAc)2 (11 mg, 5 mol %), 
P(Cy)3 (10 mol %), NEt3 (1.10 mL, 8.0 mmol), 
DMF (5 mL) at 90 °C for 12 h following 
general procedure H, as a brown oil (322 mg, 
55%). 
1
H NMR (250 MHz, CDCl3):  = 0.90 
(d, 24H, J = 6.7 Hz, 8CH3), 1.87-1.99 (m, 4H, 4CH), 3.72 (s, 3H, NCH3), 3.91 (d, 4H, J = 6.6 
Hz, 2CH2O), 3.93 (d, 4H, J = 6.9 Hz, 2CH2O), 6.03 (d, 2H, J = 16.0 Hz, 2CH), 6.14 (d, 2H, J 
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= 16.2 Hz, 2CH), 7.60 (d, 2H, J =  16.3 Hz, 2CH), 7.67 (d, 2H, J = 16.1 Hz, 2CH). 
13
C NMR 
(62 MHz, CDCl3):  = 18.1 (4CH3), 18.2 (4CH3), 26.8 (4CH), 33.1 (NCH3), 69.7 (2CH2O), 
70.0 (2CH2O), 120.9 (2CH), 121.2 (2C), 121.5 (2CH), 129.6 (2CH), 131.8 (2C), 134.7 (2CH), 
165.3 (2CO), 165.5 (2CO). IR (KBr, cm
1
): v = 2958 (m), 2873 (w), 1701 (s), 1617, 1468, 
1376, 1283, 1242 (m), 1155 (s), 1016, 973, 863, 705, 537 (m). MS (EI, 70 eV): m/z (%) = 
585(76) [M]
+
, 512(26), 484(30), 428(26), 412(34), 410(100), 384(10), 354(32), 310(61), 
254(39), 226(18), 210(34), 182(18), 57(63), 41(23). HRMS (EI, 70 eV): calcd for C33H47N O8 
[M]
+
: 585.32962; found: 585.11000. 
 
(2E,2'E,2''E,2'''E)-tert-Butyl-3,3',3'',3'''-(1-methyl-1H-pyrrole-2,3,4,5-tetrayl)tetra 
acrylate  (59c): 
Product 59c was prepared starting with  58  
(392 mg, 1.0 mmol), tert-butyl acrylate  (0.72 
mL, 5.0  mmol), Pd(OAc)2 (11 mg, 5 mol %), 
P(Cy)3 (10 mol %), NEt3 (1.10 mL, 8.0 mmol), 
DMF (5 mL) at 90 °C for 12 h following 
general procedure H, as a brown oil (322 mg, 
55%). 
1
H NMR (250 MHz, CDCl3):  = 1.46 (br, 36H, 12CH3), 3.68 (s, 3H, NCH3), 5.94 (d, 
2H, J = 16.0 Hz, 2CH), 6.03 (d, 2H, J = 16.1 Hz, 2CH), 7.50 (d, 2H, J =  16.2 Hz, 2CH), 7.55 
(d, 2H, J = 16.0 Hz, 2CH). 
13
C NMR (62 MHz, CDCl3):  = 28.1 (6CH3), 28.2 (6CH3), 34.2 
(NCH3), 80.4 (2C), 81.0 (2C), 122.1 (2C), 123.3 (2CH), 124.0 (2CH), 129.9 (2CH), 132.6 
(2C), 134.9 (2CH), 165.6 (2CO), 165.9 (2CO). IR (KBr, cm
1
): v = 2975, 2930, 2871 (w), 
1702, 1620 (m), 1474, 1455, 1390 (w), 1366, 1280, 1253 (m), 1140 (s), 971, 949, 847, 767, 
730 (m). MS (EI, 70 eV): m/z (%) = 585(04) [M]
+
, 287(24), 233(79), 199(12), 173(100), 
121(32), 114(49), 82(29), 71(21), 58(60), 44(44), 41(84). HRMS (ESI): calcd for C33H47NNa 
O8 [M]
+
: 608.3194; found: 608.3204. 
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(2E,2'E,2''E,2'''E)-Tetrahexyl-3,3',3'',3'''-(1-methyl-1H-pyrrole-2,3,4,5-tetrayl)tetraacrylate 
(59d): 
Product 59d was prepared 
starting with 58 (392 mg, 
1.0 mmol), n-hexyl acrylate 
 (0.88 mL, 5.0 mmol), 
Pd(OAc)2 (11  mg, 5 mol  
%), P(Cy)3 (10  mol %), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 90 °C for 12 h following 
general procedure H, as a brown oil (508 mg, 73%). 
1
H NMR (300 MHz, CDCl3):  = 0.83 (t, 
12H, J = 7.0 Hz, 4CH3), 1.22-1.34 (m, 24H, 12CH2), 1.58-1.65 (m, 8H, 4CH2), 3.71 (s, 3H, 
NCH3), 4.12 (t, 4H, J = 6.7 Hz, 2CH2O), 4.14 (t, 4H, J = 6.7 Hz, 2CH2O),  6.02 (d, 2H, J = 
16.0 Hz, 2CH), 6.12 (d, 2H, J = 16.1 Hz, 2CH), 7.58 (d, 2H, J =  16.1 Hz, 2CH), 7.66 (d, 2H, 
J = 16.0 Hz, 2CH). 
13
C NMR (62 MHz, CDCl3):  = 13.0 (4CH3), 22.5 (4CH2), 24.6 (4CH2), 
27.6 (4CH2), 30.4(2CH2), 30.5 (2CH2), 33.2 (NCH3), 63.8 (2CH2O), 64.1 (2CH2O), 120.9 
(2CH), 121.3 (2C), 121.5 (2CH), 129.5 (2CH), 131.8 (2C), 134.7 (2CH), 165.4 (2CO), 165.6 
(2CO). IR (KBr, cm
1
): v = 2953, 2927 (m), 2857 (w), 1706, 1618 (m), 1466, 1380 (w), 1279, 
1247 (m), 1161 (s), 1057, 967, 858 (m), 725, 611 (w). MS (EI, 70 eV): m/z (%) = 697(84) 
[M]
+
,  695(20), 596(12), 568(21), 484(16), 482(22), 466(100), 382(17), 380(12), 354(15), 
338(21), 296(20), 270(10), 252(30), 226(21), 210(10), 182(16), 173(18), 114(10), 56(21), 
43(68). HRMS (ESI): calcd for C41H64NO8 [M+H]
+
: 698.4626; found: 698.4609. 
 
(2E,2'E,2''E,2'''E)-Tetramethyl-3,3',3'',3'''-(1-methyl-1H-pyrrole-2,3,4,5-tetrayl) 
tetraacrylate (59e): 
Product 59e was prepared starting with 58 (392 mg, 
1.0 mmol), methyl acrylate (0.45 mL, 5.0 mmol), 
Pd(OAc)2  (11 mg, 5 mol %), P(Cy)3 (10 mol %), 
NEt3 (1.10 mL , 8.0 mmol), DMF (5 mL) at 90 °C 
for 12 h following general procedure H, as a brown 
oil (216 mg, 52%). 
1
H NMR (250 MHz, CDCl3):  = 3.70 (s, 3H, NCH3), 3.73 (s, 6H, 
2OCH3), 3.75 (s, 6H, 2OCH3), 6.01 (d, 2H, J = 16.0 Hz, 2CH), 6.12 (d, 2H, J = 16.2 Hz, 
2CH), 7.58 (d, 2H, J =  16.2 Hz, 2CH), 7.64 (d, 2H, J = 16.0 Hz, 2CH). 
13
C NMR (62 MHz, 
CDCl3):  = 34.2 (NCH3), 51.7 (2OCH3), 51.9 (2OCH3), 121.6 (2CH), 122.1 (2CH), 122.2 
(2C), 130.7 (2CH), 132.8 (2C), 135.8 (2CH), 166.6 (2CO), 166.9 (2CO). IR (KBr, cm
1
): v = 
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2998, 2952, 2849 (w), 1704 (s), 1620, 1432 (m), 1279, 1191, 1165 (s), 1103, 1016 (m), 963 
(s), 890, 853, 728, 715 (m). MS (EI, 70 eV): m/z (%) = 417(29) [M]
+
, 358 (32), 327(17), 
326(100), 324(13), 298(14), 282(15), 266(17), 240(10), 239(13), 208(15), 181(16), 180(13). 
HRMS (ESI): calcd for C21H24NO8 [M+H]
+
: 418.1496; found: 418.1501. 
 
(2E,2'E,2''E,2'''E)-Tetraethyl -3,3',3'',3'''-(1-methyl-1H-pyrrole-2,3,4,5-tetrayl)tetraacrylate 
(59f): 
Product 59f was prepared starting with 58 (392 mg, 
1.0 mmol), ethyl acrylate (5.0 mmol), Pd(OAc)2 
 (11 mg, 5 mol %), P(Cy)3 (10 mol %), NEt3 
 (1.10 mL, 8.0 mmol), DMF (5 mL) at 90 °C for 
12 h following general procedure H, as brownish 
solid (326 mg, 69%), mp 97-99 °C. 
1
H NMR (250 
MHz, CDCl3):  = 1.26 (t, 6H, J = 7.1 Hz, 2CH3), 1.27 (t, 6H, J = 7.1 Hz, 2CH3), 3.71 (s, 3H, 
NCH3), 4.15-4.25 (m, 8H, 4CH2O), 6.01 (d, 2H, J = 16.0 Hz, 2CH), 6.12 (d, 2H, J = 16.1 Hz, 
2CH), 7.58 (d, 2H, J =  16.2 Hz, 2CH), 7.65 (d, 2H, J = 16.0 Hz, 2CH). 
13
C NMR (75 MHz, 
CDCl3):  = 14.3 (4CH3), 34.2 (NCH3), 60.6 (2CH2O), 60.9 (2CH2O), 121.9 (2CH), 122.3 
(2C), 122.5 (2CH), 130.6 (2CH), 132.8 (2C), 135.7 (2CH), 166.3 (2CO), 166.6 (2CO). IR 
(KBr, cm
1
): v = 2981, 1936, 2873 (w), 1710, 1620 (s), 1450, 1392 (w), 1364, 1277 (m), 
1255, 1161, 1031, 968 (s), 933, 853, 727 (m), 649 (w). MS (EI, 70 eV): m/z (%) = 471(15) 
[M]
+
, 428(14), 400(35), 356(17), 354(100), 352(23), 326(35), 282(41), 254(38), 225(12), 
210(24), 181(37), 169(15), 131(17), 119(17), 97(11), 83(13), 69(65), 57(22), 44(27), 41(14). 
HRMS (EI, 70 eV): calcd for C25H31NO8 [M
+
]: 471.18877; found: 471.18739. 
 
(2E,2'E,2''E,2'''E)-Tetrakis(2-ethylhexyl)-3,3',3'',3'''-(1-methyl-1H-pyrrole-2,3,4,5-
tetrayl)tetraacrylate (59g): 
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Product 59g was prepared starting with 58 (392 mg, 1.0 mmol), 2-ethylhexyl acrylate  (1.1 
mL, 5.0 mmol), Pd(OAc)2 (11  mg, 5 mol %), P(Cy)3 (10  mol %), NEt3 (1.10 mL, 8.0 
 mmol), DMF (5 mL) at 90 °C for 12 h following general procedure H, as a brown oil 
(607 mg, 75%). 
1
H NMR (250 MHz, CDCl3):  = 0.82-0.88 (m, 24H, 8CH3), 1.17-1.28 (m, 
24H, 12CH2), 1.29-1.36 (m, 8H, 4CH2), 1.54-1.61 (m, 4H, 4CH), 3.71 (s, 3H, NCH3), 4.02-
4.08 (m, 8H, 4CH2O), 6.01 (d, 2H, J = 16.0 Hz, 2CH), 6.12 (d, 2H, J = 16.1 Hz, 2CH), 7.59 
(d, 2H, J =  16.2 Hz, 2CH), 7.65 (d, 2H, J = 16.2 Hz, 2CH). 
13
C NMR (62 MHz, CDCl3):  = 
10.9 (4CH3), 14.0 (4CH3), 22.9 (4CH2), 23.8 (4CH2),  28.9 (4CH2), 30.4 (4CH2), 34.2 
(NCH3), 38.8 (4CH), 67.1 (2CH2O), 67.5 (2CH2O), 121.9 (2CH), 122.2 (2C), 122.6 (2CH), 
130.5 (2CH), 132.8 (2C), 135.6 (2CH), 166.4 (2CO), 166.6 (2CO). IR (KBr, cm
1
): v = 2956, 
2927 (m), 2858 (w), 1708 (s), 1619 (m), 1459, 1380 (w), 1278, 1244 (m), 1163 (s), 1028, 966 
(m), 858, 769, 727 (w). MS (EI, 70 eV): m/z (%) = 809(25) [M]
+
, 627(18), 522(22), 499(13) 
498(41), 410(16), 358(18), 340(11), 228(11), 83(15), 71(31), 70(20), 57(100), 55(25), 44(21), 
43(39), 41(27). HRMS (ESI): calcd for C49H80NO8 [M+H]
+
: 810.5878; found: 810.5873. 
 
General procedure J for synthesis of Carbazol (60): 
 
A diphenyl ether solution (3 mL) of 59a-g (0.25 mmol) was stirred at 200 °C for 24 h in a 
pressure tube. The solution was allowed to cool to 20 °C and Pd/C (30 mg, 10 mol %) was 
added. The solution was stirred at 200 °C for 48 h under an argon atmosphere. The reaction 
mixture was filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (flash silica gel, eluent: heptanes-EtOAc). 
 
Tetrabutyl-9-methyl-9H-carbazole-2,3,6,7-tetracarboxylate (60a): 
Compound 60a was synthesized starting 
with 59a (100 mg, 0.17 mmol), follow 
ing general procedure J, as brown oil 
(74 mg, 75%).  
1
H NMR (300 MHz, 
CDCl3):  = 0.90 (t, 6H, J = 7.4 Hz, 
2CH3), 0.92 (t, 6H, J = 7.3 Hz, 2CH3), 1.33-1.48 (m, 8H, 4CH2), 1.64-1.75 (m, 8H, 4CH2), 
3.86 (s, 3H, NCH3), 4.28 (t, 4H, J = 6.7 Hz, 2CH2O), 4.30 (t, 4H, J = 6.7 Hz, 2CH2O), 7.62 (s, 
2H, ArH), 8.50 (s, 2H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 13.7 (2CH3), 13.8 (2CH3), 19.2 
(2CH2), 19.3 (2CH2), 29.8 (NCH3), 30.6 (2CH2), 30.8 (2CH2), 65.5 (2CH2O), 65.9 (2CH2O), 
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109.7 (2CH), 123.0 (2CH), 123.1 (4C), 132.6 (2C), 142.8 (2C), 167.3 (2CO), 168.8 (2CO). IR 
(KBr, cm
1
): v = 2957, 2932 (m), 2872 (w), 1712 (s), 1634, 1601, 1563 (w), 1457 (m), 1384, 
1340 (w), 1254, 1230, 1107, 1084, 1074 (s), 1018, 961, 784 (m), 681, 603 (w). MS (EI, 70 
eV): m/z (%) = 581(100) [M]
+
, 525(12), 453(23), 422(85), 396(21), 340(11), 322(25), 
173(11). HRMS (ESI): calcd for C33H44NO8 [M+H]
+
: 582.3061; found: 582.3064. 
 
Tetraisobutyl-9-methyl-9H-carbazole-2,3,6,7-tetracarboxylate (60b): 
Compound 60b was synthesized starting with  
59b  (100 mg, 0.17 mmol), following general 
procedure J, as a brown oil (88 mg, 89%). 
1
H 
NMR (300 MHz, CDCl3):  = 0.94 (d, 12H, J 
= 6.6 Hz, 4CH3), 0.95 (d, 12H, J = 6.6 Hz, 
4CH3), 1.96-2.06 (m, 4H, 4CH), 3.89 (s, 3H, 
NCH3), 4.07 (d, 4H,  J = 6.7 Hz, 2CH2O), 4.08 (d, 4H, J = 6.7 Hz, 2CH2O), 7.65 (s, 2H, 
ArH), 8.54 (s, 2H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 18.2 (4CH3), 18.3 (4CH3), 26.7 
(2CH), 26.8 (2CH), 28.8 (NCH3), 70.8 (2CH2O), 71.1 (2CH2O), 108.8 (2CH), 122.0 (2CH), 
122.1 (2C), 122.3 (2C), 131.6 (2C), 141.8 (2C), 166.3 (2CO), 167.8 (2CO). IR (KBr, cm
1
): v 
= 2958 (m), 2873 (w), 1713 (s), 1634, 1602 (w), 1467, 1377 (m), 1257, 1229, 1108 (s), 1085, 
1035, 1008, 988, 945, 783 (m). GC-MS (EI, 70 eV): m/z (%) = 581(84) [M]
+
, 525(19), 
469(17), 452(100), 413(12), 396(30), 357(14), 340(30), 322(38), 251(24), 57(55), 41(70). 
HRMS (EI, 70 eV): calcd for C33H43NO8 [M]
+
: 581.29832; found: 581.29761. 
 
Tetrahexyl-9-methyl-9H-carbazole-2,3,6,7-tetracarboxylate (60d): 
Compound 60d was synthe 
sized starting with 59d 
(100 mg, 0.14 mmol), follo 
wing general procedure J, 
as yellow oil (79 mg, 
80%).  
1
H NMR (300 MHz, CDCl3):  = 0.82 (t, 6H, J = 7.3 Hz, 2CH3), 0.84 (t, 6H, J = 7.0 
Hz, 2CH3), 1.25-1.40 (m, 24H, 12CH2), 1.63-1.76 (m, 8H, 4CH2), 3.87 (s, 3H, NCH3), 4.27 (t, 
4H, J = 6.8 Hz, 2CH2O), 4.29 (t, 4H, J = 6.8 Hz, 2CH2O), 7.62 (s, 2H, ArH), 8.52 (s, 2H, 
ArH). 
13
C NMR (75 MHz, CDCl3):  = 13.0 (4CH3), 21.5 (4CH2), 24.6 (2CH2), 24.7 (2CH2), 
27.5 (2CH2), 27.6 (2CH2), 28.8 (NCH3), 30.4(2CH2), 30.5 (2CH2), 64.8 (2CH2O), 65.2 
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(2CH2O), 108.7 (2CH), 122.0 (2CH), 122.1 (2C), 122.2 (2C), 131.6 (2C), 141.8 (2C), 166.3 
(2CO), 167.8 (2CO).  IR (KBr, cm
1
): v = 2953, 2927 (m), 2856 (w), 1713 (s), 1635, 1602, 
1460, 1390, 1341 (w), 1256, 1230, 1108 (s), 1085, 992 (m), 899, 866 (w), 784 (m), 725, 604 
(w). MS (EI, 70 eV): m/z (%) = 693(80) [M]
+
, 609(14), 508(70), 424(26), 339(15), 322(34), 
251(12), 173(11), 149(11), 147(12), 135(16), 133(15), 125(12), 123(13), 119(16), 111(13), 
109(23), 107(18), 105(14), 97(15), 81(32), 69(27), 55(39), 43(100). HRMS (ESI): calcd for 
C41H60NO8 [M+H]
+
: 694.4313; found: 694.4313. Anal. calcd for C41H59NO8: C, 70.97; H, 
8.57; N, 2.02. Found: C, 70.42; H, 8.53; N, 2.19. 
 
Tetramethyl-9-methyl-9H-carbazole-2,3,6,7-tetracarboxylate (60e): 
Compound 60e was synthesized starting with 59e 
(100 mg, 0.24 mmol), following general procedure J, 
as a yellow oil (68 mg, 69%). 
1
H NMR (300 MHz, 
CDCl3):  = 3.85 (s, 3H, NCH3), 3.89 (s, 6H, 
2OCH3), 3.91 (s, 6H, 2OCH3), 7.62 (s, 2H, ArH), 
8.51 (s, 2H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 29.8 (NCH3), 52.6 (2OCH3), 52.9 
(2OCH3), 109.8 (2CH), 122.7 (2C), 123.2 (2C), 123.3 (2CH), 132.3 (2C), 142.8 (2C), 167.6 
(2CO), 169.2 (2CO). IR (KBr, cm
1
): v = 2959, 2910, 2834 (w), 1614, 1579, 1519, 1502, 
1463, 1427, 1417, 1287 (m), 1239 (s), 1200, 1183, 1165, 1159, 1118 (w), 1030 (s), 991, 950 
(m), 827 (s), 770, 708, 665, 636, 582 (m), 546 (s). GC-MS (EI, 70 eV): m/z (%) = 413(799 
[M]
+
, 383(22), 382(100), 336(15), 265(13), 176(16). HRMS (EI, 70 eV): calcd for C21H19NO8 
[M]
+
: 413.11052; found: 413.11033. 
 
Tetraethyl-9-methyl-9H-carbazole-2,3,6,7-tetracarboxylate (60f): 
Compound 60f was synthesized starting with 59f 
(100 mg, 0.21 mmol), following general procedure J, 
as whitish solid (62 mg, 63%), mp 120-122 °C.  
1
H 
NMR (300 MHz, CDCl3):  = 1.34 (t, 6H, J = 7.2 Hz, 
2CH3), 1.36 (t, 6H, J = 7.1 Hz, 2CH3), 3.87 (s, 3H, 
NCH3), 4.34 (q, 4H, J = 7.1 Hz, 2CH2O), 4.35 (q, 4H, J = 7.1 Hz, 2CH2O), 7.62 (s, 2H, ArH), 
8.52 (s, 2H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 14.1 (2CH3), 14.3 (2CH3), 29.8 (NCH3), 
61.5 (2CH2O), 61.9 (2CH2O), 109.7 (2CH), 123.0 (2CH), 123.1 (4C), 132.5 (2C), 142.8 (2C), 
167.2 (2CO), 168.8 (2CO). IR (KBr, cm
1
): v = 2979, 2929 (w), 1709 (s), 1635, 1600, 1563 
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(w), 1463, 1443, 1367 (m), 1251, 1229, 1213, 1107, 1084, 1073, 1013 (s), 949, 900, 872, 772 
(m), 654, 616, 559 (w). MS (EI, 70 eV): m/z (%) = 469(100) [M]
+
, 424(19), 396(88), 368(12), 
322(21), 251(14). HRMS (EI, 70 eV): calcd for C25H27NO8 [M]
+
: 469.17312; found: 
469.17296. 
 
Tetrakis(2-ethylhexyl)-9-methyl-9H-carbazole-2,3,6,7-tetracarboxylate (60g): 
 
 
 
 
 
 
 
Compound 60g was synthesized  starting with 59g (100 mg, 0.12  mmol), following general 
procedure J, as a yellow oil (81 mg, 82%). 
1
H NMR (300 MHz, CDCl3):  = 0.83-0.92 (m, 
24H, 8CH3), 1.27-1.45 (m, 32H, 16CH2), 1.61-1.72 (m, 4H, 4CH), 3.88 (s, 3H, NCH3), 4.16-
4.23 (m, 8H, 4CH2O), 7.62 (s, 2H, ArH), 8.52 (s, 2H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 
10.9 (2CH3), 11.0 (2CH3), 14.1 (4CH3), 23.0 (4CH2), 23.8 (2CH2), 23.9 (2CH2), 28.9 (2CH2), 
29.0 (2CH2), 29.8 (NCH3), 30.4 (2CH2), 30.5 (2CH2), 38.7 (2CH), 38.9 (2CH), 68.2 (2CH2O), 
68.6 (2CH2O), 109.7 (2CH), 123.0 (2CH), 123.1 (2C), 123.3 (2C), 132.7 (2C), 142.8 (2C), 
167.4 (2CO), 168.9 (2CO).  IR (KBr, cm
1
): v = 2956, 2926, 2858 (m), 1713 (s), 1634, 1601 
(w), 1458, 1379 (m), 1260, 1229, 1109 (s), 1084, 1000, 772 (m), 725, 625 (w). MS (EI, 70 
eV): m/z (%) = 805(100) [M]
+
, 693(18), 581(15), 564(99), 452(32), 357(26), 340(30), 
322(27), 71(16), 57(34), 55(17), 43(21), 41(17). HRMS (EI, 70 eV): calcd for C49H75NO8 
[M]
+
: 805.54872; found: 805.55104. 
 
General procedure K for synthesis of 2,3,4,5-tetra(alkenyl)thiophenes (62):  
 
A pressure tube (glass bomb) a suspension of Pd(OAc)2 (3.4 mg, 0.03 mmol, 3 mol%) and 
P(Cy)3 (5 mol%) in DMF (5 mL) was purged with Argon and stirred at 20 °C to give a 
yellowish clear solution. To the stirred solution were added 61 (200 mg, 0.5 mmol), Na2CO3 
(216 mg, 4.0 mmol) and the alkene (1.25 equiv per bromine atom of the substrate). The 
reaction mixture was stirred at 90-100 °C for 12 h.  The solution was poured into H2O, brine, 
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and EtOAc (25 mL each) and the organic and the aqueous layers were separated. The latter 
was extracted with EtOAc (3 × 25mL), dried (Na2SO4), filtered, and concentrated in vacuo. 
The residue was purified by flash column chromatography (flash silica gel, eluent: n-heptane- 
EtOAc). 
 
(2E,2'E,2''E,2'''E)-Tetramethyl-3,3',3'',3'''-(thiophene-2,3,4,5-tetrayl)tetraacrylate 
(62a): 
Product 62a was prepared starting with 61 (200 mg, 
0.5 mmol), methylacrylate  (0.23  mL, 2.5 mmol), 
Pd(OAc)2 (3.4 mg, 3 mol %), P(Cy)3 (5 mol %),  
Na2CO3 (216 mg, 4.0 mmol), DMF (5 mL) at 90 °C 
for 12 h according to general procedure K, as 
yellowish solid (149 mg, 71%), mp 80-82 °C. 
1
H NMR (300 MHz, CDCl3):  = 3.75 (s, 6H, 
2OCH3), 3.77 (s, 6H, 2OCH3), 6.04 (d, 2H, J = 16.0 Hz, 2CH), 6.28 (d, 2H, J = 15.7 Hz, 
2CH), 7.61 (d, 2H, J = 16.0 Hz, 2CH), 7.76 (d, 2H, J = 15.7 Hz, 2CH). 
13
C NMR (62 MHz, 
CDCl3):  = 52.0 (2OCH3), 52.1 (2OCH3), 121.1 (2CH), 125.8 (2CH), 133.8 (2CH), 135.4 
(2CH), 138.3 (2C), 139.0 (2C), 166.0 (2CO), 166.2 (2CO). IR (KBr, cm
1
): v = 3000, 2952, 
2921, 2848 (w), 1710 (s), 1615, 1432, 1306 (m), 1267, 1192, 1164 (s), 1081, 1018 (m), 964 
(s), 919, 852, 801, 735, 701, 657, 575 (m). MS (EI, 70 eV): m/z (%) = 420(28) [M]
+
, 389(12), 
361(25), 360(33), 331(10), 330(18), 329(100), 327(16), 302(10), 301(20), 297(15), 285(30), 
270(10), 269(29), 242(16), 211(23), 198(11), 184(29), 183(12), 139(11), 59(18). HRMS (EI, 
70 eV): calcd for C20H20O8S [M]
+
: 420.08734; found: 420.08705. 
 
(2E,2'E,2''E,2'''E)-Tetraethyl-3,3',3'',3'''-(thiophene-2,3,4,5-tetrayl)tetraacrylate (62b): 
Product 62b was prepared starting with 61 (200 mg, 
0.5 mmol), ethyl acrylate (0.27 mL, 2.5 mmol), 
Pd(OAc)2 ( 3.4 mg, 3 mol %), P(Cy)3 (5 mol %),  
Na2CO3 (216 mg, 4.0 mmol), DMF (5 mL) at 90 °C 
for 12 h according to general procedure K, as  
brownish oil (129 mg, 54%). 
1
H NMR (300 MHz, CDCl3):  = 1.27 (t, 6H, J = 7.1 Hz, 2CH3), 
1.28 (t, 6H, J = 7.1 Hz, 2CH3),  4.20 (q, 4H, J = 7.1 Hz, 2CH2O), 4.22 (q, 4H, J = 7.1 Hz, 
2CH2O), 6.04 (d, 2H, J = 16.0 Hz, 2CH), 6.27 (d, 2H, J = 15.7 Hz, 2CH), 7.60 (d, 2H, J =  
16.0 Hz, 2CH), 7.76 (d, 2H, J = 15.7 Hz, 2CH). 
13
C NMR (62 MHz, CDCl3):  = 14.2 
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(2CH3), 14.2 (2CH3), 60.9 (2CH2O), 61.0 (2CH2O), 121.4 (2CH), 126.2 (2CH), 133.7 (2CH), 
135.2 (2CH), 138.3 (2C), 138.9 (2C), 165.7 (2CO), 165.8 (2CO). IR (KBr, cm
1
): v = 2980, 
2936, 2904, 2872 (w), 1708 (s), 1617 (m), 1547, 1498, 1464, 1445, 1391 (w), 1365, 1301 (m), 
1266, 1162 (s), 1094 (m), 1029, 960 (s), 917, 856 (m), 810, 784 (w), 729 (m), 699, 613, 575, 
552 (w). MS (EI, 70 eV): m/z (%) = 476(25) [M]
+
, 474(11), 431(15), 403(27), 402(37), 
385(11), 359(23), 357(100), 355(22), 329(25), 313(14), 311(11), 285(74), 257(43), 241(15), 
239(17), 213(55), 185(52), 171(12), 139(15), 44(42). HRMS (ESI): calcd for C24H28NaO8S 
[M+Na]
+
: 499.13971; found: 499.13974. 
 
 (2E,2'E,2''E,2'''E)-Tetrabutyl-3,3',3'',3'''-(thiophene-2,3,4,5-tetrayl)tetraacrylate (62c) 
Product 62c was prepared starting 
with 61 (200 mg, 0.5 mmol), n-
butyl acrylate (0.36 mL, 2.5 mmol), 
Pd(OAc)2 (3.4 mg, 3mol%), P(Cy)3 
(5 mol %), Na2CO3 (216 mg,  4.0 
mmol), DMF (5 mL) at 90 °C for 12 h according to general procedure K, as brownish oil (150 
mg, 51%). 
1
H NMR (300 MHz, CDCl3):  = 0.90 (t, 12H, J = 7.2 Hz, 4CH3), 1.30-1.43 (m, 
8H, 4CH2), 1.57-1.67 (m, 8H, 4CH2), 4.14 (t, 4H, J = 6.7 Hz, 2CH2O), 4.16 (t, 4H, J = 6.7 Hz, 
2CH2O), 6.04 (d, 2H, J = 16.2 Hz, 2CH), 6.27 (d, 2H, J = 15.7 Hz, 2CH), 7.59 (d, 2H, J = 
16.0 Hz, 2CH), 7.76 (d, 2H, J = 15.5 Hz, 2CH). 
13
C NMR (75 MHz, CDCl3):  = 13.7 
(4CH3), 19.2 (4CH2), 30.6 (2CH2), 30.7 (2CH2), 64.8 (2CH2O), 64.9 (2CH2O), 121.5 (2CH), 
126.2 (2CH), 133.7 (2CH), 135.3 (2CH), 138.3 (2C), 138.9 (2C), 165.7 (2CO), 165.9 (2CO). 
IR (KBr, cm
1
): v = 2958 (m), 2933, 2872 (w), 1710 (s), 1617 (m), 1458, 1383 (w), 1302 (m), 
1257, 1161 (s), 1062, 1023, 962, 855 (m), 734, 576 (w). MS (EI, 70 eV): m/z (%) = 588(25) 
[M]
+
, 515(12), 488(10), 487(25), 486(48), 431(18), 415(30), 414(24), 413(100), 387(11), 
357(20), 329(11), 313(85), 257(47), 255(20), 229(14), 213(59), 211(12), 185(20), 57(97), 
44(19), 41(70). HRMS (EI, 70 eV): calcd for C32H44O8S [M]
+
: 588.27514; found: 588.27510. 
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(2E,2'E,2''E,2'''E)-Isobutyl-3,3',3'',3'''-(thiophene-2,3,4,5-tetrayl)tetraacrylate (62d): 
Product 62d  was prepared starting with 61 
(200 mg, 0.5 mmol), iso-butyl acrylate 
 (0.36 mL, 2.5 mmol), Pd(OAc)2 (3.4 mg, 3 
mol %), P(Cy)3 (5 mol %), Na2CO3 (216 mg, 
4.0 mmol), DMF (5 mL) at 90 °C for 12 h 
according to general procedure B, as 
brownish oil (199 mg, 68%). 
1
H NMR (300 MHz, CDCl3):  = 0.91 (d, 24H, J = 6.7 Hz, 
8CH3), 1.89-1.99 (m, 4H, 4CH), 3.92 (d, 4H, J = 6.6 Hz, 2CH2O), 3.94 (d, 4H, J = 6.7 Hz, 
2CH2O), 6.06 (d, 2H, J = 16.0 Hz, 2CH), 6.29 (d, 2H, J = 15.5 Hz, 2CH), 7.61 (d, 2H, J = 
16.0 Hz, 2CH), 7.78 (d, 2H, J = 15.6 Hz, 2CH). 
13
C NMR (62 MHz, CDCl3):  = 19.0 
(4CH3), 19.1 (4CH3), 27.7 (2CH), 27.8 (2CH), 71.0 (2CH2O), 71.1 (2CH2O), 121.4 (2CH), 
126.1 (2CH), 133.6 (2CH), 135.3 (2CH), 138.3 (2C), 138.9 (2C), 165.7 (2CO), 165.9 (2CO). 
IR (KBr, cm
1
): v = 2959 (m), 2874 (w), 1713 (s), 1620, 1469, 1369, 1306 (m), 1207, 1162 
(s), 1015, 967, 944 (m), 857, 778, 576 (w). MS (EI, 70 eV): m/z (%) = 588(12) [M]
+
, 487(10), 
486(18), 455(11), 431(15), 429(21), 415(22), 413(43), 411(16), 360(12), 357(17), 355(19), 
329(13), 316(11), 313(40), 301(13), 299(30), 257(38), 255(36), 229(13), 213(27), 211(10), 
185(15), 184(11), 57(100), 56(13), 44(56), 41(77), 39(18). HRMS (ESI): calcd for C32H45O8S 
[M+H]
+
: 589.28297; found: 589.28149. 
 
(2E,2'E,2''E,2'''E)-Tetrakis(2-ethylhexyl) 3,3',3'',3'''-(thiophene-2,3,4,5-tetrayl) 
tetraacrylate (62e): 
 
 
Product 62e was prepared starting with 61 (200 mg, 0.5 mmol), 2-ethylhexyl acrylate (0.52 
mL, 2.5 mmol), Pd(OAc)2 (3.4 mg , 3 mol %), P(Cy)3 (5  mol %), Na2CO3 (216 mg, 4.0 
mmol), DMF (5 mL) at 90 °C for 12 h according to general procedure K, as brownish oil (211 
mg, 52%).  
1
H NMR (300 MHz, CDCl3):  = 0.81-0.88 (m, 24H, 8CH3), 1.25-1.41 (m, 32H, 
16CH2), 1.56-1.62 (m, 4H, 4CH), 4.04-4.08 (m, 8H, 4CH2O), 6.04 (d, 2H, J = 16.0 Hz, 
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2CH), 6.28 (d, 2H, J = 15.6 Hz, 2CH), 7.59 (d, 2H, J =  16.0 Hz, 2CH), 7.77 (d, 2H, J = 15.6 
Hz, 2CH). 
13
C NMR (75 MHz, CDCl3):  = 10.9 (2CH3), 11.0 (2CH3), 14.0 (4CH3), 22.9 
(4CH2), 23.8 (2CH2), 23.9 (2CH2), 28.9 (4CH2), 30.4 (2CH2), 30.5 (2CH2), 38.7 (2CH), 38.8 
(2CH), 67.4 (2CH2O), 67.6 (2CH2O), 121.5 (2CH), 126.2 (2CH), 133.6 (2CH), 135.2 (2CH), 
138.4 (2C), 138.9 (2C), 165.8 (2CO), 166.0 (2CO). IR (KBr, cm
1
): v = 2956, 2927 (m), 2858 
(w), 1713 (s), 1618 (m), 1460, 1379 (w), 1302, 1261 (m), 1164 (s), 1080 (w), 1027, 965 (m), 
856, 772, 726, 576 (w). MS (EI, 70 eV): m/z (%) = 812(11) [M]
+
, 654(17), 543(15), 541(21), 
527(23), 525(38), 523(11), 413(13), 411(11), 385(12), 369(21), 301(24), 299(25), 273(12), 
257(31), 255(13), 213(11), 71(73), 70(20), 57(100), 55(31), 44(14), 43(59), 41(32). HRMS 
(ESI): calcd for C48H77O8S [M+H]
+
: 813.53337; found: 813.53293. 
 
(2E,2'E,2''E,2'''E)-Tetrahexyl-3,3',3'',3'''-(thiophene-2,3,4,5-tetrayl)tetraacrylate (62f): 
Product 62f was prepared 
starting with 61 (200 mg, 
0.5 mmol), n-hexyl acrylate  
 (0.44 mL,  2.5 mmol), Pd 
(OAc)2 (3.4 mg, 3 mol % ), 
P(Cy)3 (5 mol %), Na2CO3 (216 mg, 4.0 mmol), DMF (5 mL) at 90 °C for 12 h according to 
general procedure K, as brownish oil (220 mg, 63%).  
1
H NMR (300 MHz, CDCl3):  = 0.83 
(t, 12H, J = 6.7 Hz, 4CH3), 1.25-1.37 (m, 24H, 12CH2), 1.60-1.69 (m, 8H, 4CH2), 4.13 (t, 4H, 
J = 6.7 Hz, 2CH2O), 4.15 (t, 4H, J = 6.8 Hz, 2CH2O), 6.04 (d, 2H, J = 16.0 Hz, 2CH), 6.27 (d, 
2H, J = 15.6 Hz, 2CH), 7.59 (d, 2H, J =  16.0 Hz, 2CH), 7.74 (d, 2H, J = 15.6 Hz, 2CH). 
13
C 
NMR (62 MHz, CDCl3):  = 14.0 (4CH3), 22.5 (4CH2), 25.6 (4CH2), 28.5 (2CH2), 28.6 
(2CH2), 31.4 (4CH2), 65.1 (2CH2O), 65.2 (2CH2O), 121.4 (2CH), 126.2 (2CH), 133.7 (2CH), 
135.2 (2CH), 138.3 (2C), 138.9 (2C), 165.7 (2CO), 165.9 (2CO). IR (KBr, cm
1
): v = 2954, 
2926, 2856 (w), 1712, 1617 (m), 1465, 1457, 1379 (w), 1302, 1259 (m), 1162 (s), 1061, 1013 
(w), 964 (m) 905, 855, 778, 724, 576 (w). MS (EI, 70 eV): m/z (%) = 700(13) [M]
+
, 571(15), 
570(30), 569(15), 511(23), 485(43), 469(67), 467(34), 427(11), 385(12), 383(27), 341(44), 
299(45), 257(30), 255(40), 229(11), 213(19), 85(10), 57(13), 43(100), 41(13). HRMS (ESI): 
calcd for C40H60NaO8S [M+Na]
+
: 723.39011; found: 723.38923. 
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2,3,4,5-Tetrastyrylthiophene (62g): 
Product 62g was prepared starting with  61 
(200 mg, 0.5 mmol), styrene  (0.33 mL, 2.5 mmol), 
Pd(OAc)2  (3.4 mg, 3 mol %), P(Cy)3 (5 mol %),  
Na2CO3 (216 mg, 4.0 mmol), DMF (5 mL) at 
100 °C for 12 h according to general procedure K, 
as a brown solid (197 mg, 80%), mp 162-164 °C. 
1
H NMR (300 MHz, CDCl3):  = 6.74 (d, 
2H, J = 16.3 Hz, 2CH), 6.93 (d, 2H, J = 16.1 Hz, CH), 7.07 (d, 2H, J = 16.3 Hz, CH), 7.10-
7.17 (m, 6H, ArH and 2CH), 7.19-7.23 (m, 4H, ArH), 7.25-7.29 (m, 6H, ArH), 7.37-7.43 (m, 
6H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 120.8 (2CH), 122.2 (2CH), 126.4 (4CH), 126.5 
(4CH), 127.8 (2CH), 127.9 (2CH), 128.8 (8CH), 129.5 (2CH), 134.7 (2CH), 136.7 (2C), 
137.1 (2C), 137.3 (2C), 137.4 (2C). IR (KBr, cm
1
): v = 3026, 2921, 2850, 1595, 1489, 1445, 
1178, 1154, 1072, 1025, 969 (w), 942, 740 (m), 688 (s), 648, 580, 550 (w). MS (EI, 70 eV): 
m/z (%) = 492(100) [M]
+
, 490(30), 488(25), 401(25), 324(13), 167(14), 115(11), 91(32), 
44(13). HRMS (EI, 70 eV): calcd for C36H28S [M]
+
: 492.19062; found: 492.18969. 
 
2,3,4,5-Tetrakis(4-tert-butylstyryl)thiophene (62h): 
Product 62h was prepared starting with 
61 (200 mg, 0.5 mmol), 4-tert-butyl  
styrene (0.45 mL, 2.5 mmol), Pd(OAc)2 
 (3.4 mg, 3 mol %), P(Cy)3 (5 mol %), 
Na2CO3 (216 mg, 4.0 mmol), DMF (5 
mL) at 100 °C for 12 h according to 
general procedure K, as brownish solid 
(258 mg, 72%). 
1
H NMR (250 MHz, 
CDCl3):  = 1.24 (s, 18H, 6CH3), 1.27 (s, 18H, 6CH3), 6.70 (d, 2H, J = 16.3 Hz, 2CH), 6.90 
(d, 2H, J = 16.0 Hz, 2CH), 7.02 (d, 2H, J = 16.3 Hz, 2CH), 7.27-7.34 (m, 18H, ArH and 
2CH). 
13
C NMR (62 MHz, CDCl3):  = 31.2 (6CH3), 31.3 (6CH3), 34.6 (2C), 34.7 (2C), 120.3 
(2CH), 121.6 (2CH), 125.7 (8CH), 126.2 (4CH), 126.3 (4CH), 129.0 (2CH), 134.3 (2CH), 
134.4 (2C), 134.7 (2C), 136.5 (2C), 137.3 (2C), 150.9 (2C), 151.1 (2C). IR (KBr, cm
1
): v = 
3026 (w), 2957 (m), 2902, 2865, 1513, 1462, 1408, 1392 (w), 1361, 1267, 1108 (m), 1014 
(w), 948, 937, 823, 812 (m), 698, 6330, 572 (w), 555 (s). MS (EI, 70 eV): m/z (%) = 716(100) 
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[M]
+
, 715(23), 714(42), 713(12), 712(21), 424(12), 277(13), 43(28), 42(12), 41(28), 39(10). 
HRMS (EI, 70 eV): calcd for C52H60S [M]
+
: 716.44102; found: 716.43964. 
 
2,3,4,5-Tetrakis(4-methoxystyryl)thiophene (62i): 
Product 62i was prepared starting with 
 61 (200 mg, 0.5 mmol), 4-methoxy 
styrene  (0.33 mL, 2.5 mmol), Pd(OAc)2 
 (3.4 mg, 3 mol %), P(Cy)3 (5 mol %),  
Na2CO3 (216 mg, 4.0 mmol), DMF (5 
mL) at 100 °C for 12 h according to 
general procedure K, as a brown solid 
(190 mg, 62%), mp 150-152 °C. 
1
H 
NMR (300 MHz, CDCl3):  = 3.74 (s, 6H, 2CH3O), 3.76 (s, 6H, 2CH3O), 6.67 (d, 2H, J = 
16.2 Hz, 2CH), 6.79 (d, 4H, J = 9.0 Hz, ArH), 6.81-6.88 (m, 6H, ArH and CH), 6.91 (d, 2H, J 
= 16.3 Hz, CH), 7.20 (d, 2H, J = 16.0 Hz, CH), 7.32 (d, 4H, J = 8.8 Hz, ArH), 7.35 (d, 4H, J 
= 8.7 Hz, ArH). 
13
C NMR (75 MHz, CDCl3):  = 55.3 (2CH3O), 55.4 (2CH3O), 114.2 (4CH), 
114.3 (4CH), 119.2 (2CH), 120.5 (2CH), 127.6 (4CH), 127.7 (4CH), 128.5 (2CH), 130.1 
(2C), 130.3 (2C), 133.8 (2CH), 136.1 (2C), 137.1 (2C), 159.3 (2C), 159.5 (2C). IR (KBr, 
cm
1
): v = 3028, 2953, 2930, 2833 (w), 1600 (m), 1573 (w), 1508 (s), 1461, 1455, 1439 (m), 
1418 (w), 1302 (m), 1286, 1272 (w), 1241, 1171 (s), 1108 (m), 1029 (s), 969 (m), 941 (s), 
848, 812, 766, 731, 608 (m), 580 (w). MS (EI, 70 eV): m/z (%) = 612(100) [M]
+
, 611(15), 
610(31), 493(10), 491(17), 121(29), 44(15), 43(16). HRMS (EI, 70 eV): calcd for C40H36O4S 
[M]
+
: 612.23288; found: 612.23136. 
 
2,3,4,5-Tetrakis(4-methylstyryl)thiophene (62j): 
Product 62j was prepared starting with 61 
(200 mg, 0.5 mmol), 4-methyl styrene 
 (0.33 mL, 2.5 mmol), Pd(OAc)2 ( 3.4 mg, 
3 mol %), P(Cy)3 (5 mol %), Na2CO3 
 (216 mg, 4.0 mmol), DMF (5 mL) at 
100 °C for 12 h according to general 
procedure K, as a brown solid (213 mg, 
78%), mp. 178-180 °C. 
1
H NMR (300 MHz, CDCl3):  = 2.27 (s, 6H, 2CH3), 2.30 (s, 6H, 
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2CH3), 6.69 (d, 2H, J = 16.3 Hz, 2CH), 6.88 (d, 2H, J = 15.9 Hz, 2CH), 6.98-7.04 (m, 2H, 
2CH), 7.05 (d, 4H, J = 8.6 Hz, ArH), 7.09 (d, 4H, J = 8.3 Hz, ArH), 7.10-7.16 (m, 2H, 2CH), 
7.28 (d, 4H, J = 7.0 Hz, ArH), 7.31 (d, 4H, J = 7.5 Hz, ArH). 
13
C NMR (62 MHz, CDCl3):  = 
20.2 (4CH3), 119.0 (2CH), 120.4 (2CH), 125.3 (4CH), 125.4 (4CH), 128.1 (2CH), 128.4 
(8CH), 133.3 (2CH), 133.4 (2C), 133.6 (2C), 135.4 (2C), 136.2 (2C), 136.6 (2C), 136.8 (2C). 
IR (KBr, cm
1
): v = 3021, 2919, 2851, 1731, 1613, 1511, 1453, 1376 (w), 1259, 1179 (m), 
1031, 1017, 945, 934 (s), 869, 849 (m), 798 (s), 700, 547 (m). MS (EI, 70 eV): m/z (%) = 
548(100) [M]
+
, 546(17), 445(13), 443(19), 105(16), 44(46), 43(15). HRMS (EI, 70 eV): calcd 
for C40H36S [M]
+
: 548.25322; found: 548.25237. 
 
General procedure L  for synthesis of dibenzothiophenes (63):  
 
 A pressure tube (glass bomb) a suspension of Pd(OAc)2 (3.4 mg, 0.03 mmol, 3 mol%) and 
P(Cy)3 (5 mol%) in DMF (5 mL) was purged with Argon and stirred at 20 °C to give a 
yellowish clear solution. To the stirred solution were added 61 (200 mg, 0.5 mmol), Na2CO3 
(216 mg, 4.0 mmol) and the alkene or styrene (5.0 equiv per bromine atom of the substrate). 
The reaction mixture was stirred at 140 °C for 24-36h.  The solution was poured into H2O, 
brine and EtOAc (25 mL each) and the organic and the aqueous layers were separated. The 
latter was extracted with EtOAc (3 × 25mL), dried (Na2SO4), filtered, and concentrated in 
vacuo. The residue was purified by flash column chromatography (flash silica gel, eluent: n-
heptane- EtOAc). 
 
General procedure M for synthesis of dibenzothiophenes (63): 
 
A diphenyl ether solution (3 mL) of 62a-j was stirred at 200 °C for 24 h in a pressure tube. 
The solution was allowed to cool to 20 °C and Pd/C (30 mg, 10 mol %) was added. The 
solution was stirred at 200 °C for 48 h under an argon atmosphere. The reaction mixture was 
filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (flash silica gel, eluent: heptanes-EtOAc). 
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Tetramethyl dibenzo[b,d]thiophene-2,3,7,8-tetracarboxylate (63a): 
Product 63a was prepared starting with 62a (100 mg, 
0.24 mmol), following general procedure M, as 
whitish solid (59 mg, 60%), mp. = 146-148 °C. 
1
H 
NMR (300 MHz, CDCl3):  = 3.90 (s, 6H, 2CH3O), 
3.92 (s, 6H, 2CH3O), 8.15 (s, 2H, ArH), 8.54 (s, 2H, 
ArH). 
13
C NMR (62 MHz, CDCl3):  = 51.9 (2CH3O), 52.0 (2CH3O), 122.4 (2CH), 122.8 
(2CH), 127.5 (2C), 130.6 (2C), 134.9 (2C), 142.3 (2C), 166.4 (2CO), 166.7 (2CO). IR (KBr, 
cm
1
): v = 2999, 2951, 2923, 2850 (w), 1716 (s), 1600, 1548, 1465 (w), 1431 (m), 1351, 1316 
(w), 1270, 1243 (m), 1191 (m), 1123, 1094 (s), 1012, 962, 896, 881, 820, 781, 746 (m), 609, 
575 (w). GC-MS (EI, 70 eV): m/z (%) = 416(57) [M]
+
, 386(21), 385(100), 339(11), 268(13). 
HRMS (EI, 70 eV): calcd for C20H16O8S [M]
+
: 416.05604; found: 416.05600. 
 
Tetraethyl dibenzo[b,d]thiophene-2,3,7,8-tetracarboxylate (63b): 
Product 63b was prepared starting with 62b (100 mg, 
0.21 mmol), following general procedure M, as a light 
yellow semi solid (50 mg, 51%). 
1
H NMR (300 MHz, 
CDCl3):  = 1.34 (t, 6H, J = 7.1 Hz, 2CH3), 1.36 (t, 6H, 
J = 7.1 Hz, 2CH3), 4.36 (q, 4H, J = 7.1 Hz, 2CH2O), 
4.37 (q, 4H, J = 7.1 Hz, 2CH2O), 8.16 (s, 2H, ArH), 8.54 (s, 2H, ArH). 
13
C NMR (62 MHz, 
CDCl3):  = 14.1 (2CH3), 14.2 (2CH3), 61.9 (2CH2O), 62.0 (2CH2O), 123.3 (2CH), 123.7 
(2CH), 129.0 (2C), 131.9 (2C), 135.9 (2C), 143.1 (2C), 167.1 (2CO), 167.2 (2CO). IR (KBr, 
cm
1
): v = 2979, 2936, 2905, 2874 (w), 1732, 1707 (s), 1607, 1550, 1470, 1446, 1419, 1384 
(w), 1365, 1314 (m), 1271, 1258, 1241, 1223 (s), 1172, 1118 (m), 1092, 1077, 1029, 1019 (s), 
896, 872, 849, 779, 744 (m), 721, 664, 625, 614, 591, 540 (w). GC-MS (EI, 70 eV): m/z (%) = 
472(95) [M]
+
, 427(20), 400(26), 399(100), 371(12), 325(19), 254(15). HRMS (EI, 70 eV): 
calcd for C24H24O8S [M]
+
: 472.11864; found: 472.11846. Anal. calcd for C24H24O8S: C, 
61.01; H, 5.12; S, 6.79. Found: C, 60.88; H, 5.66; S, 6.90. 
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Tetrabutyl dibenzo[b,d]thiophene-2,3,7,8-tetracarboxylate (63c): 
Product 63c was prepared starting with  
61 (200 mg, 0.5 mmol), n-butyl acrylate  
(0.36 mL, 2.5 mmol), Pd(OAc)2 (3.4 mg, 
3 mol %), P(Cy)3 (5 mol %), Na2CO3 
 (216 mg, 4.0 mmol), DMF (5 mL) at 
140 °C for 24 h according to general procedure L, as brownish oil (117 mg, 40%). 
1
H NMR 
(300 MHz, CDCl3):  = 0.91 (t, 6H, J = 7.3 Hz, 2CH3), 0.92 (t, 6H, J = 7.4 Hz, 2CH3), 1.35-
1.45 (m, 8H, 4CH2), 1.64-1.75 (m, 8H, 4CH2), 4.30 (t, 4H, J = 6.7 Hz, 2CH2O), 4.31 (t, 4H, J 
= 6.7 Hz, 2CH2O), 8.15 (s, 2H, ArH), 8.52 (s, 2H, ArH). 
13
C NMR (75 MHz, CDCl3):  = 
12.7 (4CH3), 18.2 (4CH2), 29.5 (2CH2), 29.6 (2CH2), 64.9 (2CH2O), 65.0 (2CH2O), 122.3 
(2CH), 122.7 (2CH), 128.1 (2C), 130.9 (2C), 134.9 (2C), 142.0 (2C), 166.2 (2CO), 166.3 
(2CO). IR (KBr, cm
1
): v = 2953, 2925, 2856 (m), 1716 (s), 1608, 1547, 1466, 1379 (m), 
1268, 1240, 1119, 1097 (s), 991, 897, 781 (m), 746, 600, 542 (w). MS (EI, 70 eV): m/z (%) = 
584(39) [M]
+
, 528(10), 457(10), 456(31), 457(100), 399(50), 360(17), 343(27), 342(12), 
325(27), 254(12), 57(14), 44(16), 41(21). HRMS (ESI): calcd for C32H41O8S [M+H]
+
: 
585.2516; found: 585.2517. 
 
Tetraisobutyl dibenzo[b,d]thiophene-2,3,7,8-tetracarboxylate (63d): 
Product 63d was prepared starting with 61 
(200 mg, 0.5 mmol), iso-butyl acrylate (0.36 
mL, 2.5 mmol), Pd(OAc)2 (3.4 mg, 3 mol %) , 
P(Cy)3 (5 mol %), Na2CO3 (216 mg, 4.0 
mmol), DMF (5 mL) at 140 °C for 24 h 
according to general procedure L, as yellowish semi solid (152 mg, 52%). 
1
H NMR (300 
MHz, CDCl3):  = 0.94 (d, 12H, J = 6.7 Hz, 4CH3), 0.96 (d, 12H, J = 6.7 Hz, 4CH3), 1.96-
2.07 (m, 4H, 4CH), 4.07 (d, 4H, J = 6.7 Hz, 2CH2O), 4.08 (d, 4H, J = 6.7 Hz, 2CH2O), 8.16 
(s, 2H, ArH), 8.51 (s, 2H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 19.2 (8CH3), 27.7 (4CH), 
72.1 (2CH2O), 72.2 (2CH2O), 123.2 (2CH), 123.8 (2CH), 129.2 (2C), 131.9 (2C), 135.9 (2C), 
143.0 (2C), 167.2 (4CO). IR (KBr, cm
1
): v = 2959 (m), 2874 (w), 1719 (s), 1609, 1548, 1521 
(w), 1468 (m), 1418, 1393, 1376, 1324 (w), 1266, 1237 (s), 1161 (m), 1122 (s), 1097, 1006, 
981, 944 (m), 895, 823, 807 (w), 779 (m), 759, 707, 621, 569 (w). MS (EI, 70 eV): m/z (%) = 
584(41) [M]
+
, 456(43), 455(100), 400(11), 399(57), 361(12), 360(78), 342(12), 325(42), 
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254(21), 57(66), 56(11), 41(50). HRMS (ESI): calcd for C32H41O8S [M+H]
+
: 585.25167; 
found: 585.25244. 
 
Tetrakis(2-ethylhexyl) dibenzo[b,d]thiophene-2,3,7,8-tetracarboxylate (63e): 
 
 
 
 
 
 
 
Product 63e was prepared starting with 62e (100 mg, 0.12 mmol), following general  
procedure M, as brownish oil (69 mg, 70%). 
1
H NMR (300 MHz, CDCl3):  = 0.84-0.91 (m, 
24H, 8CH3), 1.27-1.45 (m, 32H, 16CH2), 1.61-1.71 (m, 4H, 4CH), 4.19-4.24 (m, 8H, 
4CH2O), 8.15 (s, 2H, ArH), 8.48 (s, 2H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 11.0 (4CH3), 
14.0 (4CH3), 23.0 (4CH2), 23.7 (2CH2), 23.8 (2CH2), 28.9 (4CH2), 30.4 (4CH2), 38.8 (4CH), 
68.6 (4CH2O), 123.1 (2CH), 123.7 (2CH), 129.3 (2C), 131.9 (2C), 135.9 (2C), 143.0 (2C), 
167.3 (2CO), 167.3 (2CO).  IR (KBr, cm
1
): v = 2956, 2926, 2858 (w), 1721 (s), 1608, 1549 
(w), 1460, 1379, 1314 (m), 1265, 1236, 1122, 1097 (s), 1004, 957, 894 (w), 776 (m), 517 (w). 
MS (EI, 70 eV): m/z (%) = 808(2) [M]
+
, 568(19), 567(57), 473(15), 456(11), 455(41), 
360(68), 343(38), 325(23), 216(17), 112(24), 83(14), 71(48), 57(100), 43(60), 41(36). HRMS 
(EI, 70 eV): calcd for C48H72O8S [M]
+
: 808.49424; found: 808.49384. 
 
Tetrahexyl dibenzo[b,d]thiophene-2,3,7,8-tetracarboxylate (63f): 
Product 63f was prepared 
starting with 61 (200 mg, 
0.5 mmol), n-hexyl acrylate 
(0.44 mL, 2.5 mmol), 
Pd(OAc)2 (3.4 mg, 3 mol 
%), P(Cy)3 (5 mol %), 
Na2CO3 (216 mg, 4.0 mmol), DMF (5 mL) at 140 °C for 24 h according to general procedure 
L, as brownish semi solid (139 mg, 40%).  
1
H NMR (300 MHz, CDCl3):  = 0.83 (t, 6H, J = 
6.8 Hz, 2CH3), 0.84 (t, 6H, J = 6.9 Hz, 2CH3), 1.24-1.31 (m, 16H, 8CH2), 1.33-1.40 (m, 8H, 
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4CH2), 1.65-1.77 (m, 8H, 4CH2), 4.28 (t, 4H, J = 6.8 Hz, 2CH2O), 4.30 (t, 4H, J = 6.8 Hz, 
2CH2O), 8.15 (s, 2H, ArH), 8.52 (s, 2H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 14.0 (4CH3), 
22.5 (4CH2), 25.6 (4CH2), 28.5 (2CH2), 28.6 (2CH2), 31.5 (4CH2), 66.2 (2CH2O), 66.3 
(2CH2O), 123.2 (2CH), 123.7 (2CH), 129.1 (2C), 131.9 (2C), 135.9 (2C), 143.0 (2C), 167.2 
(2CO), 167.3 (2CO). IR (KBr, cm
1
): v = 2953, 2925, 2856 (m), 1716 (s), 1608, 1547, 1466, 
1379 (m), 1268, 1240, 1119, 1097 (s), 991, 897, 781 (m), 746, 600, 542 (w). MS (EI, 70 eV): 
m/z (%) = 696(11) [M]
+
, 512(26), 511(100), 428(12), 427(50), 360(13), 343(29), 342(12), 
325(47), 290(15), 258(12), 69(12), 55(25), 43(62). HRMS (EI, 70 eV): calcd for C40H56O8S 
[M]
+
: 696.36904; found: 696.36962. Anal. calcd for C40H56O8S: C, 68.93; H, 8.10; S, 4.60. 
Found: C, 69.17; H, 8.57; S, 4.99. 
 
2,3,7,8-Tetraphenyldibenzo[b,d]thiophene (63g): 
Product 63g was prepared starting with 62g (100 
mg, 0.20 mmol), following general procedure M, as 
a yellow solid (73 mg, 74%), mp. = 228-230 °C. 
1
H 
NMR (300 MHz, CDCl3):  = 7.16 (br, 20H, ArH), 
7.83 (s, 2H, ArH), 8.11 (s, 2H, ArH. 
13
C NMR (75 
MHz, CDCl3):  = 123.6 (2CH), 124.6 (2CH), 126.6 
(2CH), 126.8 (2CH), 128.0 (8CH), 130.1 (4CH), 130.2 (4CH), 134.8 (2C), 137.9 (2C), 139.3 
(2C), 139.9 (2C), 141.3 (2C), 141.6 (2C). IR (KBr, cm
1
): v = 3079, 3055, 2921, 2851, 1598, 
1493 (w), 1457 (m), 1441, 1403, 1305, 1262, 1178, 1089, 1072, 966 (w), 905, 882, 764 (m), 
728, 695 (s), 670, 648, 603, 585 (m). MS (EI, 70 eV): m/z (%) = 488(100) [M]
+
, 312(13), 
299(18), 71(10), 57(15), 43(15). HRMS (EI, 70 eV): calcd for C36H24S [M]
+
: 488.15932; 
found: 488.15903. 
 
2,3,7,8-Tetrakis(4-tert-butylphenyl)dibenzo[b,d]thiophene (63h): 
Product 63h was prepared starting with 
 62h (100 mg, 0.14 mmol), following 
general procedure M, as a yellow solid 
(62 mg, 63%), mp.= 92-94°C. 
1
H NMR 
(300 MHz, CDCl3):  = 1.23 (s, 36H, 12 
CH3), 7.07 (d, 8H, J = 8.3 Hz, ArH), 
7.17 (d, 8H, J = 8.3 Hz, 2CH), 7.80 (s, 
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2H, ArH), 8.09 (s, 2H, ArH). 
13
C NMR (62 MHz, CDCl3):  = 31.4 (12CH3), 34.4 (2C), 34.5 
(2C), 123.5 (2CH), 124.4 (2CH), 124.7 (8CH), 129.6 (4CH), 129.7 (4CH), 134.7 (2C), 137.7 
(2C), 138.4 (2C), 138.6 (2C), 134.9 (2C), 139.7 (2C), 149.3 (2C), 149.5 (2C). IR (KBr, cm
1
): 
v = 2955 (m), 2902, 2864, 1515, 1506 (w), 1456, 1361, 1267 (m), 1200 (w), 1111 (m), 1014, 
884 (m), 831 (s), 761, 710, 626 (w), 601, 562 (m). MS (EI, 70 eV): m/z (%) = 712(100) [M]
+
, 
697(13), 424(13), 341(21), 71(10), 69(14), 57(68), 55(11), 43(11), 41(14). HRMS (EI, 70 
eV): calcd for C52H56S [M]
+
: 712.40972; found: 712.40988. 
 
2,3,7,8-Tetrakis(4-methoxyphenyl)dibenzo[b,d]thiophene (63i): 
Product 63i was prepared starting with 
62i (100 mg, 0.16 mmol), following 
general procedure M, as whitish solid 
(65 mg, 67%), mp. = 269-271 °C. 
1
H 
NMR (300 MHz, CDCl3):  = 3.71 (s, 
12H, 4OCH3), 6.71 (dd, 8H, J = 1.7, 
8.6 Hz, ArH), 7.06 (dd, 8H, J = 1.4, 8.6 Hz, 2CH), 7.76 (s, 2H, ArH), 8.03 (s, 2H, ArH). 
13
C 
NMR (75 MHz, CDCl3):  = 54.2 (4OCH3), 112.4 (4CH), 112.5 (4CH), 122.3 (2CH), 123.3 
(2CH), 130.0 (4CH), 130.1 (4CH), 132.8 (2C), 133.1 (2C), 133.5 (2C), 136.2 (2C), 137.8 
(2C), 138.3 (2C), 157.3 (2C), 157.4 (2C). IR (KBr, cm
1
): v = 3034, 2952, 2831 (w), 1606 
(m), 1574 (w), 1510 (s), 1455, 1439 (m), 1420, 1398 (w), 1290 (m), 1242, 1174 (s), 1107, 
1045, 1023 (m), 957, 936, 882 (w), 827 (s), 799, 785, 733, 678, 642, 598, 585, 573 (m). MS 
(EI, 70 eV): m/z (%) = 608(100) [M]
+
, 579(30), 578(77), 44(12). HRMS (EI, 70 eV): calcd for 
C40H32O4S [M]
+
: 608.20158; found: 608.20256. 
 
2,3,7,8-Tetra-p-tolyldibenzo[b,d]thiophene (63j): 
Product 63j was prepared starting with 
62j (100 mg, 0.18 mmol), following 
general procedure C, as whitish solid 
(58 mg, 59%). mp. = 82-84 °C. 
1
H NMR 
(300 MHz, CDCl3):  = 2.25 (s, 12H, 
4CH3), 6.98 (d, 8H, J = 8.1 Hz, ArH), 
7.05 (d, 8H, J = 8.1 Hz, 2CH), 7.78 (s, 2H, ArH), 8.06 (s, 2H, ArH). 
13
C NMR (62 MHz, 
CDCl3):  = 20.1 (4CH3), 122.5 (2CH), 123.4 (2CH), 127.7 (8CH), 128.8 (4CH), 128.9 
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(4CH), 133.6 (2C), 135.0 (2C), 135.2 (2C), 136.6 (2C), 137.5 (2C), 137.7 (2C), 137.9 (2C), 
138.7 (2C). IR (KBr, cm
1
): v = 3021, 2918, 2852, 1513, 1455, 1376, 1259, 1183, 1109, 1018, 
881 (w), 815 (s), 724 (m), 660, 641, 599, (w), 578 (m). MS (EI, 70 eV): m/z (%) = 544(65) 
[M]
+
, 515(15), 514(39), 432(38), 404(62), 327(100), 285(23), 271(29), 257(11), 112(21), 
105(33), 85(11), 83(14), 71(27), 57(42), 43(27), 41(16). HRMS (EI, 70 eV): calcd for 
C40H32S [M]
+
: 544.22192; found: 544.22257. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
232 
 
                 8.2      Crystallographic Data 
 
 
Table 47.  Crystal data and structure refinement for 2a. 
 
Identification code  is_st2081 
Empirical formula  C11H8Br2S 
Formula weight  332.05 
Temperature  173 (2) K 
Wavelength  0.71073  Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/n 
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 7.5006 (5) Å α= 90.00°. 
 b = 11.4919 (8) Å β = 97.945 (4)°. 
 c = 25.8482 (17) Å  = 90.00°. 
Volume 2206.6 (3)  Å3 
Z 8 
Density (calculated) 1.999 Mg/m
3
 
Absorption coefficient 7.491 mm
−1
 
F(000) 1280 
Crystal size 0.86 × 0.26 × 0.04  mm3 
 range for data collection 3.55 to 27.49° 
Index ranges -9≤h≤9, -14≤k≤14, -33≤l≤33 
Reflections collected 38013 
Independent reflections 5029 [R(int) = 0.0761] 
Completeness to  = 29.00° 99.4%  
Absorption correction multi-scan 
Max. and min. transmission 0.0599 and 0.7537 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3602 / 2  / 268 
Goodness-of-fit on F2 1.074 
Final R indices [I>2(I)] R1 = 0.0429, wR2 = 0.0987 
R indices (all data) R1 = 0.0743, wR2 = 0.1066 
Largest diff. peak and hole 0.822 and -0.802 e.Å-3 
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Table 48.  Crystal data and structure refinement for 3a. 
 
Identification code  av_st208-2 
Empirical formula  C18H15BrS 
Formula weight  343.27 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.515 (4) Å α= 90.00°. 
 b = 9.856 (6)   Å β = 105.959 (13)°. 
 c = 9.983 (5) Å  = 90.00°. 
Volume 746.9 (7)  Å3 
Z 2 
Density (calculated) 1.526   Mg/m
3
 
Absorption coefficient 2.878 mm
−1
 
F(000) 348  
Crystal size 0.48 × 0.28 × 0.04  mm3 
 range for data collection 4.25 to 30.00° 
Index ranges -11≤h≤11, -13≤k≤13, -13≤l≤14 
Reflections collected 15327 
Independent reflections 4278 [R(int) = 0.0352] 
Completeness to  = 29.00° 98.2%  
Absorption correction multi-scan 
Max. and min. transmission 0.3388 and 0.8936 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3480 / 0  / 183 
Goodness-of-fit on F2 1.061 
Final R indices [I>2(I)] R1 = 0.0333, wR2 = 0.0884 
R indices (all data) R1 = 0.0466, wR2 = 0.0927 
Largest diff. peak and hole 0.687 and -0.412 e.Å-3 
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Table 49.  Crystal data and structure refinement for 4i. 
 
Identification code  is_st203 
Empirical formula  C22H13F3S 
Formula weight  366.38 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/n 
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 6.186 (5) Å α= 90.00°. 
 b = 24.301 (16)  Å β = 92.74 (3)°. 
 c = 11.336 (8) Å  = 90.00°. 
Volume 1702 (2) Å3 
Z 4 
Density (calculated) 1.430  Mg/m
3
 
Absorption coefficient 0.223 mm
−1
 
F(000) 752 
Crystal size 0.63 × 0.44 × 0.34 mm3 
 range for data collection 1.98 to 29.00° 
Index ranges -8≤h≤8, -33≤k≤33, -15≤l≤15 
Reflections collected 17349 
Independent reflections 4497 [R(int) = 0.0348] 
Completeness to  = 29.00° 99.2%  
Absorption correction multi-scan 
Max. and min. transmission 0.8724 and 0.9281 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3820 / 0  / 248 
Goodness-of-fit on F2 1.048 
Final R indices [I>2(I)] R1 = 0.0410, wR2 = 0.0994 
R indices (all data) R1 = 0.0507, wR2 = 0.1037 
Largest diff. peak and hole 0.349 and -0.274 e.Å-3 
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Table 50.  Crystal data and structure refinement for 11a. 
 
Identification code  is_st327-1 
Empirical formula  C18H15BrS 
Formula weight  343.27 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  P n m a 
Space group (Hall)  -P 2ac 2n 
Unit cell dimensions a = 7.4143 (15) Å α = 90.00°. 
 b = 17.139 (3) Å β = 90.00°. 
 c = 11.617 (2) Å  = 90.00°. 
Volume 1476.1 (5)  Å3 
Z 4 
Density (calculated) 1.545  Mg/m3 
Absorption coefficient 2.913 mm-1 
F(000) 696 
Crystal size 1.00 × 0.26 × 0.18 mm3 
 range for data collection 4.76 to 32.50°. 
Index ranges -11≤h≤ 10, -25≤k≤ 13, -17≤l≤ 16 
Reflections collected 11430 
Independent reflections 2724 [R(int) = 0.0343] 
Completeness to  = 29.00° 99.2% 
Absorption correction multi-scan 
Max. and min. transmission 0.1587 and 0.6222 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2210 / 0/ 98 
Goodness-of-fit on F2 1.038 
Final R indices [I>2(I)] R1 = 0.0299, wR2 = 0.0803 
R indices (all data) R1 = 0.0435, wR2 = 0.0837 
Largest diff. peak and hole 0.743 and -0.352 e.Å-3 
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Table 51.  Crystal data and structure refinement for 12c. 
 
Identification code  is_st3113 
Empirical formula  C34H40S 
Formula weight  480.72 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 9.302 (5) Å α= 105.606 (12)°. 
 b = 12.594 (7)   Å β = 95.188 (14)°. 
 c = 13.009 (7) Å  = 97.384 (19)°. 
Volume 1443.0 (13)  Å3 
Z 2 
Density (calculated) 1.106    Mg/m
3
 
Absorption coefficient 0.131 mm
−1
 
F(000) 520  
Crystal size 0.50 × 0.26 × 0.18  mm3 
 range for data collection 2.23 to 29.00° 
Index ranges -12≤h≤12, -17≤k≤17, -17≤l≤17 
Reflections collected 28799 
Independent reflections 7630 [R(int) = 0.0399] 
Completeness to  = 29.00° 99.2%  
Absorption correction multi-scan 
Max. and min. transmission 0.9372 and 0.9767 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5662 / 0  / 363 
Goodness-of-fit on F2 1.095 
Final R indices [I>2(I)] R1 = 0.0489, wR2 = 0.1359 
R indices (all data) R1 = 0.0698, wR2 = 0.1459 
Largest diff. peak and hole 0.743 and -0.352 e.Å-3 
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Table 52.  Crystal data and structure refinement for 19a. 
 
Identification code  is_st319 
Empirical formula  C13H13Br2NO2 
Formula weight  375.06 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  P 21 21 21 
Space group (Hall)  P 2ac 2ab 
Unit cell dimensions a = 7.807 (4) Å α= 90.00°. 
 b = 7.859 (4) Å β = 90.00°. 
 c = 22.553 (12) Å  = 90.00°. 
Volume 1383.7 (13) Å3 
Z 4 
Density (calculated) 1.800 Mg/m
3
 
Absorption coefficient 5.851 mm
−1
 
F(000) 736 
Crystal size 0.26 × 0.15 × 0.07 mm3 
 range for data collection 2.74 to 30.02° 
Index ranges -9≤h≤10, -11≤k≤10, -29≤l≤31 
Reflections collected 8845 
Independent reflections 3926 [R(int) = 0.0322] 
Completeness to  = 29.00° 98.8%  
Absorption correction multi-scan 
Max. and min. transmission 0.3115 and 0.6848 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3150 / 0  / 166 
Goodness-of-fit on F2 1.001 
Final R indices [I>2(I)] R1 = 0.0347, wR2 = 0.0682 
R indices (all data) R1 = 0.0510, wR2 = 0.0712 
Largest diff. peak and hole 0.932 and -0.746 e.Å-3 
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Table 53.  Crystal data and structure refinement for 22a. 
 
Identification code  ch_st541 
Empirical formula  C25H22ClNO2 
Formula weight  403.89 
Temperature  173 (2) K 
Wavelength  0.71073  Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 12.3435 (2) Å α= 106.070 (1)°. 
 b = 14.5892 (2) Å β = 97.205 (1)°. 
 c = 18.5121 (3) Å  = 101.973 (1)°. 
Volume 3073.88 (8)  Å3 
Z 6 
Density (calculated) 1.309 Mg/m
3
 
Absorption coefficient 0.208 mm
−1
 
F(000) 1272 
Crystal size 0.31 × 0.30 × 0.12 mm3 
 range for data collection 1.88 to 30.00° 
Index ranges -17≤h≤16, -20≤k≤20, -25≤l≤26 
Reflections collected 64412 
Independent reflections 17700 [R(int) = 0.0344] 
Completeness to  = 29.00° 98.7%  
Absorption correction multi-scan 
Max. and min. transmission 0.9384 and 0.9755 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11998 / 0  / 793 
Goodness-of-fit on F2 1.036 
Final R indices [I>2(I)] R1 = 0.0463, wR2 = 0.1088 
R indices (all data) R1 = 0.0819, wR2 = 0.1191 
Largest diff. peak and hole 0.335 and -0.352 e.Å-3 
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Table 54.  Crystal data and structure refinement for 27b. 
 
Identification code  av_st962 
Empirical formula  C14H16O4S 
Formula weight  280.33 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/n 
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 7.998 (8) Å α= 90.00°. 
 b = 13.898 (13)   Å β = 91.13 (2)°. 
 c = 12.924 (13) Å  = 90.00°. 
Volume 1436 (2)  Å3 
Z 4 
Density (calculated) 1.296     Mg/m
3
 
Absorption coefficient 0.232 mm
−1
 
F(000) 592 
Crystal size 0.40 × 0.30 × 0.27  mm3 
 range for data collection 2.15 to 28.00° 
Index ranges -9≤h≤10, -18≤k≤18, -17≤l≤17 
Reflections collected 28799 
Independent reflections 3441 [R(int) = 0.0285] 
Completeness to  = 29.00° 99.4%  
Absorption correction multi-scan 
Max. and min. transmission 0.9129 and 0.9400 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2700 / 3  / 184 
Goodness-of-fit on F2 1.062 
Final R indices [I>2(I)] R1 = 0.0420, wR2 = 0.1199 
R indices (all data) R1 = 0.0575, wR2 = 0.1280 
Largest diff. peak and hole 0.350 and -0.253 e.Å-3 
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Table 55.  Crystal data and structure refinement for 27i. 
 
Identification code  av_st106 
Empirical formula  C22H20O2S 
Formula weight  348.44 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 6.1658 (5) Å α= 90.00°. 
 b = 8.2731 (8) Å β = 92.852 (3)° 
 c = 35.418 (3) Å  = 90.00°. 
Volume 1804.5 (3)Å3 
Z 4 
Density (calculated) 1.283 Mg/m
3
 
Absorption coefficient 0.191 mm
−1
 
F(000) 736 
Crystal size 0.24 × 0.14 × 0.05 mm3 
 range for data collection 4.19 to 22.95° 
Index ranges -6≤h≤5, -8≤k≤9, -33≤l≤38 
Reflections collected 9310 
Independent reflections 2451 [R(int) = 0.0592] 
Completeness to  = 29.00° 98.0%  
Absorption correction multi-scan 
Max. and min. transmission 0.9556 and 0.9905 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1552 / 4 / 243 
Goodness-of-fit on F2 1.006 
Final R indices [I>2(I)] R1 = 0.0469, wR2 = 0.1006 
R indices (all data) R1 = 0.0953, wR2 = 0.1140 
Largest diff. peak and hole 0.165 and -0.197 e.Å-3 
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Table 56.  Crystal data and structure refinement for 31. 
 
Identification code  is_st150 
Empirical formula  C12H9Br2NOS 
Formula weight  375.08 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/n 
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 11.5759 (6) Å α= 90.00°. 
 b = 10.4612 (6)  Å β = 115.361 (1)°. 
 c = 11.8700 (7) Å  = 90.00°. 
Volume 1298.90 (13)  Å3 
Z 4 
Density (calculated) 1.918  Mg/m
3
 
Absorption coefficient 6.383 mm
−1
 
F(000) 728 
Crystal size 0.30 × 0.29 × 0.26  mm3 
 range for data collection 4.03 to 30.00° 
Index ranges -15≤h≤16, -14≤k≤14, -16≤l≤15 
Reflections collected 14885 
Independent reflections 3774 [R(int) = 0.0972] 
Completeness to  = 29.00° 99.7%  
Absorption correction multi-scan 
Max. and min. transmission 0.2504 and 0.2876 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2938 / 0  / 155 
Goodness-of-fit on F2 1.005 
Final R indices [I>2(I)] R1 = 0.0311, wR2 = 0.0762 
R indices (all data) R1 = 0.0435, wR2 = 0.0784 
Largest diff. peak and hole 1.230 and -0.689 e.Å-3 
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Table 57.  Crystal data and structure refinement for 36b. 
 
Identification code  ch_st592 
Empirical formula  C25H28O5S 
Formula weight  440.53 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 10.2275 (3) Å α= 69.527 (1)°. 
 b = 11.3135 (3) Å β = 66.716 (1)°. 
 c = 11.4252 (3)Å  = 80.957 (1)° 
Volume 1137.35 (5) Å3 
Z 2 
Density (calculated) 1.286 Mg/m
3
 
Absorption coefficient 0.176 mm
−1
 
F(000) 468 
Crystal size 0.35 × 0.31 × 0.24 mm3 
 range for data collection 2.05 to 29.93° 
Index ranges -14≤h≤14, -15≤k≤15, -16≤l≤16 
Reflections collected 23380 
Independent reflections 6502 [R(int) = 0.0184] 
Completeness to  = 29.00° 98.6%  
Absorption correction multi-scan 
Max. and min. transmission 0.9410 and 0.9590 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5481 / 12  / 344 
Goodness-of-fit on F2 1.035 
Final R indices [I>2(I)] R1 = 0.0402, wR2 = 0.1033 
R indices (all data) R1 = 0.0497, wR2 = 0.1074 
Largest diff. peak and hole 0.330 and -0.228 e.Å-3 
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Table 58. Crystal data and structure refinement for 44f. 
 
Identification code  av_st504 
Empirical formula  C29H26N2O2 
Formula weight  434.52 
Temperature  173 (2) K 
Wavelength  0.71073Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 9.9187 (3)Å α = 98.132 (2)°. 
 b = 13.2291 (4)Å β = 99.594 (2)°. 
 c = 18.0652 (6)Å  = 96.469 (2)°. 
Volume 2291.13 (12) Å3 
Z 4 
Density (calculated) 1.260Mg/m3 
Absorption coefficient 0.08 mm-1 
F(000) 920 
Crystal size 0.64 × 0.13 × 0.09mm3 
 range for data collection 2.10 to 26.00°. 
Index ranges -12≤h≤ 9, -14≤k≤ 16, -21≤l≤ 22 
Reflections collected 36320 
Independent reflections 8982 [R(int) = 0.0615] 
Completeness to  = 29.00° 99.7% 
Absorption correction multi-scan 
Max. and min. transmission 0.9510 and 0.9929 
Refinement method Full matrix 
Data / restraints / parameters 4537 / 1/ 624 
Goodness-of-fit on F2 0.921 
Final R indices [I>2(I)] R1 = 0.0545, wR2 = 0.1057 
R indices (all data) R1 = 0.1482, wR2 = 0.1259 
Largest diff. peak and hole 0.216 and -0.196e.Å-3 
244 
 
References 
 
[1] De Meijere, A.; Diederich, F. “Metal-Catalyzed Cross-Coupling Reactions” 2nd ed., 
Vol.1 and 2, Wiley-VCH, Weinheim, Germany, 2004. 
[2] a) Diederich, F.; Stang, P. J. (Eds.) “Metal-catalyzed Cross-coupling Reactions”, 
Wiley-VCH, Weinheim, 1998; b) N. Miyaura, T. Yanagi, A. Suzuki, Synth. Commun. 
1981, 11, 513. 
[3]   a) King, A. O.; Yasuda, N. “Palladium-Catalyzed Cross-Coupling Reactions in the 
Synthesis of Pharmaceuticals”, In Topics in Organometallic Chemistry Vol. 
6: Springer; New York: 2004, 205; b) Myers, A. G.;  Tom, N. J.; Fraley, M. E.; Cohen, 
S. B.; Madar, D. J.; J. Am. Chem. Soc. 1997, 119, 6072; c) Sambasivarao, K.; Kakali, 
L.; Dhurke, K. Tetrahedron 2002, 58, 9633; d) Hirashima, S.; Aoyagi, S.; Kibayashi, 
C. J. Am. Chem. Soc. 1999, 121, 9873. 
[4] a) Heck, R. F.; Nolley, J. P. J. Org. Chem. 1972, 37, 2320; b) Dieck, H. A.; Heck, R. 
F. J .Am. Chem. Soc.1974, 96, 1133; c) Ahmed-Omer, B.; Barrow, D. A.; Wirth, T. 
Tetrahedron Lett. 2009, 50, 3352. 
[5] a) Miyaura, N.; Yamada, K.; Suzuki, A. Tetrahedron Lett. 1979, 20, 3437; b) Miyaura, 
N.; Suzuki, A. J. Chem. Soc. Chem. Commun. 1979, 866. 
[6]  Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 16, 4467. 
[7] a) Milstein, D.; Stille, J. K. J. Am. Chem. Soc. 1978, 100, 3636; b) Stille, J. K. Angew. 
Chem. Int. Ed. Engl. 1986, 25, 508. 
[8]  Mizoroki, T.; Mori, K.; Ozaki, A. Bull. Chem. Soc. Jap. 1971, 44, 581. 
[9] a) Hong, C. Y.; Kado, N.; Overman, L. E. J. Am. Chem. Soc. 1993, 115, 11028; b) 
Chang, Y.; Wu, G.; Agnel, G.; Negishi, E. -I. J. Am. Chem. Soc. 1990, 112, 8590; c) 
Rawal, V. H.; Iwasa, S. J. Org. Chem. 1994, 59, 2685; d) Overman, L. E.; Ricca, D. J.; 
Tran,  V. D. J. Am. Chem. Soc. 1993, 115, 2042; e) Kucera, D. J.; O‟Connor, S. J.; 
Overman, L. E. J. Org. Chem. 1993, 58, 5304. 
[10] Manrique-Moreno, M.;  Suwalsky, M.;  Villena, F.; Garidel, P. Biophys. Chem. 
2010,147, 53. 
[11] De Vries, Johannes G. "The Heck reaction in the production of fine chemicals". Can. 
J. Chem. 2001, 79, 1086. 
 [12]   a) Phan N.T.S.; Sluys M.V.D.; Jones C.V. Adv. Synth. Catal. 2006, 348, 60; b) Safin 
D. A.;  Babashkina M. G.;  Klein A.; Catalysis Lett. 2008, 129, 363; c) Bellina F.; 
245 
 
Carpita A:, Rossi R. Synthesis 2004, 15, 2419; d) Kotha S.; Lahiri K.; Kashinath D. 
Tetrahedron 2002, 58, 963. 
[13]  Baumeister P.; Seifert G.; Steiner H. European Patent EP584043, 1994. 
[14]  Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 245. 
[15] a) Liu W.-J.; Xie Y.-X.; Liang Y.; Li J.-H. Synthesis, 2006, 860; b) Liu L.; Zhang Y.; 
Wang Y. J. Org. Chem. 2005, 70, 6122.  
[16] Dembitsky V. M.; Ali A. H.; Srebnik M. Studies in Inorganic Chemistry 
2006,  22, 119. 
[17] a) Chemler, S. R.; D. Trauner,  Danishefsky, S. J. Angew. Chem., Int. ed.  2001, 40, 
4544; b) Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem., Int. ed.  2005, 44, 
4442. 
[18] a) Schluter, A. D. J. Polym. Sci. A. 2001, 39, 1533; b) Schiedel, M. -S., Briehn, C.A.; 
Bauerle, P. J. Organomet. Chem. 2002, 653, 200. 
[19] Doucet, H.; Hierso, J. -C. Curr. Opin. Drug Disc. Dev. 2007, 10, 672. 
[20] a) Bringmann G.; Goetz R.; Keller P. A.; Walter R.; Boyd M. R.; Lang F.; Garcia A.; 
Walsh J. J.; Tellitu I.; Bhaskar K. V.; Kelly T. R. J. Org. Chem. 1998, 63, 1090; b)  
Hobbs P. D.; Upender V.;  Dawson M. I. Synlett 1997, 965. 
[21]   For reviews of cross-coupling reactions of polyhalogenated heterocycles, see: a) 
Schröter, S.; Stock, C.; Bach, T. Tetrahedron 2005, 61, 2245; b) Schnürch, M.; Flasik, 
R.; Khan, A. F.; Spina, M.; Mihovilovic, M. D.; Stanetty, P. Eur. J. Org. Chem. 2006, 
3283; c) Wang, R.; Manabe, K. Synthesis 2009, 1405. 
[22] Fairlamb, I. J. S. Chem. Soc. Rev. 2007, 36, 1036. 
[23]  Hussain, M.; Hung, N. T.; Khera, R. A.; Malik, I.; Zinad, D. S.; Langer, P. Adv. Synth. 
Catal. 2010, 352, 1429. 
[24]  Mahal, A.; Villinger, A.; Langer, P. Synlett 2010, 7, 1085. 
[25]  For work from our laboratories, see: a) Dang, T. T.; Dang, T. T.; Ahmad, R.; Reinke, 
H.; Langer, P. Tetrahedron Lett. 2008, 49, 1698; b) Dang, T. T.; Villinger, A.; Langer, 
P. Adv. Synth. Catal. 2008, 350, 2109; c) Hussain, M.; Nguyen, T. H.; Langer, P. 
Tetrahedron Lett. 2009, 50, 3929; d) Toguem, T. S.-M.; Hussain, M.; Malik, I.; 
Villinger, A.; Langer, P. Tetrahedron Lett. 2009, 50, 4962; e) Hussain, M.; Malik, I.; 
Langer, P. Synlett 2009, 2691; f) Dang, T. T.;
 
Dang, T. T.; Rasool, N.; Villinger, A.; 
Langer, P.
 
Adv. Synth. Catal. 2009, 351, 1595; g) Ullah, I.; Khera, R. A.; Hussain, M.; 
Langer, P. Tetrahedron Lett. 2009, 50, 4651; h) Nawaz, M.; Farooq, M. I.; Obaid-Ur-
246 
 
Rahman, A.; Khera, R. A.; Villinger, A.; Langer, P. Synlett 2010, 150; i) Toguem, S.-
M. T.; Villinger, A.; Langer, P. Synlett 2009, 3311; j)  Toguem, S.-M. T.; Villinger, A.; 
Langer, P. Synlett 2010, 909; 
[26] a) Chandra, R.; Kung, M. -P.; Kung, H. F. Bioorg. Med. Chem. Lett. 2006, 16, 1350; 
b) Athri, P.; Wenzler, T.; Ruiz, P.; Brun, R.; Boykin, D. W.; Tidwell, R.; Wilson, W. 
D. Bioorg. Med.Chem. 2006, 14, 3144; c) Han, Y.; Giroux, A., Lepine, C.; Latiberte, 
 F.; Huang, Z.;  Perrier, H.; Bayly, C. I.; Young, R. N.  Tetrahedron 1999, 55, 11669;  
d)  Mortensen, D. S.; Rodriguez, A. L.; Carlson, K. E.; Sun, J.; Katzenellenbogen, B. 
S.; Katzenellenbogen, J. A.  J. Med. Chem. 2001, 44, 3838; e) Gallant, M.; Belley, M.; 
Carriere, M.-C.; Chateauneuf, A.; Denis, D.; Lachance, N.; Lamontagne, S.; Metters, 
 K. M.; Sawyer, N.; Slipetz, D.; Truchon, J. F.; Labelle, M. Bioorg. Med. Chem. Lett.  
2003, 13, 3813; f) Givens, M. D.; Dykstra, C. C.; Brock, K. V.; Stringfellow, D. A.; 
Kumar, A.; Stephens, C. E.; Goker, H.; Boykin, D. W. Antimicrob. Agents 
Chemother. 2003, 47, 2223; g) Brendle, J. J.; Outlaw, A.; Kumar,  A.; Boykin, D. W.; 
Patrick, D. A.; Tidwell, R. R.; Werbovetz, K. A. Antimicrob. Agents Chemother. 
2002, 46, 97; h) Vachal, P.; Toth, L. M.; Hale, J. J.; Yan, L.; Mills, S. G.; Chrebet, G. 
L.; Koehane, C. A.; Hajdu, R.; Milligan, J. A.; Rosenbach, M. J.; Mandela, S. Bioorg. 
Med. Chem. Lett. 2006, 16, 3684; i)  Gonzalez,  J. L.; Stephens, C. E.; Wenzler, T.; 
Brun, R.; Tanious, F. A.; Wilson, W. D.; Barszcz, T.; Werbovetz, K. A.; Boykin, D. 
W. Eur. J. Med. Chem. Chim. Ther. 2007, 42, 552;  
[27] a) Ahmad , V. U.; Alam, N.; Qaisar, M. Phytochemistry 1998, 49, 259; b) Ahmad, V. 
U.; Alam, N. Phytochemistry 1996, 42, 733. c) Kroutil, W.; Staempfli, A. A.; 
Dahinden,  R.; Jörg, M.; Müller, U.; Pachlatko, J. P. Tetrahedron 2002, 58, 2589; 
d) Nakajima, S.; Kawazu, K. Agric. Biol. Chem. 1980, 44, 1529; e) Margl, L.; 
Eisenreich, W.; Adam, P.; Bacher, A.; Zenk, M. H. Phytochemistry 2001, 58, 875; 
f) Bohlmann, F.; Zdero, C.; King, R. M.; Robinson, H. Phytochemistry 1983, 22, 1035 
; g) Fokialakis, N.; Cantrell, C. L.; Duke, S. O.; Skaltsounis, A. L.; Wedge, D. E. J. 
Agric. Food Chem. 2006, 54, 1651.  
[28] For oligothiophenes with low-lying triplet states, see: a) Garnier, F. Angew. Chem., 
Int. Ed. Engl. 1989, 28, 513; b) Garnier, F.; Yassar, A.; Hajlaoui, R.; Horowitz, G.; 
Deloffre, F.; Servet, B.; Ries, S.; Alnot, P. J. Am. Chem. Soc. 1993, 115, 8716; c) 
Garnier, F.; Hajlaoui, R.; Yassar, A. ; Srivastava, P.; Science 1994, 265, 1684;  
d) Dodabalapur, A.; Torsi, L.; Katz, H. E. Science 1995, 268, 270; e) Dodabalapur,  A. 
247 
 
; Rothberg, L. J.; Fung, A. W. P.; Katz, H. E. Science 1996, 272, 1462; f)  Noda, T.; 
Ogawa, H.; Noma, N.; Shirota, Y. Appl. Phys. Lett. 1997, 70, 699; g) Noda, T.; Imae, 
I.; Noma, N.; Shirota, Y. Adv. Mater.  1997, 9, 239; h) Cui, Y.; Zhang, X.;  Jenekhe, S. 
A. Marcomolecules 1999, 32, 3824; i) Thayumanavan, S.; Mendez, J.;  Marder, S. R. 
J. Org. Chem. 1999, 64, 4289.  
[29] Mori, Y.; Taneda, S.; Hayashi, H.; Sakushima, A.; Kamata, K.; Suzuki, A.K.;Yoshino, 
S.; Sakata, M.; Sagai, M.; Seki, K. -I. Biol. Pharm. Bull. 2002, 25, 145.  
[30] a) Liu, P.; Zhang, Y.; Feng, G.; Hu, J.; Zhou, X.; Zhao, Q.; Xu, Y.; Tong, Z.; Deng, W 
.Tetrahedron 2004, 60, 5259; b) Huss, U.; Ringbom, T.; Perera, P.; Bohlin, L.;Vasaen
ge, M. J. Nat.Prod. 2002, 65, 1517; c) Albano, V. G.; Bandini, M.;  Melucci,  M.;  
Monari, M.; Piccinelli, F.; Tommasi, S.; Umani-Ronchi, A. Adv. Synth. Catal. 2005, 
11, 1507; d) Melucci, M.; Barbarella, G.; Zambianchi, M.; Pietro, P. D.; Bongini, A. J. 
Org. Chem. 2004, 69, 4821; e) Ciofalo, M; Petruso, S.; Schillaci, D. Planta 
Med. 1996, 62, 374.  
[31]  a) Guillet, G.; Philogene, B. J. R.; O'Meara, J.; Durst, T.; Arnason, J. T.; Phyto 
chemistry 1997, 46, 495;  b) Kawai, K.; Sugimoto, A.; Yoshida, H.; Tojo, S.; Fujitsuka 
, M.;Majima, T. Bioorg. Med. Chem. Lett. 2005, 20, 4547; c) Bohlmann, F.; Zdero, R. 
Chem. Ber. 1970, 103, 834.  
[32]  Pereira, R.; Iglesias, B.; de Lera, A. R. Tetrahedron 2001, 57, 7871.  
[33]  Carpita, A.; Rossi, R. Gazz. Chim. Ital. 1985, 115, 575.  
[34] Hawkins, D. W.; Iddon, B.; Longthorne, D. S.; Rosyk, P. J. J. Chem. Soc., Perkin 
Trans. 1 1994, 2735.  
[35]  Yamazaki, T.; Murata, Y.; Komatsu, K.; Furukawa, K.; Morita, M.; Maruyama, N.; 
Yamao, T.; Fujita, S. Org. Lett. 2004, 6, 4865.  
[36]  For an isolated example of a polymer synthesis using the Suzuki reaction, see: Xu, M. 
-H.; Zhang, H. -C.; Pu, L. Macromolecules 2003, 36, 2689.  
[37]  Neenan, T. X.; Whitesides, G. M. J. Org. Chem. 1988, 53, 2489.  
[38] Eichhorn, S. H.; Paraskos A. J.; Kishikawa, K.; Swager, T. M. J. Am. Chem. Soc. 
2002, 124, 12742.  
 [39]  a) Jones, R. A.; Bean, G. P. The chemistry of pyrrole, Academic Press, London, 1977;  
b) Pyrroles Part 1, Jones, R. A., ed., Wiley-Interscience, New York, 1990; c) Jefford, 
C. W. Curr. Org. Chem. 2000, 4, 205; d) Banwell, M. G.; Beck, D. A. S.; Stanislawski, 
P. C.; Sydnes, M. O.; Taylor, R. M. Curr. Org. Chem. 2005, 9, 1589; e) Baumann, K. 
248 
 
L.; Butler, D. E.; Deering, C. F.; Mennen, K. E.; Millar, A.; Nanninga, T. N.; Palmer, 
C. W.; Roth, B. D. Tetrahedron Lett. 1992, 33, 2283; f) Sternberg, E. D.; Dolphin, D.; 
Brückner, C. Tetrahedron 1998, 54, 4151; g) Sato, A.; McNulty, L.; Cox, K.; Kim, S.; 
Scott, A.; Daniell, K.; Summerville, K.; Price, C.; Hudson, S.; Kiakos, K.; Hartley, J. 
A.; Asao, T.; Lee, M. J. Med. Chem. 2005, 48, 3903. 
[40]   a) Bailly, C. Curr. Med. Chem. Anti-Cancer Agents 2004, 4, 363. (b) Handy, S. T.; 
Zhang, Y. Org. Prep. Proced. Int. 2005, 37, 411; c) Pla, D.; Marchal, A.; Olsen, C. A.; 
Albericio, F.; Álvarez, M. J. Org. Chem. 2005, 70, 8231. 
[41]  Li, J. J.; Gribble, G. W. Palladium in Heterocyclic Chemistry, Tetrahedron Organic 
Chemistry Series, vol. 20, Elsevier Science Ltd., Oxford, 2000, Chapter 2. 
[42]  (a) Cox, M.; Lehninger, A. L.; Nelson, D. R. Lehninger principles of biochemistry, 
New York, 2000, Worth Publishers; b) De Leon, C. Y.; Ganem, B. Tetrahedron 1997, 
53, 7731; c) Danso-Danquah, R. E.; Scott, A. I. Tetrahedron 1993, 49, 8195. 
[43]  van Pée, K.-H.; Ligon, J. M. Nat. Prod. Rep. 2000, 17, 157. 
[44]   Schröter, S.;  Bach, T. Synlett 2005, 1957. 
[45]  a) Handy, S. T.; Sabatini, J. J. Org. Lett. 2006, 8, 1537; b) Handy, S. T.; Zhang, Y. N. 
Synthesis 2006, 3883. 
[46] Gilow, H. M.; Burton, D. E. J. Org. Chem. 1981, 46, 2221. 
[47]  For a simple guide to predict the regioselectivity based on 
1
H NMR chemical shifts of 
the non-halogenated parent compound, see: Handy, S. T.; Zhang, Y. Chem. Commun. 
2006, 299. 
[48] Beletskaya I. P., Cheprakov A. V. Chem. Rev. 2000, 100, 3009. 
[49] a) Brase, S.; De Meijere, A. In Metal-Catalyzed Cross-Coupling Reactions; Diederich, 
F.; b) Stang, P. J., Eds.; Wiley-VCH: New York, 1998; c) Cabri, W.; Candiani, I. Acc. 
Chem. Res. 1995, 28, 2; d) Jeffery, T. In Advances in Metal-Organic Chemistry; 
Liebeskind, L. S., Ed.; Jai Press Inc: Greenwich, CT, 1996; Vol. 5; e) Heck, R. F. Org. 
React. (N.Y.) 1982, 27, 345; f) De Meijere, A.; Braese, S. In Transition Metal 
Catalyzed Reactions; Davies, S. G., Murahashi, S.-I., Eds.; Blackwell Science: 
Oxford, 1999. 
[50] Dieck H. A.; Heck R. F. “Organophosphinepalladium complexes as catalysts for 
vinylic hydrogen substitution reactions”. J. Am. Chem. Soc. 1974, 96, 1133. 
[51] Ziegler, C. B.; Heck, R. F. “Palladium-catalyzed vinylic substitution with highly 
activated aryl halides”. J. Org. Chem. 1978, 43, 2941. 
249 
 
 [52]  Clayden J.; Greeves N.; Warren S.; Wothers, P. Organic Chemistry, Oxford. 
University Press, New York, 2001. 956. 
[53] a) Gaasbeek C. J.; Hogeven H.; Volger H. C. Rec.Trav. chim. 1972, 91, 821; b) 
Marvell E. N.; Caple G.; Schatz B. Tetrahedron Lett. 1965, 385; c) Vogel E.; Grimma 
W.; Dinne E. Tetrahedron Lett. 1965, 3, 91. 
[54] a) O. Reiser, S. Reichow, and A. de Meijere, Angew. Chem. Int. Ed. Engl. 1987, 26, 
1277; b)  O. Reiser, S. Reichow, A. de Meijere,  Angew. Chem. 1987 99, 1285.   
[55] a) Voigt K.; von Zezschwitz P.; Rosauer K.; Lansky A.; Adams A.; Reiser O.; De 
Meijere A. Eur. J. Org. Chem. 1998, 1521. 
[56] a) Jeong S.-J.; Higuchi R.; Miyamoto T.; Ono M.; Kuwano M.; Mawatari S.F. J. Nat. 
Prod. 2002, 65, 1344; b) Kelly T. R.; Fu Y.; Sieglen J. T.; De Silva H. Org. Lett.  
2000, 2, 2351.   
[57]  a) Williams C. H.; Casterline Jr. J. L.; Jacobson  K. H. Toxicol. Appl. Pharm. 1967, 
11, 302; b) Kurtz P. J. Pharmacol. Biochem. Behav. 1977, 6, 303.   
[58] Eicher T.; Hauptmann S. Chemie der Heterocyclen, Thieme, Stuttgart 1994, 80. 
[59] a) Reviews: Iddon B.; Scrowston R. M. Adv. Heterocycl. Chem.  1970, 11, 177; b) 
Scrowston R. M. Adv. Heterocycl. Chem. 1981, 29, 171. 
[60] B. Iddon In: Mitra R. B. Editor, New Trends in Heterocyclic Chemistry, Elsevier, 
Amsterdam 1979, 250. 
[61] Pereira R. ; Iglesias B. ; de Lera, A. R. Tetrahedron  2001, 57, 7871.   
[62] Carpita A.; Rossi R. Gazz. Chim. Ital. 1985, 115, 575. 
[63] a) Gronowitz S.; Hörnfeld A.-B.; Yang Y. Croat. Chem. Acta. 1986, 59, 313; b) Raju 
B.; Wu C.; Kois A.; Vermer E.; Okun I.; Stavros F.; Chan M. F. Bioorg. Med. Chem. 
Lett. 1996, 6, 2651.    
[64] Yamamura K.; Kusuhara N.; Kondou A.; Hashimoto M. Tetrahedron 2002, 58, 7653.   
[65] a) For reviews of domino reactions, see: Tietze L. F.; Beifuss, U. Angew. Chem. 1993, 
105, 137; Angew. Chem. Int. Ed. Engl.   1993, 32, 131; b) Tietze L. F. Chem. Rev. 
1996, 96, 115.  
[66] Billingsley K.; Buchwald S. L. J. Am. Chem. Soc. 2007, 129, 3358. 
[67] Troyanowsky C. Bull. Soc. Chim. France, 1955, 1424. 
[68]  a) Alamgir M.; Black D. S. C.; Kumar N, Top. Heterocycl. Chem.  Springer; Berlin: 
2007, 87; b) Imidazole and Benzimidazole Synthesis   Grimmett M. R. Academic 
Press; Boston: 1997; c) Römpp Lexikon Naturstoffe   Steglich W.; Fugmann B.; Lang-
250 
 
Fugmann S. Thieme; Stuttgart: 1997; d) Spasov A. A.; Yozhitsa I. N.; Bugaeva L. 
I.; Anisimova V. A.; Pharm. Chem. J. 1999, 33, 6; e) Benzimidazoles and Cogeneric 
Tricyclic Compounds, In The Chemistry of Heterocyclic Compounds  Part 1, Vol. 
40:  Preston P. N. Wiley-VCH; Weinheim: 1981; f) Grimmett M. R. Imidazoles, In  
Comprehensive Heterocyclic Chemistry II  Vol. 3:  Katritzky  A. R.; Rees C. W.; 
Scriven E. F. V. Elsevier; Amsterdam: 1996, 77; g) Grimmett M. R. Imidazole and 
Benzimidazole Synthesis  Academic Press; Boston: 1997; h) Brown E. G. Ring 
Nitrogen and Key Biomolecules  Kluwer Academic Press; Boston: 1998; i) Gilchrist T. 
L. Heterocyclic Chemistry  The Bath Press; Bath: 1985.  
[69] a) Kucukbay H.; Durmaz R.; Guven M.; Gunal S. Arzneim.-Forsch. 2001, 51, 420; 
b) Kawato H. C.; Nakayama K.; Inagaki H.; Ohta T. Org. Lett. 2001, 3, 3451.  
[70] a) Weidner-Wells M. A.; Ohemeng K. A.; Nguyen V. N.; Fraga-Spano S.; Macielag  
M. J.; Werblood H. M.; Foleno B. D.; Webb G. C.; Barrett J. F.; Hlasta D. J. Bioorg. 
Med. Chem. Lett. 2001, 11, 545; b) Kennedy G.; Viziano M.; Winders J.A.;  Cavallini  
P.; Gevi M.; Micheli  F.; Rodegher P.; Seneci P.; Zumerle A. Bioorg. Med. Chem. 
Lett. 2000, 10, 1751.  
[71] Navarrete-Vazquez G.; Cedillo R.; Hernandez-Campos A.; Yepez L.; Hernandez-Luis 
F.; Valdez J.; Morales R.; Cortes R.; Hernandez M.; Castillo R. Bioorg. Med. Chem. 
Lett. 2001, 11, 187.  
[72] a) Lopez-Rodriguez M. L.; Benhamu B.; Viso A.; Murcia M.; Pardo L. Tetrahedron  
2001, 57, 6745; b) Lopez-Rodriguez M. L.; Benhamu B.; Ayala D.; Rominguera J. L.;  
Murcia M.; Ramos J. A.; Viso A. Tetrahedron 2000, 56, 3245.  
[73] Chackalamannil S.; Doller D.; Eagen K.; Czamiecki M.; Ahn H. S.; Foster C. J.; 
Boykow G. Bioorg. Med. Chem. Lett. 2001, 11, 2851.  
[74] a) Kawasaki I.; Yamashita M.; Ohta S. Chem. Pharm. Bull. 1996, 44, 1831; b)  
Kawasaki I.; Yamashita M.; Ohta S. J. Chem. Soc., Chem. Commun. 1994, 2085; c)  
Revesz L.; Bonne F.; Makavou P. Tetrahedron Lett. 1998, 39, 5171; d) Revesz L.; Di 
Padova F.E.; Buhl T.; Feifel R.; Gram H.; Hiestand P.; Manning U.;Wolf  R.;  Zimmer 
lin  A. G. Bioorg. Med. Chem. Lett. 2002, 12, 2109; e) Kawasaki I.; Katsuma H.;  
Nakayama Y.; Yamashita M.; Ohta S. Heterocycles 1998, 48, 1887; f) Wang D.;  
Haseltine J. J. Heterocycl. Chem. 1994, 31, 1637.  
[75] For previous syntheses of benzimidazoles containing ester groups located at carbon 
atoms C-5 and C-6, see: a) Cummings C. G.; Ross N. T.; Katt W. P.; Hamilton A. D. 
251 
 
Org. Lett. 2009, 11, 25; b) Kalindjian S. B.; Dunstone D. J.; Low C. M. R.; Pether M. 
J.; Roberts S. P.; Tozer M. J.; Watt G. F.; Shankley N. P. J. Med. Chem. 2001, 44, 
1125; c) Neochoritis C.; Livadiotou D.; Stephanidou-Stephanatou J.; Tsoleridis C. A. 
Tetrahedron Lett. 2007, 48, 2275.  
[76] a) The Chemistry of Indoles   Sundberg R. J. Academic Press; New York: 1970; b) The 
Chemistry of Heterocyclic Compounds, Indoles   Saxton J. E.Wiley; New York: 1983, 
25; c) Indoles   Sundberg R. J. Academic Press; San Diego: 1996; d) Schmidt A. 
M.; Eilbracht P. J. Org. Chem. 2005, 70, 5528; e) Fukuyama T.; Chen X. J. Am. 
Chem. Soc. 1994, 116, 3125; f) Comprehensive Heterocyclic Chemistry III  Katritzky 
 A. R.; Ramsden C. A.; Scriven E. F. V.; Taylor R. J. K. Elsevier Science & 
Technology; Amsterdam: 2008. 3; g) Science of Synthesis Vol. 10:  Joule J. 
A.; Thomas E. J.; Georg Thieme Verlag; Stuttgart/Germany: 2000; h) Tolkachev O. 
N.; Abizov E. A.; Abizova E. V.; Mal'tsev S. D. Pharm. Chem. J. 2008, 42, 630; 
i) Murao S.; Hayashi H.; Takiuchi K.; Arai M. Agric. Biol. Chem. 1988, 52, 885.  
[77]  Weng J.-R. , Tsai C.-H , Kulp S. K.; 
 
Chen C.-S. Cancer Lett. 2008, 262, 153. 
[78] Hibino S.; Choshi T. Nat. Prod. Rep. 2002, 19, 148; b) Szantay C. Pure Appl. Chem. 
1990, 62, 1299.  
[79]  Winter J. C. Psychopharmacology 2009, 203, 251.  
[80] Hopkins C. R.; O'Neil S. V.; Laufersweiler M. C.; Wang Y.; Pokross M.; Mekel M.; 
Evdokimov A.; Walter R.; Kontoyianni M.; Petrey M. E.; Sabatakos G.; Roesgen J. T. 
; Richardson E.; Demuth T. P. Bioorg. Med. Chem. Lett. 2006, 16, 5659.  
[81]  Stolc S.; Snirc V.; Majekova M.; Gasparova Z.; Gajdosikova A.; Stvrtina S. Cell. Mol. 
Neurobiol. 2006, 26, 1495. 
[82] Dhondge R.; Chaturvedi S. C. Med. Chem. Res. 2009, 18, 167.  
[83] Samsoniya S. A. ; Trapaidze M. V. ; Kuprashvili N. A. Pharm. Chem. J. 2009, 43, 92.  
[84] a) de Sá Alves F. R.; Barreiro E.; Fraga C. A. M. Mini Rev. Med. Chem. 2009, 9, 782; 
b) Welsch E. M.; Snyder A. S.; Stockwel R. B. Curr. Opin. Chem. Biol. 2010, 14, 
347.  
[85] a) Humphrey G. R.; Kuethe J. T. Chem. Rev. 2006, 106, 2875; b) Gribble G. W. J. 
Chem. Soc., Perkin Trans. 1 2000, 1045; c) Pindur U.; Adam R. J. Heterocycl. Chem. 
1988, 25, 1; d) Gilchrist T. L. J. Chem. Soc., Perkin Trans. 1 2001, 2491; e) Wagaw  
S.; Yang B. H.; Buchwald S. L. J. Am. Chem. Soc. 1998, 120, 6621; f) Larock R. C.;  
Yum E. K.; Refvik M. D. J. Org. Chem. 1998, 63, 7652.  
252 
 
 
[86] Graebe C.; Glaser, C. Ber. Dtsch. Chem. Ges. 1872, 5, 12.  
[87] Bhattacharyya P.; Chakraborty  D. P. in ''Progress in the Chemistry of Organic Natural 
Products'' (W. Herz, H. Grisebach, GW Kirby and C. Tamm, eds.), Vol. 52. Springer-
Verlag, New York, 1987 
[88] Bergman J.; Pelcman B. Pure & Appl. Chem. 1990, 62, 10, 1967. 
[89] Chakraborty A.; Chowdhury B. K.;  Jash S. S.; Biswas G. K.; Bhattacharyya S. K.; 
Bhattacharyya P. Photochemistry 1992, 31, 2503.  
[90] Wu T.-S.; Huang S.-C.; Lai J.-S.; Teng C.-M.; Ko F.-N.; Kuoh C.-S. Phytochemistry 
1993, 32, 2449. 
[91] Fiebig M.; Pezzuto J. M.; Soejarto D. D.; Kinghorn A. D. Phytochemistry 1985, 24, 
3041. 
[92] Knölker H.-J. Top. Curr. Chem. 2005, 244, 115. 
[93]  a) Chakraborty D.P., Barman B.K., Bose P.K. Tetrahedron 1965, 21, 68; b) Wu T.-S., 
Huang S.-C., Wu P.-L. Tetrahedron Lett. 1996, 37, 781. 
[94] Knölker H.-J.;  Reddy K. R.“ The Alkaloids: Chemistry and Biology” 2008, 65, 181. 
[95] R. J. Sundberg. The Chemistry of Indoles, Academic Press, New York (1970); Indoles,  
ed. W.J. Houlihan, Parts I-III, Wiley-Interscience, New York, 1972, 1979. 
[96] Zhang, A.; Lin, G. Bioorg. Med . Lett. 2000, 10, 1021. 
[97] a) Bringmann G.; Ledermann, A.; Francois G. Heterocycles 1995, 40, 293; b) 
Bringmann G.;  Ledermann A.; Holenz J.; Kao M.-T.; Busse U.; Wu H. G.; Francois 
G. Planta Med, 1998, 64, 54;   Lin G.; Zhang A. Tetrahedron 2000, 56, 7163. 
[98] Graebe; Ullmann, Ann. 1896, 291, 16.  
[99] For a description of the main classes of indoles alkaloids and their biosynthesis see: a) 
Dalton D. R. The Alkaloids: the fundament Chemistry, Maercel Dekker, New York , 
1979; b) Cordell G. A. Introduction to Alkaloids, Wiley-Interscience, New York, 
1981. 
[100] Liégault B.; Lee D.; Huestis M. P.; Stuart D. R.; Fagnou K. J. Org. Chem. 2008, 73, 
5022.  
[101] Ackermann L., Althamme A. Angew. Chem. Int. Ed. 2007, 46, 1627. 
[102] Hussain M., Toguem T. S.-M., Ahmad R., Tùng D.T., Knepper I., Villinger A., Langer 
P., Tetrahedron 2001, 67, 5304. 
[103] Kruber, O. Ber. Dtsch. Chem. Ges. 1874, 174, 185. 
253 
 
[104] a) Carruthers, W. A.; Douglas, G. J. Chem. Soc. 1964, 4077; b) Carruthers, W. A.; 
Douglas G. J. Chem. Soc. 1959, 2813. 
[105] Mori, Y.; Taneda S.; Hayashi H.; Sakushima A.; Kamata K.; Suzuki A. K.; Yoshino 
S.; Sakata M.; Sagai M.; Seki  K. Biol. Pharm. Bull. 2002, 25, 145. 
[106] Ashby, J.; Cook C. C. Adv. Heterocycl. Chem. 1974, 16, 181. 
[107]  Gao J.; Li L.; Meng Q.; Li R.; Jiang H.; Li H.; Hu W. J. Mater. Chem. 2007, 17, 142. 
[108] Queiroz M.-J. R. P.; Abreu A. S.; Carvalho M. S. D. ; Ferreira P. M. T.; Nazareth N.;  
  Nascimento M. S.-J. Bioorg. Med. Chem. 2008, 16, 5584.  
[109]  Xu Y.; Qian X.; Yao W.; Mao P.;Cui J. Bioorg. Med. Chem. 2003, 11, 5427.  
[110] Patrick D. A.; Hall J. E.; Bender B. C.; McCurdy D. R.; Wilson W. D.; Tanious F. A.; 
Saha S.; Tidwell R. R. Eur. J. Med. Chem. 1999, 575.  
[111] Wrobel J.; Sredy J.; Moxham C.; Dietrich A.; Li Z.; Sawicki D. R.; Seestaller L.; Wu 
L.; Katz A.; Sullivan D.; Tio C.; Zhang Z.-Y. J. Med. Chem. 1999, 42, 3199.  
[112] El-Naggar A. M.; Ahmed F. S. M.; Donia S. G. J. Indian Chem. Soc. 1983, 60, 479.  
[113] Stenhouse J. Liebigs Ann. Chem. 1870, 156, 332. 
[114] a) Rabindran k.; Tilak B. D. Proc. Indian Acad. Sci., Sect. A. 1952, 36, 411; b) McCall 
E. B.; GB 701, 267, (1953); Chem. Abstr. 1955, 49, 4027. 
[115] Jepsen T. H.; Larsen  M.; Jørgensen M.; Solanko K. A.; Bond A. D.; Kadziola A.; 
Nielsen M. B. Eur. J. Org. Chem. 2011, 53. 
[116] a) Araki K.; Endo H.; Masuda G.; Ogawa T. Chem. Eur. J. 2004, 10, 3331; b)  Janda 
M.; Srogl J.; Stibor I.; Nemec M.; Vopatrna P. Synthesis 1972, 545. 
 
 
 
 
 
 
 
 
 
 
